Students
Alumni
Parents
Contact Us
About Us
Rankings
Blog
Applicant Login
Academics
Back
Academics
School of Advanced Engineering
B.Sc.
B.Tech.
M.Sc.
M.Tech.
PhD
School of Business
B.Com. (Hons)
BBA
Integrated - B.Com. (Hons) - MBA
Integrated - BBA - MBA
MBA
PhD
School of Computer Science
B.Sc.
B.Tech. CSE
BCA
M.Tech. CSE
MCA
PhD
School of Design
B.Des.
M.Des.
PhD
School of Health Sciences & Technology
B.Pharm.
B.Sc.
B.Tech.
M.Sc.
PhD
School of Law
BA LL.B.
BBA LL.B.
LL.B. - 3 Yrs
LL.M.
PhD
School of Liberal Studies & Media
BA (H)
B.Sc. (H)
BA
MA
PhD
School for Life
UPES Online
Admissions
Student Outcomes
Placements
Campus Life
Research
Apply Now

Students
Alumni
Parents
Contact Us
About Us
Rankings
Blog
Applicant Login

Students

Alumni

Parents

Contact Us

About Us

Rankings

Blog

Applicant Login

Academics
Back
Academics
School of Advanced Engineering
B.Sc.
B.Tech.
M.Sc.
M.Tech.
PhD
School of Business
B.Com. (Hons)
BBA
Integrated - B.Com. (Hons) - MBA
Integrated - BBA - MBA
MBA
PhD
School of Computer Science
B.Sc.
B.Tech. CSE
BCA
M.Tech. CSE
MCA
PhD
School of Design
B.Des.
M.Des.
PhD
School of Health Sciences & Technology
B.Pharm.
B.Sc.
B.Tech.
M.Sc.
PhD
School of Law
BA LL.B.
BBA LL.B.
LL.B. - 3 Yrs
LL.M.
PhD
School of Liberal Studies & Media
BA (H)
B.Sc. (H)
BA
MA
PhD
School for Life
UPES Online
Admissions
Student Outcomes
Placements
Campus Life
Research
Apply Now

Academics
Back
Academics
School of Advanced Engineering
B.Sc.
B.Tech.
M.Sc.
M.Tech.
PhD
School of Business
B.Com. (Hons)
BBA
Integrated - B.Com. (Hons) - MBA
Integrated - BBA - MBA
MBA
PhD
School of Computer Science
B.Sc.
B.Tech. CSE
BCA
M.Tech. CSE
MCA
PhD
School of Design
B.Des.
M.Des.
PhD
School of Health Sciences & Technology
B.Pharm.
B.Sc.
B.Tech.
M.Sc.
PhD
School of Law
BA LL.B.
BBA LL.B.
LL.B. - 3 Yrs
LL.M.
PhD
School of Liberal Studies & Media
BA (H)
B.Sc. (H)
BA
MA
PhD
School for Life
UPES Online
Admissions
Student Outcomes
Placements
Campus Life
Research
Apply Now

Academics
Back
Academics
School of Advanced Engineering
B.Sc.
B.Tech.
M.Sc.
M.Tech.
PhD
School of Business
B.Com. (Hons)
BBA
Integrated - B.Com. (Hons) - MBA
Integrated - BBA - MBA
MBA
PhD
School of Computer Science
B.Sc.
B.Tech. CSE
BCA
M.Tech. CSE
MCA
PhD
School of Design
B.Des.
M.Des.
PhD
School of Health Sciences & Technology
B.Pharm.
B.Sc.
B.Tech.
M.Sc.
PhD
School of Law
BA LL.B.
BBA LL.B.
LL.B. - 3 Yrs
LL.M.
PhD
School of Liberal Studies & Media
BA (H)
B.Sc. (H)
BA
MA
PhD
School for Life
UPES Online

Back
Academics
School of Advanced Engineering
B.Sc.
B.Tech.
M.Sc.
M.Tech.
PhD
School of Business
B.Com. (Hons)
BBA
Integrated - B.Com. (Hons) - MBA
Integrated - BBA - MBA
MBA
PhD
School of Computer Science
B.Sc.
B.Tech. CSE
BCA
M.Tech. CSE
MCA
PhD
School of Design
B.Des.
M.Des.
PhD
School of Health Sciences & Technology
B.Pharm.
B.Sc.
B.Tech.
M.Sc.
PhD
School of Law
BA LL.B.
BBA LL.B.
LL.B. - 3 Yrs
LL.M.
PhD
School of Liberal Studies & Media
BA (H)
B.Sc. (H)
BA
MA
PhD
School for Life
UPES Online

Back
Academics
School of Advanced Engineering
B.Sc.
B.Tech.
M.Sc.
M.Tech.
PhD
School of Business
B.Com. (Hons)
BBA
Integrated - B.Com. (Hons) - MBA
Integrated - BBA - MBA
MBA
PhD
School of Computer Science
B.Sc.
B.Tech. CSE
BCA
M.Tech. CSE
MCA
PhD
School of Design
B.Des.
M.Des.
PhD
School of Health Sciences & Technology
B.Pharm.
B.Sc.
B.Tech.
M.Sc.
PhD
School of Law
BA LL.B.
BBA LL.B.
LL.B. - 3 Yrs
LL.M.
PhD
School of Liberal Studies & Media
BA (H)
B.Sc. (H)
BA
MA
PhD
School for Life
UPES Online

Back
Academics
School of Advanced Engineering
B.Sc.
B.Tech.
M.Sc.
M.Tech.
PhD
School of Business
B.Com. (Hons)
BBA
Integrated - B.Com. (Hons) - MBA
Integrated - BBA - MBA
MBA
PhD
School of Computer Science
B.Sc.
B.Tech. CSE
BCA
M.Tech. CSE
MCA
PhD
School of Design
B.Des.
M.Des.
PhD
School of Health Sciences & Technology
B.Pharm.
B.Sc.
B.Tech.
M.Sc.
PhD
School of Law
BA LL.B.
BBA LL.B.
LL.B. - 3 Yrs
LL.M.
PhD
School of Liberal Studies & Media
BA (H)
B.Sc. (H)
BA
MA
PhD
School for Life
UPES Online



Back
Academics
School of Advanced Engineering
B.Sc.
B.Tech.
M.Sc.
M.Tech.
PhD
School of Business
B.Com. (Hons)
BBA
Integrated - B.Com. (Hons) - MBA
Integrated - BBA - MBA
MBA
PhD
School of Computer Science
B.Sc.
B.Tech. CSE
BCA
M.Tech. CSE
MCA
PhD
School of Design
B.Des.
M.Des.
PhD
School of Health Sciences & Technology
B.Pharm.
B.Sc.
B.Tech.
M.Sc.
PhD
School of Law
BA LL.B.
BBA LL.B.
LL.B. - 3 Yrs
LL.M.
PhD
School of Liberal Studies & Media
BA (H)
B.Sc. (H)
BA
MA
PhD
School for Life
UPES Online

Academics

School of Advanced Engineering
B.Sc.
B.Tech.
M.Sc.
M.Tech.
PhD

B.Sc.

B.Tech.

M.Sc.

M.Tech.

PhD

School of Business
B.Com. (Hons)
BBA
Integrated - B.Com. (Hons) - MBA
Integrated - BBA - MBA
MBA
PhD

B.Com. (Hons)

BBA

Integrated - B.Com. (Hons) - MBA

Integrated - BBA - MBA

MBA

PhD

School of Computer Science
B.Sc.
B.Tech. CSE
BCA
M.Tech. CSE
MCA
PhD

B.Sc.

B.Tech. CSE

BCA

M.Tech. CSE

MCA

PhD

School of Design
B.Des.
M.Des.
PhD

B.Des.

M.Des.

PhD

School of Health Sciences & Technology
B.Pharm.
B.Sc.
B.Tech.
M.Sc.
PhD

B.Pharm.

B.Sc.

B.Tech.

M.Sc.

PhD

School of Law
BA LL.B.
BBA LL.B.
LL.B. - 3 Yrs
LL.M.
PhD

BA LL.B.

BBA LL.B.

LL.B. - 3 Yrs

LL.M.

PhD

School of Liberal Studies & Media
BA (H)
B.Sc. (H)
BA
MA
PhD

BA (H)

B.Sc. (H)

BA

MA

PhD

School for Life

UPES Online

Admissions

Student Outcomes

Placements

Campus Life

Research

Apply Now



Minimum 3 characters require
Popular Searches

Minimum 3 characters require
Popular Searches







Minimum 3 characters require

Popular Searches

Popular Searches

Popular Searches

Popular Searches

Popular Searches



Home
Faculty
School of Health Sciences and Technology
Dr. Dhruv Kumar

Home

Faculty

School of Health Sciences and Technology

Dr. Dhruv Kumar

Dr. Dhruv Kumar
Professor

Dr. Dhruv Kumar
Professor



Dr. Dhruv Kumar
Professor

Dr. Dhruv Kumar

Professor

Profile Summary
Prof. Dhruv Kumar is a Professor and Cluster Head at the Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun. Listed as a top 2% world’s most influential scientist in the area of Oncology and cancer Biology. His academic journey includes a B.Sc. in Chemistry from Banaras Hindu University (BHU), Varanasi, and M.Sc. in Bioinformatics with Distinction from the University of Allahabad (AU), Prayagraj. Dr. Dhruv Kumar further distinguished himself by completing his Ph.D. in Cellular, Molecular, and Industrial Biology from the University of Bologna (UNIBO), Italy, under the highly prestigious fellowship of the Ministry of Human Resource and Development (MHRD), Indo-Italian Government fellowship. Following the completion of his Ph.D., he embarked on a five-year Postdoctoral training at the School of Medicine, University of Kansas Medical Center, Kansas City, USA. Dr. Kumar's research has been dedicated to several cancer types, including Prostate, Pancreatic, Brain, Breast, and Head and Neck Cancer, with a primary focus on unraveling the molecular mechanisms regulating Autophagy and Apoptosis in Cancer Stem Cells. Currently, his laboratory is actively exploring the Autophagy-Metabolic axis in various cancer cells, such as head and neck, oral, breast, and brain, along with investigating the tumor microenvironment for the development of innovative therapeutic approaches. Notably, his research group has made significant contributions to Drug Designing and Drug Repurposing for COVID-19. Dr. Dhruv Kumar's scholarly contributions are evident in his extensive publication record, with articles featured in prestigious journals such as Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, Seminars in Cancer Biology, JAMA Otolaryngology, Nature Scientific Reports, and many more. Presently, Dr. Kumar is actively engaged in numerous government-funded projects and is mentoring eight Ph.D. students in the areas of Cancer and Infertility. Beyond his research endeavors, he plays a vital role in teaching courses at the undergraduate (UG), postgraduate (PG), and Ph.D. levels, covering subjects related to Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics.
Work Experience
Prof. Dhruv Kumar possesses over 15 years of extensive experience encompassing teaching, research, and administrative roles. His professional journey is outlined as follows:
06/22-Present: Professor & Cluster Head, Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand, India.
01/21-06/22: Professor & Assistant Director, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
07/19-12/20: Associate Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
04/17-07/19: Assistant Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
08/16-04/17: Assistant Professor, Department of Bioinformatics, SRM University, Delhi-NCR, Sonepat, Haryana, India.
03/12-06/16: Postdoctoral Fellow, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
In these diverse roles, Prof. Kumar has demonstrated his commitment to academia, contributing significantly to various institutions and enhancing his expertise in the fields of Molecular Medicine, Cancer Biology, Stem Cell Research, and Bioinformatics. His journey includes pivotal positions such as Assistant Professor at SRM University and various roles at Amity University Uttar Pradesh, showcasing his dedication to fostering education and research. Currently serving as a Professor and Cluster Head at UPES, Dehradun, he continues to make substantial contributions to the academic and research landscape.
Research Interests
Prof. Dhruv Kumar boasts an extensive and diverse research portfolio spanning over various critical domains in biomedical science. With over 15 years of profound expertise, he has significantly contributed to Translational Cancer Research, unraveling novel insights that bridge the gap between fundamental discoveries and clinical applications. His dedicated exploration into Cancer Stem Cells has shed light on the molecular intricacies governing these cells. Prof. Kumar's investigations into Cancer Cell Metabolism reveal a nuanced understanding of metabolic alterations in cancer cells, potentially paving the way for innovative therapeutic strategies. Additionally, his work on the Tumor Microenvironment and Tumor Heterogeneity delves into the complex interplay and diversity within cancer populations. His research illuminates the regulatory mechanisms of Autophagy and the role of Exosomes in cancer, offering crucial perspectives on cellular recycling and intercellular communication. Beyond cancer biology, Prof. Kumar's foray into Infertility research explores molecular factors underlying reproductive challenges. Proficient in Genome Editing and NGS Data Analysis, he navigates cutting-edge genetic technologies. His involvement in Drug Repurposing and Drug Discovery underscores an innovative approach to therapeutics, while his recent contributions in COVID-19 research showcase adaptability to contemporary health challenges. Prof. Kumar's overarching mastery in Bioinformatics strategically integrates computational methods, enhancing the comprehensive interpretation of complex biological data.
Teaching Philosophy
Prof. Dhruv Kumar's teaching philosophy is characterized by innovation and inclusivity. He employs a blended teaching approach that seamlessly integrates traditional methods with modern technologies, creating a dynamic and engaging learning environment. One notable aspect is his commitment to discussing cutting-edge research topics, including those recognized with Nobel Prizes, providing students with insights into the forefront of scientific inquiry. Prof. Kumar takes an innovative approach to support slow learners, implementing strategies such as pairing them with a buddy for personalized assistance, arranging expert lectures, fostering group discussions, and emphasizing hands-on training and practical experiences. By tailoring his teaching methods to diverse learning styles and providing additional support mechanisms, Prof. Kumar ensures that every student, regardless of pace, has the opportunity to thrive academically and develop a passion for lifelong learning.
Courses Taught
Prof. Dhruv Kumar has a genuine passion for teaching and a deep commitment to fostering meaningful interactions with students, creating a vibrant and engaging educational environment. With an extensive background in teaching, he has imparted knowledge across various courses at the undergraduate (UG), postgraduate (PG), and doctoral (PhD) levels. Prof. Kumar's enthusiasm for sharing new ideas and insights has been a cornerstone of his teaching approach, inspiring students to explore innovative concepts and contributing to a dynamic and intellectually stimulating learning atmosphere. His continuous dedication to teaching underscores not only his expertise in the subject matter but also his unwavering commitment to nurturing the intellectual growth of students at all levels.
Undergraduate Level (B.Sc.)
Basic Bioinformatics (BIOF202)
Basics of Cancer (BIOT223)
Cell (MMBS104)
Metals in Biology (MMBS201)
Metabolism (MMBS205)
Scientific Writing (HSCC2019)
Postgraduate Level (M.Sc.)
Animal Cell Culture & Cell Engineering (SCCB601)
Assisted Reproductive Laboratory Procedures (RTCE605)
Cancer Pharmacogenomics (SCCB704)
Computational Tools in Drug Discovery (MMBS702)
Genome Engineering & Editing (SCCB603)
OMICS in Biomedical Sciences (SCCB710)
Preventive Oncology & Psycho-Oncology (SCCB705)
Reproductive & Developmental Biology and Genetics (RTCE604)
Topics in Bioinformatics (MMBS610)
Trends in Molecular Oncology (SCCB901)
Stem Cell Bio II (SCCB 707)
Scientific Writing (HSCC8007)
Good manufacturing and Lab Practices (HSCC8008)
Biosafety and Aseptic Techniques (HSMB 7024)
PhD Level
Advances in Molecular Medicine (BIOT 955) at Institute Level
Trends in Molecular Oncology (BIOT 953) at Institute Level
Research and Publication Ethics” (RPE) –(PHD901) at University Level
Awards and Grants:
Prof. Dhruv Kumar has received several national and international awards and grants as mentioned below.
Awards:
2020: Research Excellence Award, Institute of Scholars, India
2019: Senior Scientist Award, Society of Biomedical Laboratory Scientists, India
2017: Early Career Research Award, SERB, DST-India.
2016: Postdoc of the Month Award, PostDoc Journal: Journal of Postdoctoral Research, USA.
2016: Scholar-in-Training Award, AACR, The Function of Tumor Microenvironment in Cancer Progression Conference, San Diego, USA.
2015: K-INBRE Postdoctoral Award, National Institute of General Medical Sciences, National Institute of Health (NIH), USA.
2011: 8th EBSA European Biophysics Congress Bursaries Award, European Biophysical Societies Association, Italy.
2011: Young Scientist Award, International Academy of Physical Science, Allahabad, India.
2009: Brains in Competition Award, Institute of Advance Studies, University of Bologna, Italy.
2008: Indo-Italian Government Scholarship (Ministry of Human Resource and Development, India).
Grants:
2022-2025: “Analysis of the relationship between gallbladder cancer, arsenic intake, and living-environmental factors - a case in Bihar, India”, Indo-Japan, Government of Japan, Rs 100 lakh (Co-PI): Ongoing
2021-2024: “Repurposing of drugs and validation of lead compounds against main protease and RNA dependent RNA polymerase of SARS-CoV-2”, BRICS-DST, Rs 74 lakh (PI & Coordinator): Ongoing
2020-2023: “Assessment of Female reproductive health and child health risks in Arsenic Exposed population of Bihar”, ICMR New Delhi, Rs ~ 1 Crore. (Co-PI): Ongoing
2018-2021: “Understanding the Metabolic Cross-Talk between Head and Neck Squamous Cell Carcinoma and Tumor Associated Fibroblasts”, SERB-Department of Science and Technology, Government of India, Rs ~35 Lakhs. (PI): Completed
2015-2016: “Role of Tumor-Associated Fibroblasts in Head and Neck Cancer Metabolism” National Institute of General Medical Sciences, National Institute of Health, USA (P20GM103418), $25,000. (PI): Completed
Scholarly Activities
Prof. Dhruv Kumar, has a rich portfolio of scholarly activities spanning teaching, research, and academic contributions. He actively engages in designing and instructing courses at various academic levels, including undergraduate (UG), postgraduate (PG), and doctoral (PhD) programs, covering specialized areas such as Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics. Prof. Kumar's research endeavors have resulted in numerous publications in high-impact journals, including Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, and Nature Scientific Reports. He has received recognition on both national and international platforms, garnering awards such as the Senior Scientist Award from the Society of Biomedical Laboratory Scientists, India, the Scholar-in-Training Award from the American Association for Cancer Research (AACR), USA, and the K-INBRE Postdoctoral Award from the National Institute of Health (NIH), USA. Additionally, his active involvement in government-funded projects and mentorship of PhD students in the fields of Cancer and Infertility reflects his commitment to advancing knowledge and nurturing the next generation of researchers. Prof. Kumar's scholarly activities exemplify a holistic approach to academia, seamlessly integrating teaching, research, and mentorship.
His selected publications are as below:
2023
Agrawal, K.; Asthana, S.;
Kumar, D
. Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer. Cancers 2023, 15, 4920.
https://doi.org/10.3390/cancers15204920
.
(Impact Factor: 5.2)
Maurya, S., Raj, S., Bhoi, N.R., Mani, N., Rathi, B. and
Kumar, D
., 2023. Morphological analysis of metabolically dysregulated spermatozoa using Artificial Intelligence based approach. Journal of Integrated Science and Technology, 11(4), pp.569-569.
(Impact Factor: 1.14)
Raj, S. and
Kumar, D.
, 2023. Early epigenetic markers for precision medicine. Progress in molecular biology and translational science, 198, pp.153-164.
(Impact Factor: 4.0)
Kumar, A., Ali, M., Raj, V., Kumari, A., Rachamalla, M., Niyogi, S.,
Kumar, D.
, Sharma, A., Saxena, A., Panjawani, G. and Jain, P., 2023. Arsenic causing gallbladder cancer disease in Bihar. Scientific Reports, 13(1), p.4259.
(Impact Factor: 4.9)
Goel, M., Mishra, M.K. and
Kumar, D
., 2023. Recent advances in Targeted Radionuclide therapy for Cancer treatment. Chemical Biology Letters, 10(3), pp.544-544.
(Impact Factor: 6.1)
Bhattacharjee, R., Prabhakar, N., Kumar, L., Bhattacharjee, A., Kar, S., Malik, S.,
Kumar, D
., Ruokolainen, J., Negi, A., Jha, N.K. and Kesari, K.K., 2023. Crosstalk between long noncoding RNA and microRNA in Cancer. Cellular Oncology, pp.1-24.
(Impact Factor: 6.6)
Kumar, A., Kumar, K., Ali, M., Raj, V., Srivastava, A., Kumar, M., Niraj, P.K., Kumar, M., Kumar, R.,
Kumar, D.
and Bishwapriya, A., 2023. Severe Disease Burden and the Mitigation Strategy in the Arsenic-Exposed Population of Kaliprasad Village in Bhagalpur District of Bihar, India. Biological trace element research, pp.1-17.
(Impact Factor: 4.0)
Arfin, S.;
Kumar, D
.; Lomagno, A.; Mauri, P.L.; Di Silvestre, D. Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis. Cancers 2023, 15, 4420.
https://doi.org/10.3390/cancers15174420
(Impact Factor: 5.2)
Arfin S, Agrawal K, Maurya S, Asthana S, Di Silvestre
D, Kumar D
. Lead phytochemicals and marine compounds against ceruloplasmin in cancer targeting. Journal of Biomolecular Structure and Dynamics. 2023 Oct 18.
(Impact Factor: 5.2)
Agrawal K, Chakraborty P, Dewanjee S, Arfin S, Das SS, Dey A, Moustafa M, Mishra PC, Jafari SM, Jha NK, Jha SK,
Kumar D
. Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders. Neurosci Biobehav Rev. 2023 Jan;144:104955. doi: 10.1016/j.neubiorev.2022.104955. Epub 2022 Nov 14. PMID: 36395983.
(Impact Factor: 9.0)
Agrawal K, Chauhan S,
Kumar D
. Expression analysis and regulation of GLI and its correlation with stemness and metabolic alteration in human brain tumor. 3 Biotech. 2023 Jan;13(1):10. doi: 10.1007/s13205-022-03419-5. Epub 2022 Dec 15. PMID: 36532860; PMCID: PMC9755437.
(Impact Factor: 2.9)
Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A,
Kumar D
, Ambasta RK, Jha NK, Jha SK, Dewanjee S. Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Res Rev. 2023 Mar;85:101838. doi: 10.1016/j.arr.2022.101838. Epub 2023 Jan 5. PMID: 36610558.
(Impact Factor: 11.7)
Raj, S., Rathi, B., Mehra, P., Asthana, S., &
Kumar, D
. (2023). Deciphering the role of c-MET in Metabolic reprogramming of Head and Neck squamous cell Carcinoma via In Silico analysis. Chemical Biology Letters, 10(2), 532. Retrieved from
https://pubs.thesciencein.org/journal/index.php/cbl/article/view/532
(Impact Factor: 4.4)
2022
Awasthi P, Dwivedi M, Kumar D, Hasan S. Insights into intricacies of the Latent Membrane Protein-1 (LMP-1) in EBV-associated cancers. Life Sci. 2023 Jan 15;313:121261. doi: 10.1016/j.lfs.2022.121261. Epub 2022 Dec 7. PMID: 36493876.
(Impact Factor: 3.3)
Sharma S, Tyagi R, Srivastava M, Rani K,
Kumar D
, Asthana S, Raj VS. Identification and validation of potent inhibitor of Escherichia coli DHFR from MMV pathogen box. J Biomol Struct Dyn. 2022 Jun 2:1-10. doi: 10.1080/07391102.2022.2080113. Epub ahead of print. PMID: 35652895.
(Impact Factor: 3.3)
Maurya S, Kesari KK, Roychoudhury S, Kolleboyina J, Jha NK, Jha SK, Sharma A, Kumar A, Rathi B, Kumar D. Metabolic Dysregulation and Sperm Motility in Male Infertility. Adv Exp Med Biol. 2022;1358:257-273. doi: 10.1007/978-3-030-89340-8_12. PMID: 35641874.
(Impact Factor: 2.6)
Das S, Roychoudhury S, Dey A, Jha NK, Kumar D, Roychoudhury S, Slama P, Kesari KK. Bacteriospermia and Male Infertility: Role of Oxidative Stress. Adv Exp Med Biol. 2022;1358:141-163. doi: 10.1007/978-3-030-89340-8_7. PMID: 35641869.
(Impact Factor: 2.6)
Arfin, S. .; Mani, N. .; Rathi, B.; Kumar, D. In Silico Analysis of Ceruloplasmin Alteration in Oral Squamous Cell Carcinoma. Chem Biol Lett 2022, 9, 342.
(Impact Factor: 4.4)
Jha NK, Arfin S, Jha SK, Kar R, Dey A,
Kumar D
. et al. Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling Semin Cancer Biol. 2022 Feb 23:S1044-579X(22)00049-9.
https://doi.org/10.1016/j.semcancer.2022.02.022
.
(Impact Factor: 17)
Raj S, Kesari KK, Kumar A, Rathi B, Sharma A, Gupta PK, Jha SK, Jha NK, Slama P, Roychoudhury S,
Kumar D
. Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. Molecular Cancer (BMC-Springer Nature). 2022. 26;21(1):31.
https://doi.org/10.1186/s12943-022-01503-1
(Impact Factor: 41.4): Corresponding Author
Pritam P, Deka R,
Kumar D
. et al.. Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects. Biology-MDPI. 2022. 11(2), 212.
https://doi.org/10.3390/biology11020212
(Impact Factor: 5.0)
Kumar, A.
Kumar D
. et al..Assessment of disease burden in the arsenic exposed population of Chapar village of Samastipur district, Bihar, India, and related mitigation initiative.
Environmental Science and Pollution Research.
https://doi.org/10.1007/s11356-021-18207-6
(Impact Factor: 4.3)
2021
Upadhyay C.
Kumar D
. et al.. Synthesis of the new analogs of morpholine and their antiplasmodial evaluation against the human malaria parasite Plasmodium falciparum.
New Journal of Chemistry
. 2021.
https://doi.org/10.1039/D1NJ04198C
(Impact Factor: 3.4)
Singh A, Singh AK, Giri R,
Kumar D
, Sharma R, Valis M, Kuca K, Garg N. The role of microRNA-21 in the onset and progression of cancer.
Future Med Chem
. 2021 Nov;13(21): 1885-1906.
https://doi.org/10.4155/fmc-2021-0096
.
(Impact Factor: 3.9)
Jeyaraman Madhan ,Muthu Sathish ,
Kumar D
. et al. “Total Stromal Fraction (TSF) - Fortified Adipose Tissue-Derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary Compromise”,
Coronaviruses
2021; e080921196287.
https://doi.org/10.2174/2666796702666210908151708
.
(Impact Factor: 0.0)
Asif Ali, Saleheen Bano,
Kumar D
. et al. (2021) Effect of cellulose nanocrystals on chitosan/PVA/nano β-TCP composite scaffold for bone tissue engineering application,
Journal of Biomaterials Science, Polymer Edition
,
https://doi.org/10.1080/09205063.2021.1973709
.
(Impact Factor: 3.5)
Mehreen Aftab, Maryam Ghufran,
Kumar D
. et al., In silico analysis of the role of hsa-miR-155-5p in cervical cancer, Chem. Biol. Lett. 2021, 8(3), 94-105.
(Impact Factor: 4.4) : Corresponding Author
Usman, M.B., Bhardwaj, S., Roychoudhury, S.
Kumar D
. et al.. Immunotherapy for Alzheimer’s Disease: Current Scenario and Future Perspectives.
J Prev Alzheimers Dis
8, 534–551 (2021).
https://doi.org/10.14283/jpad.2021.52
(Impact Factor: 4.4)
Sharma, P.P., Bansal, M., Sethi, A., Pena, L.,
Kumar D
. et al., 2021. Computational methods directed towards drug repurposing for COVID-19: advantages and limitations.
RSC Advances
, 11(57), pp.36181-36198.
https://doi.org/10.1039/D1RA05320E
(Impact Factor: 3.3)
Goyal, K.; Goel, H.; Baranwal, P.; Tewary, A.;
Kumar D
. et al.. Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans. Immuno 2021, 1, 442-456.
https://doi.org/10.3390/immuno1040032
(Impact Factor: 0.0)
Sharma A,
Kumar D
, Dahiya K, Hawthorne S, Jha SK, Jha NK, Nand P, Girgis S, Raj S, Srivastava R, Goswami VK, Gregoriou Y, El-Zahaby SA, Ojha S, Dureja H, Gupta G, Singh S, Chellappan DK, Dua K. Advances in pulmonary drug targeting microbial biofilms in respiratory diseases. Nanomedicine (Lond). 2021 Aug 5. delivery
https://doi.org/10.2217/nnm-2021-0057
.
(Impact Factor: 5.3): : Corresponding Author
Jeyaraman M, Muthu S, Bapat A,
Kumar D
. et al.. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon. 2021 Jul;7(7):e07635.
https://doi.org/10.1016/j.heliyon.2021.e07635
.
(Impact Factor: 1.8)
Sharma A, Hawthorne S, Jha SK, Jha NK,
Kumar D
, Girgis S, Goswami VK, Gupta G, Singh S, Dureja H, Chellappan DK, Dua K. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDAMB231 human breast cancer cells. Nanomedicine (Lond). 2021 Aug;16(20):1763-1773.
https://doi.org/10.2217/nnm-2021-0066
.
(Impact Factor: 5.3)
Chandel V, Maru S, Kumar A, Kumar A, Sharma A, Rathi B,
Kumar D
. Role of monocarboxylate transporters in head and neck squamous cell carcinoma. Life Sciences. 2021, 5;279:119709.
https://doi.org/10.1016/j.lfs.2021.119709
.
(Impact Factor: 3.6) : Corresponding Author
Raj S, Kumar A,
Kumar D
. Regulation of Glycolysis in Head and Neck Cancer. Adv Exp Med Biol. 2021;1280:219-230.
https://doi.org/10.1007/978-3-030-51652-9_15
.
(Impact Factor: 2.4) : Corresponding Author
Vaishali Chandel, Garima Tripathi, Seema A. Nayar, Brijesh Rathi, Abhijeet Kumar &
Dhruv Kumar
(2021) In silico identification and validation of triarylchromones as potential inhibitor against main protease of severe acute respiratory syndrome coronavirus 2,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1918255
.
(Impact Factor: 3.2) : Corresponding Author
Rashmi Tyagi, Mitul Srivastava, Baldeep Singh, Shingini Sharma, Ramendra Pati Pandey, Shailendra Asthana,
Dhruv Kumar
& V. Samuel Raj (2021) Identification and validation of potent Mycobacterial proteasome inhibitor from Enamine library,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1914173
.
(Impact Factor: 3.2) : Corresponding Author
Mathur, A., Raj, S., Jha, N.K. et al. Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2.
3 Biotech
11, 236 (2021).
https://doi.org/10.1007/s13205-021-02791-y
.
(Impact Factor: 2.2) : Corresponding Author
Arfin, S.; Jha, N.K.; Jha, S.K.; Kesari, K.K.; Ruokolainen, J.; Roychoudhury, S.; Rathi, B.;
Kumar, D
. Oxidative Stress in Cancer Cell Metabolism.
Antioxidants
2021, 10, 642.
https://doi.org/10.3390/antiox10050642
.
(Impact Factor: 5) : Corresponding Author
Kumar A, Kumar R, Rahman MS, Ali M, Kumar R, Nupur N, Gaurav A, Raj V, Anand G, Niraj PK, Kumar N, Srivastava A, Biswapriya A, Chand GB,
Kumar D
, Rashmi T, Kumar S, Sakamoto M, Ghosh AK. Assessment of arsenic exposure in the population of Sabalpur village of Saran District of Bihar with mitigation approach.
Environ Sci Pollut Res Int.
2021 Apr 11.
https://doi.org/10.1007/s11356-021-13521-5
(Impact Factor: 4.3)
Kumar, A., Rahman, M.S., Ali, M. et al. Assessment of arsenic exposure and its mitigation intervention in severely exposed population of Buxar district of Bihar, India.
Environ. Health Sci.
(2021).
https://doi.org/10.1007/s13530-021-00086-6
(Impact Factor: .76)
Chandel V., et al. 2021. In silico identification of potential inhibitor for TP53-induced glycolysis and apoptosis regulator in head and neck squamous cell carcinoma.
3Biotech
. 11(3):117.
https://doi.org/10.1007/s13205-021-02665-3
(Impact Factor: 2.2) : Corresponding Author
2020
Kumar A., et al. 2020. Arsenic exposure causing cancer in the Indo - Gangetic Plain - A 2000 cancer patients’ cross-sectional design.
Scientific Reports
. 11, 2376 (2021).
https://doi.org/10.1038/s41598-021-81579-9
.
(Impact Factor: 4.1)
Roychoudhury S., et al. 2020. Viral pathogenesis of SARS-CoV-2 infection and male reproductive health: Myth or fact?
Open Biology
. 11(1): 200347,
https://doi.org/10.1098/rsob.200347
(Impact Factor: 4.9)
Jha N K., et al. 2020. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS‑CoV‑2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Journal of Molecular Neuroscience.
https://doi.org/10.1007/s12031-020-01767-6
.
(Impact Factor: 2.8)
Ali A., et al. 2020. Comparative analysis of TiO2 and Ag nanoparticles on xylan/chitosan conjugate matrix for wound healing application.
International Journal of Polymeric Materials and Polymeric Biomaterials.
https://doi.org/10.1080/00914037.2020.1838519
(Impact Factor: 1.9)
Kumar D., et al. 2020. Stem Cell Based Preclinical Drug Development and Toxicity Prediction.
Current Pharmaceutical Design
.
https://doi.org/10.2174/1381612826666201019104712
(Impact Factor: 2.4) : Corresponding Author
Tyagi R., et al. 2020. Development of potential proteasome inhibitors against Mycobacterium tuberculosis.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1835722
(Impact Factor: 3.2) : Corresponding Author
Narula S, Tandon S, Kumar D et al. 2020. Human kidney stone matrix proteins alleviate hyperoxaluria induced renal stress by targeting cell-crystal interactions.
Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118498
(Impact Factor: 3.6)
Satyam R, Jha NK, Kar R et al. 2020. Deciphering the SSR incidences across viral members of Coronaviridae family.
Chemico-Biological Interactions.
https://doi.org/10.1016/j.cbi.2020.109226
(Impact Factor: 3.6)
Chandel V, Raj S, Rathi B, Choudhary R,
Kumar D
. 2020. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1811773
(Impact Factor: 3.2) : Corresponding Author
Manish D., Vijay T., Kumar D., et al. 2020. Structural and Morphological Characterization of CdS Nanoparticles,
Current Physical Chemistry.
https://doi.org/10.2174/1877946810999200730222025
(Impact Factor: 1.6)
Raj S, Chandel V, et al. 2020 Molecular mechanisms of interplay between autophagy and metabolism in cancer
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118184
(Impact Factor: 3.6) : Corresponding Author
Chandel V, Raj S, et al. 2020. Metabolic regulation in HPV associated head and neck squamous cell carcinoma
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118236
(Impact Factor: 3.6) : Corresponding Author
Chandel V,
Kumar D
. 2020. Targeting Signalling Cross-Talk between Cancer Cells and Cancer Associate Fibroblast through Monocarboxylate Transporters in Head and Neck Cancer
,Anti-Cancer Agents in Medicinal Chemistry
:
Bentham Science Publishers
,
https://doi.org/10.2174/1871520620666200721135230
(Impact Factor: 2.04) : Corresponding Author
Kumar S, Sharma PP, Shankar U,
Kumar D
et al. 2020. Discovery of New Hydroxyethylamine Analogs against 3CL pro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies.
J Chem Inf Model.
https://doi.org/10.1021/acs.jcim.0c00326
(Impact Factor: 4.5)
Pandey V, Tripathi G,
Kumar D
et al. 2020. Novel 3,4-diarylpyrazole as prospective anti-cancerous agents,
Helion
,
https://doi.org/10.1016/j.heliyon.2020.e04397
(Impact Factor: 1.6) : Corresponding Author
Chandel V, Raj S, Rathi B,
Kumar D
. 2020. In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach.
Chemical Biology Letters
. 7(3), 166‐175.
(Impact Factor: 4.4) : Corresponding Author
Chandel V, Raj S, Srivastava A,
Kumar D
. 2020. In-silico interactions of active Phytochemicals with c-MYC EGFR and ERBB2 oncoproteins.
Chemical Biology Letters
. 7(1), 47‐54.
(Impact Factor: 4.4) : Corresponding Author
Raj S, Chandel V, Rathi B,
Kumar D
. 2020. Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach, Coronavirus: Bentham Science Publishers, DOI : 10.2174/2666796701999200617155013
: Corresponding Author
2019
Sibi Raj, Sartaj Khuranaa, Ramesh Choudhari et al. 2019. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
Seminars in Cancer Biology
https://doi.org/10.1016/j.semcancer.2019.11.002
.
(Impact Factor: 15) : Corresponding Author
Anukriti, Anupam D, Swati U, Pallavi S, et al. 2019. Investigation of Precise Molecular Mechanistic Action of Tobacco-Associated Carcinogen ‘NNK’ Induced Carcinogenesis: A System Biology Approach. 10(8), 564.
(Impact Factor: 3.4)
Asif A, Saleheen B, Satish S.P,
Kumar D
, Yuvraj S N, 2019. Effect of incorporation of Montmorillonite on Xylan/Chitosan conjugate scaffold.
Colloids and Surfaces B: Biointerfaces
1(180) 75-82.
(Impact Factor: 3.9)
Vishwakarma V, New J1,
Kumar D,
et al.,
Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds.
Scientific Reports
. 15;8(1):12163.
(Impact Factor: 4.1)
Chandel V and Kumar D. 2019. The Development of Tumor Heterogeneity and Actively Targeting Therapy Resistant Subpopulations
. J Embryol Stem Cell Res
. 3(3): 000131
: Corresponding Author
2018
Kumar D, et al.,
2018
.
Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression.
Cancer Research
. 10.1158/0008-5472.CAN-17-1076.
(Impact Factor: 12) : First Author
Kumar D
, et al. Perfluoro Curcumin Strongly Interacts with ABC Transporter (ABCG2): A Molecular Docking Study.
J Embryol Stem Cell Res
2018, 2(2): 000113.
: Corresponding Author
Kumar D
. 2018. Resveratrol derivative triacetyl-resveratrol interacts directly with the Gli-DNA zinc finger complex.
J Cancer Res Oncobiol
. Apr; 1(2):110
: Corresponding Author
2017
Kumar D
, et al., 2017. Development and characterization of an in vitro model for radiation-induced fibrosis,.
Radiation Research
. 189(3):326-336
(Impact Factor: 2.5) : First Author
Kumar D
, 2017. Role of tumor heterogeneity in drug resistance.
Glob J Cancer Ther
3(2): 032-033. (Editorial).
: Corresponding Author
Kumar D
, 2017. Regulation of glycolysis in head and neck squamous cell carcinoma
. Postdoc Journal
. 2017 Jan;5 (1):14-28.
: Corresponding Author
2016
Ledgerwood LG*,
Kumar D*,
Eterovic AK, Wick J et al., 2016. The degree of intra-tumor mutational heterogeneity varies by primary tumor sub-site.
Oncotarget
. Mar 28. doi: 18632/oncotarget.8448.
(Impact Factor:6.4)
*Equal contribution
: First Author
2015
Kumar D
, Kandl C, Hamilton C, Shnayder Y, Tsue T, Kakarala K, Ledgerwood L, Sun X S, Huang H, Girod D, Thomas S 2015. Anti-HGF antibody ficlatuzumab mitigates tumor-associated fibroblast-facilitated head and neck cancer progression.
JAMA Otolaryngology-Head & Neck Surgery
. Dec 1;141 (12): 1133-9.
(Impact Factor: 6.2) : First Author
Kumar D
, Gupta D, Shankar S, Srivastava RK. 2015. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
Oncotarget:
1-12.
(Impact Factor:6.4) : First Author
2014
Plotegher N,
Kumar D
, Tessari I, Brucale M, Munari F, et al. 2014. The chaperone-like protein 14-3-3eta interacts with human alpha-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing alpha-synuclein cellular toxicity.
Human Molecular Genetics
. 23:5615-29.
(Impact Factor:5.9)
Kumar D
, Shankar S, Srivastava RK. 2014. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway.
Cancer Letters
. 343:179-89.
(Impact Factor:6.4) : First Author
Kumar D
, Plotegher N, Bubacco L, Brucale M. 2014. Quantitative AFM morphometry of non-fibrillar α- synuclein aggregation products induced by the chaperone-like protein 14-3-3.
Italian Society for Microscopical Sciences
. Vol 21, No 1. DOI: 10.4081/microscopie. 2014.4998.
: First Author
Kumar D
, Shankar S, Srivastava RK. 2014. Understanding the biological functions and therapeutic potentials of stem cells and cancer stem cells: Where are we?
Journal of Cancer Stem Cell Research
. 2:e1002:1-8.
: First Author
2013
Kumar D
, Shankar S, Srivastava RK. 2013. Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms.
Molecular Cancer
. 1476-4598-12-171.
(Impact Factor:27) : First Author
Nanta R,
Kumar D
, Meeker D, Rodova M, Van Veldhuizen PJ, et al. 2013. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rgamma null mice by regulating Bmi-1 and microRNA-128.
Oncogenesis
. 2:e42.
(Impact Factor:5.1)
Shankar S,
Kumar D
, Srivastava 2013. Epigenetic modifications by dietary phytochemicals: Implications for personalized nutrition.
Pharmacol Therapeut
. 138:1-17.
(Impact Factor:11.1)
2012
Pivato M, De Franceschi G, Tosatto L, Frare E,
Kumar D
, et al. 2012. Covalent alpha-synuclein dimers: chemico-physical and aggregation properties.
PloS one
7:e50027.
(Impact Factor:3.4)
Singh BN,
Kumar D
, Shankar S, Srivastava 2012. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells.
Biochemical Pharmacology
. 84:1154-63.
(Impact Factor:6.1)
Conference Proceedings
Tyagi,
D. Kumar
and V. S. Raj, 2018. "In silico identification of potential inhibitors against Mycobacterial proteasome," 2018 International Conference on Bioinformatics and Systems Biology (BSB), Allahabad, India,
IEEE Xplore
, pp. 193-197.
(IF: 10.6)
Shekhar Goyal, Surender Kr Beniwal, H S Kumar,
Dhruv Kumar
, B C Das. 2019. Role of Curcumin in reducing toxicity and adverse effects in locally advanced and metastatic breast cancer patients.
Annals of Oncology
. Volume 30, vi126 - vi127.
(IF: 14)
Book Chapter
Mavi, Anil Kumar, Manmohan Kumar, Amarjeet Singh, Mahendra Kumar Prajapati, Rakhi Khabiya, Saurabh Maru, and
Dhruv Kumar.
"Progress in Non‐Viral Delivery of Nucleic Acid: Advancement in Biomedical Technology." Integration of Biomaterials for Gene Therapy (2023): 281-322.
https://doi.org/10.1002/9781394175635.ch10
Mavi, Anil Kumar, Sonal Gaur, Neelesh Kumar, Avanish Kumar Shrivastav, Sankha Bhattacharya, Sateesh Belemkar, Saurabh Maru, and
Dhruv Kumar
. "Effective Gene Transfer with Non‐Viral Vectors." Integration of Biomaterials for Gene Therapy (2023): 183-222.
https://doi.org/10.1002/9781394175635.ch7
Kirti Agrawal, Malavika Saji,
Dhruv Kumar,
Drug Repurposing in Future Drug Discovery and Development, Book-Drug Repurposing and Computational Drug Discovery, Edition1st Edition 2023, Apple Academic Press, Pages26, eBook ISBN9781003347705,
https://doi.org/10.1201/9781003347705
Kumar, A., Raj, V., Ali, M., Abhinav, Rachamalla, M.,
Kumar, D
., Kumari, A., Kumar, R., Shankar, P. and Ghosh, A., 2023. Evaluation of MOF Applications for Groundwater Arsenic Mitigation of the Middle Ganga Plains of Bihar, India. Metal Organic Frameworks for Wastewater Contaminant Removal, pp.355-373. 26 August 2023,
https://doi.org/10.1002/9783527841523.ch16
Saniya Arfin,
Dhruv Kumar
, Chapter 3 - Use of vitamins and minerals as dietary supplements for better health and cancer prevention, Editor(s): Inamuddin, Tariq Altalhi, Jorddy Neves Cruz, Nutraceuticals, Academic Press, 2023, Pages 53-97, ISBN 9780443191930,
https://doi.org/10.1016/B978-0-443-19193-0.00003-4
.
A Santoshkumar, S Ray, S Narayanan,
D Kumar
, S Harihar (2023), Mitophagy in cancer and cancer stem cells: a role in metabolic reprogramming. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00009-2
T Singh, AS Kharat, B Rathi,
D Kumar
(2023), Designing metabolic target-specific inhibitors for cancer therapy. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00011-0
Sibi Raj, Manish K. Mishra, Sitaram Harihar, Ashok Kumar, Shubhadeep Roychoudhury, Arun Kumar et al. (
2022
). Regulation of Glucose Transporters in Cancer Progression, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_9
Stephen James, Saniya Arfin, Manish K. Mishra, Arun Kumar, Niraj Kumar Jha, Saurabh Kumar Jha et al. (
2022
). Role of Arsenic in Carcinogenesis, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_7
Raj S., Kumar A.,
Kumar D
. (
2020
) Regulation of Glycolysis in Head and Neck Cancer, Book. Cancer Metabolomics, Advances in Experimental Medicine and Biology, Springer Nature.
https://doi.org/10.1007/978-3-030-51652-9_15
Chandel V.,
Kumar D
. (
2020
) Role of Interferon in Cancer Metabolism. Innate Immunity in Health and Disease. IntechOpen.
https://doi.org/10.5772/intechopen.92020
Raj S, Chandel V., Maurya S,
Kumar D
. (
2020
) Role of Macrophages in Solid Tumor Metabolism. Macrophages. IntechOpen.
https://doi.org/10.5772/intechopen.93182
Maurya S, Chandel V, Raj S, (
2020
) OMICS IN CANCER: FROM DIAGNOSTICS TO THERAPEUTICS. Recent Trends in ‘Computational Omics'. ISBN: 978-1-53617-941-5
Raj S., Chandel V.,
Kumar D
. (
2020
) Cancer Cell Metabolism: Solid Tumor Versus Nonsolid Tumor. In:
Kumar D
. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_1
Pedroza D.A. et al. (
2020
) Role of Autophagy in Cancer Cell Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_6
Chandel V., Raj S., Choudhari R.,
Kumar D
. (
2020
) Role of c-Met/HGF Axis in Altered Cancer Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_7
Kumar D
., Sharma-Walia N., Kapoor S., Tandon S. (
2020
) Antibody-Targeted Nanoparticles for Cancer Treatment. In: Saxena S., Khurana S. (eds) NanoBioMedicine. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9898-9_3
Singh B., Malhotra H.,
Kumar D
., Mujtaba S.F., Upadhyay A.K. (
2019
) Understanding Cellular and Molecular Events of Skin Aging and Cancer: An Integrative Perspective. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_2
Tripathi M.K., Sinha J., Srivastava S.K.,
Kumar D
. (
2019
) Bioinformatics in Skin Cancer: A System Biology Approach to Understanding the Molecular Mechanisms and It’s Regulations. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_10
Khurana S., Bose S.,
Kumar D
. (
2019
) Applications of Microarray-Based Technologies in Identifying Disease-Associated Single Nucleotide Variations. In: Tripathi V., Kumar P., Tripathi P., Kishore A., Kamle M. (eds) Microbial Genomics in Sustainable Agroecosystems. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9860-6_4
Singh P., Tiwari D., Mishra M.,
Kumar D
. (
2019
) Molecular Mechanisms of Heavy Metal Toxicity in Cancer Progression. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_3
Chandel V., Seth G., Shukla P.,
Kumar D
. (
2019
) Role of Radiation in DNA Damage and Radiation Induced Cancer. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_1
Dhruv Kumar
, Sharmila Shankar, Rakesh Srivastava. Challenges in stem cells and translational research (Book chapter). Lost in translational and clinical research. World Scientific Publication,
2014
. ISBN: 9789814489089.
https://doi.org/10.1142/9789814489072_0020
Dhruv kumar
and Bruno Samori. Mechanochemistry: Coupling mechanical forces and chemical reactions (Book chapter). Molecular Manipulation with Atomic Force Microscopy (Book), CRC Press,
2011
, ISBN: 9781439809662.
Dwijendra Gupta,
Dhruv Kumar
, Manish Dwivedi, Vijay Tripathi, Pratibha Phadke-Gupta and Surya Pratap Singh. Nanophosphors-Nanogold immunoconjugates in Isolation of Biomembranes and in Drug Delivery (Book chapter). Recent Advances in Nanomedicine (Book), VBRI Press,
2011
, ISBN: 9788192006803.
Book
Dhruv Kumar
, Shailendra Asthana Autophagy and Metabolism Potential Target for Cancer Therapy 1st Edition - August 6, 2022 Paperback ISBN: 9780323998796 9 7 8 - 0 - 3 2 3 - 9 9 8 7 9 - 6 eBook ISBN: 9780323999458
Akhileshwar Srivastava,
Dhruv Kumar
, Divya Singh, Rajesh Singh, Xenobiotics in Chemical Carcinogenesis:Translational Aspects in Toxicology,
Elsevier,
ISBN: 9780323905602
Dhruv kumar.
Cancer Cell Metabolism: A Potential Target for Cancer Therapy.
Springer Nature
.
2020,
ISBN: 9789811519901.
Dhruv kumar
, Marco Brucale and Bruno Samori. Amyloidogenic Proceses of Intrinsically Disordered Proteins: Understanding the Aggregation Process of Intrinsically Unstructured Proteins Related to Neurodegenerative Diseases.
Lambert Academic Publishing
,
2014
, ISBN:
Dhruv kumar
. Insilico analysis of Docking between HIV-1 PR and derivatives of CUI (Docking between HIV- 1 proteases and cyclic urea inhibitors: A step towards drug designing against AIDS).
Lambert Academic Publishing
,
2011
, ISBN:
Contact
dhruv.kumar@ddn.upes.ac.in

Profile Summary
Prof. Dhruv Kumar is a Professor and Cluster Head at the Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun. Listed as a top 2% world’s most influential scientist in the area of Oncology and cancer Biology. His academic journey includes a B.Sc. in Chemistry from Banaras Hindu University (BHU), Varanasi, and M.Sc. in Bioinformatics with Distinction from the University of Allahabad (AU), Prayagraj. Dr. Dhruv Kumar further distinguished himself by completing his Ph.D. in Cellular, Molecular, and Industrial Biology from the University of Bologna (UNIBO), Italy, under the highly prestigious fellowship of the Ministry of Human Resource and Development (MHRD), Indo-Italian Government fellowship. Following the completion of his Ph.D., he embarked on a five-year Postdoctoral training at the School of Medicine, University of Kansas Medical Center, Kansas City, USA. Dr. Kumar's research has been dedicated to several cancer types, including Prostate, Pancreatic, Brain, Breast, and Head and Neck Cancer, with a primary focus on unraveling the molecular mechanisms regulating Autophagy and Apoptosis in Cancer Stem Cells. Currently, his laboratory is actively exploring the Autophagy-Metabolic axis in various cancer cells, such as head and neck, oral, breast, and brain, along with investigating the tumor microenvironment for the development of innovative therapeutic approaches. Notably, his research group has made significant contributions to Drug Designing and Drug Repurposing for COVID-19. Dr. Dhruv Kumar's scholarly contributions are evident in his extensive publication record, with articles featured in prestigious journals such as Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, Seminars in Cancer Biology, JAMA Otolaryngology, Nature Scientific Reports, and many more. Presently, Dr. Kumar is actively engaged in numerous government-funded projects and is mentoring eight Ph.D. students in the areas of Cancer and Infertility. Beyond his research endeavors, he plays a vital role in teaching courses at the undergraduate (UG), postgraduate (PG), and Ph.D. levels, covering subjects related to Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics.
Work Experience
Prof. Dhruv Kumar possesses over 15 years of extensive experience encompassing teaching, research, and administrative roles. His professional journey is outlined as follows:
06/22-Present: Professor & Cluster Head, Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand, India.
01/21-06/22: Professor & Assistant Director, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
07/19-12/20: Associate Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
04/17-07/19: Assistant Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
08/16-04/17: Assistant Professor, Department of Bioinformatics, SRM University, Delhi-NCR, Sonepat, Haryana, India.
03/12-06/16: Postdoctoral Fellow, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
In these diverse roles, Prof. Kumar has demonstrated his commitment to academia, contributing significantly to various institutions and enhancing his expertise in the fields of Molecular Medicine, Cancer Biology, Stem Cell Research, and Bioinformatics. His journey includes pivotal positions such as Assistant Professor at SRM University and various roles at Amity University Uttar Pradesh, showcasing his dedication to fostering education and research. Currently serving as a Professor and Cluster Head at UPES, Dehradun, he continues to make substantial contributions to the academic and research landscape.
Research Interests
Prof. Dhruv Kumar boasts an extensive and diverse research portfolio spanning over various critical domains in biomedical science. With over 15 years of profound expertise, he has significantly contributed to Translational Cancer Research, unraveling novel insights that bridge the gap between fundamental discoveries and clinical applications. His dedicated exploration into Cancer Stem Cells has shed light on the molecular intricacies governing these cells. Prof. Kumar's investigations into Cancer Cell Metabolism reveal a nuanced understanding of metabolic alterations in cancer cells, potentially paving the way for innovative therapeutic strategies. Additionally, his work on the Tumor Microenvironment and Tumor Heterogeneity delves into the complex interplay and diversity within cancer populations. His research illuminates the regulatory mechanisms of Autophagy and the role of Exosomes in cancer, offering crucial perspectives on cellular recycling and intercellular communication. Beyond cancer biology, Prof. Kumar's foray into Infertility research explores molecular factors underlying reproductive challenges. Proficient in Genome Editing and NGS Data Analysis, he navigates cutting-edge genetic technologies. His involvement in Drug Repurposing and Drug Discovery underscores an innovative approach to therapeutics, while his recent contributions in COVID-19 research showcase adaptability to contemporary health challenges. Prof. Kumar's overarching mastery in Bioinformatics strategically integrates computational methods, enhancing the comprehensive interpretation of complex biological data.
Teaching Philosophy
Prof. Dhruv Kumar's teaching philosophy is characterized by innovation and inclusivity. He employs a blended teaching approach that seamlessly integrates traditional methods with modern technologies, creating a dynamic and engaging learning environment. One notable aspect is his commitment to discussing cutting-edge research topics, including those recognized with Nobel Prizes, providing students with insights into the forefront of scientific inquiry. Prof. Kumar takes an innovative approach to support slow learners, implementing strategies such as pairing them with a buddy for personalized assistance, arranging expert lectures, fostering group discussions, and emphasizing hands-on training and practical experiences. By tailoring his teaching methods to diverse learning styles and providing additional support mechanisms, Prof. Kumar ensures that every student, regardless of pace, has the opportunity to thrive academically and develop a passion for lifelong learning.
Courses Taught
Prof. Dhruv Kumar has a genuine passion for teaching and a deep commitment to fostering meaningful interactions with students, creating a vibrant and engaging educational environment. With an extensive background in teaching, he has imparted knowledge across various courses at the undergraduate (UG), postgraduate (PG), and doctoral (PhD) levels. Prof. Kumar's enthusiasm for sharing new ideas and insights has been a cornerstone of his teaching approach, inspiring students to explore innovative concepts and contributing to a dynamic and intellectually stimulating learning atmosphere. His continuous dedication to teaching underscores not only his expertise in the subject matter but also his unwavering commitment to nurturing the intellectual growth of students at all levels.
Undergraduate Level (B.Sc.)
Basic Bioinformatics (BIOF202)
Basics of Cancer (BIOT223)
Cell (MMBS104)
Metals in Biology (MMBS201)
Metabolism (MMBS205)
Scientific Writing (HSCC2019)
Postgraduate Level (M.Sc.)
Animal Cell Culture & Cell Engineering (SCCB601)
Assisted Reproductive Laboratory Procedures (RTCE605)
Cancer Pharmacogenomics (SCCB704)
Computational Tools in Drug Discovery (MMBS702)
Genome Engineering & Editing (SCCB603)
OMICS in Biomedical Sciences (SCCB710)
Preventive Oncology & Psycho-Oncology (SCCB705)
Reproductive & Developmental Biology and Genetics (RTCE604)
Topics in Bioinformatics (MMBS610)
Trends in Molecular Oncology (SCCB901)
Stem Cell Bio II (SCCB 707)
Scientific Writing (HSCC8007)
Good manufacturing and Lab Practices (HSCC8008)
Biosafety and Aseptic Techniques (HSMB 7024)
PhD Level
Advances in Molecular Medicine (BIOT 955) at Institute Level
Trends in Molecular Oncology (BIOT 953) at Institute Level
Research and Publication Ethics” (RPE) –(PHD901) at University Level
Awards and Grants:
Prof. Dhruv Kumar has received several national and international awards and grants as mentioned below.
Awards:
2020: Research Excellence Award, Institute of Scholars, India
2019: Senior Scientist Award, Society of Biomedical Laboratory Scientists, India
2017: Early Career Research Award, SERB, DST-India.
2016: Postdoc of the Month Award, PostDoc Journal: Journal of Postdoctoral Research, USA.
2016: Scholar-in-Training Award, AACR, The Function of Tumor Microenvironment in Cancer Progression Conference, San Diego, USA.
2015: K-INBRE Postdoctoral Award, National Institute of General Medical Sciences, National Institute of Health (NIH), USA.
2011: 8th EBSA European Biophysics Congress Bursaries Award, European Biophysical Societies Association, Italy.
2011: Young Scientist Award, International Academy of Physical Science, Allahabad, India.
2009: Brains in Competition Award, Institute of Advance Studies, University of Bologna, Italy.
2008: Indo-Italian Government Scholarship (Ministry of Human Resource and Development, India).
Grants:
2022-2025: “Analysis of the relationship between gallbladder cancer, arsenic intake, and living-environmental factors - a case in Bihar, India”, Indo-Japan, Government of Japan, Rs 100 lakh (Co-PI): Ongoing
2021-2024: “Repurposing of drugs and validation of lead compounds against main protease and RNA dependent RNA polymerase of SARS-CoV-2”, BRICS-DST, Rs 74 lakh (PI & Coordinator): Ongoing
2020-2023: “Assessment of Female reproductive health and child health risks in Arsenic Exposed population of Bihar”, ICMR New Delhi, Rs ~ 1 Crore. (Co-PI): Ongoing
2018-2021: “Understanding the Metabolic Cross-Talk between Head and Neck Squamous Cell Carcinoma and Tumor Associated Fibroblasts”, SERB-Department of Science and Technology, Government of India, Rs ~35 Lakhs. (PI): Completed
2015-2016: “Role of Tumor-Associated Fibroblasts in Head and Neck Cancer Metabolism” National Institute of General Medical Sciences, National Institute of Health, USA (P20GM103418), $25,000. (PI): Completed
Scholarly Activities
Prof. Dhruv Kumar, has a rich portfolio of scholarly activities spanning teaching, research, and academic contributions. He actively engages in designing and instructing courses at various academic levels, including undergraduate (UG), postgraduate (PG), and doctoral (PhD) programs, covering specialized areas such as Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics. Prof. Kumar's research endeavors have resulted in numerous publications in high-impact journals, including Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, and Nature Scientific Reports. He has received recognition on both national and international platforms, garnering awards such as the Senior Scientist Award from the Society of Biomedical Laboratory Scientists, India, the Scholar-in-Training Award from the American Association for Cancer Research (AACR), USA, and the K-INBRE Postdoctoral Award from the National Institute of Health (NIH), USA. Additionally, his active involvement in government-funded projects and mentorship of PhD students in the fields of Cancer and Infertility reflects his commitment to advancing knowledge and nurturing the next generation of researchers. Prof. Kumar's scholarly activities exemplify a holistic approach to academia, seamlessly integrating teaching, research, and mentorship.
His selected publications are as below:
2023
Agrawal, K.; Asthana, S.;
Kumar, D
. Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer. Cancers 2023, 15, 4920.
https://doi.org/10.3390/cancers15204920
.
(Impact Factor: 5.2)
Maurya, S., Raj, S., Bhoi, N.R., Mani, N., Rathi, B. and
Kumar, D
., 2023. Morphological analysis of metabolically dysregulated spermatozoa using Artificial Intelligence based approach. Journal of Integrated Science and Technology, 11(4), pp.569-569.
(Impact Factor: 1.14)
Raj, S. and
Kumar, D.
, 2023. Early epigenetic markers for precision medicine. Progress in molecular biology and translational science, 198, pp.153-164.
(Impact Factor: 4.0)
Kumar, A., Ali, M., Raj, V., Kumari, A., Rachamalla, M., Niyogi, S.,
Kumar, D.
, Sharma, A., Saxena, A., Panjawani, G. and Jain, P., 2023. Arsenic causing gallbladder cancer disease in Bihar. Scientific Reports, 13(1), p.4259.
(Impact Factor: 4.9)
Goel, M., Mishra, M.K. and
Kumar, D
., 2023. Recent advances in Targeted Radionuclide therapy for Cancer treatment. Chemical Biology Letters, 10(3), pp.544-544.
(Impact Factor: 6.1)
Bhattacharjee, R., Prabhakar, N., Kumar, L., Bhattacharjee, A., Kar, S., Malik, S.,
Kumar, D
., Ruokolainen, J., Negi, A., Jha, N.K. and Kesari, K.K., 2023. Crosstalk between long noncoding RNA and microRNA in Cancer. Cellular Oncology, pp.1-24.
(Impact Factor: 6.6)
Kumar, A., Kumar, K., Ali, M., Raj, V., Srivastava, A., Kumar, M., Niraj, P.K., Kumar, M., Kumar, R.,
Kumar, D.
and Bishwapriya, A., 2023. Severe Disease Burden and the Mitigation Strategy in the Arsenic-Exposed Population of Kaliprasad Village in Bhagalpur District of Bihar, India. Biological trace element research, pp.1-17.
(Impact Factor: 4.0)
Arfin, S.;
Kumar, D
.; Lomagno, A.; Mauri, P.L.; Di Silvestre, D. Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis. Cancers 2023, 15, 4420.
https://doi.org/10.3390/cancers15174420
(Impact Factor: 5.2)
Arfin S, Agrawal K, Maurya S, Asthana S, Di Silvestre
D, Kumar D
. Lead phytochemicals and marine compounds against ceruloplasmin in cancer targeting. Journal of Biomolecular Structure and Dynamics. 2023 Oct 18.
(Impact Factor: 5.2)
Agrawal K, Chakraborty P, Dewanjee S, Arfin S, Das SS, Dey A, Moustafa M, Mishra PC, Jafari SM, Jha NK, Jha SK,
Kumar D
. Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders. Neurosci Biobehav Rev. 2023 Jan;144:104955. doi: 10.1016/j.neubiorev.2022.104955. Epub 2022 Nov 14. PMID: 36395983.
(Impact Factor: 9.0)
Agrawal K, Chauhan S,
Kumar D
. Expression analysis and regulation of GLI and its correlation with stemness and metabolic alteration in human brain tumor. 3 Biotech. 2023 Jan;13(1):10. doi: 10.1007/s13205-022-03419-5. Epub 2022 Dec 15. PMID: 36532860; PMCID: PMC9755437.
(Impact Factor: 2.9)
Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A,
Kumar D
, Ambasta RK, Jha NK, Jha SK, Dewanjee S. Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Res Rev. 2023 Mar;85:101838. doi: 10.1016/j.arr.2022.101838. Epub 2023 Jan 5. PMID: 36610558.
(Impact Factor: 11.7)
Raj, S., Rathi, B., Mehra, P., Asthana, S., &
Kumar, D
. (2023). Deciphering the role of c-MET in Metabolic reprogramming of Head and Neck squamous cell Carcinoma via In Silico analysis. Chemical Biology Letters, 10(2), 532. Retrieved from
https://pubs.thesciencein.org/journal/index.php/cbl/article/view/532
(Impact Factor: 4.4)
2022
Awasthi P, Dwivedi M, Kumar D, Hasan S. Insights into intricacies of the Latent Membrane Protein-1 (LMP-1) in EBV-associated cancers. Life Sci. 2023 Jan 15;313:121261. doi: 10.1016/j.lfs.2022.121261. Epub 2022 Dec 7. PMID: 36493876.
(Impact Factor: 3.3)
Sharma S, Tyagi R, Srivastava M, Rani K,
Kumar D
, Asthana S, Raj VS. Identification and validation of potent inhibitor of Escherichia coli DHFR from MMV pathogen box. J Biomol Struct Dyn. 2022 Jun 2:1-10. doi: 10.1080/07391102.2022.2080113. Epub ahead of print. PMID: 35652895.
(Impact Factor: 3.3)
Maurya S, Kesari KK, Roychoudhury S, Kolleboyina J, Jha NK, Jha SK, Sharma A, Kumar A, Rathi B, Kumar D. Metabolic Dysregulation and Sperm Motility in Male Infertility. Adv Exp Med Biol. 2022;1358:257-273. doi: 10.1007/978-3-030-89340-8_12. PMID: 35641874.
(Impact Factor: 2.6)
Das S, Roychoudhury S, Dey A, Jha NK, Kumar D, Roychoudhury S, Slama P, Kesari KK. Bacteriospermia and Male Infertility: Role of Oxidative Stress. Adv Exp Med Biol. 2022;1358:141-163. doi: 10.1007/978-3-030-89340-8_7. PMID: 35641869.
(Impact Factor: 2.6)
Arfin, S. .; Mani, N. .; Rathi, B.; Kumar, D. In Silico Analysis of Ceruloplasmin Alteration in Oral Squamous Cell Carcinoma. Chem Biol Lett 2022, 9, 342.
(Impact Factor: 4.4)
Jha NK, Arfin S, Jha SK, Kar R, Dey A,
Kumar D
. et al. Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling Semin Cancer Biol. 2022 Feb 23:S1044-579X(22)00049-9.
https://doi.org/10.1016/j.semcancer.2022.02.022
.
(Impact Factor: 17)
Raj S, Kesari KK, Kumar A, Rathi B, Sharma A, Gupta PK, Jha SK, Jha NK, Slama P, Roychoudhury S,
Kumar D
. Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. Molecular Cancer (BMC-Springer Nature). 2022. 26;21(1):31.
https://doi.org/10.1186/s12943-022-01503-1
(Impact Factor: 41.4): Corresponding Author
Pritam P, Deka R,
Kumar D
. et al.. Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects. Biology-MDPI. 2022. 11(2), 212.
https://doi.org/10.3390/biology11020212
(Impact Factor: 5.0)
Kumar, A.
Kumar D
. et al..Assessment of disease burden in the arsenic exposed population of Chapar village of Samastipur district, Bihar, India, and related mitigation initiative.
Environmental Science and Pollution Research.
https://doi.org/10.1007/s11356-021-18207-6
(Impact Factor: 4.3)
2021
Upadhyay C.
Kumar D
. et al.. Synthesis of the new analogs of morpholine and their antiplasmodial evaluation against the human malaria parasite Plasmodium falciparum.
New Journal of Chemistry
. 2021.
https://doi.org/10.1039/D1NJ04198C
(Impact Factor: 3.4)
Singh A, Singh AK, Giri R,
Kumar D
, Sharma R, Valis M, Kuca K, Garg N. The role of microRNA-21 in the onset and progression of cancer.
Future Med Chem
. 2021 Nov;13(21): 1885-1906.
https://doi.org/10.4155/fmc-2021-0096
.
(Impact Factor: 3.9)
Jeyaraman Madhan ,Muthu Sathish ,
Kumar D
. et al. “Total Stromal Fraction (TSF) - Fortified Adipose Tissue-Derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary Compromise”,
Coronaviruses
2021; e080921196287.
https://doi.org/10.2174/2666796702666210908151708
.
(Impact Factor: 0.0)
Asif Ali, Saleheen Bano,
Kumar D
. et al. (2021) Effect of cellulose nanocrystals on chitosan/PVA/nano β-TCP composite scaffold for bone tissue engineering application,
Journal of Biomaterials Science, Polymer Edition
,
https://doi.org/10.1080/09205063.2021.1973709
.
(Impact Factor: 3.5)
Mehreen Aftab, Maryam Ghufran,
Kumar D
. et al., In silico analysis of the role of hsa-miR-155-5p in cervical cancer, Chem. Biol. Lett. 2021, 8(3), 94-105.
(Impact Factor: 4.4) : Corresponding Author
Usman, M.B., Bhardwaj, S., Roychoudhury, S.
Kumar D
. et al.. Immunotherapy for Alzheimer’s Disease: Current Scenario and Future Perspectives.
J Prev Alzheimers Dis
8, 534–551 (2021).
https://doi.org/10.14283/jpad.2021.52
(Impact Factor: 4.4)
Sharma, P.P., Bansal, M., Sethi, A., Pena, L.,
Kumar D
. et al., 2021. Computational methods directed towards drug repurposing for COVID-19: advantages and limitations.
RSC Advances
, 11(57), pp.36181-36198.
https://doi.org/10.1039/D1RA05320E
(Impact Factor: 3.3)
Goyal, K.; Goel, H.; Baranwal, P.; Tewary, A.;
Kumar D
. et al.. Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans. Immuno 2021, 1, 442-456.
https://doi.org/10.3390/immuno1040032
(Impact Factor: 0.0)
Sharma A,
Kumar D
, Dahiya K, Hawthorne S, Jha SK, Jha NK, Nand P, Girgis S, Raj S, Srivastava R, Goswami VK, Gregoriou Y, El-Zahaby SA, Ojha S, Dureja H, Gupta G, Singh S, Chellappan DK, Dua K. Advances in pulmonary drug targeting microbial biofilms in respiratory diseases. Nanomedicine (Lond). 2021 Aug 5. delivery
https://doi.org/10.2217/nnm-2021-0057
.
(Impact Factor: 5.3): : Corresponding Author
Jeyaraman M, Muthu S, Bapat A,
Kumar D
. et al.. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon. 2021 Jul;7(7):e07635.
https://doi.org/10.1016/j.heliyon.2021.e07635
.
(Impact Factor: 1.8)
Sharma A, Hawthorne S, Jha SK, Jha NK,
Kumar D
, Girgis S, Goswami VK, Gupta G, Singh S, Dureja H, Chellappan DK, Dua K. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDAMB231 human breast cancer cells. Nanomedicine (Lond). 2021 Aug;16(20):1763-1773.
https://doi.org/10.2217/nnm-2021-0066
.
(Impact Factor: 5.3)
Chandel V, Maru S, Kumar A, Kumar A, Sharma A, Rathi B,
Kumar D
. Role of monocarboxylate transporters in head and neck squamous cell carcinoma. Life Sciences. 2021, 5;279:119709.
https://doi.org/10.1016/j.lfs.2021.119709
.
(Impact Factor: 3.6) : Corresponding Author
Raj S, Kumar A,
Kumar D
. Regulation of Glycolysis in Head and Neck Cancer. Adv Exp Med Biol. 2021;1280:219-230.
https://doi.org/10.1007/978-3-030-51652-9_15
.
(Impact Factor: 2.4) : Corresponding Author
Vaishali Chandel, Garima Tripathi, Seema A. Nayar, Brijesh Rathi, Abhijeet Kumar &
Dhruv Kumar
(2021) In silico identification and validation of triarylchromones as potential inhibitor against main protease of severe acute respiratory syndrome coronavirus 2,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1918255
.
(Impact Factor: 3.2) : Corresponding Author
Rashmi Tyagi, Mitul Srivastava, Baldeep Singh, Shingini Sharma, Ramendra Pati Pandey, Shailendra Asthana,
Dhruv Kumar
& V. Samuel Raj (2021) Identification and validation of potent Mycobacterial proteasome inhibitor from Enamine library,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1914173
.
(Impact Factor: 3.2) : Corresponding Author
Mathur, A., Raj, S., Jha, N.K. et al. Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2.
3 Biotech
11, 236 (2021).
https://doi.org/10.1007/s13205-021-02791-y
.
(Impact Factor: 2.2) : Corresponding Author
Arfin, S.; Jha, N.K.; Jha, S.K.; Kesari, K.K.; Ruokolainen, J.; Roychoudhury, S.; Rathi, B.;
Kumar, D
. Oxidative Stress in Cancer Cell Metabolism.
Antioxidants
2021, 10, 642.
https://doi.org/10.3390/antiox10050642
.
(Impact Factor: 5) : Corresponding Author
Kumar A, Kumar R, Rahman MS, Ali M, Kumar R, Nupur N, Gaurav A, Raj V, Anand G, Niraj PK, Kumar N, Srivastava A, Biswapriya A, Chand GB,
Kumar D
, Rashmi T, Kumar S, Sakamoto M, Ghosh AK. Assessment of arsenic exposure in the population of Sabalpur village of Saran District of Bihar with mitigation approach.
Environ Sci Pollut Res Int.
2021 Apr 11.
https://doi.org/10.1007/s11356-021-13521-5
(Impact Factor: 4.3)
Kumar, A., Rahman, M.S., Ali, M. et al. Assessment of arsenic exposure and its mitigation intervention in severely exposed population of Buxar district of Bihar, India.
Environ. Health Sci.
(2021).
https://doi.org/10.1007/s13530-021-00086-6
(Impact Factor: .76)
Chandel V., et al. 2021. In silico identification of potential inhibitor for TP53-induced glycolysis and apoptosis regulator in head and neck squamous cell carcinoma.
3Biotech
. 11(3):117.
https://doi.org/10.1007/s13205-021-02665-3
(Impact Factor: 2.2) : Corresponding Author
2020
Kumar A., et al. 2020. Arsenic exposure causing cancer in the Indo - Gangetic Plain - A 2000 cancer patients’ cross-sectional design.
Scientific Reports
. 11, 2376 (2021).
https://doi.org/10.1038/s41598-021-81579-9
.
(Impact Factor: 4.1)
Roychoudhury S., et al. 2020. Viral pathogenesis of SARS-CoV-2 infection and male reproductive health: Myth or fact?
Open Biology
. 11(1): 200347,
https://doi.org/10.1098/rsob.200347
(Impact Factor: 4.9)
Jha N K., et al. 2020. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS‑CoV‑2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Journal of Molecular Neuroscience.
https://doi.org/10.1007/s12031-020-01767-6
.
(Impact Factor: 2.8)
Ali A., et al. 2020. Comparative analysis of TiO2 and Ag nanoparticles on xylan/chitosan conjugate matrix for wound healing application.
International Journal of Polymeric Materials and Polymeric Biomaterials.
https://doi.org/10.1080/00914037.2020.1838519
(Impact Factor: 1.9)
Kumar D., et al. 2020. Stem Cell Based Preclinical Drug Development and Toxicity Prediction.
Current Pharmaceutical Design
.
https://doi.org/10.2174/1381612826666201019104712
(Impact Factor: 2.4) : Corresponding Author
Tyagi R., et al. 2020. Development of potential proteasome inhibitors against Mycobacterium tuberculosis.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1835722
(Impact Factor: 3.2) : Corresponding Author
Narula S, Tandon S, Kumar D et al. 2020. Human kidney stone matrix proteins alleviate hyperoxaluria induced renal stress by targeting cell-crystal interactions.
Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118498
(Impact Factor: 3.6)
Satyam R, Jha NK, Kar R et al. 2020. Deciphering the SSR incidences across viral members of Coronaviridae family.
Chemico-Biological Interactions.
https://doi.org/10.1016/j.cbi.2020.109226
(Impact Factor: 3.6)
Chandel V, Raj S, Rathi B, Choudhary R,
Kumar D
. 2020. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1811773
(Impact Factor: 3.2) : Corresponding Author
Manish D., Vijay T., Kumar D., et al. 2020. Structural and Morphological Characterization of CdS Nanoparticles,
Current Physical Chemistry.
https://doi.org/10.2174/1877946810999200730222025
(Impact Factor: 1.6)
Raj S, Chandel V, et al. 2020 Molecular mechanisms of interplay between autophagy and metabolism in cancer
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118184
(Impact Factor: 3.6) : Corresponding Author
Chandel V, Raj S, et al. 2020. Metabolic regulation in HPV associated head and neck squamous cell carcinoma
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118236
(Impact Factor: 3.6) : Corresponding Author
Chandel V,
Kumar D
. 2020. Targeting Signalling Cross-Talk between Cancer Cells and Cancer Associate Fibroblast through Monocarboxylate Transporters in Head and Neck Cancer
,Anti-Cancer Agents in Medicinal Chemistry
:
Bentham Science Publishers
,
https://doi.org/10.2174/1871520620666200721135230
(Impact Factor: 2.04) : Corresponding Author
Kumar S, Sharma PP, Shankar U,
Kumar D
et al. 2020. Discovery of New Hydroxyethylamine Analogs against 3CL pro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies.
J Chem Inf Model.
https://doi.org/10.1021/acs.jcim.0c00326
(Impact Factor: 4.5)
Pandey V, Tripathi G,
Kumar D
et al. 2020. Novel 3,4-diarylpyrazole as prospective anti-cancerous agents,
Helion
,
https://doi.org/10.1016/j.heliyon.2020.e04397
(Impact Factor: 1.6) : Corresponding Author
Chandel V, Raj S, Rathi B,
Kumar D
. 2020. In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach.
Chemical Biology Letters
. 7(3), 166‐175.
(Impact Factor: 4.4) : Corresponding Author
Chandel V, Raj S, Srivastava A,
Kumar D
. 2020. In-silico interactions of active Phytochemicals with c-MYC EGFR and ERBB2 oncoproteins.
Chemical Biology Letters
. 7(1), 47‐54.
(Impact Factor: 4.4) : Corresponding Author
Raj S, Chandel V, Rathi B,
Kumar D
. 2020. Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach, Coronavirus: Bentham Science Publishers, DOI : 10.2174/2666796701999200617155013
: Corresponding Author
2019
Sibi Raj, Sartaj Khuranaa, Ramesh Choudhari et al. 2019. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
Seminars in Cancer Biology
https://doi.org/10.1016/j.semcancer.2019.11.002
.
(Impact Factor: 15) : Corresponding Author
Anukriti, Anupam D, Swati U, Pallavi S, et al. 2019. Investigation of Precise Molecular Mechanistic Action of Tobacco-Associated Carcinogen ‘NNK’ Induced Carcinogenesis: A System Biology Approach. 10(8), 564.
(Impact Factor: 3.4)
Asif A, Saleheen B, Satish S.P,
Kumar D
, Yuvraj S N, 2019. Effect of incorporation of Montmorillonite on Xylan/Chitosan conjugate scaffold.
Colloids and Surfaces B: Biointerfaces
1(180) 75-82.
(Impact Factor: 3.9)
Vishwakarma V, New J1,
Kumar D,
et al.,
Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds.
Scientific Reports
. 15;8(1):12163.
(Impact Factor: 4.1)
Chandel V and Kumar D. 2019. The Development of Tumor Heterogeneity and Actively Targeting Therapy Resistant Subpopulations
. J Embryol Stem Cell Res
. 3(3): 000131
: Corresponding Author
2018
Kumar D, et al.,
2018
.
Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression.
Cancer Research
. 10.1158/0008-5472.CAN-17-1076.
(Impact Factor: 12) : First Author
Kumar D
, et al. Perfluoro Curcumin Strongly Interacts with ABC Transporter (ABCG2): A Molecular Docking Study.
J Embryol Stem Cell Res
2018, 2(2): 000113.
: Corresponding Author
Kumar D
. 2018. Resveratrol derivative triacetyl-resveratrol interacts directly with the Gli-DNA zinc finger complex.
J Cancer Res Oncobiol
. Apr; 1(2):110
: Corresponding Author
2017
Kumar D
, et al., 2017. Development and characterization of an in vitro model for radiation-induced fibrosis,.
Radiation Research
. 189(3):326-336
(Impact Factor: 2.5) : First Author
Kumar D
, 2017. Role of tumor heterogeneity in drug resistance.
Glob J Cancer Ther
3(2): 032-033. (Editorial).
: Corresponding Author
Kumar D
, 2017. Regulation of glycolysis in head and neck squamous cell carcinoma
. Postdoc Journal
. 2017 Jan;5 (1):14-28.
: Corresponding Author
2016
Ledgerwood LG*,
Kumar D*,
Eterovic AK, Wick J et al., 2016. The degree of intra-tumor mutational heterogeneity varies by primary tumor sub-site.
Oncotarget
. Mar 28. doi: 18632/oncotarget.8448.
(Impact Factor:6.4)
*Equal contribution
: First Author
2015
Kumar D
, Kandl C, Hamilton C, Shnayder Y, Tsue T, Kakarala K, Ledgerwood L, Sun X S, Huang H, Girod D, Thomas S 2015. Anti-HGF antibody ficlatuzumab mitigates tumor-associated fibroblast-facilitated head and neck cancer progression.
JAMA Otolaryngology-Head & Neck Surgery
. Dec 1;141 (12): 1133-9.
(Impact Factor: 6.2) : First Author
Kumar D
, Gupta D, Shankar S, Srivastava RK. 2015. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
Oncotarget:
1-12.
(Impact Factor:6.4) : First Author
2014
Plotegher N,
Kumar D
, Tessari I, Brucale M, Munari F, et al. 2014. The chaperone-like protein 14-3-3eta interacts with human alpha-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing alpha-synuclein cellular toxicity.
Human Molecular Genetics
. 23:5615-29.
(Impact Factor:5.9)
Kumar D
, Shankar S, Srivastava RK. 2014. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway.
Cancer Letters
. 343:179-89.
(Impact Factor:6.4) : First Author
Kumar D
, Plotegher N, Bubacco L, Brucale M. 2014. Quantitative AFM morphometry of non-fibrillar α- synuclein aggregation products induced by the chaperone-like protein 14-3-3.
Italian Society for Microscopical Sciences
. Vol 21, No 1. DOI: 10.4081/microscopie. 2014.4998.
: First Author
Kumar D
, Shankar S, Srivastava RK. 2014. Understanding the biological functions and therapeutic potentials of stem cells and cancer stem cells: Where are we?
Journal of Cancer Stem Cell Research
. 2:e1002:1-8.
: First Author
2013
Kumar D
, Shankar S, Srivastava RK. 2013. Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms.
Molecular Cancer
. 1476-4598-12-171.
(Impact Factor:27) : First Author
Nanta R,
Kumar D
, Meeker D, Rodova M, Van Veldhuizen PJ, et al. 2013. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rgamma null mice by regulating Bmi-1 and microRNA-128.
Oncogenesis
. 2:e42.
(Impact Factor:5.1)
Shankar S,
Kumar D
, Srivastava 2013. Epigenetic modifications by dietary phytochemicals: Implications for personalized nutrition.
Pharmacol Therapeut
. 138:1-17.
(Impact Factor:11.1)
2012
Pivato M, De Franceschi G, Tosatto L, Frare E,
Kumar D
, et al. 2012. Covalent alpha-synuclein dimers: chemico-physical and aggregation properties.
PloS one
7:e50027.
(Impact Factor:3.4)
Singh BN,
Kumar D
, Shankar S, Srivastava 2012. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells.
Biochemical Pharmacology
. 84:1154-63.
(Impact Factor:6.1)
Conference Proceedings
Tyagi,
D. Kumar
and V. S. Raj, 2018. "In silico identification of potential inhibitors against Mycobacterial proteasome," 2018 International Conference on Bioinformatics and Systems Biology (BSB), Allahabad, India,
IEEE Xplore
, pp. 193-197.
(IF: 10.6)
Shekhar Goyal, Surender Kr Beniwal, H S Kumar,
Dhruv Kumar
, B C Das. 2019. Role of Curcumin in reducing toxicity and adverse effects in locally advanced and metastatic breast cancer patients.
Annals of Oncology
. Volume 30, vi126 - vi127.
(IF: 14)
Book Chapter
Mavi, Anil Kumar, Manmohan Kumar, Amarjeet Singh, Mahendra Kumar Prajapati, Rakhi Khabiya, Saurabh Maru, and
Dhruv Kumar.
"Progress in Non‐Viral Delivery of Nucleic Acid: Advancement in Biomedical Technology." Integration of Biomaterials for Gene Therapy (2023): 281-322.
https://doi.org/10.1002/9781394175635.ch10
Mavi, Anil Kumar, Sonal Gaur, Neelesh Kumar, Avanish Kumar Shrivastav, Sankha Bhattacharya, Sateesh Belemkar, Saurabh Maru, and
Dhruv Kumar
. "Effective Gene Transfer with Non‐Viral Vectors." Integration of Biomaterials for Gene Therapy (2023): 183-222.
https://doi.org/10.1002/9781394175635.ch7
Kirti Agrawal, Malavika Saji,
Dhruv Kumar,
Drug Repurposing in Future Drug Discovery and Development, Book-Drug Repurposing and Computational Drug Discovery, Edition1st Edition 2023, Apple Academic Press, Pages26, eBook ISBN9781003347705,
https://doi.org/10.1201/9781003347705
Kumar, A., Raj, V., Ali, M., Abhinav, Rachamalla, M.,
Kumar, D
., Kumari, A., Kumar, R., Shankar, P. and Ghosh, A., 2023. Evaluation of MOF Applications for Groundwater Arsenic Mitigation of the Middle Ganga Plains of Bihar, India. Metal Organic Frameworks for Wastewater Contaminant Removal, pp.355-373. 26 August 2023,
https://doi.org/10.1002/9783527841523.ch16
Saniya Arfin,
Dhruv Kumar
, Chapter 3 - Use of vitamins and minerals as dietary supplements for better health and cancer prevention, Editor(s): Inamuddin, Tariq Altalhi, Jorddy Neves Cruz, Nutraceuticals, Academic Press, 2023, Pages 53-97, ISBN 9780443191930,
https://doi.org/10.1016/B978-0-443-19193-0.00003-4
.
A Santoshkumar, S Ray, S Narayanan,
D Kumar
, S Harihar (2023), Mitophagy in cancer and cancer stem cells: a role in metabolic reprogramming. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00009-2
T Singh, AS Kharat, B Rathi,
D Kumar
(2023), Designing metabolic target-specific inhibitors for cancer therapy. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00011-0
Sibi Raj, Manish K. Mishra, Sitaram Harihar, Ashok Kumar, Shubhadeep Roychoudhury, Arun Kumar et al. (
2022
). Regulation of Glucose Transporters in Cancer Progression, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_9
Stephen James, Saniya Arfin, Manish K. Mishra, Arun Kumar, Niraj Kumar Jha, Saurabh Kumar Jha et al. (
2022
). Role of Arsenic in Carcinogenesis, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_7
Raj S., Kumar A.,
Kumar D
. (
2020
) Regulation of Glycolysis in Head and Neck Cancer, Book. Cancer Metabolomics, Advances in Experimental Medicine and Biology, Springer Nature.
https://doi.org/10.1007/978-3-030-51652-9_15
Chandel V.,
Kumar D
. (
2020
) Role of Interferon in Cancer Metabolism. Innate Immunity in Health and Disease. IntechOpen.
https://doi.org/10.5772/intechopen.92020
Raj S, Chandel V., Maurya S,
Kumar D
. (
2020
) Role of Macrophages in Solid Tumor Metabolism. Macrophages. IntechOpen.
https://doi.org/10.5772/intechopen.93182
Maurya S, Chandel V, Raj S, (
2020
) OMICS IN CANCER: FROM DIAGNOSTICS TO THERAPEUTICS. Recent Trends in ‘Computational Omics'. ISBN: 978-1-53617-941-5
Raj S., Chandel V.,
Kumar D
. (
2020
) Cancer Cell Metabolism: Solid Tumor Versus Nonsolid Tumor. In:
Kumar D
. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_1
Pedroza D.A. et al. (
2020
) Role of Autophagy in Cancer Cell Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_6
Chandel V., Raj S., Choudhari R.,
Kumar D
. (
2020
) Role of c-Met/HGF Axis in Altered Cancer Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_7
Kumar D
., Sharma-Walia N., Kapoor S., Tandon S. (
2020
) Antibody-Targeted Nanoparticles for Cancer Treatment. In: Saxena S., Khurana S. (eds) NanoBioMedicine. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9898-9_3
Singh B., Malhotra H.,
Kumar D
., Mujtaba S.F., Upadhyay A.K. (
2019
) Understanding Cellular and Molecular Events of Skin Aging and Cancer: An Integrative Perspective. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_2
Tripathi M.K., Sinha J., Srivastava S.K.,
Kumar D
. (
2019
) Bioinformatics in Skin Cancer: A System Biology Approach to Understanding the Molecular Mechanisms and It’s Regulations. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_10
Khurana S., Bose S.,
Kumar D
. (
2019
) Applications of Microarray-Based Technologies in Identifying Disease-Associated Single Nucleotide Variations. In: Tripathi V., Kumar P., Tripathi P., Kishore A., Kamle M. (eds) Microbial Genomics in Sustainable Agroecosystems. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9860-6_4
Singh P., Tiwari D., Mishra M.,
Kumar D
. (
2019
) Molecular Mechanisms of Heavy Metal Toxicity in Cancer Progression. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_3
Chandel V., Seth G., Shukla P.,
Kumar D
. (
2019
) Role of Radiation in DNA Damage and Radiation Induced Cancer. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_1
Dhruv Kumar
, Sharmila Shankar, Rakesh Srivastava. Challenges in stem cells and translational research (Book chapter). Lost in translational and clinical research. World Scientific Publication,
2014
. ISBN: 9789814489089.
https://doi.org/10.1142/9789814489072_0020
Dhruv kumar
and Bruno Samori. Mechanochemistry: Coupling mechanical forces and chemical reactions (Book chapter). Molecular Manipulation with Atomic Force Microscopy (Book), CRC Press,
2011
, ISBN: 9781439809662.
Dwijendra Gupta,
Dhruv Kumar
, Manish Dwivedi, Vijay Tripathi, Pratibha Phadke-Gupta and Surya Pratap Singh. Nanophosphors-Nanogold immunoconjugates in Isolation of Biomembranes and in Drug Delivery (Book chapter). Recent Advances in Nanomedicine (Book), VBRI Press,
2011
, ISBN: 9788192006803.
Book
Dhruv Kumar
, Shailendra Asthana Autophagy and Metabolism Potential Target for Cancer Therapy 1st Edition - August 6, 2022 Paperback ISBN: 9780323998796 9 7 8 - 0 - 3 2 3 - 9 9 8 7 9 - 6 eBook ISBN: 9780323999458
Akhileshwar Srivastava,
Dhruv Kumar
, Divya Singh, Rajesh Singh, Xenobiotics in Chemical Carcinogenesis:Translational Aspects in Toxicology,
Elsevier,
ISBN: 9780323905602
Dhruv kumar.
Cancer Cell Metabolism: A Potential Target for Cancer Therapy.
Springer Nature
.
2020,
ISBN: 9789811519901.
Dhruv kumar
, Marco Brucale and Bruno Samori. Amyloidogenic Proceses of Intrinsically Disordered Proteins: Understanding the Aggregation Process of Intrinsically Unstructured Proteins Related to Neurodegenerative Diseases.
Lambert Academic Publishing
,
2014
, ISBN:
Dhruv kumar
. Insilico analysis of Docking between HIV-1 PR and derivatives of CUI (Docking between HIV- 1 proteases and cyclic urea inhibitors: A step towards drug designing against AIDS).
Lambert Academic Publishing
,
2011
, ISBN:
Contact
dhruv.kumar@ddn.upes.ac.in

Profile Summary
Prof. Dhruv Kumar is a Professor and Cluster Head at the Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun. Listed as a top 2% world’s most influential scientist in the area of Oncology and cancer Biology. His academic journey includes a B.Sc. in Chemistry from Banaras Hindu University (BHU), Varanasi, and M.Sc. in Bioinformatics with Distinction from the University of Allahabad (AU), Prayagraj. Dr. Dhruv Kumar further distinguished himself by completing his Ph.D. in Cellular, Molecular, and Industrial Biology from the University of Bologna (UNIBO), Italy, under the highly prestigious fellowship of the Ministry of Human Resource and Development (MHRD), Indo-Italian Government fellowship. Following the completion of his Ph.D., he embarked on a five-year Postdoctoral training at the School of Medicine, University of Kansas Medical Center, Kansas City, USA. Dr. Kumar's research has been dedicated to several cancer types, including Prostate, Pancreatic, Brain, Breast, and Head and Neck Cancer, with a primary focus on unraveling the molecular mechanisms regulating Autophagy and Apoptosis in Cancer Stem Cells. Currently, his laboratory is actively exploring the Autophagy-Metabolic axis in various cancer cells, such as head and neck, oral, breast, and brain, along with investigating the tumor microenvironment for the development of innovative therapeutic approaches. Notably, his research group has made significant contributions to Drug Designing and Drug Repurposing for COVID-19. Dr. Dhruv Kumar's scholarly contributions are evident in his extensive publication record, with articles featured in prestigious journals such as Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, Seminars in Cancer Biology, JAMA Otolaryngology, Nature Scientific Reports, and many more. Presently, Dr. Kumar is actively engaged in numerous government-funded projects and is mentoring eight Ph.D. students in the areas of Cancer and Infertility. Beyond his research endeavors, he plays a vital role in teaching courses at the undergraduate (UG), postgraduate (PG), and Ph.D. levels, covering subjects related to Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics.
Work Experience
Prof. Dhruv Kumar possesses over 15 years of extensive experience encompassing teaching, research, and administrative roles. His professional journey is outlined as follows:
06/22-Present: Professor & Cluster Head, Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand, India.
01/21-06/22: Professor & Assistant Director, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
07/19-12/20: Associate Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
04/17-07/19: Assistant Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
08/16-04/17: Assistant Professor, Department of Bioinformatics, SRM University, Delhi-NCR, Sonepat, Haryana, India.
03/12-06/16: Postdoctoral Fellow, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
In these diverse roles, Prof. Kumar has demonstrated his commitment to academia, contributing significantly to various institutions and enhancing his expertise in the fields of Molecular Medicine, Cancer Biology, Stem Cell Research, and Bioinformatics. His journey includes pivotal positions such as Assistant Professor at SRM University and various roles at Amity University Uttar Pradesh, showcasing his dedication to fostering education and research. Currently serving as a Professor and Cluster Head at UPES, Dehradun, he continues to make substantial contributions to the academic and research landscape.
Research Interests
Prof. Dhruv Kumar boasts an extensive and diverse research portfolio spanning over various critical domains in biomedical science. With over 15 years of profound expertise, he has significantly contributed to Translational Cancer Research, unraveling novel insights that bridge the gap between fundamental discoveries and clinical applications. His dedicated exploration into Cancer Stem Cells has shed light on the molecular intricacies governing these cells. Prof. Kumar's investigations into Cancer Cell Metabolism reveal a nuanced understanding of metabolic alterations in cancer cells, potentially paving the way for innovative therapeutic strategies. Additionally, his work on the Tumor Microenvironment and Tumor Heterogeneity delves into the complex interplay and diversity within cancer populations. His research illuminates the regulatory mechanisms of Autophagy and the role of Exosomes in cancer, offering crucial perspectives on cellular recycling and intercellular communication. Beyond cancer biology, Prof. Kumar's foray into Infertility research explores molecular factors underlying reproductive challenges. Proficient in Genome Editing and NGS Data Analysis, he navigates cutting-edge genetic technologies. His involvement in Drug Repurposing and Drug Discovery underscores an innovative approach to therapeutics, while his recent contributions in COVID-19 research showcase adaptability to contemporary health challenges. Prof. Kumar's overarching mastery in Bioinformatics strategically integrates computational methods, enhancing the comprehensive interpretation of complex biological data.
Teaching Philosophy
Prof. Dhruv Kumar's teaching philosophy is characterized by innovation and inclusivity. He employs a blended teaching approach that seamlessly integrates traditional methods with modern technologies, creating a dynamic and engaging learning environment. One notable aspect is his commitment to discussing cutting-edge research topics, including those recognized with Nobel Prizes, providing students with insights into the forefront of scientific inquiry. Prof. Kumar takes an innovative approach to support slow learners, implementing strategies such as pairing them with a buddy for personalized assistance, arranging expert lectures, fostering group discussions, and emphasizing hands-on training and practical experiences. By tailoring his teaching methods to diverse learning styles and providing additional support mechanisms, Prof. Kumar ensures that every student, regardless of pace, has the opportunity to thrive academically and develop a passion for lifelong learning.
Courses Taught
Prof. Dhruv Kumar has a genuine passion for teaching and a deep commitment to fostering meaningful interactions with students, creating a vibrant and engaging educational environment. With an extensive background in teaching, he has imparted knowledge across various courses at the undergraduate (UG), postgraduate (PG), and doctoral (PhD) levels. Prof. Kumar's enthusiasm for sharing new ideas and insights has been a cornerstone of his teaching approach, inspiring students to explore innovative concepts and contributing to a dynamic and intellectually stimulating learning atmosphere. His continuous dedication to teaching underscores not only his expertise in the subject matter but also his unwavering commitment to nurturing the intellectual growth of students at all levels.
Undergraduate Level (B.Sc.)
Basic Bioinformatics (BIOF202)
Basics of Cancer (BIOT223)
Cell (MMBS104)
Metals in Biology (MMBS201)
Metabolism (MMBS205)
Scientific Writing (HSCC2019)
Postgraduate Level (M.Sc.)
Animal Cell Culture & Cell Engineering (SCCB601)
Assisted Reproductive Laboratory Procedures (RTCE605)
Cancer Pharmacogenomics (SCCB704)
Computational Tools in Drug Discovery (MMBS702)
Genome Engineering & Editing (SCCB603)
OMICS in Biomedical Sciences (SCCB710)
Preventive Oncology & Psycho-Oncology (SCCB705)
Reproductive & Developmental Biology and Genetics (RTCE604)
Topics in Bioinformatics (MMBS610)
Trends in Molecular Oncology (SCCB901)
Stem Cell Bio II (SCCB 707)
Scientific Writing (HSCC8007)
Good manufacturing and Lab Practices (HSCC8008)
Biosafety and Aseptic Techniques (HSMB 7024)
PhD Level
Advances in Molecular Medicine (BIOT 955) at Institute Level
Trends in Molecular Oncology (BIOT 953) at Institute Level
Research and Publication Ethics” (RPE) –(PHD901) at University Level
Awards and Grants:
Prof. Dhruv Kumar has received several national and international awards and grants as mentioned below.
Awards:
2020: Research Excellence Award, Institute of Scholars, India
2019: Senior Scientist Award, Society of Biomedical Laboratory Scientists, India
2017: Early Career Research Award, SERB, DST-India.
2016: Postdoc of the Month Award, PostDoc Journal: Journal of Postdoctoral Research, USA.
2016: Scholar-in-Training Award, AACR, The Function of Tumor Microenvironment in Cancer Progression Conference, San Diego, USA.
2015: K-INBRE Postdoctoral Award, National Institute of General Medical Sciences, National Institute of Health (NIH), USA.
2011: 8th EBSA European Biophysics Congress Bursaries Award, European Biophysical Societies Association, Italy.
2011: Young Scientist Award, International Academy of Physical Science, Allahabad, India.
2009: Brains in Competition Award, Institute of Advance Studies, University of Bologna, Italy.
2008: Indo-Italian Government Scholarship (Ministry of Human Resource and Development, India).
Grants:
2022-2025: “Analysis of the relationship between gallbladder cancer, arsenic intake, and living-environmental factors - a case in Bihar, India”, Indo-Japan, Government of Japan, Rs 100 lakh (Co-PI): Ongoing
2021-2024: “Repurposing of drugs and validation of lead compounds against main protease and RNA dependent RNA polymerase of SARS-CoV-2”, BRICS-DST, Rs 74 lakh (PI & Coordinator): Ongoing
2020-2023: “Assessment of Female reproductive health and child health risks in Arsenic Exposed population of Bihar”, ICMR New Delhi, Rs ~ 1 Crore. (Co-PI): Ongoing
2018-2021: “Understanding the Metabolic Cross-Talk between Head and Neck Squamous Cell Carcinoma and Tumor Associated Fibroblasts”, SERB-Department of Science and Technology, Government of India, Rs ~35 Lakhs. (PI): Completed
2015-2016: “Role of Tumor-Associated Fibroblasts in Head and Neck Cancer Metabolism” National Institute of General Medical Sciences, National Institute of Health, USA (P20GM103418), $25,000. (PI): Completed
Scholarly Activities
Prof. Dhruv Kumar, has a rich portfolio of scholarly activities spanning teaching, research, and academic contributions. He actively engages in designing and instructing courses at various academic levels, including undergraduate (UG), postgraduate (PG), and doctoral (PhD) programs, covering specialized areas such as Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics. Prof. Kumar's research endeavors have resulted in numerous publications in high-impact journals, including Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, and Nature Scientific Reports. He has received recognition on both national and international platforms, garnering awards such as the Senior Scientist Award from the Society of Biomedical Laboratory Scientists, India, the Scholar-in-Training Award from the American Association for Cancer Research (AACR), USA, and the K-INBRE Postdoctoral Award from the National Institute of Health (NIH), USA. Additionally, his active involvement in government-funded projects and mentorship of PhD students in the fields of Cancer and Infertility reflects his commitment to advancing knowledge and nurturing the next generation of researchers. Prof. Kumar's scholarly activities exemplify a holistic approach to academia, seamlessly integrating teaching, research, and mentorship.
His selected publications are as below:
2023
Agrawal, K.; Asthana, S.;
Kumar, D
. Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer. Cancers 2023, 15, 4920.
https://doi.org/10.3390/cancers15204920
.
(Impact Factor: 5.2)
Maurya, S., Raj, S., Bhoi, N.R., Mani, N., Rathi, B. and
Kumar, D
., 2023. Morphological analysis of metabolically dysregulated spermatozoa using Artificial Intelligence based approach. Journal of Integrated Science and Technology, 11(4), pp.569-569.
(Impact Factor: 1.14)
Raj, S. and
Kumar, D.
, 2023. Early epigenetic markers for precision medicine. Progress in molecular biology and translational science, 198, pp.153-164.
(Impact Factor: 4.0)
Kumar, A., Ali, M., Raj, V., Kumari, A., Rachamalla, M., Niyogi, S.,
Kumar, D.
, Sharma, A., Saxena, A., Panjawani, G. and Jain, P., 2023. Arsenic causing gallbladder cancer disease in Bihar. Scientific Reports, 13(1), p.4259.
(Impact Factor: 4.9)
Goel, M., Mishra, M.K. and
Kumar, D
., 2023. Recent advances in Targeted Radionuclide therapy for Cancer treatment. Chemical Biology Letters, 10(3), pp.544-544.
(Impact Factor: 6.1)
Bhattacharjee, R., Prabhakar, N., Kumar, L., Bhattacharjee, A., Kar, S., Malik, S.,
Kumar, D
., Ruokolainen, J., Negi, A., Jha, N.K. and Kesari, K.K., 2023. Crosstalk between long noncoding RNA and microRNA in Cancer. Cellular Oncology, pp.1-24.
(Impact Factor: 6.6)
Kumar, A., Kumar, K., Ali, M., Raj, V., Srivastava, A., Kumar, M., Niraj, P.K., Kumar, M., Kumar, R.,
Kumar, D.
and Bishwapriya, A., 2023. Severe Disease Burden and the Mitigation Strategy in the Arsenic-Exposed Population of Kaliprasad Village in Bhagalpur District of Bihar, India. Biological trace element research, pp.1-17.
(Impact Factor: 4.0)
Arfin, S.;
Kumar, D
.; Lomagno, A.; Mauri, P.L.; Di Silvestre, D. Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis. Cancers 2023, 15, 4420.
https://doi.org/10.3390/cancers15174420
(Impact Factor: 5.2)
Arfin S, Agrawal K, Maurya S, Asthana S, Di Silvestre
D, Kumar D
. Lead phytochemicals and marine compounds against ceruloplasmin in cancer targeting. Journal of Biomolecular Structure and Dynamics. 2023 Oct 18.
(Impact Factor: 5.2)
Agrawal K, Chakraborty P, Dewanjee S, Arfin S, Das SS, Dey A, Moustafa M, Mishra PC, Jafari SM, Jha NK, Jha SK,
Kumar D
. Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders. Neurosci Biobehav Rev. 2023 Jan;144:104955. doi: 10.1016/j.neubiorev.2022.104955. Epub 2022 Nov 14. PMID: 36395983.
(Impact Factor: 9.0)
Agrawal K, Chauhan S,
Kumar D
. Expression analysis and regulation of GLI and its correlation with stemness and metabolic alteration in human brain tumor. 3 Biotech. 2023 Jan;13(1):10. doi: 10.1007/s13205-022-03419-5. Epub 2022 Dec 15. PMID: 36532860; PMCID: PMC9755437.
(Impact Factor: 2.9)
Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A,
Kumar D
, Ambasta RK, Jha NK, Jha SK, Dewanjee S. Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Res Rev. 2023 Mar;85:101838. doi: 10.1016/j.arr.2022.101838. Epub 2023 Jan 5. PMID: 36610558.
(Impact Factor: 11.7)
Raj, S., Rathi, B., Mehra, P., Asthana, S., &
Kumar, D
. (2023). Deciphering the role of c-MET in Metabolic reprogramming of Head and Neck squamous cell Carcinoma via In Silico analysis. Chemical Biology Letters, 10(2), 532. Retrieved from
https://pubs.thesciencein.org/journal/index.php/cbl/article/view/532
(Impact Factor: 4.4)
2022
Awasthi P, Dwivedi M, Kumar D, Hasan S. Insights into intricacies of the Latent Membrane Protein-1 (LMP-1) in EBV-associated cancers. Life Sci. 2023 Jan 15;313:121261. doi: 10.1016/j.lfs.2022.121261. Epub 2022 Dec 7. PMID: 36493876.
(Impact Factor: 3.3)
Sharma S, Tyagi R, Srivastava M, Rani K,
Kumar D
, Asthana S, Raj VS. Identification and validation of potent inhibitor of Escherichia coli DHFR from MMV pathogen box. J Biomol Struct Dyn. 2022 Jun 2:1-10. doi: 10.1080/07391102.2022.2080113. Epub ahead of print. PMID: 35652895.
(Impact Factor: 3.3)
Maurya S, Kesari KK, Roychoudhury S, Kolleboyina J, Jha NK, Jha SK, Sharma A, Kumar A, Rathi B, Kumar D. Metabolic Dysregulation and Sperm Motility in Male Infertility. Adv Exp Med Biol. 2022;1358:257-273. doi: 10.1007/978-3-030-89340-8_12. PMID: 35641874.
(Impact Factor: 2.6)
Das S, Roychoudhury S, Dey A, Jha NK, Kumar D, Roychoudhury S, Slama P, Kesari KK. Bacteriospermia and Male Infertility: Role of Oxidative Stress. Adv Exp Med Biol. 2022;1358:141-163. doi: 10.1007/978-3-030-89340-8_7. PMID: 35641869.
(Impact Factor: 2.6)
Arfin, S. .; Mani, N. .; Rathi, B.; Kumar, D. In Silico Analysis of Ceruloplasmin Alteration in Oral Squamous Cell Carcinoma. Chem Biol Lett 2022, 9, 342.
(Impact Factor: 4.4)
Jha NK, Arfin S, Jha SK, Kar R, Dey A,
Kumar D
. et al. Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling Semin Cancer Biol. 2022 Feb 23:S1044-579X(22)00049-9.
https://doi.org/10.1016/j.semcancer.2022.02.022
.
(Impact Factor: 17)
Raj S, Kesari KK, Kumar A, Rathi B, Sharma A, Gupta PK, Jha SK, Jha NK, Slama P, Roychoudhury S,
Kumar D
. Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. Molecular Cancer (BMC-Springer Nature). 2022. 26;21(1):31.
https://doi.org/10.1186/s12943-022-01503-1
(Impact Factor: 41.4): Corresponding Author
Pritam P, Deka R,
Kumar D
. et al.. Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects. Biology-MDPI. 2022. 11(2), 212.
https://doi.org/10.3390/biology11020212
(Impact Factor: 5.0)
Kumar, A.
Kumar D
. et al..Assessment of disease burden in the arsenic exposed population of Chapar village of Samastipur district, Bihar, India, and related mitigation initiative.
Environmental Science and Pollution Research.
https://doi.org/10.1007/s11356-021-18207-6
(Impact Factor: 4.3)
2021
Upadhyay C.
Kumar D
. et al.. Synthesis of the new analogs of morpholine and their antiplasmodial evaluation against the human malaria parasite Plasmodium falciparum.
New Journal of Chemistry
. 2021.
https://doi.org/10.1039/D1NJ04198C
(Impact Factor: 3.4)
Singh A, Singh AK, Giri R,
Kumar D
, Sharma R, Valis M, Kuca K, Garg N. The role of microRNA-21 in the onset and progression of cancer.
Future Med Chem
. 2021 Nov;13(21): 1885-1906.
https://doi.org/10.4155/fmc-2021-0096
.
(Impact Factor: 3.9)
Jeyaraman Madhan ,Muthu Sathish ,
Kumar D
. et al. “Total Stromal Fraction (TSF) - Fortified Adipose Tissue-Derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary Compromise”,
Coronaviruses
2021; e080921196287.
https://doi.org/10.2174/2666796702666210908151708
.
(Impact Factor: 0.0)
Asif Ali, Saleheen Bano,
Kumar D
. et al. (2021) Effect of cellulose nanocrystals on chitosan/PVA/nano β-TCP composite scaffold for bone tissue engineering application,
Journal of Biomaterials Science, Polymer Edition
,
https://doi.org/10.1080/09205063.2021.1973709
.
(Impact Factor: 3.5)
Mehreen Aftab, Maryam Ghufran,
Kumar D
. et al., In silico analysis of the role of hsa-miR-155-5p in cervical cancer, Chem. Biol. Lett. 2021, 8(3), 94-105.
(Impact Factor: 4.4) : Corresponding Author
Usman, M.B., Bhardwaj, S., Roychoudhury, S.
Kumar D
. et al.. Immunotherapy for Alzheimer’s Disease: Current Scenario and Future Perspectives.
J Prev Alzheimers Dis
8, 534–551 (2021).
https://doi.org/10.14283/jpad.2021.52
(Impact Factor: 4.4)
Sharma, P.P., Bansal, M., Sethi, A., Pena, L.,
Kumar D
. et al., 2021. Computational methods directed towards drug repurposing for COVID-19: advantages and limitations.
RSC Advances
, 11(57), pp.36181-36198.
https://doi.org/10.1039/D1RA05320E
(Impact Factor: 3.3)
Goyal, K.; Goel, H.; Baranwal, P.; Tewary, A.;
Kumar D
. et al.. Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans. Immuno 2021, 1, 442-456.
https://doi.org/10.3390/immuno1040032
(Impact Factor: 0.0)
Sharma A,
Kumar D
, Dahiya K, Hawthorne S, Jha SK, Jha NK, Nand P, Girgis S, Raj S, Srivastava R, Goswami VK, Gregoriou Y, El-Zahaby SA, Ojha S, Dureja H, Gupta G, Singh S, Chellappan DK, Dua K. Advances in pulmonary drug targeting microbial biofilms in respiratory diseases. Nanomedicine (Lond). 2021 Aug 5. delivery
https://doi.org/10.2217/nnm-2021-0057
.
(Impact Factor: 5.3): : Corresponding Author
Jeyaraman M, Muthu S, Bapat A,
Kumar D
. et al.. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon. 2021 Jul;7(7):e07635.
https://doi.org/10.1016/j.heliyon.2021.e07635
.
(Impact Factor: 1.8)
Sharma A, Hawthorne S, Jha SK, Jha NK,
Kumar D
, Girgis S, Goswami VK, Gupta G, Singh S, Dureja H, Chellappan DK, Dua K. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDAMB231 human breast cancer cells. Nanomedicine (Lond). 2021 Aug;16(20):1763-1773.
https://doi.org/10.2217/nnm-2021-0066
.
(Impact Factor: 5.3)
Chandel V, Maru S, Kumar A, Kumar A, Sharma A, Rathi B,
Kumar D
. Role of monocarboxylate transporters in head and neck squamous cell carcinoma. Life Sciences. 2021, 5;279:119709.
https://doi.org/10.1016/j.lfs.2021.119709
.
(Impact Factor: 3.6) : Corresponding Author
Raj S, Kumar A,
Kumar D
. Regulation of Glycolysis in Head and Neck Cancer. Adv Exp Med Biol. 2021;1280:219-230.
https://doi.org/10.1007/978-3-030-51652-9_15
.
(Impact Factor: 2.4) : Corresponding Author
Vaishali Chandel, Garima Tripathi, Seema A. Nayar, Brijesh Rathi, Abhijeet Kumar &
Dhruv Kumar
(2021) In silico identification and validation of triarylchromones as potential inhibitor against main protease of severe acute respiratory syndrome coronavirus 2,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1918255
.
(Impact Factor: 3.2) : Corresponding Author
Rashmi Tyagi, Mitul Srivastava, Baldeep Singh, Shingini Sharma, Ramendra Pati Pandey, Shailendra Asthana,
Dhruv Kumar
& V. Samuel Raj (2021) Identification and validation of potent Mycobacterial proteasome inhibitor from Enamine library,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1914173
.
(Impact Factor: 3.2) : Corresponding Author
Mathur, A., Raj, S., Jha, N.K. et al. Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2.
3 Biotech
11, 236 (2021).
https://doi.org/10.1007/s13205-021-02791-y
.
(Impact Factor: 2.2) : Corresponding Author
Arfin, S.; Jha, N.K.; Jha, S.K.; Kesari, K.K.; Ruokolainen, J.; Roychoudhury, S.; Rathi, B.;
Kumar, D
. Oxidative Stress in Cancer Cell Metabolism.
Antioxidants
2021, 10, 642.
https://doi.org/10.3390/antiox10050642
.
(Impact Factor: 5) : Corresponding Author
Kumar A, Kumar R, Rahman MS, Ali M, Kumar R, Nupur N, Gaurav A, Raj V, Anand G, Niraj PK, Kumar N, Srivastava A, Biswapriya A, Chand GB,
Kumar D
, Rashmi T, Kumar S, Sakamoto M, Ghosh AK. Assessment of arsenic exposure in the population of Sabalpur village of Saran District of Bihar with mitigation approach.
Environ Sci Pollut Res Int.
2021 Apr 11.
https://doi.org/10.1007/s11356-021-13521-5
(Impact Factor: 4.3)
Kumar, A., Rahman, M.S., Ali, M. et al. Assessment of arsenic exposure and its mitigation intervention in severely exposed population of Buxar district of Bihar, India.
Environ. Health Sci.
(2021).
https://doi.org/10.1007/s13530-021-00086-6
(Impact Factor: .76)
Chandel V., et al. 2021. In silico identification of potential inhibitor for TP53-induced glycolysis and apoptosis regulator in head and neck squamous cell carcinoma.
3Biotech
. 11(3):117.
https://doi.org/10.1007/s13205-021-02665-3
(Impact Factor: 2.2) : Corresponding Author
2020
Kumar A., et al. 2020. Arsenic exposure causing cancer in the Indo - Gangetic Plain - A 2000 cancer patients’ cross-sectional design.
Scientific Reports
. 11, 2376 (2021).
https://doi.org/10.1038/s41598-021-81579-9
.
(Impact Factor: 4.1)
Roychoudhury S., et al. 2020. Viral pathogenesis of SARS-CoV-2 infection and male reproductive health: Myth or fact?
Open Biology
. 11(1): 200347,
https://doi.org/10.1098/rsob.200347
(Impact Factor: 4.9)
Jha N K., et al. 2020. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS‑CoV‑2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Journal of Molecular Neuroscience.
https://doi.org/10.1007/s12031-020-01767-6
.
(Impact Factor: 2.8)
Ali A., et al. 2020. Comparative analysis of TiO2 and Ag nanoparticles on xylan/chitosan conjugate matrix for wound healing application.
International Journal of Polymeric Materials and Polymeric Biomaterials.
https://doi.org/10.1080/00914037.2020.1838519
(Impact Factor: 1.9)
Kumar D., et al. 2020. Stem Cell Based Preclinical Drug Development and Toxicity Prediction.
Current Pharmaceutical Design
.
https://doi.org/10.2174/1381612826666201019104712
(Impact Factor: 2.4) : Corresponding Author
Tyagi R., et al. 2020. Development of potential proteasome inhibitors against Mycobacterium tuberculosis.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1835722
(Impact Factor: 3.2) : Corresponding Author
Narula S, Tandon S, Kumar D et al. 2020. Human kidney stone matrix proteins alleviate hyperoxaluria induced renal stress by targeting cell-crystal interactions.
Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118498
(Impact Factor: 3.6)
Satyam R, Jha NK, Kar R et al. 2020. Deciphering the SSR incidences across viral members of Coronaviridae family.
Chemico-Biological Interactions.
https://doi.org/10.1016/j.cbi.2020.109226
(Impact Factor: 3.6)
Chandel V, Raj S, Rathi B, Choudhary R,
Kumar D
. 2020. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1811773
(Impact Factor: 3.2) : Corresponding Author
Manish D., Vijay T., Kumar D., et al. 2020. Structural and Morphological Characterization of CdS Nanoparticles,
Current Physical Chemistry.
https://doi.org/10.2174/1877946810999200730222025
(Impact Factor: 1.6)
Raj S, Chandel V, et al. 2020 Molecular mechanisms of interplay between autophagy and metabolism in cancer
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118184
(Impact Factor: 3.6) : Corresponding Author
Chandel V, Raj S, et al. 2020. Metabolic regulation in HPV associated head and neck squamous cell carcinoma
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118236
(Impact Factor: 3.6) : Corresponding Author
Chandel V,
Kumar D
. 2020. Targeting Signalling Cross-Talk between Cancer Cells and Cancer Associate Fibroblast through Monocarboxylate Transporters in Head and Neck Cancer
,Anti-Cancer Agents in Medicinal Chemistry
:
Bentham Science Publishers
,
https://doi.org/10.2174/1871520620666200721135230
(Impact Factor: 2.04) : Corresponding Author
Kumar S, Sharma PP, Shankar U,
Kumar D
et al. 2020. Discovery of New Hydroxyethylamine Analogs against 3CL pro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies.
J Chem Inf Model.
https://doi.org/10.1021/acs.jcim.0c00326
(Impact Factor: 4.5)
Pandey V, Tripathi G,
Kumar D
et al. 2020. Novel 3,4-diarylpyrazole as prospective anti-cancerous agents,
Helion
,
https://doi.org/10.1016/j.heliyon.2020.e04397
(Impact Factor: 1.6) : Corresponding Author
Chandel V, Raj S, Rathi B,
Kumar D
. 2020. In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach.
Chemical Biology Letters
. 7(3), 166‐175.
(Impact Factor: 4.4) : Corresponding Author
Chandel V, Raj S, Srivastava A,
Kumar D
. 2020. In-silico interactions of active Phytochemicals with c-MYC EGFR and ERBB2 oncoproteins.
Chemical Biology Letters
. 7(1), 47‐54.
(Impact Factor: 4.4) : Corresponding Author
Raj S, Chandel V, Rathi B,
Kumar D
. 2020. Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach, Coronavirus: Bentham Science Publishers, DOI : 10.2174/2666796701999200617155013
: Corresponding Author
2019
Sibi Raj, Sartaj Khuranaa, Ramesh Choudhari et al. 2019. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
Seminars in Cancer Biology
https://doi.org/10.1016/j.semcancer.2019.11.002
.
(Impact Factor: 15) : Corresponding Author
Anukriti, Anupam D, Swati U, Pallavi S, et al. 2019. Investigation of Precise Molecular Mechanistic Action of Tobacco-Associated Carcinogen ‘NNK’ Induced Carcinogenesis: A System Biology Approach. 10(8), 564.
(Impact Factor: 3.4)
Asif A, Saleheen B, Satish S.P,
Kumar D
, Yuvraj S N, 2019. Effect of incorporation of Montmorillonite on Xylan/Chitosan conjugate scaffold.
Colloids and Surfaces B: Biointerfaces
1(180) 75-82.
(Impact Factor: 3.9)
Vishwakarma V, New J1,
Kumar D,
et al.,
Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds.
Scientific Reports
. 15;8(1):12163.
(Impact Factor: 4.1)
Chandel V and Kumar D. 2019. The Development of Tumor Heterogeneity and Actively Targeting Therapy Resistant Subpopulations
. J Embryol Stem Cell Res
. 3(3): 000131
: Corresponding Author
2018
Kumar D, et al.,
2018
.
Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression.
Cancer Research
. 10.1158/0008-5472.CAN-17-1076.
(Impact Factor: 12) : First Author
Kumar D
, et al. Perfluoro Curcumin Strongly Interacts with ABC Transporter (ABCG2): A Molecular Docking Study.
J Embryol Stem Cell Res
2018, 2(2): 000113.
: Corresponding Author
Kumar D
. 2018. Resveratrol derivative triacetyl-resveratrol interacts directly with the Gli-DNA zinc finger complex.
J Cancer Res Oncobiol
. Apr; 1(2):110
: Corresponding Author
2017
Kumar D
, et al., 2017. Development and characterization of an in vitro model for radiation-induced fibrosis,.
Radiation Research
. 189(3):326-336
(Impact Factor: 2.5) : First Author
Kumar D
, 2017. Role of tumor heterogeneity in drug resistance.
Glob J Cancer Ther
3(2): 032-033. (Editorial).
: Corresponding Author
Kumar D
, 2017. Regulation of glycolysis in head and neck squamous cell carcinoma
. Postdoc Journal
. 2017 Jan;5 (1):14-28.
: Corresponding Author
2016
Ledgerwood LG*,
Kumar D*,
Eterovic AK, Wick J et al., 2016. The degree of intra-tumor mutational heterogeneity varies by primary tumor sub-site.
Oncotarget
. Mar 28. doi: 18632/oncotarget.8448.
(Impact Factor:6.4)
*Equal contribution
: First Author
2015
Kumar D
, Kandl C, Hamilton C, Shnayder Y, Tsue T, Kakarala K, Ledgerwood L, Sun X S, Huang H, Girod D, Thomas S 2015. Anti-HGF antibody ficlatuzumab mitigates tumor-associated fibroblast-facilitated head and neck cancer progression.
JAMA Otolaryngology-Head & Neck Surgery
. Dec 1;141 (12): 1133-9.
(Impact Factor: 6.2) : First Author
Kumar D
, Gupta D, Shankar S, Srivastava RK. 2015. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
Oncotarget:
1-12.
(Impact Factor:6.4) : First Author
2014
Plotegher N,
Kumar D
, Tessari I, Brucale M, Munari F, et al. 2014. The chaperone-like protein 14-3-3eta interacts with human alpha-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing alpha-synuclein cellular toxicity.
Human Molecular Genetics
. 23:5615-29.
(Impact Factor:5.9)
Kumar D
, Shankar S, Srivastava RK. 2014. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway.
Cancer Letters
. 343:179-89.
(Impact Factor:6.4) : First Author
Kumar D
, Plotegher N, Bubacco L, Brucale M. 2014. Quantitative AFM morphometry of non-fibrillar α- synuclein aggregation products induced by the chaperone-like protein 14-3-3.
Italian Society for Microscopical Sciences
. Vol 21, No 1. DOI: 10.4081/microscopie. 2014.4998.
: First Author
Kumar D
, Shankar S, Srivastava RK. 2014. Understanding the biological functions and therapeutic potentials of stem cells and cancer stem cells: Where are we?
Journal of Cancer Stem Cell Research
. 2:e1002:1-8.
: First Author
2013
Kumar D
, Shankar S, Srivastava RK. 2013. Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms.
Molecular Cancer
. 1476-4598-12-171.
(Impact Factor:27) : First Author
Nanta R,
Kumar D
, Meeker D, Rodova M, Van Veldhuizen PJ, et al. 2013. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rgamma null mice by regulating Bmi-1 and microRNA-128.
Oncogenesis
. 2:e42.
(Impact Factor:5.1)
Shankar S,
Kumar D
, Srivastava 2013. Epigenetic modifications by dietary phytochemicals: Implications for personalized nutrition.
Pharmacol Therapeut
. 138:1-17.
(Impact Factor:11.1)
2012
Pivato M, De Franceschi G, Tosatto L, Frare E,
Kumar D
, et al. 2012. Covalent alpha-synuclein dimers: chemico-physical and aggregation properties.
PloS one
7:e50027.
(Impact Factor:3.4)
Singh BN,
Kumar D
, Shankar S, Srivastava 2012. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells.
Biochemical Pharmacology
. 84:1154-63.
(Impact Factor:6.1)
Conference Proceedings
Tyagi,
D. Kumar
and V. S. Raj, 2018. "In silico identification of potential inhibitors against Mycobacterial proteasome," 2018 International Conference on Bioinformatics and Systems Biology (BSB), Allahabad, India,
IEEE Xplore
, pp. 193-197.
(IF: 10.6)
Shekhar Goyal, Surender Kr Beniwal, H S Kumar,
Dhruv Kumar
, B C Das. 2019. Role of Curcumin in reducing toxicity and adverse effects in locally advanced and metastatic breast cancer patients.
Annals of Oncology
. Volume 30, vi126 - vi127.
(IF: 14)
Book Chapter
Mavi, Anil Kumar, Manmohan Kumar, Amarjeet Singh, Mahendra Kumar Prajapati, Rakhi Khabiya, Saurabh Maru, and
Dhruv Kumar.
"Progress in Non‐Viral Delivery of Nucleic Acid: Advancement in Biomedical Technology." Integration of Biomaterials for Gene Therapy (2023): 281-322.
https://doi.org/10.1002/9781394175635.ch10
Mavi, Anil Kumar, Sonal Gaur, Neelesh Kumar, Avanish Kumar Shrivastav, Sankha Bhattacharya, Sateesh Belemkar, Saurabh Maru, and
Dhruv Kumar
. "Effective Gene Transfer with Non‐Viral Vectors." Integration of Biomaterials for Gene Therapy (2023): 183-222.
https://doi.org/10.1002/9781394175635.ch7
Kirti Agrawal, Malavika Saji,
Dhruv Kumar,
Drug Repurposing in Future Drug Discovery and Development, Book-Drug Repurposing and Computational Drug Discovery, Edition1st Edition 2023, Apple Academic Press, Pages26, eBook ISBN9781003347705,
https://doi.org/10.1201/9781003347705
Kumar, A., Raj, V., Ali, M., Abhinav, Rachamalla, M.,
Kumar, D
., Kumari, A., Kumar, R., Shankar, P. and Ghosh, A., 2023. Evaluation of MOF Applications for Groundwater Arsenic Mitigation of the Middle Ganga Plains of Bihar, India. Metal Organic Frameworks for Wastewater Contaminant Removal, pp.355-373. 26 August 2023,
https://doi.org/10.1002/9783527841523.ch16
Saniya Arfin,
Dhruv Kumar
, Chapter 3 - Use of vitamins and minerals as dietary supplements for better health and cancer prevention, Editor(s): Inamuddin, Tariq Altalhi, Jorddy Neves Cruz, Nutraceuticals, Academic Press, 2023, Pages 53-97, ISBN 9780443191930,
https://doi.org/10.1016/B978-0-443-19193-0.00003-4
.
A Santoshkumar, S Ray, S Narayanan,
D Kumar
, S Harihar (2023), Mitophagy in cancer and cancer stem cells: a role in metabolic reprogramming. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00009-2
T Singh, AS Kharat, B Rathi,
D Kumar
(2023), Designing metabolic target-specific inhibitors for cancer therapy. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00011-0
Sibi Raj, Manish K. Mishra, Sitaram Harihar, Ashok Kumar, Shubhadeep Roychoudhury, Arun Kumar et al. (
2022
). Regulation of Glucose Transporters in Cancer Progression, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_9
Stephen James, Saniya Arfin, Manish K. Mishra, Arun Kumar, Niraj Kumar Jha, Saurabh Kumar Jha et al. (
2022
). Role of Arsenic in Carcinogenesis, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_7
Raj S., Kumar A.,
Kumar D
. (
2020
) Regulation of Glycolysis in Head and Neck Cancer, Book. Cancer Metabolomics, Advances in Experimental Medicine and Biology, Springer Nature.
https://doi.org/10.1007/978-3-030-51652-9_15
Chandel V.,
Kumar D
. (
2020
) Role of Interferon in Cancer Metabolism. Innate Immunity in Health and Disease. IntechOpen.
https://doi.org/10.5772/intechopen.92020
Raj S, Chandel V., Maurya S,
Kumar D
. (
2020
) Role of Macrophages in Solid Tumor Metabolism. Macrophages. IntechOpen.
https://doi.org/10.5772/intechopen.93182
Maurya S, Chandel V, Raj S, (
2020
) OMICS IN CANCER: FROM DIAGNOSTICS TO THERAPEUTICS. Recent Trends in ‘Computational Omics'. ISBN: 978-1-53617-941-5
Raj S., Chandel V.,
Kumar D
. (
2020
) Cancer Cell Metabolism: Solid Tumor Versus Nonsolid Tumor. In:
Kumar D
. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_1
Pedroza D.A. et al. (
2020
) Role of Autophagy in Cancer Cell Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_6
Chandel V., Raj S., Choudhari R.,
Kumar D
. (
2020
) Role of c-Met/HGF Axis in Altered Cancer Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_7
Kumar D
., Sharma-Walia N., Kapoor S., Tandon S. (
2020
) Antibody-Targeted Nanoparticles for Cancer Treatment. In: Saxena S., Khurana S. (eds) NanoBioMedicine. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9898-9_3
Singh B., Malhotra H.,
Kumar D
., Mujtaba S.F., Upadhyay A.K. (
2019
) Understanding Cellular and Molecular Events of Skin Aging and Cancer: An Integrative Perspective. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_2
Tripathi M.K., Sinha J., Srivastava S.K.,
Kumar D
. (
2019
) Bioinformatics in Skin Cancer: A System Biology Approach to Understanding the Molecular Mechanisms and It’s Regulations. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_10
Khurana S., Bose S.,
Kumar D
. (
2019
) Applications of Microarray-Based Technologies in Identifying Disease-Associated Single Nucleotide Variations. In: Tripathi V., Kumar P., Tripathi P., Kishore A., Kamle M. (eds) Microbial Genomics in Sustainable Agroecosystems. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9860-6_4
Singh P., Tiwari D., Mishra M.,
Kumar D
. (
2019
) Molecular Mechanisms of Heavy Metal Toxicity in Cancer Progression. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_3
Chandel V., Seth G., Shukla P.,
Kumar D
. (
2019
) Role of Radiation in DNA Damage and Radiation Induced Cancer. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_1
Dhruv Kumar
, Sharmila Shankar, Rakesh Srivastava. Challenges in stem cells and translational research (Book chapter). Lost in translational and clinical research. World Scientific Publication,
2014
. ISBN: 9789814489089.
https://doi.org/10.1142/9789814489072_0020
Dhruv kumar
and Bruno Samori. Mechanochemistry: Coupling mechanical forces and chemical reactions (Book chapter). Molecular Manipulation with Atomic Force Microscopy (Book), CRC Press,
2011
, ISBN: 9781439809662.
Dwijendra Gupta,
Dhruv Kumar
, Manish Dwivedi, Vijay Tripathi, Pratibha Phadke-Gupta and Surya Pratap Singh. Nanophosphors-Nanogold immunoconjugates in Isolation of Biomembranes and in Drug Delivery (Book chapter). Recent Advances in Nanomedicine (Book), VBRI Press,
2011
, ISBN: 9788192006803.
Book
Dhruv Kumar
, Shailendra Asthana Autophagy and Metabolism Potential Target for Cancer Therapy 1st Edition - August 6, 2022 Paperback ISBN: 9780323998796 9 7 8 - 0 - 3 2 3 - 9 9 8 7 9 - 6 eBook ISBN: 9780323999458
Akhileshwar Srivastava,
Dhruv Kumar
, Divya Singh, Rajesh Singh, Xenobiotics in Chemical Carcinogenesis:Translational Aspects in Toxicology,
Elsevier,
ISBN: 9780323905602
Dhruv kumar.
Cancer Cell Metabolism: A Potential Target for Cancer Therapy.
Springer Nature
.
2020,
ISBN: 9789811519901.
Dhruv kumar
, Marco Brucale and Bruno Samori. Amyloidogenic Proceses of Intrinsically Disordered Proteins: Understanding the Aggregation Process of Intrinsically Unstructured Proteins Related to Neurodegenerative Diseases.
Lambert Academic Publishing
,
2014
, ISBN:
Dhruv kumar
. Insilico analysis of Docking between HIV-1 PR and derivatives of CUI (Docking between HIV- 1 proteases and cyclic urea inhibitors: A step towards drug designing against AIDS).
Lambert Academic Publishing
,
2011
, ISBN:
Contact
dhruv.kumar@ddn.upes.ac.in

Profile Summary
Prof. Dhruv Kumar is a Professor and Cluster Head at the Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun. Listed as a top 2% world’s most influential scientist in the area of Oncology and cancer Biology. His academic journey includes a B.Sc. in Chemistry from Banaras Hindu University (BHU), Varanasi, and M.Sc. in Bioinformatics with Distinction from the University of Allahabad (AU), Prayagraj. Dr. Dhruv Kumar further distinguished himself by completing his Ph.D. in Cellular, Molecular, and Industrial Biology from the University of Bologna (UNIBO), Italy, under the highly prestigious fellowship of the Ministry of Human Resource and Development (MHRD), Indo-Italian Government fellowship. Following the completion of his Ph.D., he embarked on a five-year Postdoctoral training at the School of Medicine, University of Kansas Medical Center, Kansas City, USA. Dr. Kumar's research has been dedicated to several cancer types, including Prostate, Pancreatic, Brain, Breast, and Head and Neck Cancer, with a primary focus on unraveling the molecular mechanisms regulating Autophagy and Apoptosis in Cancer Stem Cells. Currently, his laboratory is actively exploring the Autophagy-Metabolic axis in various cancer cells, such as head and neck, oral, breast, and brain, along with investigating the tumor microenvironment for the development of innovative therapeutic approaches. Notably, his research group has made significant contributions to Drug Designing and Drug Repurposing for COVID-19. Dr. Dhruv Kumar's scholarly contributions are evident in his extensive publication record, with articles featured in prestigious journals such as Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, Seminars in Cancer Biology, JAMA Otolaryngology, Nature Scientific Reports, and many more. Presently, Dr. Kumar is actively engaged in numerous government-funded projects and is mentoring eight Ph.D. students in the areas of Cancer and Infertility. Beyond his research endeavors, he plays a vital role in teaching courses at the undergraduate (UG), postgraduate (PG), and Ph.D. levels, covering subjects related to Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics.
Work Experience
Prof. Dhruv Kumar possesses over 15 years of extensive experience encompassing teaching, research, and administrative roles. His professional journey is outlined as follows:
06/22-Present: Professor & Cluster Head, Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand, India.
01/21-06/22: Professor & Assistant Director, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
07/19-12/20: Associate Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
04/17-07/19: Assistant Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
08/16-04/17: Assistant Professor, Department of Bioinformatics, SRM University, Delhi-NCR, Sonepat, Haryana, India.
03/12-06/16: Postdoctoral Fellow, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
In these diverse roles, Prof. Kumar has demonstrated his commitment to academia, contributing significantly to various institutions and enhancing his expertise in the fields of Molecular Medicine, Cancer Biology, Stem Cell Research, and Bioinformatics. His journey includes pivotal positions such as Assistant Professor at SRM University and various roles at Amity University Uttar Pradesh, showcasing his dedication to fostering education and research. Currently serving as a Professor and Cluster Head at UPES, Dehradun, he continues to make substantial contributions to the academic and research landscape.
Research Interests
Prof. Dhruv Kumar boasts an extensive and diverse research portfolio spanning over various critical domains in biomedical science. With over 15 years of profound expertise, he has significantly contributed to Translational Cancer Research, unraveling novel insights that bridge the gap between fundamental discoveries and clinical applications. His dedicated exploration into Cancer Stem Cells has shed light on the molecular intricacies governing these cells. Prof. Kumar's investigations into Cancer Cell Metabolism reveal a nuanced understanding of metabolic alterations in cancer cells, potentially paving the way for innovative therapeutic strategies. Additionally, his work on the Tumor Microenvironment and Tumor Heterogeneity delves into the complex interplay and diversity within cancer populations. His research illuminates the regulatory mechanisms of Autophagy and the role of Exosomes in cancer, offering crucial perspectives on cellular recycling and intercellular communication. Beyond cancer biology, Prof. Kumar's foray into Infertility research explores molecular factors underlying reproductive challenges. Proficient in Genome Editing and NGS Data Analysis, he navigates cutting-edge genetic technologies. His involvement in Drug Repurposing and Drug Discovery underscores an innovative approach to therapeutics, while his recent contributions in COVID-19 research showcase adaptability to contemporary health challenges. Prof. Kumar's overarching mastery in Bioinformatics strategically integrates computational methods, enhancing the comprehensive interpretation of complex biological data.
Teaching Philosophy
Prof. Dhruv Kumar's teaching philosophy is characterized by innovation and inclusivity. He employs a blended teaching approach that seamlessly integrates traditional methods with modern technologies, creating a dynamic and engaging learning environment. One notable aspect is his commitment to discussing cutting-edge research topics, including those recognized with Nobel Prizes, providing students with insights into the forefront of scientific inquiry. Prof. Kumar takes an innovative approach to support slow learners, implementing strategies such as pairing them with a buddy for personalized assistance, arranging expert lectures, fostering group discussions, and emphasizing hands-on training and practical experiences. By tailoring his teaching methods to diverse learning styles and providing additional support mechanisms, Prof. Kumar ensures that every student, regardless of pace, has the opportunity to thrive academically and develop a passion for lifelong learning.
Courses Taught
Prof. Dhruv Kumar has a genuine passion for teaching and a deep commitment to fostering meaningful interactions with students, creating a vibrant and engaging educational environment. With an extensive background in teaching, he has imparted knowledge across various courses at the undergraduate (UG), postgraduate (PG), and doctoral (PhD) levels. Prof. Kumar's enthusiasm for sharing new ideas and insights has been a cornerstone of his teaching approach, inspiring students to explore innovative concepts and contributing to a dynamic and intellectually stimulating learning atmosphere. His continuous dedication to teaching underscores not only his expertise in the subject matter but also his unwavering commitment to nurturing the intellectual growth of students at all levels.
Undergraduate Level (B.Sc.)
Basic Bioinformatics (BIOF202)
Basics of Cancer (BIOT223)
Cell (MMBS104)
Metals in Biology (MMBS201)
Metabolism (MMBS205)
Scientific Writing (HSCC2019)
Postgraduate Level (M.Sc.)
Animal Cell Culture & Cell Engineering (SCCB601)
Assisted Reproductive Laboratory Procedures (RTCE605)
Cancer Pharmacogenomics (SCCB704)
Computational Tools in Drug Discovery (MMBS702)
Genome Engineering & Editing (SCCB603)
OMICS in Biomedical Sciences (SCCB710)
Preventive Oncology & Psycho-Oncology (SCCB705)
Reproductive & Developmental Biology and Genetics (RTCE604)
Topics in Bioinformatics (MMBS610)
Trends in Molecular Oncology (SCCB901)
Stem Cell Bio II (SCCB 707)
Scientific Writing (HSCC8007)
Good manufacturing and Lab Practices (HSCC8008)
Biosafety and Aseptic Techniques (HSMB 7024)
PhD Level
Advances in Molecular Medicine (BIOT 955) at Institute Level
Trends in Molecular Oncology (BIOT 953) at Institute Level
Research and Publication Ethics” (RPE) –(PHD901) at University Level
Awards and Grants:
Prof. Dhruv Kumar has received several national and international awards and grants as mentioned below.
Awards:
2020: Research Excellence Award, Institute of Scholars, India
2019: Senior Scientist Award, Society of Biomedical Laboratory Scientists, India
2017: Early Career Research Award, SERB, DST-India.
2016: Postdoc of the Month Award, PostDoc Journal: Journal of Postdoctoral Research, USA.
2016: Scholar-in-Training Award, AACR, The Function of Tumor Microenvironment in Cancer Progression Conference, San Diego, USA.
2015: K-INBRE Postdoctoral Award, National Institute of General Medical Sciences, National Institute of Health (NIH), USA.
2011: 8th EBSA European Biophysics Congress Bursaries Award, European Biophysical Societies Association, Italy.
2011: Young Scientist Award, International Academy of Physical Science, Allahabad, India.
2009: Brains in Competition Award, Institute of Advance Studies, University of Bologna, Italy.
2008: Indo-Italian Government Scholarship (Ministry of Human Resource and Development, India).
Grants:
2022-2025: “Analysis of the relationship between gallbladder cancer, arsenic intake, and living-environmental factors - a case in Bihar, India”, Indo-Japan, Government of Japan, Rs 100 lakh (Co-PI): Ongoing
2021-2024: “Repurposing of drugs and validation of lead compounds against main protease and RNA dependent RNA polymerase of SARS-CoV-2”, BRICS-DST, Rs 74 lakh (PI & Coordinator): Ongoing
2020-2023: “Assessment of Female reproductive health and child health risks in Arsenic Exposed population of Bihar”, ICMR New Delhi, Rs ~ 1 Crore. (Co-PI): Ongoing
2018-2021: “Understanding the Metabolic Cross-Talk between Head and Neck Squamous Cell Carcinoma and Tumor Associated Fibroblasts”, SERB-Department of Science and Technology, Government of India, Rs ~35 Lakhs. (PI): Completed
2015-2016: “Role of Tumor-Associated Fibroblasts in Head and Neck Cancer Metabolism” National Institute of General Medical Sciences, National Institute of Health, USA (P20GM103418), $25,000. (PI): Completed
Scholarly Activities
Prof. Dhruv Kumar, has a rich portfolio of scholarly activities spanning teaching, research, and academic contributions. He actively engages in designing and instructing courses at various academic levels, including undergraduate (UG), postgraduate (PG), and doctoral (PhD) programs, covering specialized areas such as Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics. Prof. Kumar's research endeavors have resulted in numerous publications in high-impact journals, including Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, and Nature Scientific Reports. He has received recognition on both national and international platforms, garnering awards such as the Senior Scientist Award from the Society of Biomedical Laboratory Scientists, India, the Scholar-in-Training Award from the American Association for Cancer Research (AACR), USA, and the K-INBRE Postdoctoral Award from the National Institute of Health (NIH), USA. Additionally, his active involvement in government-funded projects and mentorship of PhD students in the fields of Cancer and Infertility reflects his commitment to advancing knowledge and nurturing the next generation of researchers. Prof. Kumar's scholarly activities exemplify a holistic approach to academia, seamlessly integrating teaching, research, and mentorship.
His selected publications are as below:
2023
Agrawal, K.; Asthana, S.;
Kumar, D
. Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer. Cancers 2023, 15, 4920.
https://doi.org/10.3390/cancers15204920
.
(Impact Factor: 5.2)
Maurya, S., Raj, S., Bhoi, N.R., Mani, N., Rathi, B. and
Kumar, D
., 2023. Morphological analysis of metabolically dysregulated spermatozoa using Artificial Intelligence based approach. Journal of Integrated Science and Technology, 11(4), pp.569-569.
(Impact Factor: 1.14)
Raj, S. and
Kumar, D.
, 2023. Early epigenetic markers for precision medicine. Progress in molecular biology and translational science, 198, pp.153-164.
(Impact Factor: 4.0)
Kumar, A., Ali, M., Raj, V., Kumari, A., Rachamalla, M., Niyogi, S.,
Kumar, D.
, Sharma, A., Saxena, A., Panjawani, G. and Jain, P., 2023. Arsenic causing gallbladder cancer disease in Bihar. Scientific Reports, 13(1), p.4259.
(Impact Factor: 4.9)
Goel, M., Mishra, M.K. and
Kumar, D
., 2023. Recent advances in Targeted Radionuclide therapy for Cancer treatment. Chemical Biology Letters, 10(3), pp.544-544.
(Impact Factor: 6.1)
Bhattacharjee, R., Prabhakar, N., Kumar, L., Bhattacharjee, A., Kar, S., Malik, S.,
Kumar, D
., Ruokolainen, J., Negi, A., Jha, N.K. and Kesari, K.K., 2023. Crosstalk between long noncoding RNA and microRNA in Cancer. Cellular Oncology, pp.1-24.
(Impact Factor: 6.6)
Kumar, A., Kumar, K., Ali, M., Raj, V., Srivastava, A., Kumar, M., Niraj, P.K., Kumar, M., Kumar, R.,
Kumar, D.
and Bishwapriya, A., 2023. Severe Disease Burden and the Mitigation Strategy in the Arsenic-Exposed Population of Kaliprasad Village in Bhagalpur District of Bihar, India. Biological trace element research, pp.1-17.
(Impact Factor: 4.0)
Arfin, S.;
Kumar, D
.; Lomagno, A.; Mauri, P.L.; Di Silvestre, D. Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis. Cancers 2023, 15, 4420.
https://doi.org/10.3390/cancers15174420
(Impact Factor: 5.2)
Arfin S, Agrawal K, Maurya S, Asthana S, Di Silvestre
D, Kumar D
. Lead phytochemicals and marine compounds against ceruloplasmin in cancer targeting. Journal of Biomolecular Structure and Dynamics. 2023 Oct 18.
(Impact Factor: 5.2)
Agrawal K, Chakraborty P, Dewanjee S, Arfin S, Das SS, Dey A, Moustafa M, Mishra PC, Jafari SM, Jha NK, Jha SK,
Kumar D
. Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders. Neurosci Biobehav Rev. 2023 Jan;144:104955. doi: 10.1016/j.neubiorev.2022.104955. Epub 2022 Nov 14. PMID: 36395983.
(Impact Factor: 9.0)
Agrawal K, Chauhan S,
Kumar D
. Expression analysis and regulation of GLI and its correlation with stemness and metabolic alteration in human brain tumor. 3 Biotech. 2023 Jan;13(1):10. doi: 10.1007/s13205-022-03419-5. Epub 2022 Dec 15. PMID: 36532860; PMCID: PMC9755437.
(Impact Factor: 2.9)
Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A,
Kumar D
, Ambasta RK, Jha NK, Jha SK, Dewanjee S. Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Res Rev. 2023 Mar;85:101838. doi: 10.1016/j.arr.2022.101838. Epub 2023 Jan 5. PMID: 36610558.
(Impact Factor: 11.7)
Raj, S., Rathi, B., Mehra, P., Asthana, S., &
Kumar, D
. (2023). Deciphering the role of c-MET in Metabolic reprogramming of Head and Neck squamous cell Carcinoma via In Silico analysis. Chemical Biology Letters, 10(2), 532. Retrieved from
https://pubs.thesciencein.org/journal/index.php/cbl/article/view/532
(Impact Factor: 4.4)
2022
Awasthi P, Dwivedi M, Kumar D, Hasan S. Insights into intricacies of the Latent Membrane Protein-1 (LMP-1) in EBV-associated cancers. Life Sci. 2023 Jan 15;313:121261. doi: 10.1016/j.lfs.2022.121261. Epub 2022 Dec 7. PMID: 36493876.
(Impact Factor: 3.3)
Sharma S, Tyagi R, Srivastava M, Rani K,
Kumar D
, Asthana S, Raj VS. Identification and validation of potent inhibitor of Escherichia coli DHFR from MMV pathogen box. J Biomol Struct Dyn. 2022 Jun 2:1-10. doi: 10.1080/07391102.2022.2080113. Epub ahead of print. PMID: 35652895.
(Impact Factor: 3.3)
Maurya S, Kesari KK, Roychoudhury S, Kolleboyina J, Jha NK, Jha SK, Sharma A, Kumar A, Rathi B, Kumar D. Metabolic Dysregulation and Sperm Motility in Male Infertility. Adv Exp Med Biol. 2022;1358:257-273. doi: 10.1007/978-3-030-89340-8_12. PMID: 35641874.
(Impact Factor: 2.6)
Das S, Roychoudhury S, Dey A, Jha NK, Kumar D, Roychoudhury S, Slama P, Kesari KK. Bacteriospermia and Male Infertility: Role of Oxidative Stress. Adv Exp Med Biol. 2022;1358:141-163. doi: 10.1007/978-3-030-89340-8_7. PMID: 35641869.
(Impact Factor: 2.6)
Arfin, S. .; Mani, N. .; Rathi, B.; Kumar, D. In Silico Analysis of Ceruloplasmin Alteration in Oral Squamous Cell Carcinoma. Chem Biol Lett 2022, 9, 342.
(Impact Factor: 4.4)
Jha NK, Arfin S, Jha SK, Kar R, Dey A,
Kumar D
. et al. Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling Semin Cancer Biol. 2022 Feb 23:S1044-579X(22)00049-9.
https://doi.org/10.1016/j.semcancer.2022.02.022
.
(Impact Factor: 17)
Raj S, Kesari KK, Kumar A, Rathi B, Sharma A, Gupta PK, Jha SK, Jha NK, Slama P, Roychoudhury S,
Kumar D
. Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. Molecular Cancer (BMC-Springer Nature). 2022. 26;21(1):31.
https://doi.org/10.1186/s12943-022-01503-1
(Impact Factor: 41.4): Corresponding Author
Pritam P, Deka R,
Kumar D
. et al.. Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects. Biology-MDPI. 2022. 11(2), 212.
https://doi.org/10.3390/biology11020212
(Impact Factor: 5.0)
Kumar, A.
Kumar D
. et al..Assessment of disease burden in the arsenic exposed population of Chapar village of Samastipur district, Bihar, India, and related mitigation initiative.
Environmental Science and Pollution Research.
https://doi.org/10.1007/s11356-021-18207-6
(Impact Factor: 4.3)
2021
Upadhyay C.
Kumar D
. et al.. Synthesis of the new analogs of morpholine and their antiplasmodial evaluation against the human malaria parasite Plasmodium falciparum.
New Journal of Chemistry
. 2021.
https://doi.org/10.1039/D1NJ04198C
(Impact Factor: 3.4)
Singh A, Singh AK, Giri R,
Kumar D
, Sharma R, Valis M, Kuca K, Garg N. The role of microRNA-21 in the onset and progression of cancer.
Future Med Chem
. 2021 Nov;13(21): 1885-1906.
https://doi.org/10.4155/fmc-2021-0096
.
(Impact Factor: 3.9)
Jeyaraman Madhan ,Muthu Sathish ,
Kumar D
. et al. “Total Stromal Fraction (TSF) - Fortified Adipose Tissue-Derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary Compromise”,
Coronaviruses
2021; e080921196287.
https://doi.org/10.2174/2666796702666210908151708
.
(Impact Factor: 0.0)
Asif Ali, Saleheen Bano,
Kumar D
. et al. (2021) Effect of cellulose nanocrystals on chitosan/PVA/nano β-TCP composite scaffold for bone tissue engineering application,
Journal of Biomaterials Science, Polymer Edition
,
https://doi.org/10.1080/09205063.2021.1973709
.
(Impact Factor: 3.5)
Mehreen Aftab, Maryam Ghufran,
Kumar D
. et al., In silico analysis of the role of hsa-miR-155-5p in cervical cancer, Chem. Biol. Lett. 2021, 8(3), 94-105.
(Impact Factor: 4.4) : Corresponding Author
Usman, M.B., Bhardwaj, S., Roychoudhury, S.
Kumar D
. et al.. Immunotherapy for Alzheimer’s Disease: Current Scenario and Future Perspectives.
J Prev Alzheimers Dis
8, 534–551 (2021).
https://doi.org/10.14283/jpad.2021.52
(Impact Factor: 4.4)
Sharma, P.P., Bansal, M., Sethi, A., Pena, L.,
Kumar D
. et al., 2021. Computational methods directed towards drug repurposing for COVID-19: advantages and limitations.
RSC Advances
, 11(57), pp.36181-36198.
https://doi.org/10.1039/D1RA05320E
(Impact Factor: 3.3)
Goyal, K.; Goel, H.; Baranwal, P.; Tewary, A.;
Kumar D
. et al.. Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans. Immuno 2021, 1, 442-456.
https://doi.org/10.3390/immuno1040032
(Impact Factor: 0.0)
Sharma A,
Kumar D
, Dahiya K, Hawthorne S, Jha SK, Jha NK, Nand P, Girgis S, Raj S, Srivastava R, Goswami VK, Gregoriou Y, El-Zahaby SA, Ojha S, Dureja H, Gupta G, Singh S, Chellappan DK, Dua K. Advances in pulmonary drug targeting microbial biofilms in respiratory diseases. Nanomedicine (Lond). 2021 Aug 5. delivery
https://doi.org/10.2217/nnm-2021-0057
.
(Impact Factor: 5.3): : Corresponding Author
Jeyaraman M, Muthu S, Bapat A,
Kumar D
. et al.. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon. 2021 Jul;7(7):e07635.
https://doi.org/10.1016/j.heliyon.2021.e07635
.
(Impact Factor: 1.8)
Sharma A, Hawthorne S, Jha SK, Jha NK,
Kumar D
, Girgis S, Goswami VK, Gupta G, Singh S, Dureja H, Chellappan DK, Dua K. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDAMB231 human breast cancer cells. Nanomedicine (Lond). 2021 Aug;16(20):1763-1773.
https://doi.org/10.2217/nnm-2021-0066
.
(Impact Factor: 5.3)
Chandel V, Maru S, Kumar A, Kumar A, Sharma A, Rathi B,
Kumar D
. Role of monocarboxylate transporters in head and neck squamous cell carcinoma. Life Sciences. 2021, 5;279:119709.
https://doi.org/10.1016/j.lfs.2021.119709
.
(Impact Factor: 3.6) : Corresponding Author
Raj S, Kumar A,
Kumar D
. Regulation of Glycolysis in Head and Neck Cancer. Adv Exp Med Biol. 2021;1280:219-230.
https://doi.org/10.1007/978-3-030-51652-9_15
.
(Impact Factor: 2.4) : Corresponding Author
Vaishali Chandel, Garima Tripathi, Seema A. Nayar, Brijesh Rathi, Abhijeet Kumar &
Dhruv Kumar
(2021) In silico identification and validation of triarylchromones as potential inhibitor against main protease of severe acute respiratory syndrome coronavirus 2,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1918255
.
(Impact Factor: 3.2) : Corresponding Author
Rashmi Tyagi, Mitul Srivastava, Baldeep Singh, Shingini Sharma, Ramendra Pati Pandey, Shailendra Asthana,
Dhruv Kumar
& V. Samuel Raj (2021) Identification and validation of potent Mycobacterial proteasome inhibitor from Enamine library,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1914173
.
(Impact Factor: 3.2) : Corresponding Author
Mathur, A., Raj, S., Jha, N.K. et al. Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2.
3 Biotech
11, 236 (2021).
https://doi.org/10.1007/s13205-021-02791-y
.
(Impact Factor: 2.2) : Corresponding Author
Arfin, S.; Jha, N.K.; Jha, S.K.; Kesari, K.K.; Ruokolainen, J.; Roychoudhury, S.; Rathi, B.;
Kumar, D
. Oxidative Stress in Cancer Cell Metabolism.
Antioxidants
2021, 10, 642.
https://doi.org/10.3390/antiox10050642
.
(Impact Factor: 5) : Corresponding Author
Kumar A, Kumar R, Rahman MS, Ali M, Kumar R, Nupur N, Gaurav A, Raj V, Anand G, Niraj PK, Kumar N, Srivastava A, Biswapriya A, Chand GB,
Kumar D
, Rashmi T, Kumar S, Sakamoto M, Ghosh AK. Assessment of arsenic exposure in the population of Sabalpur village of Saran District of Bihar with mitigation approach.
Environ Sci Pollut Res Int.
2021 Apr 11.
https://doi.org/10.1007/s11356-021-13521-5
(Impact Factor: 4.3)
Kumar, A., Rahman, M.S., Ali, M. et al. Assessment of arsenic exposure and its mitigation intervention in severely exposed population of Buxar district of Bihar, India.
Environ. Health Sci.
(2021).
https://doi.org/10.1007/s13530-021-00086-6
(Impact Factor: .76)
Chandel V., et al. 2021. In silico identification of potential inhibitor for TP53-induced glycolysis and apoptosis regulator in head and neck squamous cell carcinoma.
3Biotech
. 11(3):117.
https://doi.org/10.1007/s13205-021-02665-3
(Impact Factor: 2.2) : Corresponding Author
2020
Kumar A., et al. 2020. Arsenic exposure causing cancer in the Indo - Gangetic Plain - A 2000 cancer patients’ cross-sectional design.
Scientific Reports
. 11, 2376 (2021).
https://doi.org/10.1038/s41598-021-81579-9
.
(Impact Factor: 4.1)
Roychoudhury S., et al. 2020. Viral pathogenesis of SARS-CoV-2 infection and male reproductive health: Myth or fact?
Open Biology
. 11(1): 200347,
https://doi.org/10.1098/rsob.200347
(Impact Factor: 4.9)
Jha N K., et al. 2020. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS‑CoV‑2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Journal of Molecular Neuroscience.
https://doi.org/10.1007/s12031-020-01767-6
.
(Impact Factor: 2.8)
Ali A., et al. 2020. Comparative analysis of TiO2 and Ag nanoparticles on xylan/chitosan conjugate matrix for wound healing application.
International Journal of Polymeric Materials and Polymeric Biomaterials.
https://doi.org/10.1080/00914037.2020.1838519
(Impact Factor: 1.9)
Kumar D., et al. 2020. Stem Cell Based Preclinical Drug Development and Toxicity Prediction.
Current Pharmaceutical Design
.
https://doi.org/10.2174/1381612826666201019104712
(Impact Factor: 2.4) : Corresponding Author
Tyagi R., et al. 2020. Development of potential proteasome inhibitors against Mycobacterium tuberculosis.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1835722
(Impact Factor: 3.2) : Corresponding Author
Narula S, Tandon S, Kumar D et al. 2020. Human kidney stone matrix proteins alleviate hyperoxaluria induced renal stress by targeting cell-crystal interactions.
Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118498
(Impact Factor: 3.6)
Satyam R, Jha NK, Kar R et al. 2020. Deciphering the SSR incidences across viral members of Coronaviridae family.
Chemico-Biological Interactions.
https://doi.org/10.1016/j.cbi.2020.109226
(Impact Factor: 3.6)
Chandel V, Raj S, Rathi B, Choudhary R,
Kumar D
. 2020. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1811773
(Impact Factor: 3.2) : Corresponding Author
Manish D., Vijay T., Kumar D., et al. 2020. Structural and Morphological Characterization of CdS Nanoparticles,
Current Physical Chemistry.
https://doi.org/10.2174/1877946810999200730222025
(Impact Factor: 1.6)
Raj S, Chandel V, et al. 2020 Molecular mechanisms of interplay between autophagy and metabolism in cancer
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118184
(Impact Factor: 3.6) : Corresponding Author
Chandel V, Raj S, et al. 2020. Metabolic regulation in HPV associated head and neck squamous cell carcinoma
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118236
(Impact Factor: 3.6) : Corresponding Author
Chandel V,
Kumar D
. 2020. Targeting Signalling Cross-Talk between Cancer Cells and Cancer Associate Fibroblast through Monocarboxylate Transporters in Head and Neck Cancer
,Anti-Cancer Agents in Medicinal Chemistry
:
Bentham Science Publishers
,
https://doi.org/10.2174/1871520620666200721135230
(Impact Factor: 2.04) : Corresponding Author
Kumar S, Sharma PP, Shankar U,
Kumar D
et al. 2020. Discovery of New Hydroxyethylamine Analogs against 3CL pro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies.
J Chem Inf Model.
https://doi.org/10.1021/acs.jcim.0c00326
(Impact Factor: 4.5)
Pandey V, Tripathi G,
Kumar D
et al. 2020. Novel 3,4-diarylpyrazole as prospective anti-cancerous agents,
Helion
,
https://doi.org/10.1016/j.heliyon.2020.e04397
(Impact Factor: 1.6) : Corresponding Author
Chandel V, Raj S, Rathi B,
Kumar D
. 2020. In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach.
Chemical Biology Letters
. 7(3), 166‐175.
(Impact Factor: 4.4) : Corresponding Author
Chandel V, Raj S, Srivastava A,
Kumar D
. 2020. In-silico interactions of active Phytochemicals with c-MYC EGFR and ERBB2 oncoproteins.
Chemical Biology Letters
. 7(1), 47‐54.
(Impact Factor: 4.4) : Corresponding Author
Raj S, Chandel V, Rathi B,
Kumar D
. 2020. Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach, Coronavirus: Bentham Science Publishers, DOI : 10.2174/2666796701999200617155013
: Corresponding Author
2019
Sibi Raj, Sartaj Khuranaa, Ramesh Choudhari et al. 2019. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
Seminars in Cancer Biology
https://doi.org/10.1016/j.semcancer.2019.11.002
.
(Impact Factor: 15) : Corresponding Author
Anukriti, Anupam D, Swati U, Pallavi S, et al. 2019. Investigation of Precise Molecular Mechanistic Action of Tobacco-Associated Carcinogen ‘NNK’ Induced Carcinogenesis: A System Biology Approach. 10(8), 564.
(Impact Factor: 3.4)
Asif A, Saleheen B, Satish S.P,
Kumar D
, Yuvraj S N, 2019. Effect of incorporation of Montmorillonite on Xylan/Chitosan conjugate scaffold.
Colloids and Surfaces B: Biointerfaces
1(180) 75-82.
(Impact Factor: 3.9)
Vishwakarma V, New J1,
Kumar D,
et al.,
Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds.
Scientific Reports
. 15;8(1):12163.
(Impact Factor: 4.1)
Chandel V and Kumar D. 2019. The Development of Tumor Heterogeneity and Actively Targeting Therapy Resistant Subpopulations
. J Embryol Stem Cell Res
. 3(3): 000131
: Corresponding Author
2018
Kumar D, et al.,
2018
.
Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression.
Cancer Research
. 10.1158/0008-5472.CAN-17-1076.
(Impact Factor: 12) : First Author
Kumar D
, et al. Perfluoro Curcumin Strongly Interacts with ABC Transporter (ABCG2): A Molecular Docking Study.
J Embryol Stem Cell Res
2018, 2(2): 000113.
: Corresponding Author
Kumar D
. 2018. Resveratrol derivative triacetyl-resveratrol interacts directly with the Gli-DNA zinc finger complex.
J Cancer Res Oncobiol
. Apr; 1(2):110
: Corresponding Author
2017
Kumar D
, et al., 2017. Development and characterization of an in vitro model for radiation-induced fibrosis,.
Radiation Research
. 189(3):326-336
(Impact Factor: 2.5) : First Author
Kumar D
, 2017. Role of tumor heterogeneity in drug resistance.
Glob J Cancer Ther
3(2): 032-033. (Editorial).
: Corresponding Author
Kumar D
, 2017. Regulation of glycolysis in head and neck squamous cell carcinoma
. Postdoc Journal
. 2017 Jan;5 (1):14-28.
: Corresponding Author
2016
Ledgerwood LG*,
Kumar D*,
Eterovic AK, Wick J et al., 2016. The degree of intra-tumor mutational heterogeneity varies by primary tumor sub-site.
Oncotarget
. Mar 28. doi: 18632/oncotarget.8448.
(Impact Factor:6.4)
*Equal contribution
: First Author
2015
Kumar D
, Kandl C, Hamilton C, Shnayder Y, Tsue T, Kakarala K, Ledgerwood L, Sun X S, Huang H, Girod D, Thomas S 2015. Anti-HGF antibody ficlatuzumab mitigates tumor-associated fibroblast-facilitated head and neck cancer progression.
JAMA Otolaryngology-Head & Neck Surgery
. Dec 1;141 (12): 1133-9.
(Impact Factor: 6.2) : First Author
Kumar D
, Gupta D, Shankar S, Srivastava RK. 2015. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
Oncotarget:
1-12.
(Impact Factor:6.4) : First Author
2014
Plotegher N,
Kumar D
, Tessari I, Brucale M, Munari F, et al. 2014. The chaperone-like protein 14-3-3eta interacts with human alpha-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing alpha-synuclein cellular toxicity.
Human Molecular Genetics
. 23:5615-29.
(Impact Factor:5.9)
Kumar D
, Shankar S, Srivastava RK. 2014. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway.
Cancer Letters
. 343:179-89.
(Impact Factor:6.4) : First Author
Kumar D
, Plotegher N, Bubacco L, Brucale M. 2014. Quantitative AFM morphometry of non-fibrillar α- synuclein aggregation products induced by the chaperone-like protein 14-3-3.
Italian Society for Microscopical Sciences
. Vol 21, No 1. DOI: 10.4081/microscopie. 2014.4998.
: First Author
Kumar D
, Shankar S, Srivastava RK. 2014. Understanding the biological functions and therapeutic potentials of stem cells and cancer stem cells: Where are we?
Journal of Cancer Stem Cell Research
. 2:e1002:1-8.
: First Author
2013
Kumar D
, Shankar S, Srivastava RK. 2013. Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms.
Molecular Cancer
. 1476-4598-12-171.
(Impact Factor:27) : First Author
Nanta R,
Kumar D
, Meeker D, Rodova M, Van Veldhuizen PJ, et al. 2013. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rgamma null mice by regulating Bmi-1 and microRNA-128.
Oncogenesis
. 2:e42.
(Impact Factor:5.1)
Shankar S,
Kumar D
, Srivastava 2013. Epigenetic modifications by dietary phytochemicals: Implications for personalized nutrition.
Pharmacol Therapeut
. 138:1-17.
(Impact Factor:11.1)
2012
Pivato M, De Franceschi G, Tosatto L, Frare E,
Kumar D
, et al. 2012. Covalent alpha-synuclein dimers: chemico-physical and aggregation properties.
PloS one
7:e50027.
(Impact Factor:3.4)
Singh BN,
Kumar D
, Shankar S, Srivastava 2012. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells.
Biochemical Pharmacology
. 84:1154-63.
(Impact Factor:6.1)
Conference Proceedings
Tyagi,
D. Kumar
and V. S. Raj, 2018. "In silico identification of potential inhibitors against Mycobacterial proteasome," 2018 International Conference on Bioinformatics and Systems Biology (BSB), Allahabad, India,
IEEE Xplore
, pp. 193-197.
(IF: 10.6)
Shekhar Goyal, Surender Kr Beniwal, H S Kumar,
Dhruv Kumar
, B C Das. 2019. Role of Curcumin in reducing toxicity and adverse effects in locally advanced and metastatic breast cancer patients.
Annals of Oncology
. Volume 30, vi126 - vi127.
(IF: 14)
Book Chapter
Mavi, Anil Kumar, Manmohan Kumar, Amarjeet Singh, Mahendra Kumar Prajapati, Rakhi Khabiya, Saurabh Maru, and
Dhruv Kumar.
"Progress in Non‐Viral Delivery of Nucleic Acid: Advancement in Biomedical Technology." Integration of Biomaterials for Gene Therapy (2023): 281-322.
https://doi.org/10.1002/9781394175635.ch10
Mavi, Anil Kumar, Sonal Gaur, Neelesh Kumar, Avanish Kumar Shrivastav, Sankha Bhattacharya, Sateesh Belemkar, Saurabh Maru, and
Dhruv Kumar
. "Effective Gene Transfer with Non‐Viral Vectors." Integration of Biomaterials for Gene Therapy (2023): 183-222.
https://doi.org/10.1002/9781394175635.ch7
Kirti Agrawal, Malavika Saji,
Dhruv Kumar,
Drug Repurposing in Future Drug Discovery and Development, Book-Drug Repurposing and Computational Drug Discovery, Edition1st Edition 2023, Apple Academic Press, Pages26, eBook ISBN9781003347705,
https://doi.org/10.1201/9781003347705
Kumar, A., Raj, V., Ali, M., Abhinav, Rachamalla, M.,
Kumar, D
., Kumari, A., Kumar, R., Shankar, P. and Ghosh, A., 2023. Evaluation of MOF Applications for Groundwater Arsenic Mitigation of the Middle Ganga Plains of Bihar, India. Metal Organic Frameworks for Wastewater Contaminant Removal, pp.355-373. 26 August 2023,
https://doi.org/10.1002/9783527841523.ch16
Saniya Arfin,
Dhruv Kumar
, Chapter 3 - Use of vitamins and minerals as dietary supplements for better health and cancer prevention, Editor(s): Inamuddin, Tariq Altalhi, Jorddy Neves Cruz, Nutraceuticals, Academic Press, 2023, Pages 53-97, ISBN 9780443191930,
https://doi.org/10.1016/B978-0-443-19193-0.00003-4
.
A Santoshkumar, S Ray, S Narayanan,
D Kumar
, S Harihar (2023), Mitophagy in cancer and cancer stem cells: a role in metabolic reprogramming. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00009-2
T Singh, AS Kharat, B Rathi,
D Kumar
(2023), Designing metabolic target-specific inhibitors for cancer therapy. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00011-0
Sibi Raj, Manish K. Mishra, Sitaram Harihar, Ashok Kumar, Shubhadeep Roychoudhury, Arun Kumar et al. (
2022
). Regulation of Glucose Transporters in Cancer Progression, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_9
Stephen James, Saniya Arfin, Manish K. Mishra, Arun Kumar, Niraj Kumar Jha, Saurabh Kumar Jha et al. (
2022
). Role of Arsenic in Carcinogenesis, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_7
Raj S., Kumar A.,
Kumar D
. (
2020
) Regulation of Glycolysis in Head and Neck Cancer, Book. Cancer Metabolomics, Advances in Experimental Medicine and Biology, Springer Nature.
https://doi.org/10.1007/978-3-030-51652-9_15
Chandel V.,
Kumar D
. (
2020
) Role of Interferon in Cancer Metabolism. Innate Immunity in Health and Disease. IntechOpen.
https://doi.org/10.5772/intechopen.92020
Raj S, Chandel V., Maurya S,
Kumar D
. (
2020
) Role of Macrophages in Solid Tumor Metabolism. Macrophages. IntechOpen.
https://doi.org/10.5772/intechopen.93182
Maurya S, Chandel V, Raj S, (
2020
) OMICS IN CANCER: FROM DIAGNOSTICS TO THERAPEUTICS. Recent Trends in ‘Computational Omics'. ISBN: 978-1-53617-941-5
Raj S., Chandel V.,
Kumar D
. (
2020
) Cancer Cell Metabolism: Solid Tumor Versus Nonsolid Tumor. In:
Kumar D
. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_1
Pedroza D.A. et al. (
2020
) Role of Autophagy in Cancer Cell Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_6
Chandel V., Raj S., Choudhari R.,
Kumar D
. (
2020
) Role of c-Met/HGF Axis in Altered Cancer Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_7
Kumar D
., Sharma-Walia N., Kapoor S., Tandon S. (
2020
) Antibody-Targeted Nanoparticles for Cancer Treatment. In: Saxena S., Khurana S. (eds) NanoBioMedicine. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9898-9_3
Singh B., Malhotra H.,
Kumar D
., Mujtaba S.F., Upadhyay A.K. (
2019
) Understanding Cellular and Molecular Events of Skin Aging and Cancer: An Integrative Perspective. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_2
Tripathi M.K., Sinha J., Srivastava S.K.,
Kumar D
. (
2019
) Bioinformatics in Skin Cancer: A System Biology Approach to Understanding the Molecular Mechanisms and It’s Regulations. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_10
Khurana S., Bose S.,
Kumar D
. (
2019
) Applications of Microarray-Based Technologies in Identifying Disease-Associated Single Nucleotide Variations. In: Tripathi V., Kumar P., Tripathi P., Kishore A., Kamle M. (eds) Microbial Genomics in Sustainable Agroecosystems. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9860-6_4
Singh P., Tiwari D., Mishra M.,
Kumar D
. (
2019
) Molecular Mechanisms of Heavy Metal Toxicity in Cancer Progression. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_3
Chandel V., Seth G., Shukla P.,
Kumar D
. (
2019
) Role of Radiation in DNA Damage and Radiation Induced Cancer. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_1
Dhruv Kumar
, Sharmila Shankar, Rakesh Srivastava. Challenges in stem cells and translational research (Book chapter). Lost in translational and clinical research. World Scientific Publication,
2014
. ISBN: 9789814489089.
https://doi.org/10.1142/9789814489072_0020
Dhruv kumar
and Bruno Samori. Mechanochemistry: Coupling mechanical forces and chemical reactions (Book chapter). Molecular Manipulation with Atomic Force Microscopy (Book), CRC Press,
2011
, ISBN: 9781439809662.
Dwijendra Gupta,
Dhruv Kumar
, Manish Dwivedi, Vijay Tripathi, Pratibha Phadke-Gupta and Surya Pratap Singh. Nanophosphors-Nanogold immunoconjugates in Isolation of Biomembranes and in Drug Delivery (Book chapter). Recent Advances in Nanomedicine (Book), VBRI Press,
2011
, ISBN: 9788192006803.
Book
Dhruv Kumar
, Shailendra Asthana Autophagy and Metabolism Potential Target for Cancer Therapy 1st Edition - August 6, 2022 Paperback ISBN: 9780323998796 9 7 8 - 0 - 3 2 3 - 9 9 8 7 9 - 6 eBook ISBN: 9780323999458
Akhileshwar Srivastava,
Dhruv Kumar
, Divya Singh, Rajesh Singh, Xenobiotics in Chemical Carcinogenesis:Translational Aspects in Toxicology,
Elsevier,
ISBN: 9780323905602
Dhruv kumar.
Cancer Cell Metabolism: A Potential Target for Cancer Therapy.
Springer Nature
.
2020,
ISBN: 9789811519901.
Dhruv kumar
, Marco Brucale and Bruno Samori. Amyloidogenic Proceses of Intrinsically Disordered Proteins: Understanding the Aggregation Process of Intrinsically Unstructured Proteins Related to Neurodegenerative Diseases.
Lambert Academic Publishing
,
2014
, ISBN:
Dhruv kumar
. Insilico analysis of Docking between HIV-1 PR and derivatives of CUI (Docking between HIV- 1 proteases and cyclic urea inhibitors: A step towards drug designing against AIDS).
Lambert Academic Publishing
,
2011
, ISBN:
Contact
dhruv.kumar@ddn.upes.ac.in

Profile Summary
Prof. Dhruv Kumar is a Professor and Cluster Head at the Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun. Listed as a top 2% world’s most influential scientist in the area of Oncology and cancer Biology. His academic journey includes a B.Sc. in Chemistry from Banaras Hindu University (BHU), Varanasi, and M.Sc. in Bioinformatics with Distinction from the University of Allahabad (AU), Prayagraj. Dr. Dhruv Kumar further distinguished himself by completing his Ph.D. in Cellular, Molecular, and Industrial Biology from the University of Bologna (UNIBO), Italy, under the highly prestigious fellowship of the Ministry of Human Resource and Development (MHRD), Indo-Italian Government fellowship. Following the completion of his Ph.D., he embarked on a five-year Postdoctoral training at the School of Medicine, University of Kansas Medical Center, Kansas City, USA. Dr. Kumar's research has been dedicated to several cancer types, including Prostate, Pancreatic, Brain, Breast, and Head and Neck Cancer, with a primary focus on unraveling the molecular mechanisms regulating Autophagy and Apoptosis in Cancer Stem Cells. Currently, his laboratory is actively exploring the Autophagy-Metabolic axis in various cancer cells, such as head and neck, oral, breast, and brain, along with investigating the tumor microenvironment for the development of innovative therapeutic approaches. Notably, his research group has made significant contributions to Drug Designing and Drug Repurposing for COVID-19. Dr. Dhruv Kumar's scholarly contributions are evident in his extensive publication record, with articles featured in prestigious journals such as Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, Seminars in Cancer Biology, JAMA Otolaryngology, Nature Scientific Reports, and many more. Presently, Dr. Kumar is actively engaged in numerous government-funded projects and is mentoring eight Ph.D. students in the areas of Cancer and Infertility. Beyond his research endeavors, he plays a vital role in teaching courses at the undergraduate (UG), postgraduate (PG), and Ph.D. levels, covering subjects related to Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics.
Work Experience
Prof. Dhruv Kumar possesses over 15 years of extensive experience encompassing teaching, research, and administrative roles. His professional journey is outlined as follows:
06/22-Present: Professor & Cluster Head, Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand, India.
01/21-06/22: Professor & Assistant Director, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
07/19-12/20: Associate Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
04/17-07/19: Assistant Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
08/16-04/17: Assistant Professor, Department of Bioinformatics, SRM University, Delhi-NCR, Sonepat, Haryana, India.
03/12-06/16: Postdoctoral Fellow, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
In these diverse roles, Prof. Kumar has demonstrated his commitment to academia, contributing significantly to various institutions and enhancing his expertise in the fields of Molecular Medicine, Cancer Biology, Stem Cell Research, and Bioinformatics. His journey includes pivotal positions such as Assistant Professor at SRM University and various roles at Amity University Uttar Pradesh, showcasing his dedication to fostering education and research. Currently serving as a Professor and Cluster Head at UPES, Dehradun, he continues to make substantial contributions to the academic and research landscape.
Research Interests
Prof. Dhruv Kumar boasts an extensive and diverse research portfolio spanning over various critical domains in biomedical science. With over 15 years of profound expertise, he has significantly contributed to Translational Cancer Research, unraveling novel insights that bridge the gap between fundamental discoveries and clinical applications. His dedicated exploration into Cancer Stem Cells has shed light on the molecular intricacies governing these cells. Prof. Kumar's investigations into Cancer Cell Metabolism reveal a nuanced understanding of metabolic alterations in cancer cells, potentially paving the way for innovative therapeutic strategies. Additionally, his work on the Tumor Microenvironment and Tumor Heterogeneity delves into the complex interplay and diversity within cancer populations. His research illuminates the regulatory mechanisms of Autophagy and the role of Exosomes in cancer, offering crucial perspectives on cellular recycling and intercellular communication. Beyond cancer biology, Prof. Kumar's foray into Infertility research explores molecular factors underlying reproductive challenges. Proficient in Genome Editing and NGS Data Analysis, he navigates cutting-edge genetic technologies. His involvement in Drug Repurposing and Drug Discovery underscores an innovative approach to therapeutics, while his recent contributions in COVID-19 research showcase adaptability to contemporary health challenges. Prof. Kumar's overarching mastery in Bioinformatics strategically integrates computational methods, enhancing the comprehensive interpretation of complex biological data.
Teaching Philosophy
Prof. Dhruv Kumar's teaching philosophy is characterized by innovation and inclusivity. He employs a blended teaching approach that seamlessly integrates traditional methods with modern technologies, creating a dynamic and engaging learning environment. One notable aspect is his commitment to discussing cutting-edge research topics, including those recognized with Nobel Prizes, providing students with insights into the forefront of scientific inquiry. Prof. Kumar takes an innovative approach to support slow learners, implementing strategies such as pairing them with a buddy for personalized assistance, arranging expert lectures, fostering group discussions, and emphasizing hands-on training and practical experiences. By tailoring his teaching methods to diverse learning styles and providing additional support mechanisms, Prof. Kumar ensures that every student, regardless of pace, has the opportunity to thrive academically and develop a passion for lifelong learning.
Courses Taught
Prof. Dhruv Kumar has a genuine passion for teaching and a deep commitment to fostering meaningful interactions with students, creating a vibrant and engaging educational environment. With an extensive background in teaching, he has imparted knowledge across various courses at the undergraduate (UG), postgraduate (PG), and doctoral (PhD) levels. Prof. Kumar's enthusiasm for sharing new ideas and insights has been a cornerstone of his teaching approach, inspiring students to explore innovative concepts and contributing to a dynamic and intellectually stimulating learning atmosphere. His continuous dedication to teaching underscores not only his expertise in the subject matter but also his unwavering commitment to nurturing the intellectual growth of students at all levels.
Undergraduate Level (B.Sc.)
Basic Bioinformatics (BIOF202)
Basics of Cancer (BIOT223)
Cell (MMBS104)
Metals in Biology (MMBS201)
Metabolism (MMBS205)
Scientific Writing (HSCC2019)
Postgraduate Level (M.Sc.)
Animal Cell Culture & Cell Engineering (SCCB601)
Assisted Reproductive Laboratory Procedures (RTCE605)
Cancer Pharmacogenomics (SCCB704)
Computational Tools in Drug Discovery (MMBS702)
Genome Engineering & Editing (SCCB603)
OMICS in Biomedical Sciences (SCCB710)
Preventive Oncology & Psycho-Oncology (SCCB705)
Reproductive & Developmental Biology and Genetics (RTCE604)
Topics in Bioinformatics (MMBS610)
Trends in Molecular Oncology (SCCB901)
Stem Cell Bio II (SCCB 707)
Scientific Writing (HSCC8007)
Good manufacturing and Lab Practices (HSCC8008)
Biosafety and Aseptic Techniques (HSMB 7024)
PhD Level
Advances in Molecular Medicine (BIOT 955) at Institute Level
Trends in Molecular Oncology (BIOT 953) at Institute Level
Research and Publication Ethics” (RPE) –(PHD901) at University Level
Awards and Grants:
Prof. Dhruv Kumar has received several national and international awards and grants as mentioned below.
Awards:
2020: Research Excellence Award, Institute of Scholars, India
2019: Senior Scientist Award, Society of Biomedical Laboratory Scientists, India
2017: Early Career Research Award, SERB, DST-India.
2016: Postdoc of the Month Award, PostDoc Journal: Journal of Postdoctoral Research, USA.
2016: Scholar-in-Training Award, AACR, The Function of Tumor Microenvironment in Cancer Progression Conference, San Diego, USA.
2015: K-INBRE Postdoctoral Award, National Institute of General Medical Sciences, National Institute of Health (NIH), USA.
2011: 8th EBSA European Biophysics Congress Bursaries Award, European Biophysical Societies Association, Italy.
2011: Young Scientist Award, International Academy of Physical Science, Allahabad, India.
2009: Brains in Competition Award, Institute of Advance Studies, University of Bologna, Italy.
2008: Indo-Italian Government Scholarship (Ministry of Human Resource and Development, India).
Grants:
2022-2025: “Analysis of the relationship between gallbladder cancer, arsenic intake, and living-environmental factors - a case in Bihar, India”, Indo-Japan, Government of Japan, Rs 100 lakh (Co-PI): Ongoing
2021-2024: “Repurposing of drugs and validation of lead compounds against main protease and RNA dependent RNA polymerase of SARS-CoV-2”, BRICS-DST, Rs 74 lakh (PI & Coordinator): Ongoing
2020-2023: “Assessment of Female reproductive health and child health risks in Arsenic Exposed population of Bihar”, ICMR New Delhi, Rs ~ 1 Crore. (Co-PI): Ongoing
2018-2021: “Understanding the Metabolic Cross-Talk between Head and Neck Squamous Cell Carcinoma and Tumor Associated Fibroblasts”, SERB-Department of Science and Technology, Government of India, Rs ~35 Lakhs. (PI): Completed
2015-2016: “Role of Tumor-Associated Fibroblasts in Head and Neck Cancer Metabolism” National Institute of General Medical Sciences, National Institute of Health, USA (P20GM103418), $25,000. (PI): Completed
Scholarly Activities
Prof. Dhruv Kumar, has a rich portfolio of scholarly activities spanning teaching, research, and academic contributions. He actively engages in designing and instructing courses at various academic levels, including undergraduate (UG), postgraduate (PG), and doctoral (PhD) programs, covering specialized areas such as Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics. Prof. Kumar's research endeavors have resulted in numerous publications in high-impact journals, including Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, and Nature Scientific Reports. He has received recognition on both national and international platforms, garnering awards such as the Senior Scientist Award from the Society of Biomedical Laboratory Scientists, India, the Scholar-in-Training Award from the American Association for Cancer Research (AACR), USA, and the K-INBRE Postdoctoral Award from the National Institute of Health (NIH), USA. Additionally, his active involvement in government-funded projects and mentorship of PhD students in the fields of Cancer and Infertility reflects his commitment to advancing knowledge and nurturing the next generation of researchers. Prof. Kumar's scholarly activities exemplify a holistic approach to academia, seamlessly integrating teaching, research, and mentorship.
His selected publications are as below:
2023
Agrawal, K.; Asthana, S.;
Kumar, D
. Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer. Cancers 2023, 15, 4920.
https://doi.org/10.3390/cancers15204920
.
(Impact Factor: 5.2)
Maurya, S., Raj, S., Bhoi, N.R., Mani, N., Rathi, B. and
Kumar, D
., 2023. Morphological analysis of metabolically dysregulated spermatozoa using Artificial Intelligence based approach. Journal of Integrated Science and Technology, 11(4), pp.569-569.
(Impact Factor: 1.14)
Raj, S. and
Kumar, D.
, 2023. Early epigenetic markers for precision medicine. Progress in molecular biology and translational science, 198, pp.153-164.
(Impact Factor: 4.0)
Kumar, A., Ali, M., Raj, V., Kumari, A., Rachamalla, M., Niyogi, S.,
Kumar, D.
, Sharma, A., Saxena, A., Panjawani, G. and Jain, P., 2023. Arsenic causing gallbladder cancer disease in Bihar. Scientific Reports, 13(1), p.4259.
(Impact Factor: 4.9)
Goel, M., Mishra, M.K. and
Kumar, D
., 2023. Recent advances in Targeted Radionuclide therapy for Cancer treatment. Chemical Biology Letters, 10(3), pp.544-544.
(Impact Factor: 6.1)
Bhattacharjee, R., Prabhakar, N., Kumar, L., Bhattacharjee, A., Kar, S., Malik, S.,
Kumar, D
., Ruokolainen, J., Negi, A., Jha, N.K. and Kesari, K.K., 2023. Crosstalk between long noncoding RNA and microRNA in Cancer. Cellular Oncology, pp.1-24.
(Impact Factor: 6.6)
Kumar, A., Kumar, K., Ali, M., Raj, V., Srivastava, A., Kumar, M., Niraj, P.K., Kumar, M., Kumar, R.,
Kumar, D.
and Bishwapriya, A., 2023. Severe Disease Burden and the Mitigation Strategy in the Arsenic-Exposed Population of Kaliprasad Village in Bhagalpur District of Bihar, India. Biological trace element research, pp.1-17.
(Impact Factor: 4.0)
Arfin, S.;
Kumar, D
.; Lomagno, A.; Mauri, P.L.; Di Silvestre, D. Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis. Cancers 2023, 15, 4420.
https://doi.org/10.3390/cancers15174420
(Impact Factor: 5.2)
Arfin S, Agrawal K, Maurya S, Asthana S, Di Silvestre
D, Kumar D
. Lead phytochemicals and marine compounds against ceruloplasmin in cancer targeting. Journal of Biomolecular Structure and Dynamics. 2023 Oct 18.
(Impact Factor: 5.2)
Agrawal K, Chakraborty P, Dewanjee S, Arfin S, Das SS, Dey A, Moustafa M, Mishra PC, Jafari SM, Jha NK, Jha SK,
Kumar D
. Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders. Neurosci Biobehav Rev. 2023 Jan;144:104955. doi: 10.1016/j.neubiorev.2022.104955. Epub 2022 Nov 14. PMID: 36395983.
(Impact Factor: 9.0)
Agrawal K, Chauhan S,
Kumar D
. Expression analysis and regulation of GLI and its correlation with stemness and metabolic alteration in human brain tumor. 3 Biotech. 2023 Jan;13(1):10. doi: 10.1007/s13205-022-03419-5. Epub 2022 Dec 15. PMID: 36532860; PMCID: PMC9755437.
(Impact Factor: 2.9)
Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A,
Kumar D
, Ambasta RK, Jha NK, Jha SK, Dewanjee S. Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Res Rev. 2023 Mar;85:101838. doi: 10.1016/j.arr.2022.101838. Epub 2023 Jan 5. PMID: 36610558.
(Impact Factor: 11.7)
Raj, S., Rathi, B., Mehra, P., Asthana, S., &
Kumar, D
. (2023). Deciphering the role of c-MET in Metabolic reprogramming of Head and Neck squamous cell Carcinoma via In Silico analysis. Chemical Biology Letters, 10(2), 532. Retrieved from
https://pubs.thesciencein.org/journal/index.php/cbl/article/view/532
(Impact Factor: 4.4)
2022
Awasthi P, Dwivedi M, Kumar D, Hasan S. Insights into intricacies of the Latent Membrane Protein-1 (LMP-1) in EBV-associated cancers. Life Sci. 2023 Jan 15;313:121261. doi: 10.1016/j.lfs.2022.121261. Epub 2022 Dec 7. PMID: 36493876.
(Impact Factor: 3.3)
Sharma S, Tyagi R, Srivastava M, Rani K,
Kumar D
, Asthana S, Raj VS. Identification and validation of potent inhibitor of Escherichia coli DHFR from MMV pathogen box. J Biomol Struct Dyn. 2022 Jun 2:1-10. doi: 10.1080/07391102.2022.2080113. Epub ahead of print. PMID: 35652895.
(Impact Factor: 3.3)
Maurya S, Kesari KK, Roychoudhury S, Kolleboyina J, Jha NK, Jha SK, Sharma A, Kumar A, Rathi B, Kumar D. Metabolic Dysregulation and Sperm Motility in Male Infertility. Adv Exp Med Biol. 2022;1358:257-273. doi: 10.1007/978-3-030-89340-8_12. PMID: 35641874.
(Impact Factor: 2.6)
Das S, Roychoudhury S, Dey A, Jha NK, Kumar D, Roychoudhury S, Slama P, Kesari KK. Bacteriospermia and Male Infertility: Role of Oxidative Stress. Adv Exp Med Biol. 2022;1358:141-163. doi: 10.1007/978-3-030-89340-8_7. PMID: 35641869.
(Impact Factor: 2.6)
Arfin, S. .; Mani, N. .; Rathi, B.; Kumar, D. In Silico Analysis of Ceruloplasmin Alteration in Oral Squamous Cell Carcinoma. Chem Biol Lett 2022, 9, 342.
(Impact Factor: 4.4)
Jha NK, Arfin S, Jha SK, Kar R, Dey A,
Kumar D
. et al. Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling Semin Cancer Biol. 2022 Feb 23:S1044-579X(22)00049-9.
https://doi.org/10.1016/j.semcancer.2022.02.022
.
(Impact Factor: 17)
Raj S, Kesari KK, Kumar A, Rathi B, Sharma A, Gupta PK, Jha SK, Jha NK, Slama P, Roychoudhury S,
Kumar D
. Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. Molecular Cancer (BMC-Springer Nature). 2022. 26;21(1):31.
https://doi.org/10.1186/s12943-022-01503-1
(Impact Factor: 41.4): Corresponding Author
Pritam P, Deka R,
Kumar D
. et al.. Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects. Biology-MDPI. 2022. 11(2), 212.
https://doi.org/10.3390/biology11020212
(Impact Factor: 5.0)
Kumar, A.
Kumar D
. et al..Assessment of disease burden in the arsenic exposed population of Chapar village of Samastipur district, Bihar, India, and related mitigation initiative.
Environmental Science and Pollution Research.
https://doi.org/10.1007/s11356-021-18207-6
(Impact Factor: 4.3)
2021
Upadhyay C.
Kumar D
. et al.. Synthesis of the new analogs of morpholine and their antiplasmodial evaluation against the human malaria parasite Plasmodium falciparum.
New Journal of Chemistry
. 2021.
https://doi.org/10.1039/D1NJ04198C
(Impact Factor: 3.4)
Singh A, Singh AK, Giri R,
Kumar D
, Sharma R, Valis M, Kuca K, Garg N. The role of microRNA-21 in the onset and progression of cancer.
Future Med Chem
. 2021 Nov;13(21): 1885-1906.
https://doi.org/10.4155/fmc-2021-0096
.
(Impact Factor: 3.9)
Jeyaraman Madhan ,Muthu Sathish ,
Kumar D
. et al. “Total Stromal Fraction (TSF) - Fortified Adipose Tissue-Derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary Compromise”,
Coronaviruses
2021; e080921196287.
https://doi.org/10.2174/2666796702666210908151708
.
(Impact Factor: 0.0)
Asif Ali, Saleheen Bano,
Kumar D
. et al. (2021) Effect of cellulose nanocrystals on chitosan/PVA/nano β-TCP composite scaffold for bone tissue engineering application,
Journal of Biomaterials Science, Polymer Edition
,
https://doi.org/10.1080/09205063.2021.1973709
.
(Impact Factor: 3.5)
Mehreen Aftab, Maryam Ghufran,
Kumar D
. et al., In silico analysis of the role of hsa-miR-155-5p in cervical cancer, Chem. Biol. Lett. 2021, 8(3), 94-105.
(Impact Factor: 4.4) : Corresponding Author
Usman, M.B., Bhardwaj, S., Roychoudhury, S.
Kumar D
. et al.. Immunotherapy for Alzheimer’s Disease: Current Scenario and Future Perspectives.
J Prev Alzheimers Dis
8, 534–551 (2021).
https://doi.org/10.14283/jpad.2021.52
(Impact Factor: 4.4)
Sharma, P.P., Bansal, M., Sethi, A., Pena, L.,
Kumar D
. et al., 2021. Computational methods directed towards drug repurposing for COVID-19: advantages and limitations.
RSC Advances
, 11(57), pp.36181-36198.
https://doi.org/10.1039/D1RA05320E
(Impact Factor: 3.3)
Goyal, K.; Goel, H.; Baranwal, P.; Tewary, A.;
Kumar D
. et al.. Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans. Immuno 2021, 1, 442-456.
https://doi.org/10.3390/immuno1040032
(Impact Factor: 0.0)
Sharma A,
Kumar D
, Dahiya K, Hawthorne S, Jha SK, Jha NK, Nand P, Girgis S, Raj S, Srivastava R, Goswami VK, Gregoriou Y, El-Zahaby SA, Ojha S, Dureja H, Gupta G, Singh S, Chellappan DK, Dua K. Advances in pulmonary drug targeting microbial biofilms in respiratory diseases. Nanomedicine (Lond). 2021 Aug 5. delivery
https://doi.org/10.2217/nnm-2021-0057
.
(Impact Factor: 5.3): : Corresponding Author
Jeyaraman M, Muthu S, Bapat A,
Kumar D
. et al.. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon. 2021 Jul;7(7):e07635.
https://doi.org/10.1016/j.heliyon.2021.e07635
.
(Impact Factor: 1.8)
Sharma A, Hawthorne S, Jha SK, Jha NK,
Kumar D
, Girgis S, Goswami VK, Gupta G, Singh S, Dureja H, Chellappan DK, Dua K. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDAMB231 human breast cancer cells. Nanomedicine (Lond). 2021 Aug;16(20):1763-1773.
https://doi.org/10.2217/nnm-2021-0066
.
(Impact Factor: 5.3)
Chandel V, Maru S, Kumar A, Kumar A, Sharma A, Rathi B,
Kumar D
. Role of monocarboxylate transporters in head and neck squamous cell carcinoma. Life Sciences. 2021, 5;279:119709.
https://doi.org/10.1016/j.lfs.2021.119709
.
(Impact Factor: 3.6) : Corresponding Author
Raj S, Kumar A,
Kumar D
. Regulation of Glycolysis in Head and Neck Cancer. Adv Exp Med Biol. 2021;1280:219-230.
https://doi.org/10.1007/978-3-030-51652-9_15
.
(Impact Factor: 2.4) : Corresponding Author
Vaishali Chandel, Garima Tripathi, Seema A. Nayar, Brijesh Rathi, Abhijeet Kumar &
Dhruv Kumar
(2021) In silico identification and validation of triarylchromones as potential inhibitor against main protease of severe acute respiratory syndrome coronavirus 2,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1918255
.
(Impact Factor: 3.2) : Corresponding Author
Rashmi Tyagi, Mitul Srivastava, Baldeep Singh, Shingini Sharma, Ramendra Pati Pandey, Shailendra Asthana,
Dhruv Kumar
& V. Samuel Raj (2021) Identification and validation of potent Mycobacterial proteasome inhibitor from Enamine library,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1914173
.
(Impact Factor: 3.2) : Corresponding Author
Mathur, A., Raj, S., Jha, N.K. et al. Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2.
3 Biotech
11, 236 (2021).
https://doi.org/10.1007/s13205-021-02791-y
.
(Impact Factor: 2.2) : Corresponding Author
Arfin, S.; Jha, N.K.; Jha, S.K.; Kesari, K.K.; Ruokolainen, J.; Roychoudhury, S.; Rathi, B.;
Kumar, D
. Oxidative Stress in Cancer Cell Metabolism.
Antioxidants
2021, 10, 642.
https://doi.org/10.3390/antiox10050642
.
(Impact Factor: 5) : Corresponding Author
Kumar A, Kumar R, Rahman MS, Ali M, Kumar R, Nupur N, Gaurav A, Raj V, Anand G, Niraj PK, Kumar N, Srivastava A, Biswapriya A, Chand GB,
Kumar D
, Rashmi T, Kumar S, Sakamoto M, Ghosh AK. Assessment of arsenic exposure in the population of Sabalpur village of Saran District of Bihar with mitigation approach.
Environ Sci Pollut Res Int.
2021 Apr 11.
https://doi.org/10.1007/s11356-021-13521-5
(Impact Factor: 4.3)
Kumar, A., Rahman, M.S., Ali, M. et al. Assessment of arsenic exposure and its mitigation intervention in severely exposed population of Buxar district of Bihar, India.
Environ. Health Sci.
(2021).
https://doi.org/10.1007/s13530-021-00086-6
(Impact Factor: .76)
Chandel V., et al. 2021. In silico identification of potential inhibitor for TP53-induced glycolysis and apoptosis regulator in head and neck squamous cell carcinoma.
3Biotech
. 11(3):117.
https://doi.org/10.1007/s13205-021-02665-3
(Impact Factor: 2.2) : Corresponding Author
2020
Kumar A., et al. 2020. Arsenic exposure causing cancer in the Indo - Gangetic Plain - A 2000 cancer patients’ cross-sectional design.
Scientific Reports
. 11, 2376 (2021).
https://doi.org/10.1038/s41598-021-81579-9
.
(Impact Factor: 4.1)
Roychoudhury S., et al. 2020. Viral pathogenesis of SARS-CoV-2 infection and male reproductive health: Myth or fact?
Open Biology
. 11(1): 200347,
https://doi.org/10.1098/rsob.200347
(Impact Factor: 4.9)
Jha N K., et al. 2020. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS‑CoV‑2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Journal of Molecular Neuroscience.
https://doi.org/10.1007/s12031-020-01767-6
.
(Impact Factor: 2.8)
Ali A., et al. 2020. Comparative analysis of TiO2 and Ag nanoparticles on xylan/chitosan conjugate matrix for wound healing application.
International Journal of Polymeric Materials and Polymeric Biomaterials.
https://doi.org/10.1080/00914037.2020.1838519
(Impact Factor: 1.9)
Kumar D., et al. 2020. Stem Cell Based Preclinical Drug Development and Toxicity Prediction.
Current Pharmaceutical Design
.
https://doi.org/10.2174/1381612826666201019104712
(Impact Factor: 2.4) : Corresponding Author
Tyagi R., et al. 2020. Development of potential proteasome inhibitors against Mycobacterium tuberculosis.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1835722
(Impact Factor: 3.2) : Corresponding Author
Narula S, Tandon S, Kumar D et al. 2020. Human kidney stone matrix proteins alleviate hyperoxaluria induced renal stress by targeting cell-crystal interactions.
Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118498
(Impact Factor: 3.6)
Satyam R, Jha NK, Kar R et al. 2020. Deciphering the SSR incidences across viral members of Coronaviridae family.
Chemico-Biological Interactions.
https://doi.org/10.1016/j.cbi.2020.109226
(Impact Factor: 3.6)
Chandel V, Raj S, Rathi B, Choudhary R,
Kumar D
. 2020. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1811773
(Impact Factor: 3.2) : Corresponding Author
Manish D., Vijay T., Kumar D., et al. 2020. Structural and Morphological Characterization of CdS Nanoparticles,
Current Physical Chemistry.
https://doi.org/10.2174/1877946810999200730222025
(Impact Factor: 1.6)
Raj S, Chandel V, et al. 2020 Molecular mechanisms of interplay between autophagy and metabolism in cancer
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118184
(Impact Factor: 3.6) : Corresponding Author
Chandel V, Raj S, et al. 2020. Metabolic regulation in HPV associated head and neck squamous cell carcinoma
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118236
(Impact Factor: 3.6) : Corresponding Author
Chandel V,
Kumar D
. 2020. Targeting Signalling Cross-Talk between Cancer Cells and Cancer Associate Fibroblast through Monocarboxylate Transporters in Head and Neck Cancer
,Anti-Cancer Agents in Medicinal Chemistry
:
Bentham Science Publishers
,
https://doi.org/10.2174/1871520620666200721135230
(Impact Factor: 2.04) : Corresponding Author
Kumar S, Sharma PP, Shankar U,
Kumar D
et al. 2020. Discovery of New Hydroxyethylamine Analogs against 3CL pro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies.
J Chem Inf Model.
https://doi.org/10.1021/acs.jcim.0c00326
(Impact Factor: 4.5)
Pandey V, Tripathi G,
Kumar D
et al. 2020. Novel 3,4-diarylpyrazole as prospective anti-cancerous agents,
Helion
,
https://doi.org/10.1016/j.heliyon.2020.e04397
(Impact Factor: 1.6) : Corresponding Author
Chandel V, Raj S, Rathi B,
Kumar D
. 2020. In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach.
Chemical Biology Letters
. 7(3), 166‐175.
(Impact Factor: 4.4) : Corresponding Author
Chandel V, Raj S, Srivastava A,
Kumar D
. 2020. In-silico interactions of active Phytochemicals with c-MYC EGFR and ERBB2 oncoproteins.
Chemical Biology Letters
. 7(1), 47‐54.
(Impact Factor: 4.4) : Corresponding Author
Raj S, Chandel V, Rathi B,
Kumar D
. 2020. Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach, Coronavirus: Bentham Science Publishers, DOI : 10.2174/2666796701999200617155013
: Corresponding Author
2019
Sibi Raj, Sartaj Khuranaa, Ramesh Choudhari et al. 2019. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
Seminars in Cancer Biology
https://doi.org/10.1016/j.semcancer.2019.11.002
.
(Impact Factor: 15) : Corresponding Author
Anukriti, Anupam D, Swati U, Pallavi S, et al. 2019. Investigation of Precise Molecular Mechanistic Action of Tobacco-Associated Carcinogen ‘NNK’ Induced Carcinogenesis: A System Biology Approach. 10(8), 564.
(Impact Factor: 3.4)
Asif A, Saleheen B, Satish S.P,
Kumar D
, Yuvraj S N, 2019. Effect of incorporation of Montmorillonite on Xylan/Chitosan conjugate scaffold.
Colloids and Surfaces B: Biointerfaces
1(180) 75-82.
(Impact Factor: 3.9)
Vishwakarma V, New J1,
Kumar D,
et al.,
Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds.
Scientific Reports
. 15;8(1):12163.
(Impact Factor: 4.1)
Chandel V and Kumar D. 2019. The Development of Tumor Heterogeneity and Actively Targeting Therapy Resistant Subpopulations
. J Embryol Stem Cell Res
. 3(3): 000131
: Corresponding Author
2018
Kumar D, et al.,
2018
.
Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression.
Cancer Research
. 10.1158/0008-5472.CAN-17-1076.
(Impact Factor: 12) : First Author
Kumar D
, et al. Perfluoro Curcumin Strongly Interacts with ABC Transporter (ABCG2): A Molecular Docking Study.
J Embryol Stem Cell Res
2018, 2(2): 000113.
: Corresponding Author
Kumar D
. 2018. Resveratrol derivative triacetyl-resveratrol interacts directly with the Gli-DNA zinc finger complex.
J Cancer Res Oncobiol
. Apr; 1(2):110
: Corresponding Author
2017
Kumar D
, et al., 2017. Development and characterization of an in vitro model for radiation-induced fibrosis,.
Radiation Research
. 189(3):326-336
(Impact Factor: 2.5) : First Author
Kumar D
, 2017. Role of tumor heterogeneity in drug resistance.
Glob J Cancer Ther
3(2): 032-033. (Editorial).
: Corresponding Author
Kumar D
, 2017. Regulation of glycolysis in head and neck squamous cell carcinoma
. Postdoc Journal
. 2017 Jan;5 (1):14-28.
: Corresponding Author
2016
Ledgerwood LG*,
Kumar D*,
Eterovic AK, Wick J et al., 2016. The degree of intra-tumor mutational heterogeneity varies by primary tumor sub-site.
Oncotarget
. Mar 28. doi: 18632/oncotarget.8448.
(Impact Factor:6.4)
*Equal contribution
: First Author
2015
Kumar D
, Kandl C, Hamilton C, Shnayder Y, Tsue T, Kakarala K, Ledgerwood L, Sun X S, Huang H, Girod D, Thomas S 2015. Anti-HGF antibody ficlatuzumab mitigates tumor-associated fibroblast-facilitated head and neck cancer progression.
JAMA Otolaryngology-Head & Neck Surgery
. Dec 1;141 (12): 1133-9.
(Impact Factor: 6.2) : First Author
Kumar D
, Gupta D, Shankar S, Srivastava RK. 2015. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
Oncotarget:
1-12.
(Impact Factor:6.4) : First Author
2014
Plotegher N,
Kumar D
, Tessari I, Brucale M, Munari F, et al. 2014. The chaperone-like protein 14-3-3eta interacts with human alpha-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing alpha-synuclein cellular toxicity.
Human Molecular Genetics
. 23:5615-29.
(Impact Factor:5.9)
Kumar D
, Shankar S, Srivastava RK. 2014. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway.
Cancer Letters
. 343:179-89.
(Impact Factor:6.4) : First Author
Kumar D
, Plotegher N, Bubacco L, Brucale M. 2014. Quantitative AFM morphometry of non-fibrillar α- synuclein aggregation products induced by the chaperone-like protein 14-3-3.
Italian Society for Microscopical Sciences
. Vol 21, No 1. DOI: 10.4081/microscopie. 2014.4998.
: First Author
Kumar D
, Shankar S, Srivastava RK. 2014. Understanding the biological functions and therapeutic potentials of stem cells and cancer stem cells: Where are we?
Journal of Cancer Stem Cell Research
. 2:e1002:1-8.
: First Author
2013
Kumar D
, Shankar S, Srivastava RK. 2013. Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms.
Molecular Cancer
. 1476-4598-12-171.
(Impact Factor:27) : First Author
Nanta R,
Kumar D
, Meeker D, Rodova M, Van Veldhuizen PJ, et al. 2013. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rgamma null mice by regulating Bmi-1 and microRNA-128.
Oncogenesis
. 2:e42.
(Impact Factor:5.1)
Shankar S,
Kumar D
, Srivastava 2013. Epigenetic modifications by dietary phytochemicals: Implications for personalized nutrition.
Pharmacol Therapeut
. 138:1-17.
(Impact Factor:11.1)
2012
Pivato M, De Franceschi G, Tosatto L, Frare E,
Kumar D
, et al. 2012. Covalent alpha-synuclein dimers: chemico-physical and aggregation properties.
PloS one
7:e50027.
(Impact Factor:3.4)
Singh BN,
Kumar D
, Shankar S, Srivastava 2012. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells.
Biochemical Pharmacology
. 84:1154-63.
(Impact Factor:6.1)
Conference Proceedings
Tyagi,
D. Kumar
and V. S. Raj, 2018. "In silico identification of potential inhibitors against Mycobacterial proteasome," 2018 International Conference on Bioinformatics and Systems Biology (BSB), Allahabad, India,
IEEE Xplore
, pp. 193-197.
(IF: 10.6)
Shekhar Goyal, Surender Kr Beniwal, H S Kumar,
Dhruv Kumar
, B C Das. 2019. Role of Curcumin in reducing toxicity and adverse effects in locally advanced and metastatic breast cancer patients.
Annals of Oncology
. Volume 30, vi126 - vi127.
(IF: 14)
Book Chapter
Mavi, Anil Kumar, Manmohan Kumar, Amarjeet Singh, Mahendra Kumar Prajapati, Rakhi Khabiya, Saurabh Maru, and
Dhruv Kumar.
"Progress in Non‐Viral Delivery of Nucleic Acid: Advancement in Biomedical Technology." Integration of Biomaterials for Gene Therapy (2023): 281-322.
https://doi.org/10.1002/9781394175635.ch10
Mavi, Anil Kumar, Sonal Gaur, Neelesh Kumar, Avanish Kumar Shrivastav, Sankha Bhattacharya, Sateesh Belemkar, Saurabh Maru, and
Dhruv Kumar
. "Effective Gene Transfer with Non‐Viral Vectors." Integration of Biomaterials for Gene Therapy (2023): 183-222.
https://doi.org/10.1002/9781394175635.ch7
Kirti Agrawal, Malavika Saji,
Dhruv Kumar,
Drug Repurposing in Future Drug Discovery and Development, Book-Drug Repurposing and Computational Drug Discovery, Edition1st Edition 2023, Apple Academic Press, Pages26, eBook ISBN9781003347705,
https://doi.org/10.1201/9781003347705
Kumar, A., Raj, V., Ali, M., Abhinav, Rachamalla, M.,
Kumar, D
., Kumari, A., Kumar, R., Shankar, P. and Ghosh, A., 2023. Evaluation of MOF Applications for Groundwater Arsenic Mitigation of the Middle Ganga Plains of Bihar, India. Metal Organic Frameworks for Wastewater Contaminant Removal, pp.355-373. 26 August 2023,
https://doi.org/10.1002/9783527841523.ch16
Saniya Arfin,
Dhruv Kumar
, Chapter 3 - Use of vitamins and minerals as dietary supplements for better health and cancer prevention, Editor(s): Inamuddin, Tariq Altalhi, Jorddy Neves Cruz, Nutraceuticals, Academic Press, 2023, Pages 53-97, ISBN 9780443191930,
https://doi.org/10.1016/B978-0-443-19193-0.00003-4
.
A Santoshkumar, S Ray, S Narayanan,
D Kumar
, S Harihar (2023), Mitophagy in cancer and cancer stem cells: a role in metabolic reprogramming. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00009-2
T Singh, AS Kharat, B Rathi,
D Kumar
(2023), Designing metabolic target-specific inhibitors for cancer therapy. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00011-0
Sibi Raj, Manish K. Mishra, Sitaram Harihar, Ashok Kumar, Shubhadeep Roychoudhury, Arun Kumar et al. (
2022
). Regulation of Glucose Transporters in Cancer Progression, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_9
Stephen James, Saniya Arfin, Manish K. Mishra, Arun Kumar, Niraj Kumar Jha, Saurabh Kumar Jha et al. (
2022
). Role of Arsenic in Carcinogenesis, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_7
Raj S., Kumar A.,
Kumar D
. (
2020
) Regulation of Glycolysis in Head and Neck Cancer, Book. Cancer Metabolomics, Advances in Experimental Medicine and Biology, Springer Nature.
https://doi.org/10.1007/978-3-030-51652-9_15
Chandel V.,
Kumar D
. (
2020
) Role of Interferon in Cancer Metabolism. Innate Immunity in Health and Disease. IntechOpen.
https://doi.org/10.5772/intechopen.92020
Raj S, Chandel V., Maurya S,
Kumar D
. (
2020
) Role of Macrophages in Solid Tumor Metabolism. Macrophages. IntechOpen.
https://doi.org/10.5772/intechopen.93182
Maurya S, Chandel V, Raj S, (
2020
) OMICS IN CANCER: FROM DIAGNOSTICS TO THERAPEUTICS. Recent Trends in ‘Computational Omics'. ISBN: 978-1-53617-941-5
Raj S., Chandel V.,
Kumar D
. (
2020
) Cancer Cell Metabolism: Solid Tumor Versus Nonsolid Tumor. In:
Kumar D
. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_1
Pedroza D.A. et al. (
2020
) Role of Autophagy in Cancer Cell Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_6
Chandel V., Raj S., Choudhari R.,
Kumar D
. (
2020
) Role of c-Met/HGF Axis in Altered Cancer Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_7
Kumar D
., Sharma-Walia N., Kapoor S., Tandon S. (
2020
) Antibody-Targeted Nanoparticles for Cancer Treatment. In: Saxena S., Khurana S. (eds) NanoBioMedicine. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9898-9_3
Singh B., Malhotra H.,
Kumar D
., Mujtaba S.F., Upadhyay A.K. (
2019
) Understanding Cellular and Molecular Events of Skin Aging and Cancer: An Integrative Perspective. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_2
Tripathi M.K., Sinha J., Srivastava S.K.,
Kumar D
. (
2019
) Bioinformatics in Skin Cancer: A System Biology Approach to Understanding the Molecular Mechanisms and It’s Regulations. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_10
Khurana S., Bose S.,
Kumar D
. (
2019
) Applications of Microarray-Based Technologies in Identifying Disease-Associated Single Nucleotide Variations. In: Tripathi V., Kumar P., Tripathi P., Kishore A., Kamle M. (eds) Microbial Genomics in Sustainable Agroecosystems. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9860-6_4
Singh P., Tiwari D., Mishra M.,
Kumar D
. (
2019
) Molecular Mechanisms of Heavy Metal Toxicity in Cancer Progression. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_3
Chandel V., Seth G., Shukla P.,
Kumar D
. (
2019
) Role of Radiation in DNA Damage and Radiation Induced Cancer. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_1
Dhruv Kumar
, Sharmila Shankar, Rakesh Srivastava. Challenges in stem cells and translational research (Book chapter). Lost in translational and clinical research. World Scientific Publication,
2014
. ISBN: 9789814489089.
https://doi.org/10.1142/9789814489072_0020
Dhruv kumar
and Bruno Samori. Mechanochemistry: Coupling mechanical forces and chemical reactions (Book chapter). Molecular Manipulation with Atomic Force Microscopy (Book), CRC Press,
2011
, ISBN: 9781439809662.
Dwijendra Gupta,
Dhruv Kumar
, Manish Dwivedi, Vijay Tripathi, Pratibha Phadke-Gupta and Surya Pratap Singh. Nanophosphors-Nanogold immunoconjugates in Isolation of Biomembranes and in Drug Delivery (Book chapter). Recent Advances in Nanomedicine (Book), VBRI Press,
2011
, ISBN: 9788192006803.
Book
Dhruv Kumar
, Shailendra Asthana Autophagy and Metabolism Potential Target for Cancer Therapy 1st Edition - August 6, 2022 Paperback ISBN: 9780323998796 9 7 8 - 0 - 3 2 3 - 9 9 8 7 9 - 6 eBook ISBN: 9780323999458
Akhileshwar Srivastava,
Dhruv Kumar
, Divya Singh, Rajesh Singh, Xenobiotics in Chemical Carcinogenesis:Translational Aspects in Toxicology,
Elsevier,
ISBN: 9780323905602
Dhruv kumar.
Cancer Cell Metabolism: A Potential Target for Cancer Therapy.
Springer Nature
.
2020,
ISBN: 9789811519901.
Dhruv kumar
, Marco Brucale and Bruno Samori. Amyloidogenic Proceses of Intrinsically Disordered Proteins: Understanding the Aggregation Process of Intrinsically Unstructured Proteins Related to Neurodegenerative Diseases.
Lambert Academic Publishing
,
2014
, ISBN:
Dhruv kumar
. Insilico analysis of Docking between HIV-1 PR and derivatives of CUI (Docking between HIV- 1 proteases and cyclic urea inhibitors: A step towards drug designing against AIDS).
Lambert Academic Publishing
,
2011
, ISBN:
Contact
dhruv.kumar@ddn.upes.ac.in

Profile Summary
Prof. Dhruv Kumar is a Professor and Cluster Head at the Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun. Listed as a top 2% world’s most influential scientist in the area of Oncology and cancer Biology. His academic journey includes a B.Sc. in Chemistry from Banaras Hindu University (BHU), Varanasi, and M.Sc. in Bioinformatics with Distinction from the University of Allahabad (AU), Prayagraj. Dr. Dhruv Kumar further distinguished himself by completing his Ph.D. in Cellular, Molecular, and Industrial Biology from the University of Bologna (UNIBO), Italy, under the highly prestigious fellowship of the Ministry of Human Resource and Development (MHRD), Indo-Italian Government fellowship. Following the completion of his Ph.D., he embarked on a five-year Postdoctoral training at the School of Medicine, University of Kansas Medical Center, Kansas City, USA. Dr. Kumar's research has been dedicated to several cancer types, including Prostate, Pancreatic, Brain, Breast, and Head and Neck Cancer, with a primary focus on unraveling the molecular mechanisms regulating Autophagy and Apoptosis in Cancer Stem Cells. Currently, his laboratory is actively exploring the Autophagy-Metabolic axis in various cancer cells, such as head and neck, oral, breast, and brain, along with investigating the tumor microenvironment for the development of innovative therapeutic approaches. Notably, his research group has made significant contributions to Drug Designing and Drug Repurposing for COVID-19. Dr. Dhruv Kumar's scholarly contributions are evident in his extensive publication record, with articles featured in prestigious journals such as Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, Seminars in Cancer Biology, JAMA Otolaryngology, Nature Scientific Reports, and many more. Presently, Dr. Kumar is actively engaged in numerous government-funded projects and is mentoring eight Ph.D. students in the areas of Cancer and Infertility. Beyond his research endeavors, he plays a vital role in teaching courses at the undergraduate (UG), postgraduate (PG), and Ph.D. levels, covering subjects related to Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics.
Work Experience
Prof. Dhruv Kumar possesses over 15 years of extensive experience encompassing teaching, research, and administrative roles. His professional journey is outlined as follows:
06/22-Present: Professor & Cluster Head, Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand, India.
01/21-06/22: Professor & Assistant Director, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
07/19-12/20: Associate Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
04/17-07/19: Assistant Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
08/16-04/17: Assistant Professor, Department of Bioinformatics, SRM University, Delhi-NCR, Sonepat, Haryana, India.
03/12-06/16: Postdoctoral Fellow, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
In these diverse roles, Prof. Kumar has demonstrated his commitment to academia, contributing significantly to various institutions and enhancing his expertise in the fields of Molecular Medicine, Cancer Biology, Stem Cell Research, and Bioinformatics. His journey includes pivotal positions such as Assistant Professor at SRM University and various roles at Amity University Uttar Pradesh, showcasing his dedication to fostering education and research. Currently serving as a Professor and Cluster Head at UPES, Dehradun, he continues to make substantial contributions to the academic and research landscape.
Research Interests
Prof. Dhruv Kumar boasts an extensive and diverse research portfolio spanning over various critical domains in biomedical science. With over 15 years of profound expertise, he has significantly contributed to Translational Cancer Research, unraveling novel insights that bridge the gap between fundamental discoveries and clinical applications. His dedicated exploration into Cancer Stem Cells has shed light on the molecular intricacies governing these cells. Prof. Kumar's investigations into Cancer Cell Metabolism reveal a nuanced understanding of metabolic alterations in cancer cells, potentially paving the way for innovative therapeutic strategies. Additionally, his work on the Tumor Microenvironment and Tumor Heterogeneity delves into the complex interplay and diversity within cancer populations. His research illuminates the regulatory mechanisms of Autophagy and the role of Exosomes in cancer, offering crucial perspectives on cellular recycling and intercellular communication. Beyond cancer biology, Prof. Kumar's foray into Infertility research explores molecular factors underlying reproductive challenges. Proficient in Genome Editing and NGS Data Analysis, he navigates cutting-edge genetic technologies. His involvement in Drug Repurposing and Drug Discovery underscores an innovative approach to therapeutics, while his recent contributions in COVID-19 research showcase adaptability to contemporary health challenges. Prof. Kumar's overarching mastery in Bioinformatics strategically integrates computational methods, enhancing the comprehensive interpretation of complex biological data.
Teaching Philosophy
Prof. Dhruv Kumar's teaching philosophy is characterized by innovation and inclusivity. He employs a blended teaching approach that seamlessly integrates traditional methods with modern technologies, creating a dynamic and engaging learning environment. One notable aspect is his commitment to discussing cutting-edge research topics, including those recognized with Nobel Prizes, providing students with insights into the forefront of scientific inquiry. Prof. Kumar takes an innovative approach to support slow learners, implementing strategies such as pairing them with a buddy for personalized assistance, arranging expert lectures, fostering group discussions, and emphasizing hands-on training and practical experiences. By tailoring his teaching methods to diverse learning styles and providing additional support mechanisms, Prof. Kumar ensures that every student, regardless of pace, has the opportunity to thrive academically and develop a passion for lifelong learning.
Courses Taught
Prof. Dhruv Kumar has a genuine passion for teaching and a deep commitment to fostering meaningful interactions with students, creating a vibrant and engaging educational environment. With an extensive background in teaching, he has imparted knowledge across various courses at the undergraduate (UG), postgraduate (PG), and doctoral (PhD) levels. Prof. Kumar's enthusiasm for sharing new ideas and insights has been a cornerstone of his teaching approach, inspiring students to explore innovative concepts and contributing to a dynamic and intellectually stimulating learning atmosphere. His continuous dedication to teaching underscores not only his expertise in the subject matter but also his unwavering commitment to nurturing the intellectual growth of students at all levels.
Undergraduate Level (B.Sc.)
Basic Bioinformatics (BIOF202)
Basics of Cancer (BIOT223)
Cell (MMBS104)
Metals in Biology (MMBS201)
Metabolism (MMBS205)
Scientific Writing (HSCC2019)
Postgraduate Level (M.Sc.)
Animal Cell Culture & Cell Engineering (SCCB601)
Assisted Reproductive Laboratory Procedures (RTCE605)
Cancer Pharmacogenomics (SCCB704)
Computational Tools in Drug Discovery (MMBS702)
Genome Engineering & Editing (SCCB603)
OMICS in Biomedical Sciences (SCCB710)
Preventive Oncology & Psycho-Oncology (SCCB705)
Reproductive & Developmental Biology and Genetics (RTCE604)
Topics in Bioinformatics (MMBS610)
Trends in Molecular Oncology (SCCB901)
Stem Cell Bio II (SCCB 707)
Scientific Writing (HSCC8007)
Good manufacturing and Lab Practices (HSCC8008)
Biosafety and Aseptic Techniques (HSMB 7024)
PhD Level
Advances in Molecular Medicine (BIOT 955) at Institute Level
Trends in Molecular Oncology (BIOT 953) at Institute Level
Research and Publication Ethics” (RPE) –(PHD901) at University Level
Awards and Grants:
Prof. Dhruv Kumar has received several national and international awards and grants as mentioned below.
Awards:
2020: Research Excellence Award, Institute of Scholars, India
2019: Senior Scientist Award, Society of Biomedical Laboratory Scientists, India
2017: Early Career Research Award, SERB, DST-India.
2016: Postdoc of the Month Award, PostDoc Journal: Journal of Postdoctoral Research, USA.
2016: Scholar-in-Training Award, AACR, The Function of Tumor Microenvironment in Cancer Progression Conference, San Diego, USA.
2015: K-INBRE Postdoctoral Award, National Institute of General Medical Sciences, National Institute of Health (NIH), USA.
2011: 8th EBSA European Biophysics Congress Bursaries Award, European Biophysical Societies Association, Italy.
2011: Young Scientist Award, International Academy of Physical Science, Allahabad, India.
2009: Brains in Competition Award, Institute of Advance Studies, University of Bologna, Italy.
2008: Indo-Italian Government Scholarship (Ministry of Human Resource and Development, India).
Grants:
2022-2025: “Analysis of the relationship between gallbladder cancer, arsenic intake, and living-environmental factors - a case in Bihar, India”, Indo-Japan, Government of Japan, Rs 100 lakh (Co-PI): Ongoing
2021-2024: “Repurposing of drugs and validation of lead compounds against main protease and RNA dependent RNA polymerase of SARS-CoV-2”, BRICS-DST, Rs 74 lakh (PI & Coordinator): Ongoing
2020-2023: “Assessment of Female reproductive health and child health risks in Arsenic Exposed population of Bihar”, ICMR New Delhi, Rs ~ 1 Crore. (Co-PI): Ongoing
2018-2021: “Understanding the Metabolic Cross-Talk between Head and Neck Squamous Cell Carcinoma and Tumor Associated Fibroblasts”, SERB-Department of Science and Technology, Government of India, Rs ~35 Lakhs. (PI): Completed
2015-2016: “Role of Tumor-Associated Fibroblasts in Head and Neck Cancer Metabolism” National Institute of General Medical Sciences, National Institute of Health, USA (P20GM103418), $25,000. (PI): Completed
Scholarly Activities
Prof. Dhruv Kumar, has a rich portfolio of scholarly activities spanning teaching, research, and academic contributions. He actively engages in designing and instructing courses at various academic levels, including undergraduate (UG), postgraduate (PG), and doctoral (PhD) programs, covering specialized areas such as Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics. Prof. Kumar's research endeavors have resulted in numerous publications in high-impact journals, including Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, and Nature Scientific Reports. He has received recognition on both national and international platforms, garnering awards such as the Senior Scientist Award from the Society of Biomedical Laboratory Scientists, India, the Scholar-in-Training Award from the American Association for Cancer Research (AACR), USA, and the K-INBRE Postdoctoral Award from the National Institute of Health (NIH), USA. Additionally, his active involvement in government-funded projects and mentorship of PhD students in the fields of Cancer and Infertility reflects his commitment to advancing knowledge and nurturing the next generation of researchers. Prof. Kumar's scholarly activities exemplify a holistic approach to academia, seamlessly integrating teaching, research, and mentorship.
His selected publications are as below:
2023
Agrawal, K.; Asthana, S.;
Kumar, D
. Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer. Cancers 2023, 15, 4920.
https://doi.org/10.3390/cancers15204920
.
(Impact Factor: 5.2)
Maurya, S., Raj, S., Bhoi, N.R., Mani, N., Rathi, B. and
Kumar, D
., 2023. Morphological analysis of metabolically dysregulated spermatozoa using Artificial Intelligence based approach. Journal of Integrated Science and Technology, 11(4), pp.569-569.
(Impact Factor: 1.14)
Raj, S. and
Kumar, D.
, 2023. Early epigenetic markers for precision medicine. Progress in molecular biology and translational science, 198, pp.153-164.
(Impact Factor: 4.0)
Kumar, A., Ali, M., Raj, V., Kumari, A., Rachamalla, M., Niyogi, S.,
Kumar, D.
, Sharma, A., Saxena, A., Panjawani, G. and Jain, P., 2023. Arsenic causing gallbladder cancer disease in Bihar. Scientific Reports, 13(1), p.4259.
(Impact Factor: 4.9)
Goel, M., Mishra, M.K. and
Kumar, D
., 2023. Recent advances in Targeted Radionuclide therapy for Cancer treatment. Chemical Biology Letters, 10(3), pp.544-544.
(Impact Factor: 6.1)
Bhattacharjee, R., Prabhakar, N., Kumar, L., Bhattacharjee, A., Kar, S., Malik, S.,
Kumar, D
., Ruokolainen, J., Negi, A., Jha, N.K. and Kesari, K.K., 2023. Crosstalk between long noncoding RNA and microRNA in Cancer. Cellular Oncology, pp.1-24.
(Impact Factor: 6.6)
Kumar, A., Kumar, K., Ali, M., Raj, V., Srivastava, A., Kumar, M., Niraj, P.K., Kumar, M., Kumar, R.,
Kumar, D.
and Bishwapriya, A., 2023. Severe Disease Burden and the Mitigation Strategy in the Arsenic-Exposed Population of Kaliprasad Village in Bhagalpur District of Bihar, India. Biological trace element research, pp.1-17.
(Impact Factor: 4.0)
Arfin, S.;
Kumar, D
.; Lomagno, A.; Mauri, P.L.; Di Silvestre, D. Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis. Cancers 2023, 15, 4420.
https://doi.org/10.3390/cancers15174420
(Impact Factor: 5.2)
Arfin S, Agrawal K, Maurya S, Asthana S, Di Silvestre
D, Kumar D
. Lead phytochemicals and marine compounds against ceruloplasmin in cancer targeting. Journal of Biomolecular Structure and Dynamics. 2023 Oct 18.
(Impact Factor: 5.2)
Agrawal K, Chakraborty P, Dewanjee S, Arfin S, Das SS, Dey A, Moustafa M, Mishra PC, Jafari SM, Jha NK, Jha SK,
Kumar D
. Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders. Neurosci Biobehav Rev. 2023 Jan;144:104955. doi: 10.1016/j.neubiorev.2022.104955. Epub 2022 Nov 14. PMID: 36395983.
(Impact Factor: 9.0)
Agrawal K, Chauhan S,
Kumar D
. Expression analysis and regulation of GLI and its correlation with stemness and metabolic alteration in human brain tumor. 3 Biotech. 2023 Jan;13(1):10. doi: 10.1007/s13205-022-03419-5. Epub 2022 Dec 15. PMID: 36532860; PMCID: PMC9755437.
(Impact Factor: 2.9)
Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A,
Kumar D
, Ambasta RK, Jha NK, Jha SK, Dewanjee S. Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Res Rev. 2023 Mar;85:101838. doi: 10.1016/j.arr.2022.101838. Epub 2023 Jan 5. PMID: 36610558.
(Impact Factor: 11.7)
Raj, S., Rathi, B., Mehra, P., Asthana, S., &
Kumar, D
. (2023). Deciphering the role of c-MET in Metabolic reprogramming of Head and Neck squamous cell Carcinoma via In Silico analysis. Chemical Biology Letters, 10(2), 532. Retrieved from
https://pubs.thesciencein.org/journal/index.php/cbl/article/view/532
(Impact Factor: 4.4)
2022
Awasthi P, Dwivedi M, Kumar D, Hasan S. Insights into intricacies of the Latent Membrane Protein-1 (LMP-1) in EBV-associated cancers. Life Sci. 2023 Jan 15;313:121261. doi: 10.1016/j.lfs.2022.121261. Epub 2022 Dec 7. PMID: 36493876.
(Impact Factor: 3.3)
Sharma S, Tyagi R, Srivastava M, Rani K,
Kumar D
, Asthana S, Raj VS. Identification and validation of potent inhibitor of Escherichia coli DHFR from MMV pathogen box. J Biomol Struct Dyn. 2022 Jun 2:1-10. doi: 10.1080/07391102.2022.2080113. Epub ahead of print. PMID: 35652895.
(Impact Factor: 3.3)
Maurya S, Kesari KK, Roychoudhury S, Kolleboyina J, Jha NK, Jha SK, Sharma A, Kumar A, Rathi B, Kumar D. Metabolic Dysregulation and Sperm Motility in Male Infertility. Adv Exp Med Biol. 2022;1358:257-273. doi: 10.1007/978-3-030-89340-8_12. PMID: 35641874.
(Impact Factor: 2.6)
Das S, Roychoudhury S, Dey A, Jha NK, Kumar D, Roychoudhury S, Slama P, Kesari KK. Bacteriospermia and Male Infertility: Role of Oxidative Stress. Adv Exp Med Biol. 2022;1358:141-163. doi: 10.1007/978-3-030-89340-8_7. PMID: 35641869.
(Impact Factor: 2.6)
Arfin, S. .; Mani, N. .; Rathi, B.; Kumar, D. In Silico Analysis of Ceruloplasmin Alteration in Oral Squamous Cell Carcinoma. Chem Biol Lett 2022, 9, 342.
(Impact Factor: 4.4)
Jha NK, Arfin S, Jha SK, Kar R, Dey A,
Kumar D
. et al. Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling Semin Cancer Biol. 2022 Feb 23:S1044-579X(22)00049-9.
https://doi.org/10.1016/j.semcancer.2022.02.022
.
(Impact Factor: 17)
Raj S, Kesari KK, Kumar A, Rathi B, Sharma A, Gupta PK, Jha SK, Jha NK, Slama P, Roychoudhury S,
Kumar D
. Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. Molecular Cancer (BMC-Springer Nature). 2022. 26;21(1):31.
https://doi.org/10.1186/s12943-022-01503-1
(Impact Factor: 41.4): Corresponding Author
Pritam P, Deka R,
Kumar D
. et al.. Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects. Biology-MDPI. 2022. 11(2), 212.
https://doi.org/10.3390/biology11020212
(Impact Factor: 5.0)
Kumar, A.
Kumar D
. et al..Assessment of disease burden in the arsenic exposed population of Chapar village of Samastipur district, Bihar, India, and related mitigation initiative.
Environmental Science and Pollution Research.
https://doi.org/10.1007/s11356-021-18207-6
(Impact Factor: 4.3)
2021
Upadhyay C.
Kumar D
. et al.. Synthesis of the new analogs of morpholine and their antiplasmodial evaluation against the human malaria parasite Plasmodium falciparum.
New Journal of Chemistry
. 2021.
https://doi.org/10.1039/D1NJ04198C
(Impact Factor: 3.4)
Singh A, Singh AK, Giri R,
Kumar D
, Sharma R, Valis M, Kuca K, Garg N. The role of microRNA-21 in the onset and progression of cancer.
Future Med Chem
. 2021 Nov;13(21): 1885-1906.
https://doi.org/10.4155/fmc-2021-0096
.
(Impact Factor: 3.9)
Jeyaraman Madhan ,Muthu Sathish ,
Kumar D
. et al. “Total Stromal Fraction (TSF) - Fortified Adipose Tissue-Derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary Compromise”,
Coronaviruses
2021; e080921196287.
https://doi.org/10.2174/2666796702666210908151708
.
(Impact Factor: 0.0)
Asif Ali, Saleheen Bano,
Kumar D
. et al. (2021) Effect of cellulose nanocrystals on chitosan/PVA/nano β-TCP composite scaffold for bone tissue engineering application,
Journal of Biomaterials Science, Polymer Edition
,
https://doi.org/10.1080/09205063.2021.1973709
.
(Impact Factor: 3.5)
Mehreen Aftab, Maryam Ghufran,
Kumar D
. et al., In silico analysis of the role of hsa-miR-155-5p in cervical cancer, Chem. Biol. Lett. 2021, 8(3), 94-105.
(Impact Factor: 4.4) : Corresponding Author
Usman, M.B., Bhardwaj, S., Roychoudhury, S.
Kumar D
. et al.. Immunotherapy for Alzheimer’s Disease: Current Scenario and Future Perspectives.
J Prev Alzheimers Dis
8, 534–551 (2021).
https://doi.org/10.14283/jpad.2021.52
(Impact Factor: 4.4)
Sharma, P.P., Bansal, M., Sethi, A., Pena, L.,
Kumar D
. et al., 2021. Computational methods directed towards drug repurposing for COVID-19: advantages and limitations.
RSC Advances
, 11(57), pp.36181-36198.
https://doi.org/10.1039/D1RA05320E
(Impact Factor: 3.3)
Goyal, K.; Goel, H.; Baranwal, P.; Tewary, A.;
Kumar D
. et al.. Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans. Immuno 2021, 1, 442-456.
https://doi.org/10.3390/immuno1040032
(Impact Factor: 0.0)
Sharma A,
Kumar D
, Dahiya K, Hawthorne S, Jha SK, Jha NK, Nand P, Girgis S, Raj S, Srivastava R, Goswami VK, Gregoriou Y, El-Zahaby SA, Ojha S, Dureja H, Gupta G, Singh S, Chellappan DK, Dua K. Advances in pulmonary drug targeting microbial biofilms in respiratory diseases. Nanomedicine (Lond). 2021 Aug 5. delivery
https://doi.org/10.2217/nnm-2021-0057
.
(Impact Factor: 5.3): : Corresponding Author
Jeyaraman M, Muthu S, Bapat A,
Kumar D
. et al.. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon. 2021 Jul;7(7):e07635.
https://doi.org/10.1016/j.heliyon.2021.e07635
.
(Impact Factor: 1.8)
Sharma A, Hawthorne S, Jha SK, Jha NK,
Kumar D
, Girgis S, Goswami VK, Gupta G, Singh S, Dureja H, Chellappan DK, Dua K. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDAMB231 human breast cancer cells. Nanomedicine (Lond). 2021 Aug;16(20):1763-1773.
https://doi.org/10.2217/nnm-2021-0066
.
(Impact Factor: 5.3)
Chandel V, Maru S, Kumar A, Kumar A, Sharma A, Rathi B,
Kumar D
. Role of monocarboxylate transporters in head and neck squamous cell carcinoma. Life Sciences. 2021, 5;279:119709.
https://doi.org/10.1016/j.lfs.2021.119709
.
(Impact Factor: 3.6) : Corresponding Author
Raj S, Kumar A,
Kumar D
. Regulation of Glycolysis in Head and Neck Cancer. Adv Exp Med Biol. 2021;1280:219-230.
https://doi.org/10.1007/978-3-030-51652-9_15
.
(Impact Factor: 2.4) : Corresponding Author
Vaishali Chandel, Garima Tripathi, Seema A. Nayar, Brijesh Rathi, Abhijeet Kumar &
Dhruv Kumar
(2021) In silico identification and validation of triarylchromones as potential inhibitor against main protease of severe acute respiratory syndrome coronavirus 2,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1918255
.
(Impact Factor: 3.2) : Corresponding Author
Rashmi Tyagi, Mitul Srivastava, Baldeep Singh, Shingini Sharma, Ramendra Pati Pandey, Shailendra Asthana,
Dhruv Kumar
& V. Samuel Raj (2021) Identification and validation of potent Mycobacterial proteasome inhibitor from Enamine library,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1914173
.
(Impact Factor: 3.2) : Corresponding Author
Mathur, A., Raj, S., Jha, N.K. et al. Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2.
3 Biotech
11, 236 (2021).
https://doi.org/10.1007/s13205-021-02791-y
.
(Impact Factor: 2.2) : Corresponding Author
Arfin, S.; Jha, N.K.; Jha, S.K.; Kesari, K.K.; Ruokolainen, J.; Roychoudhury, S.; Rathi, B.;
Kumar, D
. Oxidative Stress in Cancer Cell Metabolism.
Antioxidants
2021, 10, 642.
https://doi.org/10.3390/antiox10050642
.
(Impact Factor: 5) : Corresponding Author
Kumar A, Kumar R, Rahman MS, Ali M, Kumar R, Nupur N, Gaurav A, Raj V, Anand G, Niraj PK, Kumar N, Srivastava A, Biswapriya A, Chand GB,
Kumar D
, Rashmi T, Kumar S, Sakamoto M, Ghosh AK. Assessment of arsenic exposure in the population of Sabalpur village of Saran District of Bihar with mitigation approach.
Environ Sci Pollut Res Int.
2021 Apr 11.
https://doi.org/10.1007/s11356-021-13521-5
(Impact Factor: 4.3)
Kumar, A., Rahman, M.S., Ali, M. et al. Assessment of arsenic exposure and its mitigation intervention in severely exposed population of Buxar district of Bihar, India.
Environ. Health Sci.
(2021).
https://doi.org/10.1007/s13530-021-00086-6
(Impact Factor: .76)
Chandel V., et al. 2021. In silico identification of potential inhibitor for TP53-induced glycolysis and apoptosis regulator in head and neck squamous cell carcinoma.
3Biotech
. 11(3):117.
https://doi.org/10.1007/s13205-021-02665-3
(Impact Factor: 2.2) : Corresponding Author
2020
Kumar A., et al. 2020. Arsenic exposure causing cancer in the Indo - Gangetic Plain - A 2000 cancer patients’ cross-sectional design.
Scientific Reports
. 11, 2376 (2021).
https://doi.org/10.1038/s41598-021-81579-9
.
(Impact Factor: 4.1)
Roychoudhury S., et al. 2020. Viral pathogenesis of SARS-CoV-2 infection and male reproductive health: Myth or fact?
Open Biology
. 11(1): 200347,
https://doi.org/10.1098/rsob.200347
(Impact Factor: 4.9)
Jha N K., et al. 2020. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS‑CoV‑2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Journal of Molecular Neuroscience.
https://doi.org/10.1007/s12031-020-01767-6
.
(Impact Factor: 2.8)
Ali A., et al. 2020. Comparative analysis of TiO2 and Ag nanoparticles on xylan/chitosan conjugate matrix for wound healing application.
International Journal of Polymeric Materials and Polymeric Biomaterials.
https://doi.org/10.1080/00914037.2020.1838519
(Impact Factor: 1.9)
Kumar D., et al. 2020. Stem Cell Based Preclinical Drug Development and Toxicity Prediction.
Current Pharmaceutical Design
.
https://doi.org/10.2174/1381612826666201019104712
(Impact Factor: 2.4) : Corresponding Author
Tyagi R., et al. 2020. Development of potential proteasome inhibitors against Mycobacterium tuberculosis.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1835722
(Impact Factor: 3.2) : Corresponding Author
Narula S, Tandon S, Kumar D et al. 2020. Human kidney stone matrix proteins alleviate hyperoxaluria induced renal stress by targeting cell-crystal interactions.
Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118498
(Impact Factor: 3.6)
Satyam R, Jha NK, Kar R et al. 2020. Deciphering the SSR incidences across viral members of Coronaviridae family.
Chemico-Biological Interactions.
https://doi.org/10.1016/j.cbi.2020.109226
(Impact Factor: 3.6)
Chandel V, Raj S, Rathi B, Choudhary R,
Kumar D
. 2020. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1811773
(Impact Factor: 3.2) : Corresponding Author
Manish D., Vijay T., Kumar D., et al. 2020. Structural and Morphological Characterization of CdS Nanoparticles,
Current Physical Chemistry.
https://doi.org/10.2174/1877946810999200730222025
(Impact Factor: 1.6)
Raj S, Chandel V, et al. 2020 Molecular mechanisms of interplay between autophagy and metabolism in cancer
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118184
(Impact Factor: 3.6) : Corresponding Author
Chandel V, Raj S, et al. 2020. Metabolic regulation in HPV associated head and neck squamous cell carcinoma
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118236
(Impact Factor: 3.6) : Corresponding Author
Chandel V,
Kumar D
. 2020. Targeting Signalling Cross-Talk between Cancer Cells and Cancer Associate Fibroblast through Monocarboxylate Transporters in Head and Neck Cancer
,Anti-Cancer Agents in Medicinal Chemistry
:
Bentham Science Publishers
,
https://doi.org/10.2174/1871520620666200721135230
(Impact Factor: 2.04) : Corresponding Author
Kumar S, Sharma PP, Shankar U,
Kumar D
et al. 2020. Discovery of New Hydroxyethylamine Analogs against 3CL pro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies.
J Chem Inf Model.
https://doi.org/10.1021/acs.jcim.0c00326
(Impact Factor: 4.5)
Pandey V, Tripathi G,
Kumar D
et al. 2020. Novel 3,4-diarylpyrazole as prospective anti-cancerous agents,
Helion
,
https://doi.org/10.1016/j.heliyon.2020.e04397
(Impact Factor: 1.6) : Corresponding Author
Chandel V, Raj S, Rathi B,
Kumar D
. 2020. In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach.
Chemical Biology Letters
. 7(3), 166‐175.
(Impact Factor: 4.4) : Corresponding Author
Chandel V, Raj S, Srivastava A,
Kumar D
. 2020. In-silico interactions of active Phytochemicals with c-MYC EGFR and ERBB2 oncoproteins.
Chemical Biology Letters
. 7(1), 47‐54.
(Impact Factor: 4.4) : Corresponding Author
Raj S, Chandel V, Rathi B,
Kumar D
. 2020. Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach, Coronavirus: Bentham Science Publishers, DOI : 10.2174/2666796701999200617155013
: Corresponding Author
2019
Sibi Raj, Sartaj Khuranaa, Ramesh Choudhari et al. 2019. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
Seminars in Cancer Biology
https://doi.org/10.1016/j.semcancer.2019.11.002
.
(Impact Factor: 15) : Corresponding Author
Anukriti, Anupam D, Swati U, Pallavi S, et al. 2019. Investigation of Precise Molecular Mechanistic Action of Tobacco-Associated Carcinogen ‘NNK’ Induced Carcinogenesis: A System Biology Approach. 10(8), 564.
(Impact Factor: 3.4)
Asif A, Saleheen B, Satish S.P,
Kumar D
, Yuvraj S N, 2019. Effect of incorporation of Montmorillonite on Xylan/Chitosan conjugate scaffold.
Colloids and Surfaces B: Biointerfaces
1(180) 75-82.
(Impact Factor: 3.9)
Vishwakarma V, New J1,
Kumar D,
et al.,
Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds.
Scientific Reports
. 15;8(1):12163.
(Impact Factor: 4.1)
Chandel V and Kumar D. 2019. The Development of Tumor Heterogeneity and Actively Targeting Therapy Resistant Subpopulations
. J Embryol Stem Cell Res
. 3(3): 000131
: Corresponding Author
2018
Kumar D, et al.,
2018
.
Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression.
Cancer Research
. 10.1158/0008-5472.CAN-17-1076.
(Impact Factor: 12) : First Author
Kumar D
, et al. Perfluoro Curcumin Strongly Interacts with ABC Transporter (ABCG2): A Molecular Docking Study.
J Embryol Stem Cell Res
2018, 2(2): 000113.
: Corresponding Author
Kumar D
. 2018. Resveratrol derivative triacetyl-resveratrol interacts directly with the Gli-DNA zinc finger complex.
J Cancer Res Oncobiol
. Apr; 1(2):110
: Corresponding Author
2017
Kumar D
, et al., 2017. Development and characterization of an in vitro model for radiation-induced fibrosis,.
Radiation Research
. 189(3):326-336
(Impact Factor: 2.5) : First Author
Kumar D
, 2017. Role of tumor heterogeneity in drug resistance.
Glob J Cancer Ther
3(2): 032-033. (Editorial).
: Corresponding Author
Kumar D
, 2017. Regulation of glycolysis in head and neck squamous cell carcinoma
. Postdoc Journal
. 2017 Jan;5 (1):14-28.
: Corresponding Author
2016
Ledgerwood LG*,
Kumar D*,
Eterovic AK, Wick J et al., 2016. The degree of intra-tumor mutational heterogeneity varies by primary tumor sub-site.
Oncotarget
. Mar 28. doi: 18632/oncotarget.8448.
(Impact Factor:6.4)
*Equal contribution
: First Author
2015
Kumar D
, Kandl C, Hamilton C, Shnayder Y, Tsue T, Kakarala K, Ledgerwood L, Sun X S, Huang H, Girod D, Thomas S 2015. Anti-HGF antibody ficlatuzumab mitigates tumor-associated fibroblast-facilitated head and neck cancer progression.
JAMA Otolaryngology-Head & Neck Surgery
. Dec 1;141 (12): 1133-9.
(Impact Factor: 6.2) : First Author
Kumar D
, Gupta D, Shankar S, Srivastava RK. 2015. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
Oncotarget:
1-12.
(Impact Factor:6.4) : First Author
2014
Plotegher N,
Kumar D
, Tessari I, Brucale M, Munari F, et al. 2014. The chaperone-like protein 14-3-3eta interacts with human alpha-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing alpha-synuclein cellular toxicity.
Human Molecular Genetics
. 23:5615-29.
(Impact Factor:5.9)
Kumar D
, Shankar S, Srivastava RK. 2014. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway.
Cancer Letters
. 343:179-89.
(Impact Factor:6.4) : First Author
Kumar D
, Plotegher N, Bubacco L, Brucale M. 2014. Quantitative AFM morphometry of non-fibrillar α- synuclein aggregation products induced by the chaperone-like protein 14-3-3.
Italian Society for Microscopical Sciences
. Vol 21, No 1. DOI: 10.4081/microscopie. 2014.4998.
: First Author
Kumar D
, Shankar S, Srivastava RK. 2014. Understanding the biological functions and therapeutic potentials of stem cells and cancer stem cells: Where are we?
Journal of Cancer Stem Cell Research
. 2:e1002:1-8.
: First Author
2013
Kumar D
, Shankar S, Srivastava RK. 2013. Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms.
Molecular Cancer
. 1476-4598-12-171.
(Impact Factor:27) : First Author
Nanta R,
Kumar D
, Meeker D, Rodova M, Van Veldhuizen PJ, et al. 2013. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rgamma null mice by regulating Bmi-1 and microRNA-128.
Oncogenesis
. 2:e42.
(Impact Factor:5.1)
Shankar S,
Kumar D
, Srivastava 2013. Epigenetic modifications by dietary phytochemicals: Implications for personalized nutrition.
Pharmacol Therapeut
. 138:1-17.
(Impact Factor:11.1)
2012
Pivato M, De Franceschi G, Tosatto L, Frare E,
Kumar D
, et al. 2012. Covalent alpha-synuclein dimers: chemico-physical and aggregation properties.
PloS one
7:e50027.
(Impact Factor:3.4)
Singh BN,
Kumar D
, Shankar S, Srivastava 2012. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells.
Biochemical Pharmacology
. 84:1154-63.
(Impact Factor:6.1)
Conference Proceedings
Tyagi,
D. Kumar
and V. S. Raj, 2018. "In silico identification of potential inhibitors against Mycobacterial proteasome," 2018 International Conference on Bioinformatics and Systems Biology (BSB), Allahabad, India,
IEEE Xplore
, pp. 193-197.
(IF: 10.6)
Shekhar Goyal, Surender Kr Beniwal, H S Kumar,
Dhruv Kumar
, B C Das. 2019. Role of Curcumin in reducing toxicity and adverse effects in locally advanced and metastatic breast cancer patients.
Annals of Oncology
. Volume 30, vi126 - vi127.
(IF: 14)
Book Chapter
Mavi, Anil Kumar, Manmohan Kumar, Amarjeet Singh, Mahendra Kumar Prajapati, Rakhi Khabiya, Saurabh Maru, and
Dhruv Kumar.
"Progress in Non‐Viral Delivery of Nucleic Acid: Advancement in Biomedical Technology." Integration of Biomaterials for Gene Therapy (2023): 281-322.
https://doi.org/10.1002/9781394175635.ch10
Mavi, Anil Kumar, Sonal Gaur, Neelesh Kumar, Avanish Kumar Shrivastav, Sankha Bhattacharya, Sateesh Belemkar, Saurabh Maru, and
Dhruv Kumar
. "Effective Gene Transfer with Non‐Viral Vectors." Integration of Biomaterials for Gene Therapy (2023): 183-222.
https://doi.org/10.1002/9781394175635.ch7
Kirti Agrawal, Malavika Saji,
Dhruv Kumar,
Drug Repurposing in Future Drug Discovery and Development, Book-Drug Repurposing and Computational Drug Discovery, Edition1st Edition 2023, Apple Academic Press, Pages26, eBook ISBN9781003347705,
https://doi.org/10.1201/9781003347705
Kumar, A., Raj, V., Ali, M., Abhinav, Rachamalla, M.,
Kumar, D
., Kumari, A., Kumar, R., Shankar, P. and Ghosh, A., 2023. Evaluation of MOF Applications for Groundwater Arsenic Mitigation of the Middle Ganga Plains of Bihar, India. Metal Organic Frameworks for Wastewater Contaminant Removal, pp.355-373. 26 August 2023,
https://doi.org/10.1002/9783527841523.ch16
Saniya Arfin,
Dhruv Kumar
, Chapter 3 - Use of vitamins and minerals as dietary supplements for better health and cancer prevention, Editor(s): Inamuddin, Tariq Altalhi, Jorddy Neves Cruz, Nutraceuticals, Academic Press, 2023, Pages 53-97, ISBN 9780443191930,
https://doi.org/10.1016/B978-0-443-19193-0.00003-4
.
A Santoshkumar, S Ray, S Narayanan,
D Kumar
, S Harihar (2023), Mitophagy in cancer and cancer stem cells: a role in metabolic reprogramming. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00009-2
T Singh, AS Kharat, B Rathi,
D Kumar
(2023), Designing metabolic target-specific inhibitors for cancer therapy. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00011-0
Sibi Raj, Manish K. Mishra, Sitaram Harihar, Ashok Kumar, Shubhadeep Roychoudhury, Arun Kumar et al. (
2022
). Regulation of Glucose Transporters in Cancer Progression, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_9
Stephen James, Saniya Arfin, Manish K. Mishra, Arun Kumar, Niraj Kumar Jha, Saurabh Kumar Jha et al. (
2022
). Role of Arsenic in Carcinogenesis, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_7
Raj S., Kumar A.,
Kumar D
. (
2020
) Regulation of Glycolysis in Head and Neck Cancer, Book. Cancer Metabolomics, Advances in Experimental Medicine and Biology, Springer Nature.
https://doi.org/10.1007/978-3-030-51652-9_15
Chandel V.,
Kumar D
. (
2020
) Role of Interferon in Cancer Metabolism. Innate Immunity in Health and Disease. IntechOpen.
https://doi.org/10.5772/intechopen.92020
Raj S, Chandel V., Maurya S,
Kumar D
. (
2020
) Role of Macrophages in Solid Tumor Metabolism. Macrophages. IntechOpen.
https://doi.org/10.5772/intechopen.93182
Maurya S, Chandel V, Raj S, (
2020
) OMICS IN CANCER: FROM DIAGNOSTICS TO THERAPEUTICS. Recent Trends in ‘Computational Omics'. ISBN: 978-1-53617-941-5
Raj S., Chandel V.,
Kumar D
. (
2020
) Cancer Cell Metabolism: Solid Tumor Versus Nonsolid Tumor. In:
Kumar D
. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_1
Pedroza D.A. et al. (
2020
) Role of Autophagy in Cancer Cell Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_6
Chandel V., Raj S., Choudhari R.,
Kumar D
. (
2020
) Role of c-Met/HGF Axis in Altered Cancer Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_7
Kumar D
., Sharma-Walia N., Kapoor S., Tandon S. (
2020
) Antibody-Targeted Nanoparticles for Cancer Treatment. In: Saxena S., Khurana S. (eds) NanoBioMedicine. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9898-9_3
Singh B., Malhotra H.,
Kumar D
., Mujtaba S.F., Upadhyay A.K. (
2019
) Understanding Cellular and Molecular Events of Skin Aging and Cancer: An Integrative Perspective. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_2
Tripathi M.K., Sinha J., Srivastava S.K.,
Kumar D
. (
2019
) Bioinformatics in Skin Cancer: A System Biology Approach to Understanding the Molecular Mechanisms and It’s Regulations. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_10
Khurana S., Bose S.,
Kumar D
. (
2019
) Applications of Microarray-Based Technologies in Identifying Disease-Associated Single Nucleotide Variations. In: Tripathi V., Kumar P., Tripathi P., Kishore A., Kamle M. (eds) Microbial Genomics in Sustainable Agroecosystems. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9860-6_4
Singh P., Tiwari D., Mishra M.,
Kumar D
. (
2019
) Molecular Mechanisms of Heavy Metal Toxicity in Cancer Progression. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_3
Chandel V., Seth G., Shukla P.,
Kumar D
. (
2019
) Role of Radiation in DNA Damage and Radiation Induced Cancer. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_1
Dhruv Kumar
, Sharmila Shankar, Rakesh Srivastava. Challenges in stem cells and translational research (Book chapter). Lost in translational and clinical research. World Scientific Publication,
2014
. ISBN: 9789814489089.
https://doi.org/10.1142/9789814489072_0020
Dhruv kumar
and Bruno Samori. Mechanochemistry: Coupling mechanical forces and chemical reactions (Book chapter). Molecular Manipulation with Atomic Force Microscopy (Book), CRC Press,
2011
, ISBN: 9781439809662.
Dwijendra Gupta,
Dhruv Kumar
, Manish Dwivedi, Vijay Tripathi, Pratibha Phadke-Gupta and Surya Pratap Singh. Nanophosphors-Nanogold immunoconjugates in Isolation of Biomembranes and in Drug Delivery (Book chapter). Recent Advances in Nanomedicine (Book), VBRI Press,
2011
, ISBN: 9788192006803.
Book
Dhruv Kumar
, Shailendra Asthana Autophagy and Metabolism Potential Target for Cancer Therapy 1st Edition - August 6, 2022 Paperback ISBN: 9780323998796 9 7 8 - 0 - 3 2 3 - 9 9 8 7 9 - 6 eBook ISBN: 9780323999458
Akhileshwar Srivastava,
Dhruv Kumar
, Divya Singh, Rajesh Singh, Xenobiotics in Chemical Carcinogenesis:Translational Aspects in Toxicology,
Elsevier,
ISBN: 9780323905602
Dhruv kumar.
Cancer Cell Metabolism: A Potential Target for Cancer Therapy.
Springer Nature
.
2020,
ISBN: 9789811519901.
Dhruv kumar
, Marco Brucale and Bruno Samori. Amyloidogenic Proceses of Intrinsically Disordered Proteins: Understanding the Aggregation Process of Intrinsically Unstructured Proteins Related to Neurodegenerative Diseases.
Lambert Academic Publishing
,
2014
, ISBN:
Dhruv kumar
. Insilico analysis of Docking between HIV-1 PR and derivatives of CUI (Docking between HIV- 1 proteases and cyclic urea inhibitors: A step towards drug designing against AIDS).
Lambert Academic Publishing
,
2011
, ISBN:
Contact
dhruv.kumar@ddn.upes.ac.in

Profile Summary
Prof. Dhruv Kumar is a Professor and Cluster Head at the Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun. Listed as a top 2% world’s most influential scientist in the area of Oncology and cancer Biology. His academic journey includes a B.Sc. in Chemistry from Banaras Hindu University (BHU), Varanasi, and M.Sc. in Bioinformatics with Distinction from the University of Allahabad (AU), Prayagraj. Dr. Dhruv Kumar further distinguished himself by completing his Ph.D. in Cellular, Molecular, and Industrial Biology from the University of Bologna (UNIBO), Italy, under the highly prestigious fellowship of the Ministry of Human Resource and Development (MHRD), Indo-Italian Government fellowship. Following the completion of his Ph.D., he embarked on a five-year Postdoctoral training at the School of Medicine, University of Kansas Medical Center, Kansas City, USA. Dr. Kumar's research has been dedicated to several cancer types, including Prostate, Pancreatic, Brain, Breast, and Head and Neck Cancer, with a primary focus on unraveling the molecular mechanisms regulating Autophagy and Apoptosis in Cancer Stem Cells. Currently, his laboratory is actively exploring the Autophagy-Metabolic axis in various cancer cells, such as head and neck, oral, breast, and brain, along with investigating the tumor microenvironment for the development of innovative therapeutic approaches. Notably, his research group has made significant contributions to Drug Designing and Drug Repurposing for COVID-19. Dr. Dhruv Kumar's scholarly contributions are evident in his extensive publication record, with articles featured in prestigious journals such as Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, Seminars in Cancer Biology, JAMA Otolaryngology, Nature Scientific Reports, and many more. Presently, Dr. Kumar is actively engaged in numerous government-funded projects and is mentoring eight Ph.D. students in the areas of Cancer and Infertility. Beyond his research endeavors, he plays a vital role in teaching courses at the undergraduate (UG), postgraduate (PG), and Ph.D. levels, covering subjects related to Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics.
Work Experience
Prof. Dhruv Kumar possesses over 15 years of extensive experience encompassing teaching, research, and administrative roles. His professional journey is outlined as follows:
06/22-Present: Professor & Cluster Head, Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand, India.
01/21-06/22: Professor & Assistant Director, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
07/19-12/20: Associate Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
04/17-07/19: Assistant Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
08/16-04/17: Assistant Professor, Department of Bioinformatics, SRM University, Delhi-NCR, Sonepat, Haryana, India.
03/12-06/16: Postdoctoral Fellow, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
In these diverse roles, Prof. Kumar has demonstrated his commitment to academia, contributing significantly to various institutions and enhancing his expertise in the fields of Molecular Medicine, Cancer Biology, Stem Cell Research, and Bioinformatics. His journey includes pivotal positions such as Assistant Professor at SRM University and various roles at Amity University Uttar Pradesh, showcasing his dedication to fostering education and research. Currently serving as a Professor and Cluster Head at UPES, Dehradun, he continues to make substantial contributions to the academic and research landscape.
Research Interests
Prof. Dhruv Kumar boasts an extensive and diverse research portfolio spanning over various critical domains in biomedical science. With over 15 years of profound expertise, he has significantly contributed to Translational Cancer Research, unraveling novel insights that bridge the gap between fundamental discoveries and clinical applications. His dedicated exploration into Cancer Stem Cells has shed light on the molecular intricacies governing these cells. Prof. Kumar's investigations into Cancer Cell Metabolism reveal a nuanced understanding of metabolic alterations in cancer cells, potentially paving the way for innovative therapeutic strategies. Additionally, his work on the Tumor Microenvironment and Tumor Heterogeneity delves into the complex interplay and diversity within cancer populations. His research illuminates the regulatory mechanisms of Autophagy and the role of Exosomes in cancer, offering crucial perspectives on cellular recycling and intercellular communication. Beyond cancer biology, Prof. Kumar's foray into Infertility research explores molecular factors underlying reproductive challenges. Proficient in Genome Editing and NGS Data Analysis, he navigates cutting-edge genetic technologies. His involvement in Drug Repurposing and Drug Discovery underscores an innovative approach to therapeutics, while his recent contributions in COVID-19 research showcase adaptability to contemporary health challenges. Prof. Kumar's overarching mastery in Bioinformatics strategically integrates computational methods, enhancing the comprehensive interpretation of complex biological data.
Teaching Philosophy
Prof. Dhruv Kumar's teaching philosophy is characterized by innovation and inclusivity. He employs a blended teaching approach that seamlessly integrates traditional methods with modern technologies, creating a dynamic and engaging learning environment. One notable aspect is his commitment to discussing cutting-edge research topics, including those recognized with Nobel Prizes, providing students with insights into the forefront of scientific inquiry. Prof. Kumar takes an innovative approach to support slow learners, implementing strategies such as pairing them with a buddy for personalized assistance, arranging expert lectures, fostering group discussions, and emphasizing hands-on training and practical experiences. By tailoring his teaching methods to diverse learning styles and providing additional support mechanisms, Prof. Kumar ensures that every student, regardless of pace, has the opportunity to thrive academically and develop a passion for lifelong learning.
Courses Taught
Prof. Dhruv Kumar has a genuine passion for teaching and a deep commitment to fostering meaningful interactions with students, creating a vibrant and engaging educational environment. With an extensive background in teaching, he has imparted knowledge across various courses at the undergraduate (UG), postgraduate (PG), and doctoral (PhD) levels. Prof. Kumar's enthusiasm for sharing new ideas and insights has been a cornerstone of his teaching approach, inspiring students to explore innovative concepts and contributing to a dynamic and intellectually stimulating learning atmosphere. His continuous dedication to teaching underscores not only his expertise in the subject matter but also his unwavering commitment to nurturing the intellectual growth of students at all levels.
Undergraduate Level (B.Sc.)
Basic Bioinformatics (BIOF202)
Basics of Cancer (BIOT223)
Cell (MMBS104)
Metals in Biology (MMBS201)
Metabolism (MMBS205)
Scientific Writing (HSCC2019)
Postgraduate Level (M.Sc.)
Animal Cell Culture & Cell Engineering (SCCB601)
Assisted Reproductive Laboratory Procedures (RTCE605)
Cancer Pharmacogenomics (SCCB704)
Computational Tools in Drug Discovery (MMBS702)
Genome Engineering & Editing (SCCB603)
OMICS in Biomedical Sciences (SCCB710)
Preventive Oncology & Psycho-Oncology (SCCB705)
Reproductive & Developmental Biology and Genetics (RTCE604)
Topics in Bioinformatics (MMBS610)
Trends in Molecular Oncology (SCCB901)
Stem Cell Bio II (SCCB 707)
Scientific Writing (HSCC8007)
Good manufacturing and Lab Practices (HSCC8008)
Biosafety and Aseptic Techniques (HSMB 7024)
PhD Level
Advances in Molecular Medicine (BIOT 955) at Institute Level
Trends in Molecular Oncology (BIOT 953) at Institute Level
Research and Publication Ethics” (RPE) –(PHD901) at University Level
Awards and Grants:
Prof. Dhruv Kumar has received several national and international awards and grants as mentioned below.
Awards:
2020: Research Excellence Award, Institute of Scholars, India
2019: Senior Scientist Award, Society of Biomedical Laboratory Scientists, India
2017: Early Career Research Award, SERB, DST-India.
2016: Postdoc of the Month Award, PostDoc Journal: Journal of Postdoctoral Research, USA.
2016: Scholar-in-Training Award, AACR, The Function of Tumor Microenvironment in Cancer Progression Conference, San Diego, USA.
2015: K-INBRE Postdoctoral Award, National Institute of General Medical Sciences, National Institute of Health (NIH), USA.
2011: 8th EBSA European Biophysics Congress Bursaries Award, European Biophysical Societies Association, Italy.
2011: Young Scientist Award, International Academy of Physical Science, Allahabad, India.
2009: Brains in Competition Award, Institute of Advance Studies, University of Bologna, Italy.
2008: Indo-Italian Government Scholarship (Ministry of Human Resource and Development, India).
Grants:
2022-2025: “Analysis of the relationship between gallbladder cancer, arsenic intake, and living-environmental factors - a case in Bihar, India”, Indo-Japan, Government of Japan, Rs 100 lakh (Co-PI): Ongoing
2021-2024: “Repurposing of drugs and validation of lead compounds against main protease and RNA dependent RNA polymerase of SARS-CoV-2”, BRICS-DST, Rs 74 lakh (PI & Coordinator): Ongoing
2020-2023: “Assessment of Female reproductive health and child health risks in Arsenic Exposed population of Bihar”, ICMR New Delhi, Rs ~ 1 Crore. (Co-PI): Ongoing
2018-2021: “Understanding the Metabolic Cross-Talk between Head and Neck Squamous Cell Carcinoma and Tumor Associated Fibroblasts”, SERB-Department of Science and Technology, Government of India, Rs ~35 Lakhs. (PI): Completed
2015-2016: “Role of Tumor-Associated Fibroblasts in Head and Neck Cancer Metabolism” National Institute of General Medical Sciences, National Institute of Health, USA (P20GM103418), $25,000. (PI): Completed
Scholarly Activities
Prof. Dhruv Kumar, has a rich portfolio of scholarly activities spanning teaching, research, and academic contributions. He actively engages in designing and instructing courses at various academic levels, including undergraduate (UG), postgraduate (PG), and doctoral (PhD) programs, covering specialized areas such as Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics. Prof. Kumar's research endeavors have resulted in numerous publications in high-impact journals, including Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, and Nature Scientific Reports. He has received recognition on both national and international platforms, garnering awards such as the Senior Scientist Award from the Society of Biomedical Laboratory Scientists, India, the Scholar-in-Training Award from the American Association for Cancer Research (AACR), USA, and the K-INBRE Postdoctoral Award from the National Institute of Health (NIH), USA. Additionally, his active involvement in government-funded projects and mentorship of PhD students in the fields of Cancer and Infertility reflects his commitment to advancing knowledge and nurturing the next generation of researchers. Prof. Kumar's scholarly activities exemplify a holistic approach to academia, seamlessly integrating teaching, research, and mentorship.
His selected publications are as below:
2023
Agrawal, K.; Asthana, S.;
Kumar, D
. Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer. Cancers 2023, 15, 4920.
https://doi.org/10.3390/cancers15204920
.
(Impact Factor: 5.2)
Maurya, S., Raj, S., Bhoi, N.R., Mani, N., Rathi, B. and
Kumar, D
., 2023. Morphological analysis of metabolically dysregulated spermatozoa using Artificial Intelligence based approach. Journal of Integrated Science and Technology, 11(4), pp.569-569.
(Impact Factor: 1.14)
Raj, S. and
Kumar, D.
, 2023. Early epigenetic markers for precision medicine. Progress in molecular biology and translational science, 198, pp.153-164.
(Impact Factor: 4.0)
Kumar, A., Ali, M., Raj, V., Kumari, A., Rachamalla, M., Niyogi, S.,
Kumar, D.
, Sharma, A., Saxena, A., Panjawani, G. and Jain, P., 2023. Arsenic causing gallbladder cancer disease in Bihar. Scientific Reports, 13(1), p.4259.
(Impact Factor: 4.9)
Goel, M., Mishra, M.K. and
Kumar, D
., 2023. Recent advances in Targeted Radionuclide therapy for Cancer treatment. Chemical Biology Letters, 10(3), pp.544-544.
(Impact Factor: 6.1)
Bhattacharjee, R., Prabhakar, N., Kumar, L., Bhattacharjee, A., Kar, S., Malik, S.,
Kumar, D
., Ruokolainen, J., Negi, A., Jha, N.K. and Kesari, K.K., 2023. Crosstalk between long noncoding RNA and microRNA in Cancer. Cellular Oncology, pp.1-24.
(Impact Factor: 6.6)
Kumar, A., Kumar, K., Ali, M., Raj, V., Srivastava, A., Kumar, M., Niraj, P.K., Kumar, M., Kumar, R.,
Kumar, D.
and Bishwapriya, A., 2023. Severe Disease Burden and the Mitigation Strategy in the Arsenic-Exposed Population of Kaliprasad Village in Bhagalpur District of Bihar, India. Biological trace element research, pp.1-17.
(Impact Factor: 4.0)
Arfin, S.;
Kumar, D
.; Lomagno, A.; Mauri, P.L.; Di Silvestre, D. Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis. Cancers 2023, 15, 4420.
https://doi.org/10.3390/cancers15174420
(Impact Factor: 5.2)
Arfin S, Agrawal K, Maurya S, Asthana S, Di Silvestre
D, Kumar D
. Lead phytochemicals and marine compounds against ceruloplasmin in cancer targeting. Journal of Biomolecular Structure and Dynamics. 2023 Oct 18.
(Impact Factor: 5.2)
Agrawal K, Chakraborty P, Dewanjee S, Arfin S, Das SS, Dey A, Moustafa M, Mishra PC, Jafari SM, Jha NK, Jha SK,
Kumar D
. Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders. Neurosci Biobehav Rev. 2023 Jan;144:104955. doi: 10.1016/j.neubiorev.2022.104955. Epub 2022 Nov 14. PMID: 36395983.
(Impact Factor: 9.0)
Agrawal K, Chauhan S,
Kumar D
. Expression analysis and regulation of GLI and its correlation with stemness and metabolic alteration in human brain tumor. 3 Biotech. 2023 Jan;13(1):10. doi: 10.1007/s13205-022-03419-5. Epub 2022 Dec 15. PMID: 36532860; PMCID: PMC9755437.
(Impact Factor: 2.9)
Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A,
Kumar D
, Ambasta RK, Jha NK, Jha SK, Dewanjee S. Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Res Rev. 2023 Mar;85:101838. doi: 10.1016/j.arr.2022.101838. Epub 2023 Jan 5. PMID: 36610558.
(Impact Factor: 11.7)
Raj, S., Rathi, B., Mehra, P., Asthana, S., &
Kumar, D
. (2023). Deciphering the role of c-MET in Metabolic reprogramming of Head and Neck squamous cell Carcinoma via In Silico analysis. Chemical Biology Letters, 10(2), 532. Retrieved from
https://pubs.thesciencein.org/journal/index.php/cbl/article/view/532
(Impact Factor: 4.4)
2022
Awasthi P, Dwivedi M, Kumar D, Hasan S. Insights into intricacies of the Latent Membrane Protein-1 (LMP-1) in EBV-associated cancers. Life Sci. 2023 Jan 15;313:121261. doi: 10.1016/j.lfs.2022.121261. Epub 2022 Dec 7. PMID: 36493876.
(Impact Factor: 3.3)
Sharma S, Tyagi R, Srivastava M, Rani K,
Kumar D
, Asthana S, Raj VS. Identification and validation of potent inhibitor of Escherichia coli DHFR from MMV pathogen box. J Biomol Struct Dyn. 2022 Jun 2:1-10. doi: 10.1080/07391102.2022.2080113. Epub ahead of print. PMID: 35652895.
(Impact Factor: 3.3)
Maurya S, Kesari KK, Roychoudhury S, Kolleboyina J, Jha NK, Jha SK, Sharma A, Kumar A, Rathi B, Kumar D. Metabolic Dysregulation and Sperm Motility in Male Infertility. Adv Exp Med Biol. 2022;1358:257-273. doi: 10.1007/978-3-030-89340-8_12. PMID: 35641874.
(Impact Factor: 2.6)
Das S, Roychoudhury S, Dey A, Jha NK, Kumar D, Roychoudhury S, Slama P, Kesari KK. Bacteriospermia and Male Infertility: Role of Oxidative Stress. Adv Exp Med Biol. 2022;1358:141-163. doi: 10.1007/978-3-030-89340-8_7. PMID: 35641869.
(Impact Factor: 2.6)
Arfin, S. .; Mani, N. .; Rathi, B.; Kumar, D. In Silico Analysis of Ceruloplasmin Alteration in Oral Squamous Cell Carcinoma. Chem Biol Lett 2022, 9, 342.
(Impact Factor: 4.4)
Jha NK, Arfin S, Jha SK, Kar R, Dey A,
Kumar D
. et al. Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling Semin Cancer Biol. 2022 Feb 23:S1044-579X(22)00049-9.
https://doi.org/10.1016/j.semcancer.2022.02.022
.
(Impact Factor: 17)
Raj S, Kesari KK, Kumar A, Rathi B, Sharma A, Gupta PK, Jha SK, Jha NK, Slama P, Roychoudhury S,
Kumar D
. Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. Molecular Cancer (BMC-Springer Nature). 2022. 26;21(1):31.
https://doi.org/10.1186/s12943-022-01503-1
(Impact Factor: 41.4): Corresponding Author
Pritam P, Deka R,
Kumar D
. et al.. Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects. Biology-MDPI. 2022. 11(2), 212.
https://doi.org/10.3390/biology11020212
(Impact Factor: 5.0)
Kumar, A.
Kumar D
. et al..Assessment of disease burden in the arsenic exposed population of Chapar village of Samastipur district, Bihar, India, and related mitigation initiative.
Environmental Science and Pollution Research.
https://doi.org/10.1007/s11356-021-18207-6
(Impact Factor: 4.3)
2021
Upadhyay C.
Kumar D
. et al.. Synthesis of the new analogs of morpholine and their antiplasmodial evaluation against the human malaria parasite Plasmodium falciparum.
New Journal of Chemistry
. 2021.
https://doi.org/10.1039/D1NJ04198C
(Impact Factor: 3.4)
Singh A, Singh AK, Giri R,
Kumar D
, Sharma R, Valis M, Kuca K, Garg N. The role of microRNA-21 in the onset and progression of cancer.
Future Med Chem
. 2021 Nov;13(21): 1885-1906.
https://doi.org/10.4155/fmc-2021-0096
.
(Impact Factor: 3.9)
Jeyaraman Madhan ,Muthu Sathish ,
Kumar D
. et al. “Total Stromal Fraction (TSF) - Fortified Adipose Tissue-Derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary Compromise”,
Coronaviruses
2021; e080921196287.
https://doi.org/10.2174/2666796702666210908151708
.
(Impact Factor: 0.0)
Asif Ali, Saleheen Bano,
Kumar D
. et al. (2021) Effect of cellulose nanocrystals on chitosan/PVA/nano β-TCP composite scaffold for bone tissue engineering application,
Journal of Biomaterials Science, Polymer Edition
,
https://doi.org/10.1080/09205063.2021.1973709
.
(Impact Factor: 3.5)
Mehreen Aftab, Maryam Ghufran,
Kumar D
. et al., In silico analysis of the role of hsa-miR-155-5p in cervical cancer, Chem. Biol. Lett. 2021, 8(3), 94-105.
(Impact Factor: 4.4) : Corresponding Author
Usman, M.B., Bhardwaj, S., Roychoudhury, S.
Kumar D
. et al.. Immunotherapy for Alzheimer’s Disease: Current Scenario and Future Perspectives.
J Prev Alzheimers Dis
8, 534–551 (2021).
https://doi.org/10.14283/jpad.2021.52
(Impact Factor: 4.4)
Sharma, P.P., Bansal, M., Sethi, A., Pena, L.,
Kumar D
. et al., 2021. Computational methods directed towards drug repurposing for COVID-19: advantages and limitations.
RSC Advances
, 11(57), pp.36181-36198.
https://doi.org/10.1039/D1RA05320E
(Impact Factor: 3.3)
Goyal, K.; Goel, H.; Baranwal, P.; Tewary, A.;
Kumar D
. et al.. Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans. Immuno 2021, 1, 442-456.
https://doi.org/10.3390/immuno1040032
(Impact Factor: 0.0)
Sharma A,
Kumar D
, Dahiya K, Hawthorne S, Jha SK, Jha NK, Nand P, Girgis S, Raj S, Srivastava R, Goswami VK, Gregoriou Y, El-Zahaby SA, Ojha S, Dureja H, Gupta G, Singh S, Chellappan DK, Dua K. Advances in pulmonary drug targeting microbial biofilms in respiratory diseases. Nanomedicine (Lond). 2021 Aug 5. delivery
https://doi.org/10.2217/nnm-2021-0057
.
(Impact Factor: 5.3): : Corresponding Author
Jeyaraman M, Muthu S, Bapat A,
Kumar D
. et al.. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon. 2021 Jul;7(7):e07635.
https://doi.org/10.1016/j.heliyon.2021.e07635
.
(Impact Factor: 1.8)
Sharma A, Hawthorne S, Jha SK, Jha NK,
Kumar D
, Girgis S, Goswami VK, Gupta G, Singh S, Dureja H, Chellappan DK, Dua K. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDAMB231 human breast cancer cells. Nanomedicine (Lond). 2021 Aug;16(20):1763-1773.
https://doi.org/10.2217/nnm-2021-0066
.
(Impact Factor: 5.3)
Chandel V, Maru S, Kumar A, Kumar A, Sharma A, Rathi B,
Kumar D
. Role of monocarboxylate transporters in head and neck squamous cell carcinoma. Life Sciences. 2021, 5;279:119709.
https://doi.org/10.1016/j.lfs.2021.119709
.
(Impact Factor: 3.6) : Corresponding Author
Raj S, Kumar A,
Kumar D
. Regulation of Glycolysis in Head and Neck Cancer. Adv Exp Med Biol. 2021;1280:219-230.
https://doi.org/10.1007/978-3-030-51652-9_15
.
(Impact Factor: 2.4) : Corresponding Author
Vaishali Chandel, Garima Tripathi, Seema A. Nayar, Brijesh Rathi, Abhijeet Kumar &
Dhruv Kumar
(2021) In silico identification and validation of triarylchromones as potential inhibitor against main protease of severe acute respiratory syndrome coronavirus 2,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1918255
.
(Impact Factor: 3.2) : Corresponding Author
Rashmi Tyagi, Mitul Srivastava, Baldeep Singh, Shingini Sharma, Ramendra Pati Pandey, Shailendra Asthana,
Dhruv Kumar
& V. Samuel Raj (2021) Identification and validation of potent Mycobacterial proteasome inhibitor from Enamine library,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1914173
.
(Impact Factor: 3.2) : Corresponding Author
Mathur, A., Raj, S., Jha, N.K. et al. Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2.
3 Biotech
11, 236 (2021).
https://doi.org/10.1007/s13205-021-02791-y
.
(Impact Factor: 2.2) : Corresponding Author
Arfin, S.; Jha, N.K.; Jha, S.K.; Kesari, K.K.; Ruokolainen, J.; Roychoudhury, S.; Rathi, B.;
Kumar, D
. Oxidative Stress in Cancer Cell Metabolism.
Antioxidants
2021, 10, 642.
https://doi.org/10.3390/antiox10050642
.
(Impact Factor: 5) : Corresponding Author
Kumar A, Kumar R, Rahman MS, Ali M, Kumar R, Nupur N, Gaurav A, Raj V, Anand G, Niraj PK, Kumar N, Srivastava A, Biswapriya A, Chand GB,
Kumar D
, Rashmi T, Kumar S, Sakamoto M, Ghosh AK. Assessment of arsenic exposure in the population of Sabalpur village of Saran District of Bihar with mitigation approach.
Environ Sci Pollut Res Int.
2021 Apr 11.
https://doi.org/10.1007/s11356-021-13521-5
(Impact Factor: 4.3)
Kumar, A., Rahman, M.S., Ali, M. et al. Assessment of arsenic exposure and its mitigation intervention in severely exposed population of Buxar district of Bihar, India.
Environ. Health Sci.
(2021).
https://doi.org/10.1007/s13530-021-00086-6
(Impact Factor: .76)
Chandel V., et al. 2021. In silico identification of potential inhibitor for TP53-induced glycolysis and apoptosis regulator in head and neck squamous cell carcinoma.
3Biotech
. 11(3):117.
https://doi.org/10.1007/s13205-021-02665-3
(Impact Factor: 2.2) : Corresponding Author
2020
Kumar A., et al. 2020. Arsenic exposure causing cancer in the Indo - Gangetic Plain - A 2000 cancer patients’ cross-sectional design.
Scientific Reports
. 11, 2376 (2021).
https://doi.org/10.1038/s41598-021-81579-9
.
(Impact Factor: 4.1)
Roychoudhury S., et al. 2020. Viral pathogenesis of SARS-CoV-2 infection and male reproductive health: Myth or fact?
Open Biology
. 11(1): 200347,
https://doi.org/10.1098/rsob.200347
(Impact Factor: 4.9)
Jha N K., et al. 2020. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS‑CoV‑2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Journal of Molecular Neuroscience.
https://doi.org/10.1007/s12031-020-01767-6
.
(Impact Factor: 2.8)
Ali A., et al. 2020. Comparative analysis of TiO2 and Ag nanoparticles on xylan/chitosan conjugate matrix for wound healing application.
International Journal of Polymeric Materials and Polymeric Biomaterials.
https://doi.org/10.1080/00914037.2020.1838519
(Impact Factor: 1.9)
Kumar D., et al. 2020. Stem Cell Based Preclinical Drug Development and Toxicity Prediction.
Current Pharmaceutical Design
.
https://doi.org/10.2174/1381612826666201019104712
(Impact Factor: 2.4) : Corresponding Author
Tyagi R., et al. 2020. Development of potential proteasome inhibitors against Mycobacterium tuberculosis.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1835722
(Impact Factor: 3.2) : Corresponding Author
Narula S, Tandon S, Kumar D et al. 2020. Human kidney stone matrix proteins alleviate hyperoxaluria induced renal stress by targeting cell-crystal interactions.
Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118498
(Impact Factor: 3.6)
Satyam R, Jha NK, Kar R et al. 2020. Deciphering the SSR incidences across viral members of Coronaviridae family.
Chemico-Biological Interactions.
https://doi.org/10.1016/j.cbi.2020.109226
(Impact Factor: 3.6)
Chandel V, Raj S, Rathi B, Choudhary R,
Kumar D
. 2020. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1811773
(Impact Factor: 3.2) : Corresponding Author
Manish D., Vijay T., Kumar D., et al. 2020. Structural and Morphological Characterization of CdS Nanoparticles,
Current Physical Chemistry.
https://doi.org/10.2174/1877946810999200730222025
(Impact Factor: 1.6)
Raj S, Chandel V, et al. 2020 Molecular mechanisms of interplay between autophagy and metabolism in cancer
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118184
(Impact Factor: 3.6) : Corresponding Author
Chandel V, Raj S, et al. 2020. Metabolic regulation in HPV associated head and neck squamous cell carcinoma
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118236
(Impact Factor: 3.6) : Corresponding Author
Chandel V,
Kumar D
. 2020. Targeting Signalling Cross-Talk between Cancer Cells and Cancer Associate Fibroblast through Monocarboxylate Transporters in Head and Neck Cancer
,Anti-Cancer Agents in Medicinal Chemistry
:
Bentham Science Publishers
,
https://doi.org/10.2174/1871520620666200721135230
(Impact Factor: 2.04) : Corresponding Author
Kumar S, Sharma PP, Shankar U,
Kumar D
et al. 2020. Discovery of New Hydroxyethylamine Analogs against 3CL pro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies.
J Chem Inf Model.
https://doi.org/10.1021/acs.jcim.0c00326
(Impact Factor: 4.5)
Pandey V, Tripathi G,
Kumar D
et al. 2020. Novel 3,4-diarylpyrazole as prospective anti-cancerous agents,
Helion
,
https://doi.org/10.1016/j.heliyon.2020.e04397
(Impact Factor: 1.6) : Corresponding Author
Chandel V, Raj S, Rathi B,
Kumar D
. 2020. In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach.
Chemical Biology Letters
. 7(3), 166‐175.
(Impact Factor: 4.4) : Corresponding Author
Chandel V, Raj S, Srivastava A,
Kumar D
. 2020. In-silico interactions of active Phytochemicals with c-MYC EGFR and ERBB2 oncoproteins.
Chemical Biology Letters
. 7(1), 47‐54.
(Impact Factor: 4.4) : Corresponding Author
Raj S, Chandel V, Rathi B,
Kumar D
. 2020. Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach, Coronavirus: Bentham Science Publishers, DOI : 10.2174/2666796701999200617155013
: Corresponding Author
2019
Sibi Raj, Sartaj Khuranaa, Ramesh Choudhari et al. 2019. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
Seminars in Cancer Biology
https://doi.org/10.1016/j.semcancer.2019.11.002
.
(Impact Factor: 15) : Corresponding Author
Anukriti, Anupam D, Swati U, Pallavi S, et al. 2019. Investigation of Precise Molecular Mechanistic Action of Tobacco-Associated Carcinogen ‘NNK’ Induced Carcinogenesis: A System Biology Approach. 10(8), 564.
(Impact Factor: 3.4)
Asif A, Saleheen B, Satish S.P,
Kumar D
, Yuvraj S N, 2019. Effect of incorporation of Montmorillonite on Xylan/Chitosan conjugate scaffold.
Colloids and Surfaces B: Biointerfaces
1(180) 75-82.
(Impact Factor: 3.9)
Vishwakarma V, New J1,
Kumar D,
et al.,
Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds.
Scientific Reports
. 15;8(1):12163.
(Impact Factor: 4.1)
Chandel V and Kumar D. 2019. The Development of Tumor Heterogeneity and Actively Targeting Therapy Resistant Subpopulations
. J Embryol Stem Cell Res
. 3(3): 000131
: Corresponding Author
2018
Kumar D, et al.,
2018
.
Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression.
Cancer Research
. 10.1158/0008-5472.CAN-17-1076.
(Impact Factor: 12) : First Author
Kumar D
, et al. Perfluoro Curcumin Strongly Interacts with ABC Transporter (ABCG2): A Molecular Docking Study.
J Embryol Stem Cell Res
2018, 2(2): 000113.
: Corresponding Author
Kumar D
. 2018. Resveratrol derivative triacetyl-resveratrol interacts directly with the Gli-DNA zinc finger complex.
J Cancer Res Oncobiol
. Apr; 1(2):110
: Corresponding Author
2017
Kumar D
, et al., 2017. Development and characterization of an in vitro model for radiation-induced fibrosis,.
Radiation Research
. 189(3):326-336
(Impact Factor: 2.5) : First Author
Kumar D
, 2017. Role of tumor heterogeneity in drug resistance.
Glob J Cancer Ther
3(2): 032-033. (Editorial).
: Corresponding Author
Kumar D
, 2017. Regulation of glycolysis in head and neck squamous cell carcinoma
. Postdoc Journal
. 2017 Jan;5 (1):14-28.
: Corresponding Author
2016
Ledgerwood LG*,
Kumar D*,
Eterovic AK, Wick J et al., 2016. The degree of intra-tumor mutational heterogeneity varies by primary tumor sub-site.
Oncotarget
. Mar 28. doi: 18632/oncotarget.8448.
(Impact Factor:6.4)
*Equal contribution
: First Author
2015
Kumar D
, Kandl C, Hamilton C, Shnayder Y, Tsue T, Kakarala K, Ledgerwood L, Sun X S, Huang H, Girod D, Thomas S 2015. Anti-HGF antibody ficlatuzumab mitigates tumor-associated fibroblast-facilitated head and neck cancer progression.
JAMA Otolaryngology-Head & Neck Surgery
. Dec 1;141 (12): 1133-9.
(Impact Factor: 6.2) : First Author
Kumar D
, Gupta D, Shankar S, Srivastava RK. 2015. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
Oncotarget:
1-12.
(Impact Factor:6.4) : First Author
2014
Plotegher N,
Kumar D
, Tessari I, Brucale M, Munari F, et al. 2014. The chaperone-like protein 14-3-3eta interacts with human alpha-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing alpha-synuclein cellular toxicity.
Human Molecular Genetics
. 23:5615-29.
(Impact Factor:5.9)
Kumar D
, Shankar S, Srivastava RK. 2014. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway.
Cancer Letters
. 343:179-89.
(Impact Factor:6.4) : First Author
Kumar D
, Plotegher N, Bubacco L, Brucale M. 2014. Quantitative AFM morphometry of non-fibrillar α- synuclein aggregation products induced by the chaperone-like protein 14-3-3.
Italian Society for Microscopical Sciences
. Vol 21, No 1. DOI: 10.4081/microscopie. 2014.4998.
: First Author
Kumar D
, Shankar S, Srivastava RK. 2014. Understanding the biological functions and therapeutic potentials of stem cells and cancer stem cells: Where are we?
Journal of Cancer Stem Cell Research
. 2:e1002:1-8.
: First Author
2013
Kumar D
, Shankar S, Srivastava RK. 2013. Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms.
Molecular Cancer
. 1476-4598-12-171.
(Impact Factor:27) : First Author
Nanta R,
Kumar D
, Meeker D, Rodova M, Van Veldhuizen PJ, et al. 2013. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rgamma null mice by regulating Bmi-1 and microRNA-128.
Oncogenesis
. 2:e42.
(Impact Factor:5.1)
Shankar S,
Kumar D
, Srivastava 2013. Epigenetic modifications by dietary phytochemicals: Implications for personalized nutrition.
Pharmacol Therapeut
. 138:1-17.
(Impact Factor:11.1)
2012
Pivato M, De Franceschi G, Tosatto L, Frare E,
Kumar D
, et al. 2012. Covalent alpha-synuclein dimers: chemico-physical and aggregation properties.
PloS one
7:e50027.
(Impact Factor:3.4)
Singh BN,
Kumar D
, Shankar S, Srivastava 2012. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells.
Biochemical Pharmacology
. 84:1154-63.
(Impact Factor:6.1)
Conference Proceedings
Tyagi,
D. Kumar
and V. S. Raj, 2018. "In silico identification of potential inhibitors against Mycobacterial proteasome," 2018 International Conference on Bioinformatics and Systems Biology (BSB), Allahabad, India,
IEEE Xplore
, pp. 193-197.
(IF: 10.6)
Shekhar Goyal, Surender Kr Beniwal, H S Kumar,
Dhruv Kumar
, B C Das. 2019. Role of Curcumin in reducing toxicity and adverse effects in locally advanced and metastatic breast cancer patients.
Annals of Oncology
. Volume 30, vi126 - vi127.
(IF: 14)
Book Chapter
Mavi, Anil Kumar, Manmohan Kumar, Amarjeet Singh, Mahendra Kumar Prajapati, Rakhi Khabiya, Saurabh Maru, and
Dhruv Kumar.
"Progress in Non‐Viral Delivery of Nucleic Acid: Advancement in Biomedical Technology." Integration of Biomaterials for Gene Therapy (2023): 281-322.
https://doi.org/10.1002/9781394175635.ch10
Mavi, Anil Kumar, Sonal Gaur, Neelesh Kumar, Avanish Kumar Shrivastav, Sankha Bhattacharya, Sateesh Belemkar, Saurabh Maru, and
Dhruv Kumar
. "Effective Gene Transfer with Non‐Viral Vectors." Integration of Biomaterials for Gene Therapy (2023): 183-222.
https://doi.org/10.1002/9781394175635.ch7
Kirti Agrawal, Malavika Saji,
Dhruv Kumar,
Drug Repurposing in Future Drug Discovery and Development, Book-Drug Repurposing and Computational Drug Discovery, Edition1st Edition 2023, Apple Academic Press, Pages26, eBook ISBN9781003347705,
https://doi.org/10.1201/9781003347705
Kumar, A., Raj, V., Ali, M., Abhinav, Rachamalla, M.,
Kumar, D
., Kumari, A., Kumar, R., Shankar, P. and Ghosh, A., 2023. Evaluation of MOF Applications for Groundwater Arsenic Mitigation of the Middle Ganga Plains of Bihar, India. Metal Organic Frameworks for Wastewater Contaminant Removal, pp.355-373. 26 August 2023,
https://doi.org/10.1002/9783527841523.ch16
Saniya Arfin,
Dhruv Kumar
, Chapter 3 - Use of vitamins and minerals as dietary supplements for better health and cancer prevention, Editor(s): Inamuddin, Tariq Altalhi, Jorddy Neves Cruz, Nutraceuticals, Academic Press, 2023, Pages 53-97, ISBN 9780443191930,
https://doi.org/10.1016/B978-0-443-19193-0.00003-4
.
A Santoshkumar, S Ray, S Narayanan,
D Kumar
, S Harihar (2023), Mitophagy in cancer and cancer stem cells: a role in metabolic reprogramming. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00009-2
T Singh, AS Kharat, B Rathi,
D Kumar
(2023), Designing metabolic target-specific inhibitors for cancer therapy. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00011-0
Sibi Raj, Manish K. Mishra, Sitaram Harihar, Ashok Kumar, Shubhadeep Roychoudhury, Arun Kumar et al. (
2022
). Regulation of Glucose Transporters in Cancer Progression, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_9
Stephen James, Saniya Arfin, Manish K. Mishra, Arun Kumar, Niraj Kumar Jha, Saurabh Kumar Jha et al. (
2022
). Role of Arsenic in Carcinogenesis, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_7
Raj S., Kumar A.,
Kumar D
. (
2020
) Regulation of Glycolysis in Head and Neck Cancer, Book. Cancer Metabolomics, Advances in Experimental Medicine and Biology, Springer Nature.
https://doi.org/10.1007/978-3-030-51652-9_15
Chandel V.,
Kumar D
. (
2020
) Role of Interferon in Cancer Metabolism. Innate Immunity in Health and Disease. IntechOpen.
https://doi.org/10.5772/intechopen.92020
Raj S, Chandel V., Maurya S,
Kumar D
. (
2020
) Role of Macrophages in Solid Tumor Metabolism. Macrophages. IntechOpen.
https://doi.org/10.5772/intechopen.93182
Maurya S, Chandel V, Raj S, (
2020
) OMICS IN CANCER: FROM DIAGNOSTICS TO THERAPEUTICS. Recent Trends in ‘Computational Omics'. ISBN: 978-1-53617-941-5
Raj S., Chandel V.,
Kumar D
. (
2020
) Cancer Cell Metabolism: Solid Tumor Versus Nonsolid Tumor. In:
Kumar D
. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_1
Pedroza D.A. et al. (
2020
) Role of Autophagy in Cancer Cell Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_6
Chandel V., Raj S., Choudhari R.,
Kumar D
. (
2020
) Role of c-Met/HGF Axis in Altered Cancer Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_7
Kumar D
., Sharma-Walia N., Kapoor S., Tandon S. (
2020
) Antibody-Targeted Nanoparticles for Cancer Treatment. In: Saxena S., Khurana S. (eds) NanoBioMedicine. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9898-9_3
Singh B., Malhotra H.,
Kumar D
., Mujtaba S.F., Upadhyay A.K. (
2019
) Understanding Cellular and Molecular Events of Skin Aging and Cancer: An Integrative Perspective. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_2
Tripathi M.K., Sinha J., Srivastava S.K.,
Kumar D
. (
2019
) Bioinformatics in Skin Cancer: A System Biology Approach to Understanding the Molecular Mechanisms and It’s Regulations. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_10
Khurana S., Bose S.,
Kumar D
. (
2019
) Applications of Microarray-Based Technologies in Identifying Disease-Associated Single Nucleotide Variations. In: Tripathi V., Kumar P., Tripathi P., Kishore A., Kamle M. (eds) Microbial Genomics in Sustainable Agroecosystems. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9860-6_4
Singh P., Tiwari D., Mishra M.,
Kumar D
. (
2019
) Molecular Mechanisms of Heavy Metal Toxicity in Cancer Progression. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_3
Chandel V., Seth G., Shukla P.,
Kumar D
. (
2019
) Role of Radiation in DNA Damage and Radiation Induced Cancer. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_1
Dhruv Kumar
, Sharmila Shankar, Rakesh Srivastava. Challenges in stem cells and translational research (Book chapter). Lost in translational and clinical research. World Scientific Publication,
2014
. ISBN: 9789814489089.
https://doi.org/10.1142/9789814489072_0020
Dhruv kumar
and Bruno Samori. Mechanochemistry: Coupling mechanical forces and chemical reactions (Book chapter). Molecular Manipulation with Atomic Force Microscopy (Book), CRC Press,
2011
, ISBN: 9781439809662.
Dwijendra Gupta,
Dhruv Kumar
, Manish Dwivedi, Vijay Tripathi, Pratibha Phadke-Gupta and Surya Pratap Singh. Nanophosphors-Nanogold immunoconjugates in Isolation of Biomembranes and in Drug Delivery (Book chapter). Recent Advances in Nanomedicine (Book), VBRI Press,
2011
, ISBN: 9788192006803.
Book
Dhruv Kumar
, Shailendra Asthana Autophagy and Metabolism Potential Target for Cancer Therapy 1st Edition - August 6, 2022 Paperback ISBN: 9780323998796 9 7 8 - 0 - 3 2 3 - 9 9 8 7 9 - 6 eBook ISBN: 9780323999458
Akhileshwar Srivastava,
Dhruv Kumar
, Divya Singh, Rajesh Singh, Xenobiotics in Chemical Carcinogenesis:Translational Aspects in Toxicology,
Elsevier,
ISBN: 9780323905602
Dhruv kumar.
Cancer Cell Metabolism: A Potential Target for Cancer Therapy.
Springer Nature
.
2020,
ISBN: 9789811519901.
Dhruv kumar
, Marco Brucale and Bruno Samori. Amyloidogenic Proceses of Intrinsically Disordered Proteins: Understanding the Aggregation Process of Intrinsically Unstructured Proteins Related to Neurodegenerative Diseases.
Lambert Academic Publishing
,
2014
, ISBN:
Dhruv kumar
. Insilico analysis of Docking between HIV-1 PR and derivatives of CUI (Docking between HIV- 1 proteases and cyclic urea inhibitors: A step towards drug designing against AIDS).
Lambert Academic Publishing
,
2011
, ISBN:
Contact
dhruv.kumar@ddn.upes.ac.in

Profile Summary
Prof. Dhruv Kumar is a Professor and Cluster Head at the Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun. Listed as a top 2% world’s most influential scientist in the area of Oncology and cancer Biology. His academic journey includes a B.Sc. in Chemistry from Banaras Hindu University (BHU), Varanasi, and M.Sc. in Bioinformatics with Distinction from the University of Allahabad (AU), Prayagraj. Dr. Dhruv Kumar further distinguished himself by completing his Ph.D. in Cellular, Molecular, and Industrial Biology from the University of Bologna (UNIBO), Italy, under the highly prestigious fellowship of the Ministry of Human Resource and Development (MHRD), Indo-Italian Government fellowship. Following the completion of his Ph.D., he embarked on a five-year Postdoctoral training at the School of Medicine, University of Kansas Medical Center, Kansas City, USA. Dr. Kumar's research has been dedicated to several cancer types, including Prostate, Pancreatic, Brain, Breast, and Head and Neck Cancer, with a primary focus on unraveling the molecular mechanisms regulating Autophagy and Apoptosis in Cancer Stem Cells. Currently, his laboratory is actively exploring the Autophagy-Metabolic axis in various cancer cells, such as head and neck, oral, breast, and brain, along with investigating the tumor microenvironment for the development of innovative therapeutic approaches. Notably, his research group has made significant contributions to Drug Designing and Drug Repurposing for COVID-19. Dr. Dhruv Kumar's scholarly contributions are evident in his extensive publication record, with articles featured in prestigious journals such as Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, Seminars in Cancer Biology, JAMA Otolaryngology, Nature Scientific Reports, and many more. Presently, Dr. Kumar is actively engaged in numerous government-funded projects and is mentoring eight Ph.D. students in the areas of Cancer and Infertility. Beyond his research endeavors, he plays a vital role in teaching courses at the undergraduate (UG), postgraduate (PG), and Ph.D. levels, covering subjects related to Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics.

Profile Summary

Profile Summary

Prof. Dhruv Kumar is a Professor and Cluster Head at the Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun. Listed as a top 2% world’s most influential scientist in the area of Oncology and cancer Biology. His academic journey includes a B.Sc. in Chemistry from Banaras Hindu University (BHU), Varanasi, and M.Sc. in Bioinformatics with Distinction from the University of Allahabad (AU), Prayagraj. Dr. Dhruv Kumar further distinguished himself by completing his Ph.D. in Cellular, Molecular, and Industrial Biology from the University of Bologna (UNIBO), Italy, under the highly prestigious fellowship of the Ministry of Human Resource and Development (MHRD), Indo-Italian Government fellowship. Following the completion of his Ph.D., he embarked on a five-year Postdoctoral training at the School of Medicine, University of Kansas Medical Center, Kansas City, USA. Dr. Kumar's research has been dedicated to several cancer types, including Prostate, Pancreatic, Brain, Breast, and Head and Neck Cancer, with a primary focus on unraveling the molecular mechanisms regulating Autophagy and Apoptosis in Cancer Stem Cells. Currently, his laboratory is actively exploring the Autophagy-Metabolic axis in various cancer cells, such as head and neck, oral, breast, and brain, along with investigating the tumor microenvironment for the development of innovative therapeutic approaches. Notably, his research group has made significant contributions to Drug Designing and Drug Repurposing for COVID-19. Dr. Dhruv Kumar's scholarly contributions are evident in his extensive publication record, with articles featured in prestigious journals such as Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, Seminars in Cancer Biology, JAMA Otolaryngology, Nature Scientific Reports, and many more. Presently, Dr. Kumar is actively engaged in numerous government-funded projects and is mentoring eight Ph.D. students in the areas of Cancer and Infertility. Beyond his research endeavors, he plays a vital role in teaching courses at the undergraduate (UG), postgraduate (PG), and Ph.D. levels, covering subjects related to Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics.

Prof. Dhruv Kumar is a Professor and Cluster Head at the Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun. Listed as a top 2% world’s most influential scientist in the area of Oncology and cancer Biology. His academic journey includes a B.Sc. in Chemistry from Banaras Hindu University (BHU), Varanasi, and M.Sc. in Bioinformatics with Distinction from the University of Allahabad (AU), Prayagraj. Dr. Dhruv Kumar further distinguished himself by completing his Ph.D. in Cellular, Molecular, and Industrial Biology from the University of Bologna (UNIBO), Italy, under the highly prestigious fellowship of the Ministry of Human Resource and Development (MHRD), Indo-Italian Government fellowship. Following the completion of his Ph.D., he embarked on a five-year Postdoctoral training at the School of Medicine, University of Kansas Medical Center, Kansas City, USA. Dr. Kumar's research has been dedicated to several cancer types, including Prostate, Pancreatic, Brain, Breast, and Head and Neck Cancer, with a primary focus on unraveling the molecular mechanisms regulating Autophagy and Apoptosis in Cancer Stem Cells. Currently, his laboratory is actively exploring the Autophagy-Metabolic axis in various cancer cells, such as head and neck, oral, breast, and brain, along with investigating the tumor microenvironment for the development of innovative therapeutic approaches. Notably, his research group has made significant contributions to Drug Designing and Drug Repurposing for COVID-19. Dr. Dhruv Kumar's scholarly contributions are evident in his extensive publication record, with articles featured in prestigious journals such as Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, Seminars in Cancer Biology, JAMA Otolaryngology, Nature Scientific Reports, and many more. Presently, Dr. Kumar is actively engaged in numerous government-funded projects and is mentoring eight Ph.D. students in the areas of Cancer and Infertility. Beyond his research endeavors, he plays a vital role in teaching courses at the undergraduate (UG), postgraduate (PG), and Ph.D. levels, covering subjects related to Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics.

Work Experience
Prof. Dhruv Kumar possesses over 15 years of extensive experience encompassing teaching, research, and administrative roles. His professional journey is outlined as follows:
06/22-Present: Professor & Cluster Head, Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand, India.
01/21-06/22: Professor & Assistant Director, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
07/19-12/20: Associate Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
04/17-07/19: Assistant Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
08/16-04/17: Assistant Professor, Department of Bioinformatics, SRM University, Delhi-NCR, Sonepat, Haryana, India.
03/12-06/16: Postdoctoral Fellow, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
In these diverse roles, Prof. Kumar has demonstrated his commitment to academia, contributing significantly to various institutions and enhancing his expertise in the fields of Molecular Medicine, Cancer Biology, Stem Cell Research, and Bioinformatics. His journey includes pivotal positions such as Assistant Professor at SRM University and various roles at Amity University Uttar Pradesh, showcasing his dedication to fostering education and research. Currently serving as a Professor and Cluster Head at UPES, Dehradun, he continues to make substantial contributions to the academic and research landscape.

Work Experience

Work Experience

Prof. Dhruv Kumar possesses over 15 years of extensive experience encompassing teaching, research, and administrative roles. His professional journey is outlined as follows:
06/22-Present: Professor & Cluster Head, Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand, India.
01/21-06/22: Professor & Assistant Director, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
07/19-12/20: Associate Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
04/17-07/19: Assistant Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.
08/16-04/17: Assistant Professor, Department of Bioinformatics, SRM University, Delhi-NCR, Sonepat, Haryana, India.
03/12-06/16: Postdoctoral Fellow, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
In these diverse roles, Prof. Kumar has demonstrated his commitment to academia, contributing significantly to various institutions and enhancing his expertise in the fields of Molecular Medicine, Cancer Biology, Stem Cell Research, and Bioinformatics. His journey includes pivotal positions such as Assistant Professor at SRM University and various roles at Amity University Uttar Pradesh, showcasing his dedication to fostering education and research. Currently serving as a Professor and Cluster Head at UPES, Dehradun, he continues to make substantial contributions to the academic and research landscape.

Prof. Dhruv Kumar possesses over 15 years of extensive experience encompassing teaching, research, and administrative roles. His professional journey is outlined as follows:

06/22-Present: Professor & Cluster Head, Allied Health Sciences, School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand, India.

01/21-06/22: Professor & Assistant Director, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.

07/19-12/20: Associate Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.

04/17-07/19: Assistant Professor, Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida (UP), India.

08/16-04/17: Assistant Professor, Department of Bioinformatics, SRM University, Delhi-NCR, Sonepat, Haryana, India.

03/12-06/16: Postdoctoral Fellow, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.

In these diverse roles, Prof. Kumar has demonstrated his commitment to academia, contributing significantly to various institutions and enhancing his expertise in the fields of Molecular Medicine, Cancer Biology, Stem Cell Research, and Bioinformatics. His journey includes pivotal positions such as Assistant Professor at SRM University and various roles at Amity University Uttar Pradesh, showcasing his dedication to fostering education and research. Currently serving as a Professor and Cluster Head at UPES, Dehradun, he continues to make substantial contributions to the academic and research landscape.

Research Interests
Prof. Dhruv Kumar boasts an extensive and diverse research portfolio spanning over various critical domains in biomedical science. With over 15 years of profound expertise, he has significantly contributed to Translational Cancer Research, unraveling novel insights that bridge the gap between fundamental discoveries and clinical applications. His dedicated exploration into Cancer Stem Cells has shed light on the molecular intricacies governing these cells. Prof. Kumar's investigations into Cancer Cell Metabolism reveal a nuanced understanding of metabolic alterations in cancer cells, potentially paving the way for innovative therapeutic strategies. Additionally, his work on the Tumor Microenvironment and Tumor Heterogeneity delves into the complex interplay and diversity within cancer populations. His research illuminates the regulatory mechanisms of Autophagy and the role of Exosomes in cancer, offering crucial perspectives on cellular recycling and intercellular communication. Beyond cancer biology, Prof. Kumar's foray into Infertility research explores molecular factors underlying reproductive challenges. Proficient in Genome Editing and NGS Data Analysis, he navigates cutting-edge genetic technologies. His involvement in Drug Repurposing and Drug Discovery underscores an innovative approach to therapeutics, while his recent contributions in COVID-19 research showcase adaptability to contemporary health challenges. Prof. Kumar's overarching mastery in Bioinformatics strategically integrates computational methods, enhancing the comprehensive interpretation of complex biological data.

Research Interests

Research Interests

Prof. Dhruv Kumar boasts an extensive and diverse research portfolio spanning over various critical domains in biomedical science. With over 15 years of profound expertise, he has significantly contributed to Translational Cancer Research, unraveling novel insights that bridge the gap between fundamental discoveries and clinical applications. His dedicated exploration into Cancer Stem Cells has shed light on the molecular intricacies governing these cells. Prof. Kumar's investigations into Cancer Cell Metabolism reveal a nuanced understanding of metabolic alterations in cancer cells, potentially paving the way for innovative therapeutic strategies. Additionally, his work on the Tumor Microenvironment and Tumor Heterogeneity delves into the complex interplay and diversity within cancer populations. His research illuminates the regulatory mechanisms of Autophagy and the role of Exosomes in cancer, offering crucial perspectives on cellular recycling and intercellular communication. Beyond cancer biology, Prof. Kumar's foray into Infertility research explores molecular factors underlying reproductive challenges. Proficient in Genome Editing and NGS Data Analysis, he navigates cutting-edge genetic technologies. His involvement in Drug Repurposing and Drug Discovery underscores an innovative approach to therapeutics, while his recent contributions in COVID-19 research showcase adaptability to contemporary health challenges. Prof. Kumar's overarching mastery in Bioinformatics strategically integrates computational methods, enhancing the comprehensive interpretation of complex biological data.

Prof. Dhruv Kumar boasts an extensive and diverse research portfolio spanning over various critical domains in biomedical science. With over 15 years of profound expertise, he has significantly contributed to Translational Cancer Research, unraveling novel insights that bridge the gap between fundamental discoveries and clinical applications. His dedicated exploration into Cancer Stem Cells has shed light on the molecular intricacies governing these cells. Prof. Kumar's investigations into Cancer Cell Metabolism reveal a nuanced understanding of metabolic alterations in cancer cells, potentially paving the way for innovative therapeutic strategies. Additionally, his work on the Tumor Microenvironment and Tumor Heterogeneity delves into the complex interplay and diversity within cancer populations. His research illuminates the regulatory mechanisms of Autophagy and the role of Exosomes in cancer, offering crucial perspectives on cellular recycling and intercellular communication. Beyond cancer biology, Prof. Kumar's foray into Infertility research explores molecular factors underlying reproductive challenges. Proficient in Genome Editing and NGS Data Analysis, he navigates cutting-edge genetic technologies. His involvement in Drug Repurposing and Drug Discovery underscores an innovative approach to therapeutics, while his recent contributions in COVID-19 research showcase adaptability to contemporary health challenges. Prof. Kumar's overarching mastery in Bioinformatics strategically integrates computational methods, enhancing the comprehensive interpretation of complex biological data.

Teaching Philosophy
Prof. Dhruv Kumar's teaching philosophy is characterized by innovation and inclusivity. He employs a blended teaching approach that seamlessly integrates traditional methods with modern technologies, creating a dynamic and engaging learning environment. One notable aspect is his commitment to discussing cutting-edge research topics, including those recognized with Nobel Prizes, providing students with insights into the forefront of scientific inquiry. Prof. Kumar takes an innovative approach to support slow learners, implementing strategies such as pairing them with a buddy for personalized assistance, arranging expert lectures, fostering group discussions, and emphasizing hands-on training and practical experiences. By tailoring his teaching methods to diverse learning styles and providing additional support mechanisms, Prof. Kumar ensures that every student, regardless of pace, has the opportunity to thrive academically and develop a passion for lifelong learning.

Teaching Philosophy

Teaching Philosophy

Prof. Dhruv Kumar's teaching philosophy is characterized by innovation and inclusivity. He employs a blended teaching approach that seamlessly integrates traditional methods with modern technologies, creating a dynamic and engaging learning environment. One notable aspect is his commitment to discussing cutting-edge research topics, including those recognized with Nobel Prizes, providing students with insights into the forefront of scientific inquiry. Prof. Kumar takes an innovative approach to support slow learners, implementing strategies such as pairing them with a buddy for personalized assistance, arranging expert lectures, fostering group discussions, and emphasizing hands-on training and practical experiences. By tailoring his teaching methods to diverse learning styles and providing additional support mechanisms, Prof. Kumar ensures that every student, regardless of pace, has the opportunity to thrive academically and develop a passion for lifelong learning.

Prof. Dhruv Kumar's teaching philosophy is characterized by innovation and inclusivity. He employs a blended teaching approach that seamlessly integrates traditional methods with modern technologies, creating a dynamic and engaging learning environment. One notable aspect is his commitment to discussing cutting-edge research topics, including those recognized with Nobel Prizes, providing students with insights into the forefront of scientific inquiry. Prof. Kumar takes an innovative approach to support slow learners, implementing strategies such as pairing them with a buddy for personalized assistance, arranging expert lectures, fostering group discussions, and emphasizing hands-on training and practical experiences. By tailoring his teaching methods to diverse learning styles and providing additional support mechanisms, Prof. Kumar ensures that every student, regardless of pace, has the opportunity to thrive academically and develop a passion for lifelong learning.

Courses Taught
Prof. Dhruv Kumar has a genuine passion for teaching and a deep commitment to fostering meaningful interactions with students, creating a vibrant and engaging educational environment. With an extensive background in teaching, he has imparted knowledge across various courses at the undergraduate (UG), postgraduate (PG), and doctoral (PhD) levels. Prof. Kumar's enthusiasm for sharing new ideas and insights has been a cornerstone of his teaching approach, inspiring students to explore innovative concepts and contributing to a dynamic and intellectually stimulating learning atmosphere. His continuous dedication to teaching underscores not only his expertise in the subject matter but also his unwavering commitment to nurturing the intellectual growth of students at all levels.
Undergraduate Level (B.Sc.)
Basic Bioinformatics (BIOF202)
Basics of Cancer (BIOT223)
Cell (MMBS104)
Metals in Biology (MMBS201)
Metabolism (MMBS205)
Scientific Writing (HSCC2019)
Postgraduate Level (M.Sc.)
Animal Cell Culture & Cell Engineering (SCCB601)
Assisted Reproductive Laboratory Procedures (RTCE605)
Cancer Pharmacogenomics (SCCB704)
Computational Tools in Drug Discovery (MMBS702)
Genome Engineering & Editing (SCCB603)
OMICS in Biomedical Sciences (SCCB710)
Preventive Oncology & Psycho-Oncology (SCCB705)
Reproductive & Developmental Biology and Genetics (RTCE604)
Topics in Bioinformatics (MMBS610)
Trends in Molecular Oncology (SCCB901)
Stem Cell Bio II (SCCB 707)
Scientific Writing (HSCC8007)
Good manufacturing and Lab Practices (HSCC8008)
Biosafety and Aseptic Techniques (HSMB 7024)
PhD Level
Advances in Molecular Medicine (BIOT 955) at Institute Level
Trends in Molecular Oncology (BIOT 953) at Institute Level
Research and Publication Ethics” (RPE) –(PHD901) at University Level

Courses Taught

Courses Taught

Prof. Dhruv Kumar has a genuine passion for teaching and a deep commitment to fostering meaningful interactions with students, creating a vibrant and engaging educational environment. With an extensive background in teaching, he has imparted knowledge across various courses at the undergraduate (UG), postgraduate (PG), and doctoral (PhD) levels. Prof. Kumar's enthusiasm for sharing new ideas and insights has been a cornerstone of his teaching approach, inspiring students to explore innovative concepts and contributing to a dynamic and intellectually stimulating learning atmosphere. His continuous dedication to teaching underscores not only his expertise in the subject matter but also his unwavering commitment to nurturing the intellectual growth of students at all levels.
Undergraduate Level (B.Sc.)
Basic Bioinformatics (BIOF202)
Basics of Cancer (BIOT223)
Cell (MMBS104)
Metals in Biology (MMBS201)
Metabolism (MMBS205)
Scientific Writing (HSCC2019)
Postgraduate Level (M.Sc.)
Animal Cell Culture & Cell Engineering (SCCB601)
Assisted Reproductive Laboratory Procedures (RTCE605)
Cancer Pharmacogenomics (SCCB704)
Computational Tools in Drug Discovery (MMBS702)
Genome Engineering & Editing (SCCB603)
OMICS in Biomedical Sciences (SCCB710)
Preventive Oncology & Psycho-Oncology (SCCB705)
Reproductive & Developmental Biology and Genetics (RTCE604)
Topics in Bioinformatics (MMBS610)
Trends in Molecular Oncology (SCCB901)
Stem Cell Bio II (SCCB 707)
Scientific Writing (HSCC8007)
Good manufacturing and Lab Practices (HSCC8008)
Biosafety and Aseptic Techniques (HSMB 7024)
PhD Level
Advances in Molecular Medicine (BIOT 955) at Institute Level
Trends in Molecular Oncology (BIOT 953) at Institute Level
Research and Publication Ethics” (RPE) –(PHD901) at University Level

Prof. Dhruv Kumar has a genuine passion for teaching and a deep commitment to fostering meaningful interactions with students, creating a vibrant and engaging educational environment. With an extensive background in teaching, he has imparted knowledge across various courses at the undergraduate (UG), postgraduate (PG), and doctoral (PhD) levels. Prof. Kumar's enthusiasm for sharing new ideas and insights has been a cornerstone of his teaching approach, inspiring students to explore innovative concepts and contributing to a dynamic and intellectually stimulating learning atmosphere. His continuous dedication to teaching underscores not only his expertise in the subject matter but also his unwavering commitment to nurturing the intellectual growth of students at all levels.

Undergraduate Level (B.Sc.)

Basic Bioinformatics (BIOF202)

Basics of Cancer (BIOT223)

Cell (MMBS104)

Metals in Biology (MMBS201)

Metabolism (MMBS205)

Scientific Writing (HSCC2019)

Postgraduate Level (M.Sc.)

Animal Cell Culture & Cell Engineering (SCCB601)

Assisted Reproductive Laboratory Procedures (RTCE605)

Cancer Pharmacogenomics (SCCB704)

Computational Tools in Drug Discovery (MMBS702)

Genome Engineering & Editing (SCCB603)

OMICS in Biomedical Sciences (SCCB710)

Preventive Oncology & Psycho-Oncology (SCCB705)

Reproductive & Developmental Biology and Genetics (RTCE604)

Topics in Bioinformatics (MMBS610)

Trends in Molecular Oncology (SCCB901)

Stem Cell Bio II (SCCB 707)

Scientific Writing (HSCC8007)

Good manufacturing and Lab Practices (HSCC8008)

Biosafety and Aseptic Techniques (HSMB 7024)

PhD Level

Advances in Molecular Medicine (BIOT 955) at Institute Level

Trends in Molecular Oncology (BIOT 953) at Institute Level

Research and Publication Ethics” (RPE) –(PHD901) at University Level

Awards and Grants:
Prof. Dhruv Kumar has received several national and international awards and grants as mentioned below.
Awards:
2020: Research Excellence Award, Institute of Scholars, India
2019: Senior Scientist Award, Society of Biomedical Laboratory Scientists, India
2017: Early Career Research Award, SERB, DST-India.
2016: Postdoc of the Month Award, PostDoc Journal: Journal of Postdoctoral Research, USA.
2016: Scholar-in-Training Award, AACR, The Function of Tumor Microenvironment in Cancer Progression Conference, San Diego, USA.
2015: K-INBRE Postdoctoral Award, National Institute of General Medical Sciences, National Institute of Health (NIH), USA.
2011: 8th EBSA European Biophysics Congress Bursaries Award, European Biophysical Societies Association, Italy.
2011: Young Scientist Award, International Academy of Physical Science, Allahabad, India.
2009: Brains in Competition Award, Institute of Advance Studies, University of Bologna, Italy.
2008: Indo-Italian Government Scholarship (Ministry of Human Resource and Development, India).
Grants:
2022-2025: “Analysis of the relationship between gallbladder cancer, arsenic intake, and living-environmental factors - a case in Bihar, India”, Indo-Japan, Government of Japan, Rs 100 lakh (Co-PI): Ongoing
2021-2024: “Repurposing of drugs and validation of lead compounds against main protease and RNA dependent RNA polymerase of SARS-CoV-2”, BRICS-DST, Rs 74 lakh (PI & Coordinator): Ongoing
2020-2023: “Assessment of Female reproductive health and child health risks in Arsenic Exposed population of Bihar”, ICMR New Delhi, Rs ~ 1 Crore. (Co-PI): Ongoing
2018-2021: “Understanding the Metabolic Cross-Talk between Head and Neck Squamous Cell Carcinoma and Tumor Associated Fibroblasts”, SERB-Department of Science and Technology, Government of India, Rs ~35 Lakhs. (PI): Completed
2015-2016: “Role of Tumor-Associated Fibroblasts in Head and Neck Cancer Metabolism” National Institute of General Medical Sciences, National Institute of Health, USA (P20GM103418), $25,000. (PI): Completed

Awards and Grants:

Awards and Grants:

Prof. Dhruv Kumar has received several national and international awards and grants as mentioned below.
Awards:
2020: Research Excellence Award, Institute of Scholars, India
2019: Senior Scientist Award, Society of Biomedical Laboratory Scientists, India
2017: Early Career Research Award, SERB, DST-India.
2016: Postdoc of the Month Award, PostDoc Journal: Journal of Postdoctoral Research, USA.
2016: Scholar-in-Training Award, AACR, The Function of Tumor Microenvironment in Cancer Progression Conference, San Diego, USA.
2015: K-INBRE Postdoctoral Award, National Institute of General Medical Sciences, National Institute of Health (NIH), USA.
2011: 8th EBSA European Biophysics Congress Bursaries Award, European Biophysical Societies Association, Italy.
2011: Young Scientist Award, International Academy of Physical Science, Allahabad, India.
2009: Brains in Competition Award, Institute of Advance Studies, University of Bologna, Italy.
2008: Indo-Italian Government Scholarship (Ministry of Human Resource and Development, India).
Grants:
2022-2025: “Analysis of the relationship between gallbladder cancer, arsenic intake, and living-environmental factors - a case in Bihar, India”, Indo-Japan, Government of Japan, Rs 100 lakh (Co-PI): Ongoing
2021-2024: “Repurposing of drugs and validation of lead compounds against main protease and RNA dependent RNA polymerase of SARS-CoV-2”, BRICS-DST, Rs 74 lakh (PI & Coordinator): Ongoing
2020-2023: “Assessment of Female reproductive health and child health risks in Arsenic Exposed population of Bihar”, ICMR New Delhi, Rs ~ 1 Crore. (Co-PI): Ongoing
2018-2021: “Understanding the Metabolic Cross-Talk between Head and Neck Squamous Cell Carcinoma and Tumor Associated Fibroblasts”, SERB-Department of Science and Technology, Government of India, Rs ~35 Lakhs. (PI): Completed
2015-2016: “Role of Tumor-Associated Fibroblasts in Head and Neck Cancer Metabolism” National Institute of General Medical Sciences, National Institute of Health, USA (P20GM103418), $25,000. (PI): Completed

Prof. Dhruv Kumar has received several national and international awards and grants as mentioned below.

Awards:

2020: Research Excellence Award, Institute of Scholars, India

2019: Senior Scientist Award, Society of Biomedical Laboratory Scientists, India

2017: Early Career Research Award, SERB, DST-India.

2016: Postdoc of the Month Award, PostDoc Journal: Journal of Postdoctoral Research, USA.

2016: Scholar-in-Training Award, AACR, The Function of Tumor Microenvironment in Cancer Progression Conference, San Diego, USA.

2015: K-INBRE Postdoctoral Award, National Institute of General Medical Sciences, National Institute of Health (NIH), USA.

2011: 8th EBSA European Biophysics Congress Bursaries Award, European Biophysical Societies Association, Italy.

2011: Young Scientist Award, International Academy of Physical Science, Allahabad, India.

2009: Brains in Competition Award, Institute of Advance Studies, University of Bologna, Italy.

2008: Indo-Italian Government Scholarship (Ministry of Human Resource and Development, India).

Grants:

2022-2025: “Analysis of the relationship between gallbladder cancer, arsenic intake, and living-environmental factors - a case in Bihar, India”, Indo-Japan, Government of Japan, Rs 100 lakh (Co-PI): Ongoing

2021-2024: “Repurposing of drugs and validation of lead compounds against main protease and RNA dependent RNA polymerase of SARS-CoV-2”, BRICS-DST, Rs 74 lakh (PI & Coordinator): Ongoing

2020-2023: “Assessment of Female reproductive health and child health risks in Arsenic Exposed population of Bihar”, ICMR New Delhi, Rs ~ 1 Crore. (Co-PI): Ongoing

2018-2021: “Understanding the Metabolic Cross-Talk between Head and Neck Squamous Cell Carcinoma and Tumor Associated Fibroblasts”, SERB-Department of Science and Technology, Government of India, Rs ~35 Lakhs. (PI): Completed

2015-2016: “Role of Tumor-Associated Fibroblasts in Head and Neck Cancer Metabolism” National Institute of General Medical Sciences, National Institute of Health, USA (P20GM103418), $25,000. (PI): Completed

Scholarly Activities
Prof. Dhruv Kumar, has a rich portfolio of scholarly activities spanning teaching, research, and academic contributions. He actively engages in designing and instructing courses at various academic levels, including undergraduate (UG), postgraduate (PG), and doctoral (PhD) programs, covering specialized areas such as Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics. Prof. Kumar's research endeavors have resulted in numerous publications in high-impact journals, including Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, and Nature Scientific Reports. He has received recognition on both national and international platforms, garnering awards such as the Senior Scientist Award from the Society of Biomedical Laboratory Scientists, India, the Scholar-in-Training Award from the American Association for Cancer Research (AACR), USA, and the K-INBRE Postdoctoral Award from the National Institute of Health (NIH), USA. Additionally, his active involvement in government-funded projects and mentorship of PhD students in the fields of Cancer and Infertility reflects his commitment to advancing knowledge and nurturing the next generation of researchers. Prof. Kumar's scholarly activities exemplify a holistic approach to academia, seamlessly integrating teaching, research, and mentorship.
His selected publications are as below:
2023
Agrawal, K.; Asthana, S.;
Kumar, D
. Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer. Cancers 2023, 15, 4920.
https://doi.org/10.3390/cancers15204920
.
(Impact Factor: 5.2)
Maurya, S., Raj, S., Bhoi, N.R., Mani, N., Rathi, B. and
Kumar, D
., 2023. Morphological analysis of metabolically dysregulated spermatozoa using Artificial Intelligence based approach. Journal of Integrated Science and Technology, 11(4), pp.569-569.
(Impact Factor: 1.14)
Raj, S. and
Kumar, D.
, 2023. Early epigenetic markers for precision medicine. Progress in molecular biology and translational science, 198, pp.153-164.
(Impact Factor: 4.0)
Kumar, A., Ali, M., Raj, V., Kumari, A., Rachamalla, M., Niyogi, S.,
Kumar, D.
, Sharma, A., Saxena, A., Panjawani, G. and Jain, P., 2023. Arsenic causing gallbladder cancer disease in Bihar. Scientific Reports, 13(1), p.4259.
(Impact Factor: 4.9)
Goel, M., Mishra, M.K. and
Kumar, D
., 2023. Recent advances in Targeted Radionuclide therapy for Cancer treatment. Chemical Biology Letters, 10(3), pp.544-544.
(Impact Factor: 6.1)
Bhattacharjee, R., Prabhakar, N., Kumar, L., Bhattacharjee, A., Kar, S., Malik, S.,
Kumar, D
., Ruokolainen, J., Negi, A., Jha, N.K. and Kesari, K.K., 2023. Crosstalk between long noncoding RNA and microRNA in Cancer. Cellular Oncology, pp.1-24.
(Impact Factor: 6.6)
Kumar, A., Kumar, K., Ali, M., Raj, V., Srivastava, A., Kumar, M., Niraj, P.K., Kumar, M., Kumar, R.,
Kumar, D.
and Bishwapriya, A., 2023. Severe Disease Burden and the Mitigation Strategy in the Arsenic-Exposed Population of Kaliprasad Village in Bhagalpur District of Bihar, India. Biological trace element research, pp.1-17.
(Impact Factor: 4.0)
Arfin, S.;
Kumar, D
.; Lomagno, A.; Mauri, P.L.; Di Silvestre, D. Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis. Cancers 2023, 15, 4420.
https://doi.org/10.3390/cancers15174420
(Impact Factor: 5.2)
Arfin S, Agrawal K, Maurya S, Asthana S, Di Silvestre
D, Kumar D
. Lead phytochemicals and marine compounds against ceruloplasmin in cancer targeting. Journal of Biomolecular Structure and Dynamics. 2023 Oct 18.
(Impact Factor: 5.2)
Agrawal K, Chakraborty P, Dewanjee S, Arfin S, Das SS, Dey A, Moustafa M, Mishra PC, Jafari SM, Jha NK, Jha SK,
Kumar D
. Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders. Neurosci Biobehav Rev. 2023 Jan;144:104955. doi: 10.1016/j.neubiorev.2022.104955. Epub 2022 Nov 14. PMID: 36395983.
(Impact Factor: 9.0)
Agrawal K, Chauhan S,
Kumar D
. Expression analysis and regulation of GLI and its correlation with stemness and metabolic alteration in human brain tumor. 3 Biotech. 2023 Jan;13(1):10. doi: 10.1007/s13205-022-03419-5. Epub 2022 Dec 15. PMID: 36532860; PMCID: PMC9755437.
(Impact Factor: 2.9)
Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A,
Kumar D
, Ambasta RK, Jha NK, Jha SK, Dewanjee S. Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Res Rev. 2023 Mar;85:101838. doi: 10.1016/j.arr.2022.101838. Epub 2023 Jan 5. PMID: 36610558.
(Impact Factor: 11.7)
Raj, S., Rathi, B., Mehra, P., Asthana, S., &
Kumar, D
. (2023). Deciphering the role of c-MET in Metabolic reprogramming of Head and Neck squamous cell Carcinoma via In Silico analysis. Chemical Biology Letters, 10(2), 532. Retrieved from
https://pubs.thesciencein.org/journal/index.php/cbl/article/view/532
(Impact Factor: 4.4)
2022
Awasthi P, Dwivedi M, Kumar D, Hasan S. Insights into intricacies of the Latent Membrane Protein-1 (LMP-1) in EBV-associated cancers. Life Sci. 2023 Jan 15;313:121261. doi: 10.1016/j.lfs.2022.121261. Epub 2022 Dec 7. PMID: 36493876.
(Impact Factor: 3.3)
Sharma S, Tyagi R, Srivastava M, Rani K,
Kumar D
, Asthana S, Raj VS. Identification and validation of potent inhibitor of Escherichia coli DHFR from MMV pathogen box. J Biomol Struct Dyn. 2022 Jun 2:1-10. doi: 10.1080/07391102.2022.2080113. Epub ahead of print. PMID: 35652895.
(Impact Factor: 3.3)
Maurya S, Kesari KK, Roychoudhury S, Kolleboyina J, Jha NK, Jha SK, Sharma A, Kumar A, Rathi B, Kumar D. Metabolic Dysregulation and Sperm Motility in Male Infertility. Adv Exp Med Biol. 2022;1358:257-273. doi: 10.1007/978-3-030-89340-8_12. PMID: 35641874.
(Impact Factor: 2.6)
Das S, Roychoudhury S, Dey A, Jha NK, Kumar D, Roychoudhury S, Slama P, Kesari KK. Bacteriospermia and Male Infertility: Role of Oxidative Stress. Adv Exp Med Biol. 2022;1358:141-163. doi: 10.1007/978-3-030-89340-8_7. PMID: 35641869.
(Impact Factor: 2.6)
Arfin, S. .; Mani, N. .; Rathi, B.; Kumar, D. In Silico Analysis of Ceruloplasmin Alteration in Oral Squamous Cell Carcinoma. Chem Biol Lett 2022, 9, 342.
(Impact Factor: 4.4)
Jha NK, Arfin S, Jha SK, Kar R, Dey A,
Kumar D
. et al. Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling Semin Cancer Biol. 2022 Feb 23:S1044-579X(22)00049-9.
https://doi.org/10.1016/j.semcancer.2022.02.022
.
(Impact Factor: 17)
Raj S, Kesari KK, Kumar A, Rathi B, Sharma A, Gupta PK, Jha SK, Jha NK, Slama P, Roychoudhury S,
Kumar D
. Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. Molecular Cancer (BMC-Springer Nature). 2022. 26;21(1):31.
https://doi.org/10.1186/s12943-022-01503-1
(Impact Factor: 41.4): Corresponding Author
Pritam P, Deka R,
Kumar D
. et al.. Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects. Biology-MDPI. 2022. 11(2), 212.
https://doi.org/10.3390/biology11020212
(Impact Factor: 5.0)
Kumar, A.
Kumar D
. et al..Assessment of disease burden in the arsenic exposed population of Chapar village of Samastipur district, Bihar, India, and related mitigation initiative.
Environmental Science and Pollution Research.
https://doi.org/10.1007/s11356-021-18207-6
(Impact Factor: 4.3)
2021
Upadhyay C.
Kumar D
. et al.. Synthesis of the new analogs of morpholine and their antiplasmodial evaluation against the human malaria parasite Plasmodium falciparum.
New Journal of Chemistry
. 2021.
https://doi.org/10.1039/D1NJ04198C
(Impact Factor: 3.4)
Singh A, Singh AK, Giri R,
Kumar D
, Sharma R, Valis M, Kuca K, Garg N. The role of microRNA-21 in the onset and progression of cancer.
Future Med Chem
. 2021 Nov;13(21): 1885-1906.
https://doi.org/10.4155/fmc-2021-0096
.
(Impact Factor: 3.9)
Jeyaraman Madhan ,Muthu Sathish ,
Kumar D
. et al. “Total Stromal Fraction (TSF) - Fortified Adipose Tissue-Derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary Compromise”,
Coronaviruses
2021; e080921196287.
https://doi.org/10.2174/2666796702666210908151708
.
(Impact Factor: 0.0)
Asif Ali, Saleheen Bano,
Kumar D
. et al. (2021) Effect of cellulose nanocrystals on chitosan/PVA/nano β-TCP composite scaffold for bone tissue engineering application,
Journal of Biomaterials Science, Polymer Edition
,
https://doi.org/10.1080/09205063.2021.1973709
.
(Impact Factor: 3.5)
Mehreen Aftab, Maryam Ghufran,
Kumar D
. et al., In silico analysis of the role of hsa-miR-155-5p in cervical cancer, Chem. Biol. Lett. 2021, 8(3), 94-105.
(Impact Factor: 4.4) : Corresponding Author
Usman, M.B., Bhardwaj, S., Roychoudhury, S.
Kumar D
. et al.. Immunotherapy for Alzheimer’s Disease: Current Scenario and Future Perspectives.
J Prev Alzheimers Dis
8, 534–551 (2021).
https://doi.org/10.14283/jpad.2021.52
(Impact Factor: 4.4)
Sharma, P.P., Bansal, M., Sethi, A., Pena, L.,
Kumar D
. et al., 2021. Computational methods directed towards drug repurposing for COVID-19: advantages and limitations.
RSC Advances
, 11(57), pp.36181-36198.
https://doi.org/10.1039/D1RA05320E
(Impact Factor: 3.3)
Goyal, K.; Goel, H.; Baranwal, P.; Tewary, A.;
Kumar D
. et al.. Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans. Immuno 2021, 1, 442-456.
https://doi.org/10.3390/immuno1040032
(Impact Factor: 0.0)
Sharma A,
Kumar D
, Dahiya K, Hawthorne S, Jha SK, Jha NK, Nand P, Girgis S, Raj S, Srivastava R, Goswami VK, Gregoriou Y, El-Zahaby SA, Ojha S, Dureja H, Gupta G, Singh S, Chellappan DK, Dua K. Advances in pulmonary drug targeting microbial biofilms in respiratory diseases. Nanomedicine (Lond). 2021 Aug 5. delivery
https://doi.org/10.2217/nnm-2021-0057
.
(Impact Factor: 5.3): : Corresponding Author
Jeyaraman M, Muthu S, Bapat A,
Kumar D
. et al.. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon. 2021 Jul;7(7):e07635.
https://doi.org/10.1016/j.heliyon.2021.e07635
.
(Impact Factor: 1.8)
Sharma A, Hawthorne S, Jha SK, Jha NK,
Kumar D
, Girgis S, Goswami VK, Gupta G, Singh S, Dureja H, Chellappan DK, Dua K. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDAMB231 human breast cancer cells. Nanomedicine (Lond). 2021 Aug;16(20):1763-1773.
https://doi.org/10.2217/nnm-2021-0066
.
(Impact Factor: 5.3)
Chandel V, Maru S, Kumar A, Kumar A, Sharma A, Rathi B,
Kumar D
. Role of monocarboxylate transporters in head and neck squamous cell carcinoma. Life Sciences. 2021, 5;279:119709.
https://doi.org/10.1016/j.lfs.2021.119709
.
(Impact Factor: 3.6) : Corresponding Author
Raj S, Kumar A,
Kumar D
. Regulation of Glycolysis in Head and Neck Cancer. Adv Exp Med Biol. 2021;1280:219-230.
https://doi.org/10.1007/978-3-030-51652-9_15
.
(Impact Factor: 2.4) : Corresponding Author
Vaishali Chandel, Garima Tripathi, Seema A. Nayar, Brijesh Rathi, Abhijeet Kumar &
Dhruv Kumar
(2021) In silico identification and validation of triarylchromones as potential inhibitor against main protease of severe acute respiratory syndrome coronavirus 2,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1918255
.
(Impact Factor: 3.2) : Corresponding Author
Rashmi Tyagi, Mitul Srivastava, Baldeep Singh, Shingini Sharma, Ramendra Pati Pandey, Shailendra Asthana,
Dhruv Kumar
& V. Samuel Raj (2021) Identification and validation of potent Mycobacterial proteasome inhibitor from Enamine library,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1914173
.
(Impact Factor: 3.2) : Corresponding Author
Mathur, A., Raj, S., Jha, N.K. et al. Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2.
3 Biotech
11, 236 (2021).
https://doi.org/10.1007/s13205-021-02791-y
.
(Impact Factor: 2.2) : Corresponding Author
Arfin, S.; Jha, N.K.; Jha, S.K.; Kesari, K.K.; Ruokolainen, J.; Roychoudhury, S.; Rathi, B.;
Kumar, D
. Oxidative Stress in Cancer Cell Metabolism.
Antioxidants
2021, 10, 642.
https://doi.org/10.3390/antiox10050642
.
(Impact Factor: 5) : Corresponding Author
Kumar A, Kumar R, Rahman MS, Ali M, Kumar R, Nupur N, Gaurav A, Raj V, Anand G, Niraj PK, Kumar N, Srivastava A, Biswapriya A, Chand GB,
Kumar D
, Rashmi T, Kumar S, Sakamoto M, Ghosh AK. Assessment of arsenic exposure in the population of Sabalpur village of Saran District of Bihar with mitigation approach.
Environ Sci Pollut Res Int.
2021 Apr 11.
https://doi.org/10.1007/s11356-021-13521-5
(Impact Factor: 4.3)
Kumar, A., Rahman, M.S., Ali, M. et al. Assessment of arsenic exposure and its mitigation intervention in severely exposed population of Buxar district of Bihar, India.
Environ. Health Sci.
(2021).
https://doi.org/10.1007/s13530-021-00086-6
(Impact Factor: .76)
Chandel V., et al. 2021. In silico identification of potential inhibitor for TP53-induced glycolysis and apoptosis regulator in head and neck squamous cell carcinoma.
3Biotech
. 11(3):117.
https://doi.org/10.1007/s13205-021-02665-3
(Impact Factor: 2.2) : Corresponding Author
2020
Kumar A., et al. 2020. Arsenic exposure causing cancer in the Indo - Gangetic Plain - A 2000 cancer patients’ cross-sectional design.
Scientific Reports
. 11, 2376 (2021).
https://doi.org/10.1038/s41598-021-81579-9
.
(Impact Factor: 4.1)
Roychoudhury S., et al. 2020. Viral pathogenesis of SARS-CoV-2 infection and male reproductive health: Myth or fact?
Open Biology
. 11(1): 200347,
https://doi.org/10.1098/rsob.200347
(Impact Factor: 4.9)
Jha N K., et al. 2020. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS‑CoV‑2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Journal of Molecular Neuroscience.
https://doi.org/10.1007/s12031-020-01767-6
.
(Impact Factor: 2.8)
Ali A., et al. 2020. Comparative analysis of TiO2 and Ag nanoparticles on xylan/chitosan conjugate matrix for wound healing application.
International Journal of Polymeric Materials and Polymeric Biomaterials.
https://doi.org/10.1080/00914037.2020.1838519
(Impact Factor: 1.9)
Kumar D., et al. 2020. Stem Cell Based Preclinical Drug Development and Toxicity Prediction.
Current Pharmaceutical Design
.
https://doi.org/10.2174/1381612826666201019104712
(Impact Factor: 2.4) : Corresponding Author
Tyagi R., et al. 2020. Development of potential proteasome inhibitors against Mycobacterium tuberculosis.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1835722
(Impact Factor: 3.2) : Corresponding Author
Narula S, Tandon S, Kumar D et al. 2020. Human kidney stone matrix proteins alleviate hyperoxaluria induced renal stress by targeting cell-crystal interactions.
Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118498
(Impact Factor: 3.6)
Satyam R, Jha NK, Kar R et al. 2020. Deciphering the SSR incidences across viral members of Coronaviridae family.
Chemico-Biological Interactions.
https://doi.org/10.1016/j.cbi.2020.109226
(Impact Factor: 3.6)
Chandel V, Raj S, Rathi B, Choudhary R,
Kumar D
. 2020. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1811773
(Impact Factor: 3.2) : Corresponding Author
Manish D., Vijay T., Kumar D., et al. 2020. Structural and Morphological Characterization of CdS Nanoparticles,
Current Physical Chemistry.
https://doi.org/10.2174/1877946810999200730222025
(Impact Factor: 1.6)
Raj S, Chandel V, et al. 2020 Molecular mechanisms of interplay between autophagy and metabolism in cancer
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118184
(Impact Factor: 3.6) : Corresponding Author
Chandel V, Raj S, et al. 2020. Metabolic regulation in HPV associated head and neck squamous cell carcinoma
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118236
(Impact Factor: 3.6) : Corresponding Author
Chandel V,
Kumar D
. 2020. Targeting Signalling Cross-Talk between Cancer Cells and Cancer Associate Fibroblast through Monocarboxylate Transporters in Head and Neck Cancer
,Anti-Cancer Agents in Medicinal Chemistry
:
Bentham Science Publishers
,
https://doi.org/10.2174/1871520620666200721135230
(Impact Factor: 2.04) : Corresponding Author
Kumar S, Sharma PP, Shankar U,
Kumar D
et al. 2020. Discovery of New Hydroxyethylamine Analogs against 3CL pro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies.
J Chem Inf Model.
https://doi.org/10.1021/acs.jcim.0c00326
(Impact Factor: 4.5)
Pandey V, Tripathi G,
Kumar D
et al. 2020. Novel 3,4-diarylpyrazole as prospective anti-cancerous agents,
Helion
,
https://doi.org/10.1016/j.heliyon.2020.e04397
(Impact Factor: 1.6) : Corresponding Author
Chandel V, Raj S, Rathi B,
Kumar D
. 2020. In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach.
Chemical Biology Letters
. 7(3), 166‐175.
(Impact Factor: 4.4) : Corresponding Author
Chandel V, Raj S, Srivastava A,
Kumar D
. 2020. In-silico interactions of active Phytochemicals with c-MYC EGFR and ERBB2 oncoproteins.
Chemical Biology Letters
. 7(1), 47‐54.
(Impact Factor: 4.4) : Corresponding Author
Raj S, Chandel V, Rathi B,
Kumar D
. 2020. Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach, Coronavirus: Bentham Science Publishers, DOI : 10.2174/2666796701999200617155013
: Corresponding Author
2019
Sibi Raj, Sartaj Khuranaa, Ramesh Choudhari et al. 2019. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
Seminars in Cancer Biology
https://doi.org/10.1016/j.semcancer.2019.11.002
.
(Impact Factor: 15) : Corresponding Author
Anukriti, Anupam D, Swati U, Pallavi S, et al. 2019. Investigation of Precise Molecular Mechanistic Action of Tobacco-Associated Carcinogen ‘NNK’ Induced Carcinogenesis: A System Biology Approach. 10(8), 564.
(Impact Factor: 3.4)
Asif A, Saleheen B, Satish S.P,
Kumar D
, Yuvraj S N, 2019. Effect of incorporation of Montmorillonite on Xylan/Chitosan conjugate scaffold.
Colloids and Surfaces B: Biointerfaces
1(180) 75-82.
(Impact Factor: 3.9)
Vishwakarma V, New J1,
Kumar D,
et al.,
Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds.
Scientific Reports
. 15;8(1):12163.
(Impact Factor: 4.1)
Chandel V and Kumar D. 2019. The Development of Tumor Heterogeneity and Actively Targeting Therapy Resistant Subpopulations
. J Embryol Stem Cell Res
. 3(3): 000131
: Corresponding Author
2018
Kumar D, et al.,
2018
.
Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression.
Cancer Research
. 10.1158/0008-5472.CAN-17-1076.
(Impact Factor: 12) : First Author
Kumar D
, et al. Perfluoro Curcumin Strongly Interacts with ABC Transporter (ABCG2): A Molecular Docking Study.
J Embryol Stem Cell Res
2018, 2(2): 000113.
: Corresponding Author
Kumar D
. 2018. Resveratrol derivative triacetyl-resveratrol interacts directly with the Gli-DNA zinc finger complex.
J Cancer Res Oncobiol
. Apr; 1(2):110
: Corresponding Author
2017
Kumar D
, et al., 2017. Development and characterization of an in vitro model for radiation-induced fibrosis,.
Radiation Research
. 189(3):326-336
(Impact Factor: 2.5) : First Author
Kumar D
, 2017. Role of tumor heterogeneity in drug resistance.
Glob J Cancer Ther
3(2): 032-033. (Editorial).
: Corresponding Author
Kumar D
, 2017. Regulation of glycolysis in head and neck squamous cell carcinoma
. Postdoc Journal
. 2017 Jan;5 (1):14-28.
: Corresponding Author
2016
Ledgerwood LG*,
Kumar D*,
Eterovic AK, Wick J et al., 2016. The degree of intra-tumor mutational heterogeneity varies by primary tumor sub-site.
Oncotarget
. Mar 28. doi: 18632/oncotarget.8448.
(Impact Factor:6.4)
*Equal contribution
: First Author
2015
Kumar D
, Kandl C, Hamilton C, Shnayder Y, Tsue T, Kakarala K, Ledgerwood L, Sun X S, Huang H, Girod D, Thomas S 2015. Anti-HGF antibody ficlatuzumab mitigates tumor-associated fibroblast-facilitated head and neck cancer progression.
JAMA Otolaryngology-Head & Neck Surgery
. Dec 1;141 (12): 1133-9.
(Impact Factor: 6.2) : First Author
Kumar D
, Gupta D, Shankar S, Srivastava RK. 2015. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
Oncotarget:
1-12.
(Impact Factor:6.4) : First Author
2014
Plotegher N,
Kumar D
, Tessari I, Brucale M, Munari F, et al. 2014. The chaperone-like protein 14-3-3eta interacts with human alpha-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing alpha-synuclein cellular toxicity.
Human Molecular Genetics
. 23:5615-29.
(Impact Factor:5.9)
Kumar D
, Shankar S, Srivastava RK. 2014. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway.
Cancer Letters
. 343:179-89.
(Impact Factor:6.4) : First Author
Kumar D
, Plotegher N, Bubacco L, Brucale M. 2014. Quantitative AFM morphometry of non-fibrillar α- synuclein aggregation products induced by the chaperone-like protein 14-3-3.
Italian Society for Microscopical Sciences
. Vol 21, No 1. DOI: 10.4081/microscopie. 2014.4998.
: First Author
Kumar D
, Shankar S, Srivastava RK. 2014. Understanding the biological functions and therapeutic potentials of stem cells and cancer stem cells: Where are we?
Journal of Cancer Stem Cell Research
. 2:e1002:1-8.
: First Author
2013
Kumar D
, Shankar S, Srivastava RK. 2013. Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms.
Molecular Cancer
. 1476-4598-12-171.
(Impact Factor:27) : First Author
Nanta R,
Kumar D
, Meeker D, Rodova M, Van Veldhuizen PJ, et al. 2013. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rgamma null mice by regulating Bmi-1 and microRNA-128.
Oncogenesis
. 2:e42.
(Impact Factor:5.1)
Shankar S,
Kumar D
, Srivastava 2013. Epigenetic modifications by dietary phytochemicals: Implications for personalized nutrition.
Pharmacol Therapeut
. 138:1-17.
(Impact Factor:11.1)
2012
Pivato M, De Franceschi G, Tosatto L, Frare E,
Kumar D
, et al. 2012. Covalent alpha-synuclein dimers: chemico-physical and aggregation properties.
PloS one
7:e50027.
(Impact Factor:3.4)
Singh BN,
Kumar D
, Shankar S, Srivastava 2012. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells.
Biochemical Pharmacology
. 84:1154-63.
(Impact Factor:6.1)
Conference Proceedings
Tyagi,
D. Kumar
and V. S. Raj, 2018. "In silico identification of potential inhibitors against Mycobacterial proteasome," 2018 International Conference on Bioinformatics and Systems Biology (BSB), Allahabad, India,
IEEE Xplore
, pp. 193-197.
(IF: 10.6)
Shekhar Goyal, Surender Kr Beniwal, H S Kumar,
Dhruv Kumar
, B C Das. 2019. Role of Curcumin in reducing toxicity and adverse effects in locally advanced and metastatic breast cancer patients.
Annals of Oncology
. Volume 30, vi126 - vi127.
(IF: 14)
Book Chapter
Mavi, Anil Kumar, Manmohan Kumar, Amarjeet Singh, Mahendra Kumar Prajapati, Rakhi Khabiya, Saurabh Maru, and
Dhruv Kumar.
"Progress in Non‐Viral Delivery of Nucleic Acid: Advancement in Biomedical Technology." Integration of Biomaterials for Gene Therapy (2023): 281-322.
https://doi.org/10.1002/9781394175635.ch10
Mavi, Anil Kumar, Sonal Gaur, Neelesh Kumar, Avanish Kumar Shrivastav, Sankha Bhattacharya, Sateesh Belemkar, Saurabh Maru, and
Dhruv Kumar
. "Effective Gene Transfer with Non‐Viral Vectors." Integration of Biomaterials for Gene Therapy (2023): 183-222.
https://doi.org/10.1002/9781394175635.ch7
Kirti Agrawal, Malavika Saji,
Dhruv Kumar,
Drug Repurposing in Future Drug Discovery and Development, Book-Drug Repurposing and Computational Drug Discovery, Edition1st Edition 2023, Apple Academic Press, Pages26, eBook ISBN9781003347705,
https://doi.org/10.1201/9781003347705
Kumar, A., Raj, V., Ali, M., Abhinav, Rachamalla, M.,
Kumar, D
., Kumari, A., Kumar, R., Shankar, P. and Ghosh, A., 2023. Evaluation of MOF Applications for Groundwater Arsenic Mitigation of the Middle Ganga Plains of Bihar, India. Metal Organic Frameworks for Wastewater Contaminant Removal, pp.355-373. 26 August 2023,
https://doi.org/10.1002/9783527841523.ch16
Saniya Arfin,
Dhruv Kumar
, Chapter 3 - Use of vitamins and minerals as dietary supplements for better health and cancer prevention, Editor(s): Inamuddin, Tariq Altalhi, Jorddy Neves Cruz, Nutraceuticals, Academic Press, 2023, Pages 53-97, ISBN 9780443191930,
https://doi.org/10.1016/B978-0-443-19193-0.00003-4
.
A Santoshkumar, S Ray, S Narayanan,
D Kumar
, S Harihar (2023), Mitophagy in cancer and cancer stem cells: a role in metabolic reprogramming. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00009-2
T Singh, AS Kharat, B Rathi,
D Kumar
(2023), Designing metabolic target-specific inhibitors for cancer therapy. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00011-0
Sibi Raj, Manish K. Mishra, Sitaram Harihar, Ashok Kumar, Shubhadeep Roychoudhury, Arun Kumar et al. (
2022
). Regulation of Glucose Transporters in Cancer Progression, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_9
Stephen James, Saniya Arfin, Manish K. Mishra, Arun Kumar, Niraj Kumar Jha, Saurabh Kumar Jha et al. (
2022
). Role of Arsenic in Carcinogenesis, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_7
Raj S., Kumar A.,
Kumar D
. (
2020
) Regulation of Glycolysis in Head and Neck Cancer, Book. Cancer Metabolomics, Advances in Experimental Medicine and Biology, Springer Nature.
https://doi.org/10.1007/978-3-030-51652-9_15
Chandel V.,
Kumar D
. (
2020
) Role of Interferon in Cancer Metabolism. Innate Immunity in Health and Disease. IntechOpen.
https://doi.org/10.5772/intechopen.92020
Raj S, Chandel V., Maurya S,
Kumar D
. (
2020
) Role of Macrophages in Solid Tumor Metabolism. Macrophages. IntechOpen.
https://doi.org/10.5772/intechopen.93182
Maurya S, Chandel V, Raj S, (
2020
) OMICS IN CANCER: FROM DIAGNOSTICS TO THERAPEUTICS. Recent Trends in ‘Computational Omics'. ISBN: 978-1-53617-941-5
Raj S., Chandel V.,
Kumar D
. (
2020
) Cancer Cell Metabolism: Solid Tumor Versus Nonsolid Tumor. In:
Kumar D
. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_1
Pedroza D.A. et al. (
2020
) Role of Autophagy in Cancer Cell Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_6
Chandel V., Raj S., Choudhari R.,
Kumar D
. (
2020
) Role of c-Met/HGF Axis in Altered Cancer Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_7
Kumar D
., Sharma-Walia N., Kapoor S., Tandon S. (
2020
) Antibody-Targeted Nanoparticles for Cancer Treatment. In: Saxena S., Khurana S. (eds) NanoBioMedicine. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9898-9_3
Singh B., Malhotra H.,
Kumar D
., Mujtaba S.F., Upadhyay A.K. (
2019
) Understanding Cellular and Molecular Events of Skin Aging and Cancer: An Integrative Perspective. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_2
Tripathi M.K., Sinha J., Srivastava S.K.,
Kumar D
. (
2019
) Bioinformatics in Skin Cancer: A System Biology Approach to Understanding the Molecular Mechanisms and It’s Regulations. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_10
Khurana S., Bose S.,
Kumar D
. (
2019
) Applications of Microarray-Based Technologies in Identifying Disease-Associated Single Nucleotide Variations. In: Tripathi V., Kumar P., Tripathi P., Kishore A., Kamle M. (eds) Microbial Genomics in Sustainable Agroecosystems. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9860-6_4
Singh P., Tiwari D., Mishra M.,
Kumar D
. (
2019
) Molecular Mechanisms of Heavy Metal Toxicity in Cancer Progression. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_3
Chandel V., Seth G., Shukla P.,
Kumar D
. (
2019
) Role of Radiation in DNA Damage and Radiation Induced Cancer. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_1
Dhruv Kumar
, Sharmila Shankar, Rakesh Srivastava. Challenges in stem cells and translational research (Book chapter). Lost in translational and clinical research. World Scientific Publication,
2014
. ISBN: 9789814489089.
https://doi.org/10.1142/9789814489072_0020
Dhruv kumar
and Bruno Samori. Mechanochemistry: Coupling mechanical forces and chemical reactions (Book chapter). Molecular Manipulation with Atomic Force Microscopy (Book), CRC Press,
2011
, ISBN: 9781439809662.
Dwijendra Gupta,
Dhruv Kumar
, Manish Dwivedi, Vijay Tripathi, Pratibha Phadke-Gupta and Surya Pratap Singh. Nanophosphors-Nanogold immunoconjugates in Isolation of Biomembranes and in Drug Delivery (Book chapter). Recent Advances in Nanomedicine (Book), VBRI Press,
2011
, ISBN: 9788192006803.
Book
Dhruv Kumar
, Shailendra Asthana Autophagy and Metabolism Potential Target for Cancer Therapy 1st Edition - August 6, 2022 Paperback ISBN: 9780323998796 9 7 8 - 0 - 3 2 3 - 9 9 8 7 9 - 6 eBook ISBN: 9780323999458
Akhileshwar Srivastava,
Dhruv Kumar
, Divya Singh, Rajesh Singh, Xenobiotics in Chemical Carcinogenesis:Translational Aspects in Toxicology,
Elsevier,
ISBN: 9780323905602
Dhruv kumar.
Cancer Cell Metabolism: A Potential Target for Cancer Therapy.
Springer Nature
.
2020,
ISBN: 9789811519901.
Dhruv kumar
, Marco Brucale and Bruno Samori. Amyloidogenic Proceses of Intrinsically Disordered Proteins: Understanding the Aggregation Process of Intrinsically Unstructured Proteins Related to Neurodegenerative Diseases.
Lambert Academic Publishing
,
2014
, ISBN:
Dhruv kumar
. Insilico analysis of Docking between HIV-1 PR and derivatives of CUI (Docking between HIV- 1 proteases and cyclic urea inhibitors: A step towards drug designing against AIDS).
Lambert Academic Publishing
,
2011
, ISBN:

Scholarly Activities

Scholarly Activities

Prof. Dhruv Kumar, has a rich portfolio of scholarly activities spanning teaching, research, and academic contributions. He actively engages in designing and instructing courses at various academic levels, including undergraduate (UG), postgraduate (PG), and doctoral (PhD) programs, covering specialized areas such as Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics. Prof. Kumar's research endeavors have resulted in numerous publications in high-impact journals, including Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, and Nature Scientific Reports. He has received recognition on both national and international platforms, garnering awards such as the Senior Scientist Award from the Society of Biomedical Laboratory Scientists, India, the Scholar-in-Training Award from the American Association for Cancer Research (AACR), USA, and the K-INBRE Postdoctoral Award from the National Institute of Health (NIH), USA. Additionally, his active involvement in government-funded projects and mentorship of PhD students in the fields of Cancer and Infertility reflects his commitment to advancing knowledge and nurturing the next generation of researchers. Prof. Kumar's scholarly activities exemplify a holistic approach to academia, seamlessly integrating teaching, research, and mentorship.
His selected publications are as below:
2023
Agrawal, K.; Asthana, S.;
Kumar, D
. Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer. Cancers 2023, 15, 4920.
https://doi.org/10.3390/cancers15204920
.
(Impact Factor: 5.2)
Maurya, S., Raj, S., Bhoi, N.R., Mani, N., Rathi, B. and
Kumar, D
., 2023. Morphological analysis of metabolically dysregulated spermatozoa using Artificial Intelligence based approach. Journal of Integrated Science and Technology, 11(4), pp.569-569.
(Impact Factor: 1.14)
Raj, S. and
Kumar, D.
, 2023. Early epigenetic markers for precision medicine. Progress in molecular biology and translational science, 198, pp.153-164.
(Impact Factor: 4.0)
Kumar, A., Ali, M., Raj, V., Kumari, A., Rachamalla, M., Niyogi, S.,
Kumar, D.
, Sharma, A., Saxena, A., Panjawani, G. and Jain, P., 2023. Arsenic causing gallbladder cancer disease in Bihar. Scientific Reports, 13(1), p.4259.
(Impact Factor: 4.9)
Goel, M., Mishra, M.K. and
Kumar, D
., 2023. Recent advances in Targeted Radionuclide therapy for Cancer treatment. Chemical Biology Letters, 10(3), pp.544-544.
(Impact Factor: 6.1)
Bhattacharjee, R., Prabhakar, N., Kumar, L., Bhattacharjee, A., Kar, S., Malik, S.,
Kumar, D
., Ruokolainen, J., Negi, A., Jha, N.K. and Kesari, K.K., 2023. Crosstalk between long noncoding RNA and microRNA in Cancer. Cellular Oncology, pp.1-24.
(Impact Factor: 6.6)
Kumar, A., Kumar, K., Ali, M., Raj, V., Srivastava, A., Kumar, M., Niraj, P.K., Kumar, M., Kumar, R.,
Kumar, D.
and Bishwapriya, A., 2023. Severe Disease Burden and the Mitigation Strategy in the Arsenic-Exposed Population of Kaliprasad Village in Bhagalpur District of Bihar, India. Biological trace element research, pp.1-17.
(Impact Factor: 4.0)
Arfin, S.;
Kumar, D
.; Lomagno, A.; Mauri, P.L.; Di Silvestre, D. Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis. Cancers 2023, 15, 4420.
https://doi.org/10.3390/cancers15174420
(Impact Factor: 5.2)
Arfin S, Agrawal K, Maurya S, Asthana S, Di Silvestre
D, Kumar D
. Lead phytochemicals and marine compounds against ceruloplasmin in cancer targeting. Journal of Biomolecular Structure and Dynamics. 2023 Oct 18.
(Impact Factor: 5.2)
Agrawal K, Chakraborty P, Dewanjee S, Arfin S, Das SS, Dey A, Moustafa M, Mishra PC, Jafari SM, Jha NK, Jha SK,
Kumar D
. Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders. Neurosci Biobehav Rev. 2023 Jan;144:104955. doi: 10.1016/j.neubiorev.2022.104955. Epub 2022 Nov 14. PMID: 36395983.
(Impact Factor: 9.0)
Agrawal K, Chauhan S,
Kumar D
. Expression analysis and regulation of GLI and its correlation with stemness and metabolic alteration in human brain tumor. 3 Biotech. 2023 Jan;13(1):10. doi: 10.1007/s13205-022-03419-5. Epub 2022 Dec 15. PMID: 36532860; PMCID: PMC9755437.
(Impact Factor: 2.9)
Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A,
Kumar D
, Ambasta RK, Jha NK, Jha SK, Dewanjee S. Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Res Rev. 2023 Mar;85:101838. doi: 10.1016/j.arr.2022.101838. Epub 2023 Jan 5. PMID: 36610558.
(Impact Factor: 11.7)
Raj, S., Rathi, B., Mehra, P., Asthana, S., &
Kumar, D
. (2023). Deciphering the role of c-MET in Metabolic reprogramming of Head and Neck squamous cell Carcinoma via In Silico analysis. Chemical Biology Letters, 10(2), 532. Retrieved from
https://pubs.thesciencein.org/journal/index.php/cbl/article/view/532
(Impact Factor: 4.4)
2022
Awasthi P, Dwivedi M, Kumar D, Hasan S. Insights into intricacies of the Latent Membrane Protein-1 (LMP-1) in EBV-associated cancers. Life Sci. 2023 Jan 15;313:121261. doi: 10.1016/j.lfs.2022.121261. Epub 2022 Dec 7. PMID: 36493876.
(Impact Factor: 3.3)
Sharma S, Tyagi R, Srivastava M, Rani K,
Kumar D
, Asthana S, Raj VS. Identification and validation of potent inhibitor of Escherichia coli DHFR from MMV pathogen box. J Biomol Struct Dyn. 2022 Jun 2:1-10. doi: 10.1080/07391102.2022.2080113. Epub ahead of print. PMID: 35652895.
(Impact Factor: 3.3)
Maurya S, Kesari KK, Roychoudhury S, Kolleboyina J, Jha NK, Jha SK, Sharma A, Kumar A, Rathi B, Kumar D. Metabolic Dysregulation and Sperm Motility in Male Infertility. Adv Exp Med Biol. 2022;1358:257-273. doi: 10.1007/978-3-030-89340-8_12. PMID: 35641874.
(Impact Factor: 2.6)
Das S, Roychoudhury S, Dey A, Jha NK, Kumar D, Roychoudhury S, Slama P, Kesari KK. Bacteriospermia and Male Infertility: Role of Oxidative Stress. Adv Exp Med Biol. 2022;1358:141-163. doi: 10.1007/978-3-030-89340-8_7. PMID: 35641869.
(Impact Factor: 2.6)
Arfin, S. .; Mani, N. .; Rathi, B.; Kumar, D. In Silico Analysis of Ceruloplasmin Alteration in Oral Squamous Cell Carcinoma. Chem Biol Lett 2022, 9, 342.
(Impact Factor: 4.4)
Jha NK, Arfin S, Jha SK, Kar R, Dey A,
Kumar D
. et al. Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling Semin Cancer Biol. 2022 Feb 23:S1044-579X(22)00049-9.
https://doi.org/10.1016/j.semcancer.2022.02.022
.
(Impact Factor: 17)
Raj S, Kesari KK, Kumar A, Rathi B, Sharma A, Gupta PK, Jha SK, Jha NK, Slama P, Roychoudhury S,
Kumar D
. Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. Molecular Cancer (BMC-Springer Nature). 2022. 26;21(1):31.
https://doi.org/10.1186/s12943-022-01503-1
(Impact Factor: 41.4): Corresponding Author
Pritam P, Deka R,
Kumar D
. et al.. Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects. Biology-MDPI. 2022. 11(2), 212.
https://doi.org/10.3390/biology11020212
(Impact Factor: 5.0)
Kumar, A.
Kumar D
. et al..Assessment of disease burden in the arsenic exposed population of Chapar village of Samastipur district, Bihar, India, and related mitigation initiative.
Environmental Science and Pollution Research.
https://doi.org/10.1007/s11356-021-18207-6
(Impact Factor: 4.3)
2021
Upadhyay C.
Kumar D
. et al.. Synthesis of the new analogs of morpholine and their antiplasmodial evaluation against the human malaria parasite Plasmodium falciparum.
New Journal of Chemistry
. 2021.
https://doi.org/10.1039/D1NJ04198C
(Impact Factor: 3.4)
Singh A, Singh AK, Giri R,
Kumar D
, Sharma R, Valis M, Kuca K, Garg N. The role of microRNA-21 in the onset and progression of cancer.
Future Med Chem
. 2021 Nov;13(21): 1885-1906.
https://doi.org/10.4155/fmc-2021-0096
.
(Impact Factor: 3.9)
Jeyaraman Madhan ,Muthu Sathish ,
Kumar D
. et al. “Total Stromal Fraction (TSF) - Fortified Adipose Tissue-Derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary Compromise”,
Coronaviruses
2021; e080921196287.
https://doi.org/10.2174/2666796702666210908151708
.
(Impact Factor: 0.0)
Asif Ali, Saleheen Bano,
Kumar D
. et al. (2021) Effect of cellulose nanocrystals on chitosan/PVA/nano β-TCP composite scaffold for bone tissue engineering application,
Journal of Biomaterials Science, Polymer Edition
,
https://doi.org/10.1080/09205063.2021.1973709
.
(Impact Factor: 3.5)
Mehreen Aftab, Maryam Ghufran,
Kumar D
. et al., In silico analysis of the role of hsa-miR-155-5p in cervical cancer, Chem. Biol. Lett. 2021, 8(3), 94-105.
(Impact Factor: 4.4) : Corresponding Author
Usman, M.B., Bhardwaj, S., Roychoudhury, S.
Kumar D
. et al.. Immunotherapy for Alzheimer’s Disease: Current Scenario and Future Perspectives.
J Prev Alzheimers Dis
8, 534–551 (2021).
https://doi.org/10.14283/jpad.2021.52
(Impact Factor: 4.4)
Sharma, P.P., Bansal, M., Sethi, A., Pena, L.,
Kumar D
. et al., 2021. Computational methods directed towards drug repurposing for COVID-19: advantages and limitations.
RSC Advances
, 11(57), pp.36181-36198.
https://doi.org/10.1039/D1RA05320E
(Impact Factor: 3.3)
Goyal, K.; Goel, H.; Baranwal, P.; Tewary, A.;
Kumar D
. et al.. Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans. Immuno 2021, 1, 442-456.
https://doi.org/10.3390/immuno1040032
(Impact Factor: 0.0)
Sharma A,
Kumar D
, Dahiya K, Hawthorne S, Jha SK, Jha NK, Nand P, Girgis S, Raj S, Srivastava R, Goswami VK, Gregoriou Y, El-Zahaby SA, Ojha S, Dureja H, Gupta G, Singh S, Chellappan DK, Dua K. Advances in pulmonary drug targeting microbial biofilms in respiratory diseases. Nanomedicine (Lond). 2021 Aug 5. delivery
https://doi.org/10.2217/nnm-2021-0057
.
(Impact Factor: 5.3): : Corresponding Author
Jeyaraman M, Muthu S, Bapat A,
Kumar D
. et al.. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon. 2021 Jul;7(7):e07635.
https://doi.org/10.1016/j.heliyon.2021.e07635
.
(Impact Factor: 1.8)
Sharma A, Hawthorne S, Jha SK, Jha NK,
Kumar D
, Girgis S, Goswami VK, Gupta G, Singh S, Dureja H, Chellappan DK, Dua K. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDAMB231 human breast cancer cells. Nanomedicine (Lond). 2021 Aug;16(20):1763-1773.
https://doi.org/10.2217/nnm-2021-0066
.
(Impact Factor: 5.3)
Chandel V, Maru S, Kumar A, Kumar A, Sharma A, Rathi B,
Kumar D
. Role of monocarboxylate transporters in head and neck squamous cell carcinoma. Life Sciences. 2021, 5;279:119709.
https://doi.org/10.1016/j.lfs.2021.119709
.
(Impact Factor: 3.6) : Corresponding Author
Raj S, Kumar A,
Kumar D
. Regulation of Glycolysis in Head and Neck Cancer. Adv Exp Med Biol. 2021;1280:219-230.
https://doi.org/10.1007/978-3-030-51652-9_15
.
(Impact Factor: 2.4) : Corresponding Author
Vaishali Chandel, Garima Tripathi, Seema A. Nayar, Brijesh Rathi, Abhijeet Kumar &
Dhruv Kumar
(2021) In silico identification and validation of triarylchromones as potential inhibitor against main protease of severe acute respiratory syndrome coronavirus 2,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1918255
.
(Impact Factor: 3.2) : Corresponding Author
Rashmi Tyagi, Mitul Srivastava, Baldeep Singh, Shingini Sharma, Ramendra Pati Pandey, Shailendra Asthana,
Dhruv Kumar
& V. Samuel Raj (2021) Identification and validation of potent Mycobacterial proteasome inhibitor from Enamine library,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1914173
.
(Impact Factor: 3.2) : Corresponding Author
Mathur, A., Raj, S., Jha, N.K. et al. Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2.
3 Biotech
11, 236 (2021).
https://doi.org/10.1007/s13205-021-02791-y
.
(Impact Factor: 2.2) : Corresponding Author
Arfin, S.; Jha, N.K.; Jha, S.K.; Kesari, K.K.; Ruokolainen, J.; Roychoudhury, S.; Rathi, B.;
Kumar, D
. Oxidative Stress in Cancer Cell Metabolism.
Antioxidants
2021, 10, 642.
https://doi.org/10.3390/antiox10050642
.
(Impact Factor: 5) : Corresponding Author
Kumar A, Kumar R, Rahman MS, Ali M, Kumar R, Nupur N, Gaurav A, Raj V, Anand G, Niraj PK, Kumar N, Srivastava A, Biswapriya A, Chand GB,
Kumar D
, Rashmi T, Kumar S, Sakamoto M, Ghosh AK. Assessment of arsenic exposure in the population of Sabalpur village of Saran District of Bihar with mitigation approach.
Environ Sci Pollut Res Int.
2021 Apr 11.
https://doi.org/10.1007/s11356-021-13521-5
(Impact Factor: 4.3)
Kumar, A., Rahman, M.S., Ali, M. et al. Assessment of arsenic exposure and its mitigation intervention in severely exposed population of Buxar district of Bihar, India.
Environ. Health Sci.
(2021).
https://doi.org/10.1007/s13530-021-00086-6
(Impact Factor: .76)
Chandel V., et al. 2021. In silico identification of potential inhibitor for TP53-induced glycolysis and apoptosis regulator in head and neck squamous cell carcinoma.
3Biotech
. 11(3):117.
https://doi.org/10.1007/s13205-021-02665-3
(Impact Factor: 2.2) : Corresponding Author
2020
Kumar A., et al. 2020. Arsenic exposure causing cancer in the Indo - Gangetic Plain - A 2000 cancer patients’ cross-sectional design.
Scientific Reports
. 11, 2376 (2021).
https://doi.org/10.1038/s41598-021-81579-9
.
(Impact Factor: 4.1)
Roychoudhury S., et al. 2020. Viral pathogenesis of SARS-CoV-2 infection and male reproductive health: Myth or fact?
Open Biology
. 11(1): 200347,
https://doi.org/10.1098/rsob.200347
(Impact Factor: 4.9)
Jha N K., et al. 2020. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS‑CoV‑2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Journal of Molecular Neuroscience.
https://doi.org/10.1007/s12031-020-01767-6
.
(Impact Factor: 2.8)
Ali A., et al. 2020. Comparative analysis of TiO2 and Ag nanoparticles on xylan/chitosan conjugate matrix for wound healing application.
International Journal of Polymeric Materials and Polymeric Biomaterials.
https://doi.org/10.1080/00914037.2020.1838519
(Impact Factor: 1.9)
Kumar D., et al. 2020. Stem Cell Based Preclinical Drug Development and Toxicity Prediction.
Current Pharmaceutical Design
.
https://doi.org/10.2174/1381612826666201019104712
(Impact Factor: 2.4) : Corresponding Author
Tyagi R., et al. 2020. Development of potential proteasome inhibitors against Mycobacterium tuberculosis.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1835722
(Impact Factor: 3.2) : Corresponding Author
Narula S, Tandon S, Kumar D et al. 2020. Human kidney stone matrix proteins alleviate hyperoxaluria induced renal stress by targeting cell-crystal interactions.
Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118498
(Impact Factor: 3.6)
Satyam R, Jha NK, Kar R et al. 2020. Deciphering the SSR incidences across viral members of Coronaviridae family.
Chemico-Biological Interactions.
https://doi.org/10.1016/j.cbi.2020.109226
(Impact Factor: 3.6)
Chandel V, Raj S, Rathi B, Choudhary R,
Kumar D
. 2020. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1811773
(Impact Factor: 3.2) : Corresponding Author
Manish D., Vijay T., Kumar D., et al. 2020. Structural and Morphological Characterization of CdS Nanoparticles,
Current Physical Chemistry.
https://doi.org/10.2174/1877946810999200730222025
(Impact Factor: 1.6)
Raj S, Chandel V, et al. 2020 Molecular mechanisms of interplay between autophagy and metabolism in cancer
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118184
(Impact Factor: 3.6) : Corresponding Author
Chandel V, Raj S, et al. 2020. Metabolic regulation in HPV associated head and neck squamous cell carcinoma
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118236
(Impact Factor: 3.6) : Corresponding Author
Chandel V,
Kumar D
. 2020. Targeting Signalling Cross-Talk between Cancer Cells and Cancer Associate Fibroblast through Monocarboxylate Transporters in Head and Neck Cancer
,Anti-Cancer Agents in Medicinal Chemistry
:
Bentham Science Publishers
,
https://doi.org/10.2174/1871520620666200721135230
(Impact Factor: 2.04) : Corresponding Author
Kumar S, Sharma PP, Shankar U,
Kumar D
et al. 2020. Discovery of New Hydroxyethylamine Analogs against 3CL pro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies.
J Chem Inf Model.
https://doi.org/10.1021/acs.jcim.0c00326
(Impact Factor: 4.5)
Pandey V, Tripathi G,
Kumar D
et al. 2020. Novel 3,4-diarylpyrazole as prospective anti-cancerous agents,
Helion
,
https://doi.org/10.1016/j.heliyon.2020.e04397
(Impact Factor: 1.6) : Corresponding Author
Chandel V, Raj S, Rathi B,
Kumar D
. 2020. In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach.
Chemical Biology Letters
. 7(3), 166‐175.
(Impact Factor: 4.4) : Corresponding Author
Chandel V, Raj S, Srivastava A,
Kumar D
. 2020. In-silico interactions of active Phytochemicals with c-MYC EGFR and ERBB2 oncoproteins.
Chemical Biology Letters
. 7(1), 47‐54.
(Impact Factor: 4.4) : Corresponding Author
Raj S, Chandel V, Rathi B,
Kumar D
. 2020. Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach, Coronavirus: Bentham Science Publishers, DOI : 10.2174/2666796701999200617155013
: Corresponding Author
2019
Sibi Raj, Sartaj Khuranaa, Ramesh Choudhari et al. 2019. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
Seminars in Cancer Biology
https://doi.org/10.1016/j.semcancer.2019.11.002
.
(Impact Factor: 15) : Corresponding Author
Anukriti, Anupam D, Swati U, Pallavi S, et al. 2019. Investigation of Precise Molecular Mechanistic Action of Tobacco-Associated Carcinogen ‘NNK’ Induced Carcinogenesis: A System Biology Approach. 10(8), 564.
(Impact Factor: 3.4)
Asif A, Saleheen B, Satish S.P,
Kumar D
, Yuvraj S N, 2019. Effect of incorporation of Montmorillonite on Xylan/Chitosan conjugate scaffold.
Colloids and Surfaces B: Biointerfaces
1(180) 75-82.
(Impact Factor: 3.9)
Vishwakarma V, New J1,
Kumar D,
et al.,
Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds.
Scientific Reports
. 15;8(1):12163.
(Impact Factor: 4.1)
Chandel V and Kumar D. 2019. The Development of Tumor Heterogeneity and Actively Targeting Therapy Resistant Subpopulations
. J Embryol Stem Cell Res
. 3(3): 000131
: Corresponding Author
2018
Kumar D, et al.,
2018
.
Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression.
Cancer Research
. 10.1158/0008-5472.CAN-17-1076.
(Impact Factor: 12) : First Author
Kumar D
, et al. Perfluoro Curcumin Strongly Interacts with ABC Transporter (ABCG2): A Molecular Docking Study.
J Embryol Stem Cell Res
2018, 2(2): 000113.
: Corresponding Author
Kumar D
. 2018. Resveratrol derivative triacetyl-resveratrol interacts directly with the Gli-DNA zinc finger complex.
J Cancer Res Oncobiol
. Apr; 1(2):110
: Corresponding Author
2017
Kumar D
, et al., 2017. Development and characterization of an in vitro model for radiation-induced fibrosis,.
Radiation Research
. 189(3):326-336
(Impact Factor: 2.5) : First Author
Kumar D
, 2017. Role of tumor heterogeneity in drug resistance.
Glob J Cancer Ther
3(2): 032-033. (Editorial).
: Corresponding Author
Kumar D
, 2017. Regulation of glycolysis in head and neck squamous cell carcinoma
. Postdoc Journal
. 2017 Jan;5 (1):14-28.
: Corresponding Author
2016
Ledgerwood LG*,
Kumar D*,
Eterovic AK, Wick J et al., 2016. The degree of intra-tumor mutational heterogeneity varies by primary tumor sub-site.
Oncotarget
. Mar 28. doi: 18632/oncotarget.8448.
(Impact Factor:6.4)
*Equal contribution
: First Author
2015
Kumar D
, Kandl C, Hamilton C, Shnayder Y, Tsue T, Kakarala K, Ledgerwood L, Sun X S, Huang H, Girod D, Thomas S 2015. Anti-HGF antibody ficlatuzumab mitigates tumor-associated fibroblast-facilitated head and neck cancer progression.
JAMA Otolaryngology-Head & Neck Surgery
. Dec 1;141 (12): 1133-9.
(Impact Factor: 6.2) : First Author
Kumar D
, Gupta D, Shankar S, Srivastava RK. 2015. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
Oncotarget:
1-12.
(Impact Factor:6.4) : First Author
2014
Plotegher N,
Kumar D
, Tessari I, Brucale M, Munari F, et al. 2014. The chaperone-like protein 14-3-3eta interacts with human alpha-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing alpha-synuclein cellular toxicity.
Human Molecular Genetics
. 23:5615-29.
(Impact Factor:5.9)
Kumar D
, Shankar S, Srivastava RK. 2014. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway.
Cancer Letters
. 343:179-89.
(Impact Factor:6.4) : First Author
Kumar D
, Plotegher N, Bubacco L, Brucale M. 2014. Quantitative AFM morphometry of non-fibrillar α- synuclein aggregation products induced by the chaperone-like protein 14-3-3.
Italian Society for Microscopical Sciences
. Vol 21, No 1. DOI: 10.4081/microscopie. 2014.4998.
: First Author
Kumar D
, Shankar S, Srivastava RK. 2014. Understanding the biological functions and therapeutic potentials of stem cells and cancer stem cells: Where are we?
Journal of Cancer Stem Cell Research
. 2:e1002:1-8.
: First Author
2013
Kumar D
, Shankar S, Srivastava RK. 2013. Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms.
Molecular Cancer
. 1476-4598-12-171.
(Impact Factor:27) : First Author
Nanta R,
Kumar D
, Meeker D, Rodova M, Van Veldhuizen PJ, et al. 2013. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rgamma null mice by regulating Bmi-1 and microRNA-128.
Oncogenesis
. 2:e42.
(Impact Factor:5.1)
Shankar S,
Kumar D
, Srivastava 2013. Epigenetic modifications by dietary phytochemicals: Implications for personalized nutrition.
Pharmacol Therapeut
. 138:1-17.
(Impact Factor:11.1)
2012
Pivato M, De Franceschi G, Tosatto L, Frare E,
Kumar D
, et al. 2012. Covalent alpha-synuclein dimers: chemico-physical and aggregation properties.
PloS one
7:e50027.
(Impact Factor:3.4)
Singh BN,
Kumar D
, Shankar S, Srivastava 2012. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells.
Biochemical Pharmacology
. 84:1154-63.
(Impact Factor:6.1)
Conference Proceedings
Tyagi,
D. Kumar
and V. S. Raj, 2018. "In silico identification of potential inhibitors against Mycobacterial proteasome," 2018 International Conference on Bioinformatics and Systems Biology (BSB), Allahabad, India,
IEEE Xplore
, pp. 193-197.
(IF: 10.6)
Shekhar Goyal, Surender Kr Beniwal, H S Kumar,
Dhruv Kumar
, B C Das. 2019. Role of Curcumin in reducing toxicity and adverse effects in locally advanced and metastatic breast cancer patients.
Annals of Oncology
. Volume 30, vi126 - vi127.
(IF: 14)
Book Chapter
Mavi, Anil Kumar, Manmohan Kumar, Amarjeet Singh, Mahendra Kumar Prajapati, Rakhi Khabiya, Saurabh Maru, and
Dhruv Kumar.
"Progress in Non‐Viral Delivery of Nucleic Acid: Advancement in Biomedical Technology." Integration of Biomaterials for Gene Therapy (2023): 281-322.
https://doi.org/10.1002/9781394175635.ch10
Mavi, Anil Kumar, Sonal Gaur, Neelesh Kumar, Avanish Kumar Shrivastav, Sankha Bhattacharya, Sateesh Belemkar, Saurabh Maru, and
Dhruv Kumar
. "Effective Gene Transfer with Non‐Viral Vectors." Integration of Biomaterials for Gene Therapy (2023): 183-222.
https://doi.org/10.1002/9781394175635.ch7
Kirti Agrawal, Malavika Saji,
Dhruv Kumar,
Drug Repurposing in Future Drug Discovery and Development, Book-Drug Repurposing and Computational Drug Discovery, Edition1st Edition 2023, Apple Academic Press, Pages26, eBook ISBN9781003347705,
https://doi.org/10.1201/9781003347705
Kumar, A., Raj, V., Ali, M., Abhinav, Rachamalla, M.,
Kumar, D
., Kumari, A., Kumar, R., Shankar, P. and Ghosh, A., 2023. Evaluation of MOF Applications for Groundwater Arsenic Mitigation of the Middle Ganga Plains of Bihar, India. Metal Organic Frameworks for Wastewater Contaminant Removal, pp.355-373. 26 August 2023,
https://doi.org/10.1002/9783527841523.ch16
Saniya Arfin,
Dhruv Kumar
, Chapter 3 - Use of vitamins and minerals as dietary supplements for better health and cancer prevention, Editor(s): Inamuddin, Tariq Altalhi, Jorddy Neves Cruz, Nutraceuticals, Academic Press, 2023, Pages 53-97, ISBN 9780443191930,
https://doi.org/10.1016/B978-0-443-19193-0.00003-4
.
A Santoshkumar, S Ray, S Narayanan,
D Kumar
, S Harihar (2023), Mitophagy in cancer and cancer stem cells: a role in metabolic reprogramming. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00009-2
T Singh, AS Kharat, B Rathi,
D Kumar
(2023), Designing metabolic target-specific inhibitors for cancer therapy. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00011-0
Sibi Raj, Manish K. Mishra, Sitaram Harihar, Ashok Kumar, Shubhadeep Roychoudhury, Arun Kumar et al. (
2022
). Regulation of Glucose Transporters in Cancer Progression, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_9
Stephen James, Saniya Arfin, Manish K. Mishra, Arun Kumar, Niraj Kumar Jha, Saurabh Kumar Jha et al. (
2022
). Role of Arsenic in Carcinogenesis, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_7
Raj S., Kumar A.,
Kumar D
. (
2020
) Regulation of Glycolysis in Head and Neck Cancer, Book. Cancer Metabolomics, Advances in Experimental Medicine and Biology, Springer Nature.
https://doi.org/10.1007/978-3-030-51652-9_15
Chandel V.,
Kumar D
. (
2020
) Role of Interferon in Cancer Metabolism. Innate Immunity in Health and Disease. IntechOpen.
https://doi.org/10.5772/intechopen.92020
Raj S, Chandel V., Maurya S,
Kumar D
. (
2020
) Role of Macrophages in Solid Tumor Metabolism. Macrophages. IntechOpen.
https://doi.org/10.5772/intechopen.93182
Maurya S, Chandel V, Raj S, (
2020
) OMICS IN CANCER: FROM DIAGNOSTICS TO THERAPEUTICS. Recent Trends in ‘Computational Omics'. ISBN: 978-1-53617-941-5
Raj S., Chandel V.,
Kumar D
. (
2020
) Cancer Cell Metabolism: Solid Tumor Versus Nonsolid Tumor. In:
Kumar D
. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_1
Pedroza D.A. et al. (
2020
) Role of Autophagy in Cancer Cell Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_6
Chandel V., Raj S., Choudhari R.,
Kumar D
. (
2020
) Role of c-Met/HGF Axis in Altered Cancer Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_7
Kumar D
., Sharma-Walia N., Kapoor S., Tandon S. (
2020
) Antibody-Targeted Nanoparticles for Cancer Treatment. In: Saxena S., Khurana S. (eds) NanoBioMedicine. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9898-9_3
Singh B., Malhotra H.,
Kumar D
., Mujtaba S.F., Upadhyay A.K. (
2019
) Understanding Cellular and Molecular Events of Skin Aging and Cancer: An Integrative Perspective. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_2
Tripathi M.K., Sinha J., Srivastava S.K.,
Kumar D
. (
2019
) Bioinformatics in Skin Cancer: A System Biology Approach to Understanding the Molecular Mechanisms and It’s Regulations. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_10
Khurana S., Bose S.,
Kumar D
. (
2019
) Applications of Microarray-Based Technologies in Identifying Disease-Associated Single Nucleotide Variations. In: Tripathi V., Kumar P., Tripathi P., Kishore A., Kamle M. (eds) Microbial Genomics in Sustainable Agroecosystems. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9860-6_4
Singh P., Tiwari D., Mishra M.,
Kumar D
. (
2019
) Molecular Mechanisms of Heavy Metal Toxicity in Cancer Progression. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_3
Chandel V., Seth G., Shukla P.,
Kumar D
. (
2019
) Role of Radiation in DNA Damage and Radiation Induced Cancer. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_1
Dhruv Kumar
, Sharmila Shankar, Rakesh Srivastava. Challenges in stem cells and translational research (Book chapter). Lost in translational and clinical research. World Scientific Publication,
2014
. ISBN: 9789814489089.
https://doi.org/10.1142/9789814489072_0020
Dhruv kumar
and Bruno Samori. Mechanochemistry: Coupling mechanical forces and chemical reactions (Book chapter). Molecular Manipulation with Atomic Force Microscopy (Book), CRC Press,
2011
, ISBN: 9781439809662.
Dwijendra Gupta,
Dhruv Kumar
, Manish Dwivedi, Vijay Tripathi, Pratibha Phadke-Gupta and Surya Pratap Singh. Nanophosphors-Nanogold immunoconjugates in Isolation of Biomembranes and in Drug Delivery (Book chapter). Recent Advances in Nanomedicine (Book), VBRI Press,
2011
, ISBN: 9788192006803.
Book
Dhruv Kumar
, Shailendra Asthana Autophagy and Metabolism Potential Target for Cancer Therapy 1st Edition - August 6, 2022 Paperback ISBN: 9780323998796 9 7 8 - 0 - 3 2 3 - 9 9 8 7 9 - 6 eBook ISBN: 9780323999458
Akhileshwar Srivastava,
Dhruv Kumar
, Divya Singh, Rajesh Singh, Xenobiotics in Chemical Carcinogenesis:Translational Aspects in Toxicology,
Elsevier,
ISBN: 9780323905602
Dhruv kumar.
Cancer Cell Metabolism: A Potential Target for Cancer Therapy.
Springer Nature
.
2020,
ISBN: 9789811519901.
Dhruv kumar
, Marco Brucale and Bruno Samori. Amyloidogenic Proceses of Intrinsically Disordered Proteins: Understanding the Aggregation Process of Intrinsically Unstructured Proteins Related to Neurodegenerative Diseases.
Lambert Academic Publishing
,
2014
, ISBN:
Dhruv kumar
. Insilico analysis of Docking between HIV-1 PR and derivatives of CUI (Docking between HIV- 1 proteases and cyclic urea inhibitors: A step towards drug designing against AIDS).
Lambert Academic Publishing
,
2011
, ISBN:

Prof. Dhruv Kumar, has a rich portfolio of scholarly activities spanning teaching, research, and academic contributions. He actively engages in designing and instructing courses at various academic levels, including undergraduate (UG), postgraduate (PG), and doctoral (PhD) programs, covering specialized areas such as Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics. Prof. Kumar's research endeavors have resulted in numerous publications in high-impact journals, including Cancer Research, Cancer Letters, Molecular Cancer, Oncogenesis, and Nature Scientific Reports. He has received recognition on both national and international platforms, garnering awards such as the Senior Scientist Award from the Society of Biomedical Laboratory Scientists, India, the Scholar-in-Training Award from the American Association for Cancer Research (AACR), USA, and the K-INBRE Postdoctoral Award from the National Institute of Health (NIH), USA. Additionally, his active involvement in government-funded projects and mentorship of PhD students in the fields of Cancer and Infertility reflects his commitment to advancing knowledge and nurturing the next generation of researchers. Prof. Kumar's scholarly activities exemplify a holistic approach to academia, seamlessly integrating teaching, research, and mentorship.

His selected publications are as below:

2023

Agrawal, K.; Asthana, S.;
Kumar, D
. Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer. Cancers 2023, 15, 4920.
https://doi.org/10.3390/cancers15204920
.
(Impact Factor: 5.2)

Maurya, S., Raj, S., Bhoi, N.R., Mani, N., Rathi, B. and
Kumar, D
., 2023. Morphological analysis of metabolically dysregulated spermatozoa using Artificial Intelligence based approach. Journal of Integrated Science and Technology, 11(4), pp.569-569.
(Impact Factor: 1.14)

Raj, S. and
Kumar, D.
, 2023. Early epigenetic markers for precision medicine. Progress in molecular biology and translational science, 198, pp.153-164.
(Impact Factor: 4.0)

Kumar, A., Ali, M., Raj, V., Kumari, A., Rachamalla, M., Niyogi, S.,
Kumar, D.
, Sharma, A., Saxena, A., Panjawani, G. and Jain, P., 2023. Arsenic causing gallbladder cancer disease in Bihar. Scientific Reports, 13(1), p.4259.
(Impact Factor: 4.9)

Goel, M., Mishra, M.K. and
Kumar, D
., 2023. Recent advances in Targeted Radionuclide therapy for Cancer treatment. Chemical Biology Letters, 10(3), pp.544-544.
(Impact Factor: 6.1)

Bhattacharjee, R., Prabhakar, N., Kumar, L., Bhattacharjee, A., Kar, S., Malik, S.,
Kumar, D
., Ruokolainen, J., Negi, A., Jha, N.K. and Kesari, K.K., 2023. Crosstalk between long noncoding RNA and microRNA in Cancer. Cellular Oncology, pp.1-24.
(Impact Factor: 6.6)

Kumar, A., Kumar, K., Ali, M., Raj, V., Srivastava, A., Kumar, M., Niraj, P.K., Kumar, M., Kumar, R.,
Kumar, D.
and Bishwapriya, A., 2023. Severe Disease Burden and the Mitigation Strategy in the Arsenic-Exposed Population of Kaliprasad Village in Bhagalpur District of Bihar, India. Biological trace element research, pp.1-17.
(Impact Factor: 4.0)

Arfin, S.;
Kumar, D
.; Lomagno, A.; Mauri, P.L.; Di Silvestre, D. Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis. Cancers 2023, 15, 4420.
https://doi.org/10.3390/cancers15174420
(Impact Factor: 5.2)

Arfin S, Agrawal K, Maurya S, Asthana S, Di Silvestre
D, Kumar D
. Lead phytochemicals and marine compounds against ceruloplasmin in cancer targeting. Journal of Biomolecular Structure and Dynamics. 2023 Oct 18.
(Impact Factor: 5.2)

Agrawal K, Chakraborty P, Dewanjee S, Arfin S, Das SS, Dey A, Moustafa M, Mishra PC, Jafari SM, Jha NK, Jha SK,
Kumar D
. Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders. Neurosci Biobehav Rev. 2023 Jan;144:104955. doi: 10.1016/j.neubiorev.2022.104955. Epub 2022 Nov 14. PMID: 36395983.
(Impact Factor: 9.0)

Agrawal K, Chauhan S,
Kumar D
. Expression analysis and regulation of GLI and its correlation with stemness and metabolic alteration in human brain tumor. 3 Biotech. 2023 Jan;13(1):10. doi: 10.1007/s13205-022-03419-5. Epub 2022 Dec 15. PMID: 36532860; PMCID: PMC9755437.
(Impact Factor: 2.9)

Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A,
Kumar D
, Ambasta RK, Jha NK, Jha SK, Dewanjee S. Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Res Rev. 2023 Mar;85:101838. doi: 10.1016/j.arr.2022.101838. Epub 2023 Jan 5. PMID: 36610558.
(Impact Factor: 11.7)

Raj, S., Rathi, B., Mehra, P., Asthana, S., &
Kumar, D
. (2023). Deciphering the role of c-MET in Metabolic reprogramming of Head and Neck squamous cell Carcinoma via In Silico analysis. Chemical Biology Letters, 10(2), 532. Retrieved from
https://pubs.thesciencein.org/journal/index.php/cbl/article/view/532
(Impact Factor: 4.4)

2022

Awasthi P, Dwivedi M, Kumar D, Hasan S. Insights into intricacies of the Latent Membrane Protein-1 (LMP-1) in EBV-associated cancers. Life Sci. 2023 Jan 15;313:121261. doi: 10.1016/j.lfs.2022.121261. Epub 2022 Dec 7. PMID: 36493876.
(Impact Factor: 3.3)

Sharma S, Tyagi R, Srivastava M, Rani K,
Kumar D
, Asthana S, Raj VS. Identification and validation of potent inhibitor of Escherichia coli DHFR from MMV pathogen box. J Biomol Struct Dyn. 2022 Jun 2:1-10. doi: 10.1080/07391102.2022.2080113. Epub ahead of print. PMID: 35652895.
(Impact Factor: 3.3)

Maurya S, Kesari KK, Roychoudhury S, Kolleboyina J, Jha NK, Jha SK, Sharma A, Kumar A, Rathi B, Kumar D. Metabolic Dysregulation and Sperm Motility in Male Infertility. Adv Exp Med Biol. 2022;1358:257-273. doi: 10.1007/978-3-030-89340-8_12. PMID: 35641874.
(Impact Factor: 2.6)

Das S, Roychoudhury S, Dey A, Jha NK, Kumar D, Roychoudhury S, Slama P, Kesari KK. Bacteriospermia and Male Infertility: Role of Oxidative Stress. Adv Exp Med Biol. 2022;1358:141-163. doi: 10.1007/978-3-030-89340-8_7. PMID: 35641869.
(Impact Factor: 2.6)

Arfin, S. .; Mani, N. .; Rathi, B.; Kumar, D. In Silico Analysis of Ceruloplasmin Alteration in Oral Squamous Cell Carcinoma. Chem Biol Lett 2022, 9, 342.
(Impact Factor: 4.4)

Jha NK, Arfin S, Jha SK, Kar R, Dey A,
Kumar D
. et al. Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling Semin Cancer Biol. 2022 Feb 23:S1044-579X(22)00049-9.
https://doi.org/10.1016/j.semcancer.2022.02.022
.
(Impact Factor: 17)

Raj S, Kesari KK, Kumar A, Rathi B, Sharma A, Gupta PK, Jha SK, Jha NK, Slama P, Roychoudhury S,
Kumar D
. Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. Molecular Cancer (BMC-Springer Nature). 2022. 26;21(1):31.
https://doi.org/10.1186/s12943-022-01503-1
(Impact Factor: 41.4): Corresponding Author

Pritam P, Deka R,
Kumar D
. et al.. Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects. Biology-MDPI. 2022. 11(2), 212.
https://doi.org/10.3390/biology11020212
(Impact Factor: 5.0)

Kumar, A.
Kumar D
. et al..Assessment of disease burden in the arsenic exposed population of Chapar village of Samastipur district, Bihar, India, and related mitigation initiative.
Environmental Science and Pollution Research.
https://doi.org/10.1007/s11356-021-18207-6
(Impact Factor: 4.3)

2021

Upadhyay C.
Kumar D
. et al.. Synthesis of the new analogs of morpholine and their antiplasmodial evaluation against the human malaria parasite Plasmodium falciparum.
New Journal of Chemistry
. 2021.
https://doi.org/10.1039/D1NJ04198C
(Impact Factor: 3.4)

Singh A, Singh AK, Giri R,
Kumar D
, Sharma R, Valis M, Kuca K, Garg N. The role of microRNA-21 in the onset and progression of cancer.
Future Med Chem
. 2021 Nov;13(21): 1885-1906.
https://doi.org/10.4155/fmc-2021-0096
.
(Impact Factor: 3.9)

Jeyaraman Madhan ,Muthu Sathish ,
Kumar D
. et al. “Total Stromal Fraction (TSF) - Fortified Adipose Tissue-Derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary Compromise”,
Coronaviruses
2021; e080921196287.
https://doi.org/10.2174/2666796702666210908151708
.
(Impact Factor: 0.0)

Asif Ali, Saleheen Bano,
Kumar D
. et al. (2021) Effect of cellulose nanocrystals on chitosan/PVA/nano β-TCP composite scaffold for bone tissue engineering application,
Journal of Biomaterials Science, Polymer Edition
,
https://doi.org/10.1080/09205063.2021.1973709
.
(Impact Factor: 3.5)

Mehreen Aftab, Maryam Ghufran,
Kumar D
. et al., In silico analysis of the role of hsa-miR-155-5p in cervical cancer, Chem. Biol. Lett. 2021, 8(3), 94-105.
(Impact Factor: 4.4) : Corresponding Author

Usman, M.B., Bhardwaj, S., Roychoudhury, S.
Kumar D
. et al.. Immunotherapy for Alzheimer’s Disease: Current Scenario and Future Perspectives.
J Prev Alzheimers Dis
8, 534–551 (2021).
https://doi.org/10.14283/jpad.2021.52
(Impact Factor: 4.4)

Sharma, P.P., Bansal, M., Sethi, A., Pena, L.,
Kumar D
. et al., 2021. Computational methods directed towards drug repurposing for COVID-19: advantages and limitations.
RSC Advances
, 11(57), pp.36181-36198.
https://doi.org/10.1039/D1RA05320E
(Impact Factor: 3.3)

Goyal, K.; Goel, H.; Baranwal, P.; Tewary, A.;
Kumar D
. et al.. Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans. Immuno 2021, 1, 442-456.
https://doi.org/10.3390/immuno1040032
(Impact Factor: 0.0)

Sharma A,
Kumar D
, Dahiya K, Hawthorne S, Jha SK, Jha NK, Nand P, Girgis S, Raj S, Srivastava R, Goswami VK, Gregoriou Y, El-Zahaby SA, Ojha S, Dureja H, Gupta G, Singh S, Chellappan DK, Dua K. Advances in pulmonary drug targeting microbial biofilms in respiratory diseases. Nanomedicine (Lond). 2021 Aug 5. delivery
https://doi.org/10.2217/nnm-2021-0057
.
(Impact Factor: 5.3): : Corresponding Author

Jeyaraman M, Muthu S, Bapat A,
Kumar D
. et al.. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon. 2021 Jul;7(7):e07635.
https://doi.org/10.1016/j.heliyon.2021.e07635
.
(Impact Factor: 1.8)

Sharma A, Hawthorne S, Jha SK, Jha NK,
Kumar D
, Girgis S, Goswami VK, Gupta G, Singh S, Dureja H, Chellappan DK, Dua K. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDAMB231 human breast cancer cells. Nanomedicine (Lond). 2021 Aug;16(20):1763-1773.
https://doi.org/10.2217/nnm-2021-0066
.
(Impact Factor: 5.3)

Chandel V, Maru S, Kumar A, Kumar A, Sharma A, Rathi B,
Kumar D
. Role of monocarboxylate transporters in head and neck squamous cell carcinoma. Life Sciences. 2021, 5;279:119709.
https://doi.org/10.1016/j.lfs.2021.119709
.
(Impact Factor: 3.6) : Corresponding Author

Raj S, Kumar A,
Kumar D
. Regulation of Glycolysis in Head and Neck Cancer. Adv Exp Med Biol. 2021;1280:219-230.
https://doi.org/10.1007/978-3-030-51652-9_15
.
(Impact Factor: 2.4) : Corresponding Author

Vaishali Chandel, Garima Tripathi, Seema A. Nayar, Brijesh Rathi, Abhijeet Kumar &
Dhruv Kumar
(2021) In silico identification and validation of triarylchromones as potential inhibitor against main protease of severe acute respiratory syndrome coronavirus 2,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1918255
.
(Impact Factor: 3.2) : Corresponding Author

Rashmi Tyagi, Mitul Srivastava, Baldeep Singh, Shingini Sharma, Ramendra Pati Pandey, Shailendra Asthana,
Dhruv Kumar
& V. Samuel Raj (2021) Identification and validation of potent Mycobacterial proteasome inhibitor from Enamine library,
Journal of Biomolecular Structure and Dynamics
,
https://doi.org/10.1080/07391102.2021.1914173
.
(Impact Factor: 3.2) : Corresponding Author

Mathur, A., Raj, S., Jha, N.K. et al. Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2.
3 Biotech
11, 236 (2021).
https://doi.org/10.1007/s13205-021-02791-y
.
(Impact Factor: 2.2) : Corresponding Author

Arfin, S.; Jha, N.K.; Jha, S.K.; Kesari, K.K.; Ruokolainen, J.; Roychoudhury, S.; Rathi, B.;
Kumar, D
. Oxidative Stress in Cancer Cell Metabolism.
Antioxidants
2021, 10, 642.
https://doi.org/10.3390/antiox10050642
.
(Impact Factor: 5) : Corresponding Author

Kumar A, Kumar R, Rahman MS, Ali M, Kumar R, Nupur N, Gaurav A, Raj V, Anand G, Niraj PK, Kumar N, Srivastava A, Biswapriya A, Chand GB,
Kumar D
, Rashmi T, Kumar S, Sakamoto M, Ghosh AK. Assessment of arsenic exposure in the population of Sabalpur village of Saran District of Bihar with mitigation approach.
Environ Sci Pollut Res Int.
2021 Apr 11.
https://doi.org/10.1007/s11356-021-13521-5
(Impact Factor: 4.3)

Kumar, A., Rahman, M.S., Ali, M. et al. Assessment of arsenic exposure and its mitigation intervention in severely exposed population of Buxar district of Bihar, India.
Environ. Health Sci.
(2021).
https://doi.org/10.1007/s13530-021-00086-6
(Impact Factor: .76)

Chandel V., et al. 2021. In silico identification of potential inhibitor for TP53-induced glycolysis and apoptosis regulator in head and neck squamous cell carcinoma.
3Biotech
. 11(3):117.
https://doi.org/10.1007/s13205-021-02665-3
(Impact Factor: 2.2) : Corresponding Author

2020

Kumar A., et al. 2020. Arsenic exposure causing cancer in the Indo - Gangetic Plain - A 2000 cancer patients’ cross-sectional design.
Scientific Reports
. 11, 2376 (2021).
https://doi.org/10.1038/s41598-021-81579-9
.
(Impact Factor: 4.1)

Roychoudhury S., et al. 2020. Viral pathogenesis of SARS-CoV-2 infection and male reproductive health: Myth or fact?
Open Biology
. 11(1): 200347,
https://doi.org/10.1098/rsob.200347
(Impact Factor: 4.9)

Jha N K., et al. 2020. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS‑CoV‑2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Journal of Molecular Neuroscience.
https://doi.org/10.1007/s12031-020-01767-6
.
(Impact Factor: 2.8)

Ali A., et al. 2020. Comparative analysis of TiO2 and Ag nanoparticles on xylan/chitosan conjugate matrix for wound healing application.
International Journal of Polymeric Materials and Polymeric Biomaterials.
https://doi.org/10.1080/00914037.2020.1838519
(Impact Factor: 1.9)

Kumar D., et al. 2020. Stem Cell Based Preclinical Drug Development and Toxicity Prediction.
Current Pharmaceutical Design
.
https://doi.org/10.2174/1381612826666201019104712
(Impact Factor: 2.4) : Corresponding Author

Tyagi R., et al. 2020. Development of potential proteasome inhibitors against Mycobacterium tuberculosis.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1835722
(Impact Factor: 3.2) : Corresponding Author

Narula S, Tandon S, Kumar D et al. 2020. Human kidney stone matrix proteins alleviate hyperoxaluria induced renal stress by targeting cell-crystal interactions.
Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118498
(Impact Factor: 3.6)

Satyam R, Jha NK, Kar R et al. 2020. Deciphering the SSR incidences across viral members of Coronaviridae family.
Chemico-Biological Interactions.
https://doi.org/10.1016/j.cbi.2020.109226
(Impact Factor: 3.6)

Chandel V, Raj S, Rathi B, Choudhary R,
Kumar D
. 2020. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2.
Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2020.1811773
(Impact Factor: 3.2) : Corresponding Author

Manish D., Vijay T., Kumar D., et al. 2020. Structural and Morphological Characterization of CdS Nanoparticles,
Current Physical Chemistry.
https://doi.org/10.2174/1877946810999200730222025
(Impact Factor: 1.6)

Raj S, Chandel V, et al. 2020 Molecular mechanisms of interplay between autophagy and metabolism in cancer
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118184
(Impact Factor: 3.6) : Corresponding Author

Chandel V, Raj S, et al. 2020. Metabolic regulation in HPV associated head and neck squamous cell carcinoma
, Life Sciences
.
https://doi.org/10.1016/j.lfs.2020.118236
(Impact Factor: 3.6) : Corresponding Author

Chandel V,
Kumar D
. 2020. Targeting Signalling Cross-Talk between Cancer Cells and Cancer Associate Fibroblast through Monocarboxylate Transporters in Head and Neck Cancer
,Anti-Cancer Agents in Medicinal Chemistry
:
Bentham Science Publishers
,
https://doi.org/10.2174/1871520620666200721135230
(Impact Factor: 2.04) : Corresponding Author

Kumar S, Sharma PP, Shankar U,
Kumar D
et al. 2020. Discovery of New Hydroxyethylamine Analogs against 3CL pro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies.
J Chem Inf Model.
https://doi.org/10.1021/acs.jcim.0c00326
(Impact Factor: 4.5)

Pandey V, Tripathi G,
Kumar D
et al. 2020. Novel 3,4-diarylpyrazole as prospective anti-cancerous agents,
Helion
,
https://doi.org/10.1016/j.heliyon.2020.e04397
(Impact Factor: 1.6) : Corresponding Author

Chandel V, Raj S, Rathi B,
Kumar D
. 2020. In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach.
Chemical Biology Letters
. 7(3), 166‐175.
(Impact Factor: 4.4) : Corresponding Author

Chandel V, Raj S, Srivastava A,
Kumar D
. 2020. In-silico interactions of active Phytochemicals with c-MYC EGFR and ERBB2 oncoproteins.
Chemical Biology Letters
. 7(1), 47‐54.
(Impact Factor: 4.4) : Corresponding Author

Raj S, Chandel V, Rathi B,
Kumar D
. 2020. Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach, Coronavirus: Bentham Science Publishers, DOI : 10.2174/2666796701999200617155013
: Corresponding Author

2019

Sibi Raj, Sartaj Khuranaa, Ramesh Choudhari et al. 2019. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
Seminars in Cancer Biology
https://doi.org/10.1016/j.semcancer.2019.11.002
.
(Impact Factor: 15) : Corresponding Author

Anukriti, Anupam D, Swati U, Pallavi S, et al. 2019. Investigation of Precise Molecular Mechanistic Action of Tobacco-Associated Carcinogen ‘NNK’ Induced Carcinogenesis: A System Biology Approach. 10(8), 564.
(Impact Factor: 3.4)

Asif A, Saleheen B, Satish S.P,
Kumar D
, Yuvraj S N, 2019. Effect of incorporation of Montmorillonite on Xylan/Chitosan conjugate scaffold.
Colloids and Surfaces B: Biointerfaces
1(180) 75-82.
(Impact Factor: 3.9)

Vishwakarma V, New J1,
Kumar D,
et al.,
Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds.
Scientific Reports
. 15;8(1):12163.
(Impact Factor: 4.1)

Chandel V and Kumar D. 2019. The Development of Tumor Heterogeneity and Actively Targeting Therapy Resistant Subpopulations
. J Embryol Stem Cell Res
. 3(3): 000131
: Corresponding Author

2018

Kumar D, et al.,
2018
.
Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression.
Cancer Research
. 10.1158/0008-5472.CAN-17-1076.
(Impact Factor: 12) : First Author

Kumar D
, et al. Perfluoro Curcumin Strongly Interacts with ABC Transporter (ABCG2): A Molecular Docking Study.
J Embryol Stem Cell Res
2018, 2(2): 000113.
: Corresponding Author

Kumar D
. 2018. Resveratrol derivative triacetyl-resveratrol interacts directly with the Gli-DNA zinc finger complex.
J Cancer Res Oncobiol
. Apr; 1(2):110
: Corresponding Author

2017

Kumar D
, et al., 2017. Development and characterization of an in vitro model for radiation-induced fibrosis,.
Radiation Research
. 189(3):326-336
(Impact Factor: 2.5) : First Author

Kumar D
, 2017. Role of tumor heterogeneity in drug resistance.
Glob J Cancer Ther
3(2): 032-033. (Editorial).
: Corresponding Author

Kumar D
, 2017. Regulation of glycolysis in head and neck squamous cell carcinoma
. Postdoc Journal
. 2017 Jan;5 (1):14-28.
: Corresponding Author

2016

Ledgerwood LG*,
Kumar D*,
Eterovic AK, Wick J et al., 2016. The degree of intra-tumor mutational heterogeneity varies by primary tumor sub-site.
Oncotarget
. Mar 28. doi: 18632/oncotarget.8448.
(Impact Factor:6.4)
*Equal contribution
: First Author

2015

Kumar D
, Kandl C, Hamilton C, Shnayder Y, Tsue T, Kakarala K, Ledgerwood L, Sun X S, Huang H, Girod D, Thomas S 2015. Anti-HGF antibody ficlatuzumab mitigates tumor-associated fibroblast-facilitated head and neck cancer progression.
JAMA Otolaryngology-Head & Neck Surgery
. Dec 1;141 (12): 1133-9.
(Impact Factor: 6.2) : First Author

Kumar D
, Gupta D, Shankar S, Srivastava RK. 2015. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
Oncotarget:
1-12.
(Impact Factor:6.4) : First Author

2014

Plotegher N,
Kumar D
, Tessari I, Brucale M, Munari F, et al. 2014. The chaperone-like protein 14-3-3eta interacts with human alpha-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing alpha-synuclein cellular toxicity.
Human Molecular Genetics
. 23:5615-29.
(Impact Factor:5.9)

Kumar D
, Shankar S, Srivastava RK. 2014. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway.
Cancer Letters
. 343:179-89.
(Impact Factor:6.4) : First Author

Kumar D
, Plotegher N, Bubacco L, Brucale M. 2014. Quantitative AFM morphometry of non-fibrillar α- synuclein aggregation products induced by the chaperone-like protein 14-3-3.
Italian Society for Microscopical Sciences
. Vol 21, No 1. DOI: 10.4081/microscopie. 2014.4998.
: First Author

Kumar D
, Shankar S, Srivastava RK. 2014. Understanding the biological functions and therapeutic potentials of stem cells and cancer stem cells: Where are we?
Journal of Cancer Stem Cell Research
. 2:e1002:1-8.
: First Author

2013

Kumar D
, Shankar S, Srivastava RK. 2013. Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms.
Molecular Cancer
. 1476-4598-12-171.
(Impact Factor:27) : First Author

Nanta R,
Kumar D
, Meeker D, Rodova M, Van Veldhuizen PJ, et al. 2013. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rgamma null mice by regulating Bmi-1 and microRNA-128.
Oncogenesis
. 2:e42.
(Impact Factor:5.1)

Shankar S,
Kumar D
, Srivastava 2013. Epigenetic modifications by dietary phytochemicals: Implications for personalized nutrition.
Pharmacol Therapeut
. 138:1-17.
(Impact Factor:11.1)

2012

Pivato M, De Franceschi G, Tosatto L, Frare E,
Kumar D
, et al. 2012. Covalent alpha-synuclein dimers: chemico-physical and aggregation properties.
PloS one
7:e50027.
(Impact Factor:3.4)

Singh BN,
Kumar D
, Shankar S, Srivastava 2012. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells.
Biochemical Pharmacology
. 84:1154-63.
(Impact Factor:6.1)

Conference Proceedings

Tyagi,
D. Kumar
and V. S. Raj, 2018. "In silico identification of potential inhibitors against Mycobacterial proteasome," 2018 International Conference on Bioinformatics and Systems Biology (BSB), Allahabad, India,
IEEE Xplore
, pp. 193-197.
(IF: 10.6)

Shekhar Goyal, Surender Kr Beniwal, H S Kumar,
Dhruv Kumar
, B C Das. 2019. Role of Curcumin in reducing toxicity and adverse effects in locally advanced and metastatic breast cancer patients.
Annals of Oncology
. Volume 30, vi126 - vi127.
(IF: 14)

Book Chapter

Mavi, Anil Kumar, Manmohan Kumar, Amarjeet Singh, Mahendra Kumar Prajapati, Rakhi Khabiya, Saurabh Maru, and
Dhruv Kumar.
"Progress in Non‐Viral Delivery of Nucleic Acid: Advancement in Biomedical Technology." Integration of Biomaterials for Gene Therapy (2023): 281-322.
https://doi.org/10.1002/9781394175635.ch10

Mavi, Anil Kumar, Sonal Gaur, Neelesh Kumar, Avanish Kumar Shrivastav, Sankha Bhattacharya, Sateesh Belemkar, Saurabh Maru, and
Dhruv Kumar
. "Effective Gene Transfer with Non‐Viral Vectors." Integration of Biomaterials for Gene Therapy (2023): 183-222.
https://doi.org/10.1002/9781394175635.ch7

Kirti Agrawal, Malavika Saji,
Dhruv Kumar,
Drug Repurposing in Future Drug Discovery and Development, Book-Drug Repurposing and Computational Drug Discovery, Edition1st Edition 2023, Apple Academic Press, Pages26, eBook ISBN9781003347705,
https://doi.org/10.1201/9781003347705

Kumar, A., Raj, V., Ali, M., Abhinav, Rachamalla, M.,
Kumar, D
., Kumari, A., Kumar, R., Shankar, P. and Ghosh, A., 2023. Evaluation of MOF Applications for Groundwater Arsenic Mitigation of the Middle Ganga Plains of Bihar, India. Metal Organic Frameworks for Wastewater Contaminant Removal, pp.355-373. 26 August 2023,
https://doi.org/10.1002/9783527841523.ch16

Saniya Arfin,
Dhruv Kumar
, Chapter 3 - Use of vitamins and minerals as dietary supplements for better health and cancer prevention, Editor(s): Inamuddin, Tariq Altalhi, Jorddy Neves Cruz, Nutraceuticals, Academic Press, 2023, Pages 53-97, ISBN 9780443191930,
https://doi.org/10.1016/B978-0-443-19193-0.00003-4
.

A Santoshkumar, S Ray, S Narayanan,
D Kumar
, S Harihar (2023), Mitophagy in cancer and cancer stem cells: a role in metabolic reprogramming. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00009-2

T Singh, AS Kharat, B Rathi,
D Kumar
(2023), Designing metabolic target-specific inhibitors for cancer therapy. Autophagy and Metabolism-Potential Target for Cancer Therapy 1 (1), 1-364.
https://doi.org/10.1016/B978-0-323-99879-6.00011-0

Sibi Raj, Manish K. Mishra, Sitaram Harihar, Ashok Kumar, Shubhadeep Roychoudhury, Arun Kumar et al. (
2022
). Regulation of Glucose Transporters in Cancer Progression, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_9

Stephen James, Saniya Arfin, Manish K. Mishra, Arun Kumar, Niraj Kumar Jha, Saurabh Kumar Jha et al. (
2022
). Role of Arsenic in Carcinogenesis, Book, Free Radical Biology and Environmental Toxicity, Springer Nature.
https://link.springer.com/chapter/10.1007/978-3-030-83446-3_7

Raj S., Kumar A.,
Kumar D
. (
2020
) Regulation of Glycolysis in Head and Neck Cancer, Book. Cancer Metabolomics, Advances in Experimental Medicine and Biology, Springer Nature.
https://doi.org/10.1007/978-3-030-51652-9_15

Chandel V.,
Kumar D
. (
2020
) Role of Interferon in Cancer Metabolism. Innate Immunity in Health and Disease. IntechOpen.
https://doi.org/10.5772/intechopen.92020

Raj S, Chandel V., Maurya S,
Kumar D
. (
2020
) Role of Macrophages in Solid Tumor Metabolism. Macrophages. IntechOpen.
https://doi.org/10.5772/intechopen.93182

Maurya S, Chandel V, Raj S, (
2020
) OMICS IN CANCER: FROM DIAGNOSTICS TO THERAPEUTICS. Recent Trends in ‘Computational Omics'. ISBN: 978-1-53617-941-5

Raj S., Chandel V.,
Kumar D
. (
2020
) Cancer Cell Metabolism: Solid Tumor Versus Nonsolid Tumor. In:
Kumar D
. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_1

Pedroza D.A. et al. (
2020
) Role of Autophagy in Cancer Cell Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_6

Chandel V., Raj S., Choudhari R.,
Kumar D
. (
2020
) Role of c-Met/HGF Axis in Altered Cancer Metabolism. In: Kumar D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore:
https://doi.org/10.1007/978-981-15-1991-8_7

Kumar D
., Sharma-Walia N., Kapoor S., Tandon S. (
2020
) Antibody-Targeted Nanoparticles for Cancer Treatment. In: Saxena S., Khurana S. (eds) NanoBioMedicine. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9898-9_3

Singh B., Malhotra H.,
Kumar D
., Mujtaba S.F., Upadhyay A.K. (
2019
) Understanding Cellular and Molecular Events of Skin Aging and Cancer: An Integrative Perspective. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_2

Tripathi M.K., Sinha J., Srivastava S.K.,
Kumar D
. (
2019
) Bioinformatics in Skin Cancer: A System Biology Approach to Understanding the Molecular Mechanisms and It’s Regulations. In: Dwivedi A., Agarwal N., Ray L., Tripathi A. (eds) Skin Aging & Cancer. Springer, Singapore:
https://doi.org/10.1007/978-981-13-2541-0_10

Khurana S., Bose S.,
Kumar D
. (
2019
) Applications of Microarray-Based Technologies in Identifying Disease-Associated Single Nucleotide Variations. In: Tripathi V., Kumar P., Tripathi P., Kishore A., Kamle M. (eds) Microbial Genomics in Sustainable Agroecosystems. Springer, Singapore:
https://doi.org/10.1007/978-981-32-9860-6_4

Singh P., Tiwari D., Mishra M.,
Kumar D
. (
2019
) Molecular Mechanisms of Heavy Metal Toxicity in Cancer Progression. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_3

Chandel V., Seth G., Shukla P.,
Kumar D
. (
2019
) Role of Radiation in DNA Damage and Radiation Induced Cancer. In: Kesari K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham:
https://doi.org/10.1007/978-3-319-96511-6_1

Dhruv Kumar
, Sharmila Shankar, Rakesh Srivastava. Challenges in stem cells and translational research (Book chapter). Lost in translational and clinical research. World Scientific Publication,
2014
. ISBN: 9789814489089.
https://doi.org/10.1142/9789814489072_0020

Dhruv kumar
and Bruno Samori. Mechanochemistry: Coupling mechanical forces and chemical reactions (Book chapter). Molecular Manipulation with Atomic Force Microscopy (Book), CRC Press,
2011
, ISBN: 9781439809662.

Dwijendra Gupta,
Dhruv Kumar
, Manish Dwivedi, Vijay Tripathi, Pratibha Phadke-Gupta and Surya Pratap Singh. Nanophosphors-Nanogold immunoconjugates in Isolation of Biomembranes and in Drug Delivery (Book chapter). Recent Advances in Nanomedicine (Book), VBRI Press,
2011
, ISBN: 9788192006803.

Book

Dhruv Kumar
, Shailendra Asthana Autophagy and Metabolism Potential Target for Cancer Therapy 1st Edition - August 6, 2022 Paperback ISBN: 9780323998796 9 7 8 - 0 - 3 2 3 - 9 9 8 7 9 - 6 eBook ISBN: 9780323999458

Akhileshwar Srivastava,
Dhruv Kumar
, Divya Singh, Rajesh Singh, Xenobiotics in Chemical Carcinogenesis:Translational Aspects in Toxicology,
Elsevier,
ISBN: 9780323905602

Dhruv kumar.
Cancer Cell Metabolism: A Potential Target for Cancer Therapy.
Springer Nature
.
2020,
ISBN: 9789811519901.

Dhruv kumar
, Marco Brucale and Bruno Samori. Amyloidogenic Proceses of Intrinsically Disordered Proteins: Understanding the Aggregation Process of Intrinsically Unstructured Proteins Related to Neurodegenerative Diseases.
Lambert Academic Publishing
,
2014
, ISBN:

Dhruv kumar
. Insilico analysis of Docking between HIV-1 PR and derivatives of CUI (Docking between HIV- 1 proteases and cyclic urea inhibitors: A step towards drug designing against AIDS).
Lambert Academic Publishing
,
2011
, ISBN:

Contact
dhruv.kumar@ddn.upes.ac.in

Contact

Contact

dhruv.kumar@ddn.upes.ac.in

dhruv.kumar@ddn.upes.ac.in

Close
Eligibility Criteria

Close
Eligibility Criteria

Close
Eligibility Criteria

Eligibility Criteria

Eligibility Criteria



Apply Now
Speak to a Counsellor
Helpline
Download Brochure
Chat with student buddy
Chat with us

Speak to a Counsellor
Helpline
Download Brochure
Chat with student buddy
Chat with us

Speak to a Counsellor

Helpline

Download Brochure

Chat with student buddy

Chat with us

Admissions
B.Tech.
MBA
B.Des.
M.Tech.
LL.B.
M.Des.
B.Pharm.
MA
BBA
M.Sc.
BCA
LL.M.
B.Sc.
MCA
B.Com.
PhD
BA (Hons.)
Aspiring Students
Admission Alerts
FAQs
Fee Refund Portal
Global Pathways Program
International Admissions
Media
Programs
UPES Online
Important Dates
Other links
Academic Calendar
Campus
Events
NIRF Ranking Report
Careers
Faculty
Scholarships
HILL
Contact Us
Mandatory Disclosures
Student Achievements
Current Openings
NAAC
Student Corner
Downloads
Industry Connect
National Academic Depository
Sustainable Development Goal
Kandoli Campus, Dehradun
P.O. Kandoli Via Premnagar,
Dehradun-248007
Bidholi Campus, Dehradun
P.O. Bidholi Via Premnagar,
Dehradun-248007
Corporate Office
216B I, Second Floor,
Splendor Forum, Plot Bearing No. 3,
Jasola District Centre, Jasola,
New Delhi-110025
Contact Us
Toll Free :
18001028737
Email :
enrollments@upes.ac.in
For International Queries :
international.admissions@upes.ac.in
Follow Us:
Copyright © 2025 UPES. All Rights Reserved.
Privacy Policy
Terms & Condition
Sitemap

Admissions
B.Tech.
MBA
B.Des.
M.Tech.
LL.B.
M.Des.
B.Pharm.
MA
BBA
M.Sc.
BCA
LL.M.
B.Sc.
MCA
B.Com.
PhD
BA (Hons.)
Aspiring Students
Admission Alerts
FAQs
Fee Refund Portal
Global Pathways Program
International Admissions
Media
Programs
UPES Online
Important Dates
Other links
Academic Calendar
Campus
Events
NIRF Ranking Report
Careers
Faculty
Scholarships
HILL
Contact Us
Mandatory Disclosures
Student Achievements
Current Openings
NAAC
Student Corner
Downloads
Industry Connect
National Academic Depository
Sustainable Development Goal
Kandoli Campus, Dehradun
P.O. Kandoli Via Premnagar,
Dehradun-248007
Bidholi Campus, Dehradun
P.O. Bidholi Via Premnagar,
Dehradun-248007
Corporate Office
216B I, Second Floor,
Splendor Forum, Plot Bearing No. 3,
Jasola District Centre, Jasola,
New Delhi-110025
Contact Us
Toll Free :
18001028737
Email :
enrollments@upes.ac.in
For International Queries :
international.admissions@upes.ac.in

Admissions
B.Tech.
MBA
B.Des.
M.Tech.
LL.B.
M.Des.
B.Pharm.
MA
BBA
M.Sc.
BCA
LL.M.
B.Sc.
MCA
B.Com.
PhD
BA (Hons.)
Aspiring Students
Admission Alerts
FAQs
Fee Refund Portal
Global Pathways Program
International Admissions
Media
Programs
UPES Online
Important Dates
Other links
Academic Calendar
Campus
Events
NIRF Ranking Report
Careers
Faculty
Scholarships
HILL
Contact Us
Mandatory Disclosures
Student Achievements
Current Openings
NAAC
Student Corner
Downloads
Industry Connect
National Academic Depository
Sustainable Development Goal
Kandoli Campus, Dehradun
P.O. Kandoli Via Premnagar,
Dehradun-248007
Bidholi Campus, Dehradun
P.O. Bidholi Via Premnagar,
Dehradun-248007
Corporate Office
216B I, Second Floor,
Splendor Forum, Plot Bearing No. 3,
Jasola District Centre, Jasola,
New Delhi-110025
Contact Us
Toll Free :
18001028737
Email :
enrollments@upes.ac.in
For International Queries :
international.admissions@upes.ac.in

Admissions
B.Tech.
MBA
B.Des.
M.Tech.
LL.B.
M.Des.
B.Pharm.
MA
BBA
M.Sc.
BCA
LL.M.
B.Sc.
MCA
B.Com.
PhD
BA (Hons.)
Aspiring Students
Admission Alerts
FAQs
Fee Refund Portal
Global Pathways Program
International Admissions
Media
Programs
UPES Online
Important Dates
Other links
Academic Calendar
Campus
Events
NIRF Ranking Report
Careers
Faculty
Scholarships
HILL
Contact Us
Mandatory Disclosures
Student Achievements
Current Openings
NAAC
Student Corner
Downloads
Industry Connect
National Academic Depository
Sustainable Development Goal

Admissions
B.Tech.
MBA
B.Des.
M.Tech.
LL.B.
M.Des.
B.Pharm.
MA
BBA
M.Sc.
BCA
LL.M.
B.Sc.
MCA
B.Com.
PhD
BA (Hons.)

B.Tech.
MBA
B.Des.
M.Tech.
LL.B.
M.Des.
B.Pharm.
MA
BBA
M.Sc.
BCA
LL.M.
B.Sc.
MCA
B.Com.
PhD
BA (Hons.)

B.Tech.

MBA

B.Des.

M.Tech.

LL.B.

M.Des.

B.Pharm.

MA

BBA

M.Sc.

BCA

LL.M.

B.Sc.

MCA

B.Com.

PhD

BA (Hons.)

Aspiring Students
Admission Alerts
FAQs
Fee Refund Portal
Global Pathways Program
International Admissions
Media
Programs
UPES Online
Important Dates

Admission Alerts
FAQs
Fee Refund Portal
Global Pathways Program
International Admissions
Media
Programs
UPES Online
Important Dates

Admission Alerts

FAQs

Fee Refund Portal

Global Pathways Program

International Admissions

Media

Programs

UPES Online

Important Dates

Other links
Academic Calendar
Campus
Events
NIRF Ranking Report
Careers
Faculty
Scholarships
HILL
Contact Us
Mandatory Disclosures
Student Achievements
Current Openings
NAAC
Student Corner
Downloads
Industry Connect
National Academic Depository
Sustainable Development Goal

Academic Calendar
Campus
Events
NIRF Ranking Report
Careers
Faculty
Scholarships
HILL
Contact Us
Mandatory Disclosures
Student Achievements
Current Openings
NAAC
Student Corner
Downloads
Industry Connect
National Academic Depository
Sustainable Development Goal

Academic Calendar

Campus

Events

NIRF Ranking Report

Careers

Faculty

Scholarships

HILL

Contact Us

Mandatory Disclosures

Student Achievements

Current Openings

NAAC

Student Corner

Downloads

Industry Connect

National Academic Depository

Sustainable Development Goal

Kandoli Campus, Dehradun
P.O. Kandoli Via Premnagar,
Dehradun-248007
Bidholi Campus, Dehradun
P.O. Bidholi Via Premnagar,
Dehradun-248007
Corporate Office
216B I, Second Floor,
Splendor Forum, Plot Bearing No. 3,
Jasola District Centre, Jasola,
New Delhi-110025
Contact Us
Toll Free :
18001028737
Email :
enrollments@upes.ac.in
For International Queries :
international.admissions@upes.ac.in

Kandoli Campus, Dehradun
P.O. Kandoli Via Premnagar,
Dehradun-248007

P.O. Kandoli Via Premnagar,
Dehradun-248007

P.O. Kandoli Via Premnagar,
Dehradun-248007

Bidholi Campus, Dehradun
P.O. Bidholi Via Premnagar,
Dehradun-248007

P.O. Bidholi Via Premnagar,
Dehradun-248007

P.O. Bidholi Via Premnagar,
Dehradun-248007

Corporate Office
216B I, Second Floor,
Splendor Forum, Plot Bearing No. 3,
Jasola District Centre, Jasola,
New Delhi-110025

216B I, Second Floor,
Splendor Forum, Plot Bearing No. 3,
Jasola District Centre, Jasola,
New Delhi-110025

216B I, Second Floor,
Splendor Forum, Plot Bearing No. 3,
Jasola District Centre, Jasola,
New Delhi-110025

Contact Us
Toll Free :
18001028737
Email :
enrollments@upes.ac.in
For International Queries :
international.admissions@upes.ac.in

Toll Free :
18001028737
Email :
enrollments@upes.ac.in
For International Queries :
international.admissions@upes.ac.in

Toll Free :
18001028737

Email :
enrollments@upes.ac.in

For International Queries :
international.admissions@upes.ac.in

Follow Us:
Copyright © 2025 UPES. All Rights Reserved.
Privacy Policy
Terms & Condition
Sitemap

Follow Us:
Copyright © 2025 UPES. All Rights Reserved.
Privacy Policy
Terms & Condition
Sitemap

Follow Us:

Follow Us:











Copyright © 2025 UPES. All Rights Reserved.

Copyright © 2025 UPES. All Rights Reserved.

Privacy Policy
Terms & Condition
Sitemap

Privacy Policy

Terms & Condition

Sitemap

Speak to a Counsellor
*
First Name
Please enter first name
*
Last Name
Please enter last name
*
Email Address
Please enter email address
*
Mobile Number
+91
Please enter mobile number
*
Course Type
--None--
Please Select Course Type
*
Select Course
-- None --
Please select Course
Call Me

Speak to a Counsellor
*
First Name
Please enter first name
*
Last Name
Please enter last name
*
Email Address
Please enter email address
*
Mobile Number
+91
Please enter mobile number
*
Course Type
--None--
Please Select Course Type
*
Select Course
-- None --
Please select Course
Call Me

Speak to a Counsellor
*
First Name
Please enter first name
*
Last Name
Please enter last name
*
Email Address
Please enter email address
*
Mobile Number
+91
Please enter mobile number
*
Course Type
--None--
Please Select Course Type
*
Select Course
-- None --
Please select Course
Call Me

Speak to a Counsellor

*
First Name
Please enter first name
*
Last Name
Please enter last name
*
Email Address
Please enter email address
*
Mobile Number
+91
Please enter mobile number
*
Course Type
--None--
Please Select Course Type
*
Select Course
-- None --
Please select Course
Call Me

*
First Name
Please enter first name
*
Last Name
Please enter last name
*
Email Address
Please enter email address
*
Mobile Number
+91
Please enter mobile number
*
Course Type
--None--
Please Select Course Type
*
Select Course
-- None --
Please select Course
Call Me

*
First Name
Please enter first name
*
Last Name
Please enter last name
*
Email Address
Please enter email address
*
Mobile Number
+91
Please enter mobile number
*
Course Type
--None--
Please Select Course Type
*
Select Course
-- None --
Please select Course
Call Me

*
First Name
Please enter first name

*
Last Name
Please enter last name

*
Email Address
Please enter email address

*
Mobile Number
+91
Please enter mobile number

*
Course Type
--None--
Please Select Course Type

*
Select Course
-- None --
Please select Course

Call Me



Helpline
1800-102-8737

Helpline
1800-102-8737

Helpline
1800-102-8737

Helpline

1800-102-8737

1800-102-8737

Chat with us
Chat on whatsapp
Chat with an expert
Chat with student
                        buddy

Chat with us
Chat on whatsapp
Chat with an expert
Chat with student
                        buddy

Chat with us
Chat on whatsapp
Chat with an expert
Chat with student
                        buddy

Chat with us

Chat on whatsapp
Chat with an expert
Chat with student
                        buddy

Chat on whatsapp

Chat with an expert

Chat with student
                        buddy

OTP Verify
Enter OTP
Resend OTP
Verify

OTP Verify
Enter OTP
Resend OTP
Verify

OTP Verify
Enter OTP
Resend OTP
Verify

OTP Verify

Enter OTP
Resend OTP
Verify

Enter OTP
Resend OTP
Verify

Enter OTP
Resend OTP
Verify

Resend OTP

